<SEC-DOCUMENT>0001178913-23-002884.txt : 20241204
<SEC-HEADER>0001178913-23-002884.hdr.sgml : 20241204
<ACCEPTANCE-DATETIME>20230815161035
ACCESSION NUMBER:		0001178913-23-002884
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		30
CONFORMED PERIOD OF REPORT:	20230630
FILED AS OF DATE:		20230815
DATE AS OF CHANGE:		20230815

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MediWound Ltd.
		CENTRAL INDEX KEY:			0001593984
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36349
		FILM NUMBER:		231174945

	BUSINESS ADDRESS:	
		STREET 1:		42 HAYARKON STREET
		CITY:			YAVNE
		STATE:			L3
		ZIP:			8122745
		BUSINESS PHONE:		97289324010

	MAIL ADDRESS:	
		STREET 1:		42 HAYARKON STREET
		CITY:			YAVNE
		STATE:			L3
		ZIP:			8122745
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>zk2330152.htm
<DESCRIPTION>6-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--INTEGIX by Ez-XBRL--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full" xmlns:mdwd="http://mediwound.com/20230630" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0"  ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/><title>MediWound Ltd. - 1593984 - 2023</title></head><body>
        <div style="display:none">
        <ix:header><ix:hidden><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="C_20230101to20230630"  id="Fdei_EntityCentralIndexKey20210716162222544" >0001593984</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalPeriodFocus" contextRef="C_20230101to20230630"  id="Fdei_DocumentFiscalPeriodFocus20210716162636197" >Q2</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalYearFocus" contextRef="C_20230101to20230630"  id="Fdei_DocumentFiscalYearFocus20210716162643159" >2023</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="C_20230101to20230630"  id="Fdei_AmendmentFlag20210716162658228" >false</ix:nonNumeric><ix:nonNumeric name="dei:CurrentFiscalYearEndDate" contextRef="C_20230101to20230630"  id="Fdei_CurrentFiscalYearEndDate20210716171522618" >--12-31</ix:nonNumeric><ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="C_20230101to20230630"  id="Fdei_DocumentPeriodEndDate20210721135646372" >2023-06-30</ix:nonNumeric></ix:hidden>
<ix:references>
        <link:schemaRef xlink:type="simple" xlink:href="mdwd-20230630.xsd"/>
        </ix:references></ix:header></div><div><div style="">
  <div style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000">
    <div>
      <hr style="border:none;border-bottom:1px solid black;border-top:4px solid black;height:10px;color:#ffffff;background-color:#ffffff;text-align:center;margin-left:auto;margin-right:auto;text-align:center" />
      <div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-size:14pt;font-weight:bold;background-color:rgb(255, 255, 255);color:rgb(0, 0, 0);font-style:normal;font-variant:normal;text-transform:none">SECURITIES AND EXCHANGE COMMISSION</div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:center;line-height:1.25;font-weight:bold">Washington, D.C.&#160; 20549<br />______________________</div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-size:14pt;font-weight:bold;background-color:rgb(255, 255, 255);color:rgb(0, 0, 0);font-style:normal;font-variant:normal;text-transform:none">FORM <ix:nonNumeric id="Fxbrl_20230813182125172" name="dei:DocumentType" contextRef="C_20230101to20230630">6-K</ix:nonNumeric></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:center;line-height:1.25;font-weight:bold">REPORT&#160;OF FOREIGN PRIVATE ISSUER</div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:center;line-height:1.25;font-weight:bold">Pursuant to Rule 13a-16 or 15d-16 of the<br />Securities Exchange Act of 1934</div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:center;line-height:1.25;font-weight:bold">For the month of August 2023</div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:center;line-height:1.25;font-weight:bold">Commission File Number: <ix:nonNumeric id="Fxbrl_20230813182132611" name="dei:EntityFileNumber" contextRef="C_20230101to20230630">001-36349</ix:nonNumeric></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:center;line-height:1.25"><span style="text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="font-weight:bold"><span style="text-decoration:underline"><span style="background-color:rgb(255, 255, 255);font-weight:bold;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:16pt;font-style:normal;font-variant:normal;text-transform:none"><ix:nonNumeric id="Fxbrl_20230813182138942" name="dei:EntityRegistrantName" contextRef="C_20230101to20230630">MediWound Ltd.</ix:nonNumeric></span>&#160;</span></span><span style="text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><br />(Translation of registrant&#8217;s name into English)</div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:center;line-height:1.25;font-weight:bold"><ix:nonNumeric id="Fxbrl_20230813182145764" name="dei:EntityAddressAddressLine1" contextRef="C_20230101to20230630">42 Hayarkon Street</ix:nonNumeric></div>
        <div style="text-align:center;line-height:1.25;font-weight:bold"><ix:nonNumeric id="Fxbrl_20230813182151711" name="dei:EntityAddressCityOrTown" contextRef="C_20230101to20230630">Yavne</ix:nonNumeric>, <ix:nonNumeric id="Fxbrl_20230813182157924" name="dei:EntityAddressPostalZipCode" contextRef="C_20230101to20230630">8122745</ix:nonNumeric> <ix:nonNumeric id="Fxbrl_20230813182208620" name="dei:EntityAddressCountry" contextRef="C_20230101to20230630" format="ixt-sec:countrynameen">Israel</ix:nonNumeric></div>
        <div style="text-align:center;line-height:1.25">&#160;(Address of principal executive offices)</div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:36pt;line-height:1.25">Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.</div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:center;line-height:1.25"><span style="font-family:'Times New Roman',Times,serif">Form 20-F &#9746;<span style="width:9pt;font-size:1px;display:inline-block"> </span>Form 40-F &#9744;</span></div>
        <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
          <div style="page-break-after:always">
            <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
          </div>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:center;line-height:1.25;font-weight:bold">EXPLANATORY NOTE</div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;text-indent:36pt;line-height:1.25">On August 15, 2023, MediWound Ltd. (the &#8220;Company&#8221;) issued a press release entitled &#8220;MediWound Reports Second Quarter 2023 Financial Results and Provides Company Updates&#8221;. A copy of this press release is attached to this Form 6-K as Exhibit 99.1.</div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;text-indent:36pt;line-height:1.25">In addition, pursuant to the Information Rights Agreement between the Company and Clal Biotechnology Industries Ltd. ("CBI"), dated March 3, 2014 (which was attached to the Company's registration statement as exhibit 4.3), the Company is required to provide CBI with certain information necessary for CBI to meet its obligations&#160; under Israeli Securities Law. This Form 6-K includes an Un-Audited Condensed Consolidated Interim Financial Statements as of June 30, 2023, attached as Exhibit 99.2, which was provided by the Company to CBI on August 15, 2023 pursuant to such contractual obligation.</div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;text-indent:36pt;line-height:1.25">The contents of this Report of Foreign Private Issuer on Form 6-K (including the information contained in Exhibits 99.1 and 99.2, but excluding quotes of senior management of the Company) are hereby incorporated by reference into the Company&#8217;s Registration Statements on Form S-8, filed with the SEC on April 28, 2014, March 24, 2016, March 19, 2018, March 25, 2019, February 25, 2020, May 15, 2021 and August 9, 2022&#160;(Registration Nos. No. 333-195517, 333-210375, 333-223767, 333-230487, 333-236635, 333-255784, and &#160;333-266697, respectively) and on Form F-3, filed with the SEC on May 25, 2022 and March 31, 2023 (Registration Nos. 333-265203 and 333-268297, respectively).</div>
        <div style="line-height:1.25">&#160;</div>
        <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
          <div style="text-align:center"><span style="font-weight:normal;font-style:normal">2</span></div>
          <div style="page-break-after:always">
            <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
          </div>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:center;line-height:1.25;font-weight:bold">SIGNATURE</div>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-indent:36pt;line-height:1.25">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</div>
        <div style="line-height:1.25">&#160;</div>
        <table border="0" cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:50%;vertical-align:top">&#160;</td>
              <td colspan="2" style="vertical-align:top">
                <div style="line-height:1.25">MEDIWOUND LTD.</div>
                <div style="line-height:1.25">&#160;</div>
              </td>
              <td style="width:20%;vertical-align:top">&#160;</td>
            </tr>
            <tr>
              <td style="width:50%;vertical-align:top">
                <div style="line-height:1.25">Date: August 15, 2023</div>
              </td>
              <td style="width:4%;vertical-align:top">
                <div style="line-height:1.25">By:</div>
              </td>
              <td style="width:26%;vertical-align:top;border-bottom:2px solid black">
                <div style="line-height:1.25">/s/ Hani Luxenburg</div>
              </td>
              <td style="width:20%;vertical-align:top">&#160;</td>
            </tr>
            <tr>
              <td style="width:50%;vertical-align:top">&#160;</td>
              <td style="width:4%;vertical-align:top">
                <div style="line-height:1.25">Name:</div>
              </td>
              <td style="width:26%;vertical-align:top">
                <div style="line-height:1.25">Hani Luxenburg</div>
              </td>
              <td style="width:20%;vertical-align:top">&#160;</td>
            </tr>
            <tr>
              <td style="width:50%;vertical-align:top">&#160;</td>
              <td style="width:4%;vertical-align:top">
                <div style="line-height:1.25">Title:</div>
              </td>
              <td style="width:26%;vertical-align:top">
                <div style="line-height:1.25">Chief Financial Officer</div>
              </td>
              <td style="width:20%;vertical-align:top">&#160;</td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
          <div style="text-align:center"><span style="font-weight:normal;font-style:normal">3</span></div>
          <div style="page-break-after:always">
            <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
          </div>
        </div>
        <div style="text-align:center;line-height:1.25;font-weight:bold">EXHIBIT INDEX</div>
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25">The following exhibit is filed as part of this Form 6-K:</div>
        <div style="line-height:1.25">&#160;</div>
        <table border="0" cellpadding="0" cellspacing="0" style="font-family:'Times New Roman',Times,serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0)">

            <tr>
              <td style="width:9.64%;vertical-align:top">
                <div style="line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="text-decoration:underline">Exhibit</span></div>
              </td>
              <td style="width:90.36%;vertical-align:top">
                <div style="line-height:1.25;font-family:'Times New Roman', Times, serif"><span style="text-decoration:underline">Description</span></div>
              </td>
            </tr>
            <tr>
              <td style="width:9.64%;vertical-align:top">&#160;</td>
              <td style="width:90.36%;vertical-align:top">&#160;</td>
            </tr>
            <tr>
              <td style="width:9.64%;vertical-align:top">
                <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman', Times, serif"><a href="exhibit_99-1.htm">99.1</a></div>
              </td>
              <td style="width:90.36%;vertical-align:top">
                <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman', Times, serif"><a href="exhibit_99-1.htm">Press release dated August 15, 2023 titled &#8220;MediWound Reports Second Quarter 2023 Financial Results and Provides Company Updates&#8221;.</a></div>
              </td>
            </tr>
            <tr>
              <td style="width:9.64%;vertical-align:top">&#160;</td>
              <td style="width:90.36%;vertical-align:top">&#160;</td>
            </tr>
            <tr>
              <td style="width:9.64%;vertical-align:top">
                <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman', Times, serif"><a href="exhibit_99-2.htm">99.2</a></div>
              </td>
              <td style="width:90.36%;vertical-align:top">
                <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman', Times, serif"><a href="exhibit_99-2.htm">Un-Audited Condensed Consolidated Interim Financial Statements as of June 30, 2023.</a></div>
              </td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
      </div>
    </div>
    <div style="text-align:center"><span style="font-weight:normal;font-style:normal">4</span>
      <hr style="border:none;border-bottom:4px solid black;border-top:1px solid black;height:10px;color:#ffffff;background-color:#ffffff;margin-left:auto;margin-right:auto;text-align:center" />
    </div>
  </div>
</div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit_99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 23.7.1.5162
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-family: 'Times New Roman',Times,serif;"> </font>
  <div>
    <div style="font-family: 'Times New Roman',Times,serif;" class="BRPFPageHeader">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25; text-align: right;">
          <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><u><font style="font-weight: bold;">Exhibit 99.1</font></u><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;"><img src="image00001.jpg"></div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold;">MediWound Reports Second Quarter 2023 Financial Results and Provides </div>
      <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold;">Company Update</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-style: italic;">EscharEx<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Phase III study protocol: FDA/EMA-aligned; patient enrollment commencing early 2024; two key
        research collaborations with wound industry leaders</div>
      <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-style: italic;">NexoBrid<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> U.S. commercial launch timing not anticipated to impact revenues in 2023-2024</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-style: italic;">Cash of $51.3 million; operating cash runway through profitability</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-style: italic;">Conference call on Wednesday, August 16 at 8:30 a.m. Eastern Time</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">YAVNE, Israel, August 15, 2023</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> -- MediWound Ltd. (Nasdaq: MDWD), the global leader in next-generation enzymatic therapeutics for tissue repair, today announced financial results for the second quarter ended
          June 30, 2023, and provided a corporate update.</font></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">"We have achieved significant progress this quarter on many levels," stated Ofer Gonen, CEO of MediWound. "Our EscharEx Phase III study protocol is aligned with feedback from
        both FDA and EMA, and patient enrollment is planned for early 2024. Executing multiple collaborations on our EscharEx program with leading wound care companies, underscores the growing interest in this potential game-changing treatment and our
        commitment to maximize the likelihood of a successful study outcome.&#8221; Mr. Gonen added, &#8220;We dispatched initial batches of NexoBrid to both Japan and the U.S., with commercial availability already underway in Japan. Furthermore, our new manufacturing
        facility, set to be active by mid-2024, will increase our production capabilities to meet the rising global demand."</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Second Quarter 2023 Highlights and Recent Developments:</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z633d888b369d4474803ac452019533d9">

        <tr>
          <td style="width: 18pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">&#8226;</td>
          <td style="width: auto; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div>Shipped NexoBrid finished product to Vericel for the U.S. commercial launch in June 2023. However, Vericel is unable to commercially release the product at this time due to a deviation associated with a third-party testing lab used during
              the manufacturing process. MediWound and Vericel are actively engaged with the U.S. Food and Drug Administration (FDA) to address this matter. Future production lots will not be impacted by this process deviation issue. Vericel expects to
              begin commercial sales of NexoBrid from a scheduled September 2023 production run, during the first quarter of 2024. MediWound believes that a possible delay in the U.S. launch, will not have an impact on NexoBrid revenues for the years
              2023-2024.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zaa78fce8a7eb4f2c8439ea96d969b921">

        <tr>
          <td style="width: 18pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Received positive scientific advice from the Committee for Medicinal Products for Human Use (CHMP) within the European Medicine Agency (EMA) for the development of EscharEx. This advice aligns with feedback from the FDA, providing a clear
              path forward for the Company&#8217;s global Phase III study in patients with venous leg ulcers (VLUs).&#160; The Company is in the process of qualifying study sites, selecting vendors (including CRO, data management, and central labs), and producing
              final batches of EscharEx for the clinical study. These activities are to be completed by the fourth quarter of 2023, with patient enrollment in the Phase III study expected to begin in early 2024.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z18c9386ba46048afbcfdf5a886cb4b98">

        <tr>
          <td style="width: 18pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">&#8226;</td>
          <td style="width: auto; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div>Secured research and development collaborations with leading wound care companies, MIMEDX and M&#246;lnlycke, to advance the EscharEx Phase III clinical study. MediWound is actively engaged with additional prominent companies to explore further
              collaboration opportunities.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
    </div>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z56475dc89ac54385ab0a01ea4d8a760d">

        <tr>
          <td style="width: 18pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">&#8226;</td>
          <td style="width: auto; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div>Awarded an additional $10 million in funding from BARDA to support NexoBrid&#8217;s $3 million replenishment, the pediatric indication sBLA submission, and the enrollment of an additional 50 patients in the expanded access treatment protocol
              (NEXT).</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd16fef31534c4c968c48223abfb10db2">

        <tr>
          <td style="width: 18pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Signed a turnkey scale-up agreement to bolster the Company&#8217;s manufacturing infrastructure supporting its long-term growth trajectory. The Company will establish, commission, and validate a cutting-edge, sterile, and GMP-compliant
              manufacturing facility to significantly increase the Company&#8217;s current production capacity. An estimated $12 million will be invested in this new state-of-the-art facility, which is projected to be completed by mid-2024, with full-scale
              manufacturing expected to commence in 2025.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z200f21d668c147f69261d47b6d7204df">

        <tr>
          <td style="width: 18pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
            <div>Announced commercial launch of NexoBrid in Japan for the treatment of deep partial thickness and full thickness burns in adults and pediatric patients with the Company&#8217;s strategic partner, Kaken Pharmaceutical Co. Ltd., a top ranked
              Japanese pharmaceutical company.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z912f520250d44ad8b886718ebf2560d1">

        <tr>
          <td style="width: 18pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">&#8226;</td>
          <td style="width: auto; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div>Reported positive data from its Phase I/II study of MW005 in low-risk basal cell carcinoma (BCC). Results showed MW005 to be safe and well-tolerated, with eleven of the fifteen patients enrolled achieving complete clearance of their BCCs,
              with a majority of the patients also having histologically confirmed complete clearance.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z31fa17b2fc5d413481cc019441ca695f">

          <tr>
            <td style="width: 18pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>Appointed Mr. Shmuel (Milky) Rubinstein as an independent director to the Company&#8217;s Board of Directors. With a distinguished record of pharmaceutical and biotechnology leadership, Mr. Rubinstein previously held the position of CEO at
                Taro Pharmaceuticals (Nasdaq: TARO), which subsequently was acquired by Sun Pharmaceuticals. He currently holds the title of Chairperson of the Board at Trima Pharma and is a board member at Strata Skin Sciences (Nasdaq: SSKN), Medison
                Biotech, and Keystone Dental. Mr. Rubinstein will become a MediWound Board member, following the tenure of Mr. Assaf Segal, who stepped down from the MediWound Board of Directors.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z581614da6a22448eb01615c2b7f49ea7">

          <tr>
            <td style="width: 18pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div>Cash and short-term deposits of $51.3 million as of June 30, 2023.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: -18pt; margin-left: 18pt; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Second Quarter 2023 Financial Highlights</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z69c6c956d3594d93a709cc397b1c6aac">

          <tr>
            <td style="width: 18pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000; font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">Revenues</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">: Revenues for the second quarter 2023 were $4.8 million, compared to $4.7 million in the second quarter of 2022.</font></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zda57d019484c4a75ac730809b712520b">

          <tr>
            <td style="width: 18pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000; font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">Gross Profit</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">: Gross profit in the second quarter 2023 was $1.1 million, representing 24% of total revenue, unchanged from the second quarter 2022.</font></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb411cccff8b14ebda4e06836c0aaaad6">

          <tr>
            <td style="width: 18pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000; font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">Expenditures</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">:</font></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zeddb23a46b714e87b9bb700bf295291b">

          <tr>
            <td style="width: 54pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">o</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div style="color: rgb(0, 0, 0);">Research and development expenses in the second quarter 2023 were $2.0 million compared to $2.2 million in the second quarter of 2022.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z38b3e9b9e3a64c448e2bebdb157ea412">

          <tr>
            <td style="width: 54pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">o</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman',Times,serif;">
              <div style="color: rgb(0, 0, 0);">Selling, general, and administrative expenses in the second quarter 2023 were $3.1 million, compared to $2.3 million in the second quarter of 2022. This increase is primarily attributed to the addition of
                several full-time employees to bolster future growth, along with greater share-based compensation expenses.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6bb32db6913c4b02810829c313f1737f">

          <tr>
            <td style="width: 18pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000; font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">Operating Results</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">: Operating loss in the second quarter of 2023 was $4.0 million, compared to a $3.7 million loss in the second quarter of 2022.</font></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd56d97e3188a4a09952b438a2805c9bd">

          <tr>
            <td style="width: 18pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000; font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">Net Profit/Loss</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">: Net profit in the second quarter of 2023 was $0.9 million or $0.10 per share, compared to the net loss of $4.4 million, or $0.92 per share in the second quarter of 2022. This change is primarily
                  attributed to a favorable adjustment from the revaluation of warrants.</font></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb118c1561c1140ccab2950286ccd8302">

          <tr>
            <td style="width: 18pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="color: #000000; font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">Adjusted EBITDA</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">: Adjusted EBITDA in the second quarter of 2023 was a loss of $3.0 million, compared to a loss of $2.8 million in the second quarter of 2022.</font></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;"> <br>
      </div>
      <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">Year-to-Date 2023 Financial Highlights</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7dc200ba9bed4bc6a9a141f50be3724e">

        <tr>
          <td style="width: 18pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div style="color: #000000; font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">Revenues</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">: Total revenues in the first half of 2023 were $8.6 million, compared to $9.1 million in the first half of 2022. The decline in revenues is primarily a result of the sales to BARDA's emergency
                stockpile procurement in 2022.</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zeb5a5ef4f2b34bf0b182680856fcb944">

        <tr>
          <td style="width: 18pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">Operating Results</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0);">: Operating loss in the first half of 2023 was $8.4 million, up from the $7.0 million loss in the first half of 2022.</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0);">This increase is primarily attributed to the addition of several full-time employees to bolster future growth, along
                with greater share-based compensation expenses.</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd1b5ed8fdb0d4572ae84969e638c2d34">

        <tr>
          <td style="width: 18pt; font-family: 'Times New Roman',Times,serif;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold; color: rgb(0, 0, 0);">Net Loss</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0);">: Net loss in the first half of 2023 was $2.8 million, or $0.32 per share, compared to a net loss of $7.9 million or $1.79 per share in the first half of 2022.</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0);">This decrease is primarily attributed to a favorable adjustment
                from the revaluation of warrants.</font></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z90a127d770e44fea892dcca75cbce27c">

          <tr>
            <td style="width: 18pt; font-family: 'Times New Roman',Times,serif;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: #000000;">&#8226;</td>
            <td style="width: auto; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">Adjusted EBITDA</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">: Adjusted EBITDA in the first half of 2023, as further detailed below, was a loss of $6.4 million, compared to a $5.4 million loss in the first half of 2022.</font></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Balance Sheet Overview</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">As of June 30, 2023, the Company's cash and short-term deposits were $51.3 million, compared to $34.1 million reported on December 31, 2022. In the first quarter of 2023 the
        Company raised a gross amount of $27.5 million through a registered direct offering. During the second quarter of 2023, the Company used $6.0 million to fund its operating activities. Existing cash and cash equivalents are expected to provide
        sufficient funds for the Company&#8217;s current operating plan through profitability.</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Conference Call</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">MediWound management will host a conference call for investors on Wednesday, August 16, 2023, beginning at 8:30 a.m., Eastern Time to discuss these
        results and answer questions. Shareholders and other interested parties may participate in the conference call by dialing 1-833-630-1956 (in the U.S.), 1-80-921-2373 (Israel), or 1-412-317-1837 (outside the U.S. &amp; Israel). The call will be
        available via webcast by <font style="color: rgb(0, 0, 0);"><u>clicking HERE</u><u>&#160;</u></font>or on the <font style="color: rgb(0, 0, 0);"><u>Events &amp; Presentations</u></font> page of Company&#8217;s website.</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">A replay of the call will be available on the Company&#8217;s website at <font style="color: rgb(0, 0, 0);"><u>www.mediwound.com</u></font>.</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Non-IFRS Financial Measures</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="text-align: justify; line-height: 1.25;">To supplement consolidated financial statements prepared and presented in accordance with IFRS, the Company has provided a supplementary non-IFRS measure to consider in evaluating the Company's
        performance. Management uses Adjusted EBITDA, which it defines as earnings before interest, taxes, depreciation and amortization, impairment, one-time expenses, restructuring and share-based compensation expenses.</div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Although Adjusted EBITDA is not a measure of performance or liquidity calculated in accordance with IFRS, we believe the non-IFRS financial measures we
        present provide meaningful supplemental information regarding our operating results primarily because they exclude certain non-cash charges or items that we do not&#160;believe are reflective of our ongoing operating results when budgeting, planning and
        forecasting and determining&#160;compensation, and when assessing the performance of our business with our senior management.</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">However, investors should not consider these measures in isolation or as substitutes for operating income, cash flows from operating activities or any
        other measure for determining the Company's operating performance or liquidity that is calculated in accordance with IFRS. In addition, because Adjusted EBITDA is not calculated in accordance with IFRS, it may not necessarily be comparable to
        similarly titled measures employed by other companies. The non-IFRS measures included in this press release have been reconciled to the IFRS results in the tables below.</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">About&#160;MediWound</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="text-align: justify; line-height: 1.25;">MediWound Ltd. (Nasdaq: MDWD) is the global leader in next-generation enzymatic therapeutics focused on non-surgical tissue repair. Specializing in the development, production and commercialization
        of solutions that seek to replace existing standards of care. The Company is committed to providing rapid and effective biologics that improve patient experiences and outcomes, while reducing costs and unnecessary surgeries.</div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">MediWound&#8217;s first drug, NexoBrid<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical
        interventions and minimize associated costs and complications. Utilizing the same core biotherapeutic enzymatic platform technology, MediWound has developed a strong R&amp;D pipeline including the Company&#8217;s lead drug under development, EscharEx<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>.
        EscharEx is a Phase III biologic for debridement of chronic wounds with significant advantages over the $300 million monopoly legacy drug and an opportunity to expand the market. MediWound&#8217;s pipeline also includes MW005, a topical therapeutic for
        the treatment of basal cell carcinoma that has demonstrated positive results in a recently completed Phase I/II study.</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0);">For more information, please visit&#160;</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><u>www.mediwound.com</u> and follow the Company on <u>LinkedIn</u><u>.</u></font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Cautionary Note Regarding Forward-Looking Statements</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-style: italic;">MediWound&#160;cautions you that all statements
          other than statements of historical fact included in this press release that address activities, events, or developments that we expect,&#160;believe,&#160;or anticipate will or may occur in the future are forward-looking statements.&#160;Although we believe
          that we have a reasonable basis for the forward-looking statements contained herein, they are based on current&#160;expectations about future events affecting us and are subject to risks, assumptions,&#160;uncertainties,&#160;and factors, all of which are
          difficult to predict and many of which are beyond our control.&#160; Actual results may differ materially from those expressed or implied by the forward-looking statements in this press release.&#160; These statements are often, but are not always, made
          through the use of words or phrases such as &#8220;anticipates,&#8221; &#8220;intends,&#8221; &#8220;estimates,&#8221; &#8220;plans,&#8221; &#8220;expects,&#8221; &#8220;continues,&#8221; &#8220;believe,&#8221; &#8220;guidance,&#8221; &#8220;outlook,&#8221; &#8220;target,&#8221; &#8220;future,&#8221; &#8220;potential,&#8221; &#8220;goals&#8221; and similar words or phrases, or future or conditional
          verbs such as &#8220;will,&#8221; &#8220;would,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;may,&#8221; or similar expressions</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">.</font></div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> <br>
        </font></div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic;">Specifically, this press release contains forward-looking statements concerning&#160;the anticipated progress, development, study design,
        expected data timing, objectives anticipated timelines, expectations and commercial potential of our products and product candidates, including&#160;EscharEx<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>&#160;and&#160;NexoBrid<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>. Among the factors that may cause results to be materially
        different from those stated herein are the inherent uncertainties associated with the uncertain, lengthy and expensive nature of the product development process; the timing and conduct of our studies of our products and product candidates,
        including the timing, progress and results of current and future clinical studies, and our research and development programs; the approval of regulatory submission by the FDA, the European Medicines Agency or by any other regulatory authority, our
        ability to obtain marketing approval of our products and product candidates in the U.S. or other markets; the clinical utility, potential advantages and timing or likelihood of regulatory filings and approvals of our products and products; our
        expectations regarding future growth, including our ability to develop new products; risks related to our contracts with BARDA; market acceptance of our products and product candidates; our ability to maintain adequate protection of our
        intellectual property; competition risks; the need for additional financing; the impact of government laws and regulations and the impact of the current global macroeconomic climate on our ability to source supplies for our operations or our
        ability or capacity to manufacture, sell and support the use of our products and product candidates in the future.</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-style: italic;">These and other significant factors are discussed in greater detail in MediWound&#8217;s annual report on Form 20-F for the year
        ended&#160;December 31, 2022, filed with the&#160;Securities and Exchange Commission&#160;(&#8220;SEC&#8221;) on&#160;March 16, 2023 and Quarterly Reports on Form 6-K and other filings with the&#160;SEC&#160;from time-to-time. These forward-looking statements reflect MediWound&#8217;s current
        views as of the date hereof and&#160;MediWound&#160;undertakes, and specifically disclaims, any obligation to update any of these forward-looking statements to reflect a change in their respective views or events or circumstances that occur after the date of
        this release except as required by law.</div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z6b038950d9a241f9852e8ec67c33f20e">

        <tr>
          <td style="width: 25.33%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">Contacts</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">:</font></div>
          </td>
          <td style="width: 2.99%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">&#160;</td>
          <td style="width: 20.9%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">&#160;</td>
          <td style="width: 4.48%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">&#160;</td>
          <td style="width: 46.3%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 25.33%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">Hani Luxenburg</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><br>
                Chief Financial Officer<br>
                MediWound Ltd.</font></div>
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><u>ir@mediwound.com</u></div>
          </td>
          <td style="width: 2.99%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">&#160;</td>
          <td style="width: 20.9%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">&#160;</td>
          <td style="width: 4.48%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">&#160;</td>
          <td style="width: 46.3%; vertical-align: top;">
            <div style="line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-size: 11pt;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">Monique Kosse</font><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><br>
                Managing Director, LifeSci Advisors<br>
                212-915-3820</font></div>
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><u>monique@lifesciadvisors.com</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">MediWound, Ltd.</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; color: #000000; font-family: Arial, sans-serif; font-size: 11pt; font-weight: bold;"><font style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">CONDENSED CONSOLIDATED STATEMENT OF
          FINANCIAL POSITIONS&#160;(UNAUDITED)</font></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">U.S. dollars in thousands</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" class="cfttable" id="zb97c72abdec44068b1be73ad341c3a60" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; padding-bottom: 2px;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="6" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;"> June 30,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Dec 31,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; padding-bottom: 2px;">
            <div style="text-indent: 33pt; line-height: 1.25;">&#160;</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2023</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2022</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2022</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; padding-bottom: 2px;">
            <div style="text-indent: 33pt; line-height: 1.25;">&#160;</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="6" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Unaudited</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Audited</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 64%; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25;">Cash and cash equivalents and short-term bank deposits</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">51,122</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">10,406</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">33,895</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 64%;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">Trade and other receivable</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">3,818</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">4,412</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">9,982</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 64%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">Inventories</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">3,113</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">1,991</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">1,963</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 64%; padding-bottom: 4px;">
            <div style="line-height: 1.25; font-weight: bold;">Total current assets</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-weight: bold;">58,053</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-weight: bold;">16,809</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-weight: bold;">45,840</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 64%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; width: 64%;">
            <div style="text-align: justify; line-height: 1.25;">Other receivables</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">277</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">230</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">364</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 64%; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25;">Property, plant and equipment, net</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">4,705</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">2,439</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">2,366</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 64%;">
            <div style="text-align: justify; line-height: 1.25;">Right of use assets</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">1,133</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">1,364</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">1,215</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 64%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
            <div style="text-align: justify; line-height: 1.25;">Intangible assets, net</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">198</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">264</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">231</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 64%; padding-bottom: 4px;">
            <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Total non-current assets</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-weight: bold;">6,313</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-weight: bold;">4,297</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-weight: bold;">4,176</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 64%; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25;">&#160;</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 64%; padding-bottom: 4px;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">Total assets</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-weight: bold;">64,366</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-weight: bold;">21,106</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-weight: bold;">50,016</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 64%; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">&#160;</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 64%;">
            <div style="text-align: justify; line-height: 1.25;">Current maturities of long-term liabilities</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">1,961</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">2,479</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">2,242</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 64%; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25;">Trade payables and accrued expenses</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">3,531</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">4,877</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">5,656</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 64%; padding-bottom: 2px;">
            <div style="text-align: justify; line-height: 1.25;">Other payables</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">2,817</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">3,060</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">4,159</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 64%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0); font-weight: bold;">Total current liabilities</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">8,309</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">10,416</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">12,057</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 64%;">
            <div style="text-align: justify; line-height: 1.25;">&#160;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 64%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">Deferred revenues</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">61</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 64%;">
            <div style="line-height: 1.25;">Warrants</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">9,683</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">15,606</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 64%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; color: rgb(0, 0, 0);">Liabilities in respect of IIA grants</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">7,806</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">8,131</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">7,445</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 64%;">
            <div style="text-align: justify; line-height: 1.25; color: rgb(0, 0, 0);">Liability in respect of TEVA</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">2,529</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">3,361</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">2,788</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 64%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">Lease liabilities</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">677</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">1,053</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">846</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 64%; padding-bottom: 2px;">
            <div style="text-align: justify; line-height: 1.25;">Severance pay liability, net</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">433</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">319</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">360</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 64%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Total non-current liabilities</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">21,128</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">12,925</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">27,045</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 64%;">
            <div style="text-align: justify; line-height: 1.25;">&#160;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 64%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Total equity (deficit)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">34,929</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">(2,235</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">10,914</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" rowspan="1" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 64%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" rowspan="1" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" rowspan="1" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" rowspan="1" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" rowspan="1" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" rowspan="1" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" rowspan="1" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" rowspan="1" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" rowspan="1" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" rowspan="1" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" rowspan="1" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" rowspan="1" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" rowspan="1" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 64%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">Total liabilities and equity</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">64,366</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">21,106</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">50,016</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">MediWound, Ltd.</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">CONDENSED CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHET COMPREHENSIVE </div>
      <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">INCOME OR LOSS (UNAUDITED)</div>
      <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif;">U.S. dollars in thousands</div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" class="cfttable" id="z36dd86d816944c99a5ad6e5dd4ce244d" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif;">
            <div style="text-indent: 33pt; line-height: 1.25;">&#160;</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom;">&#160;</td>
          <td valign="bottom" colspan="6" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Six months ended</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom;">&#160;</td>
          <td valign="bottom" colspan="6" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Three months ended</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; padding-bottom: 2px;">
            <div style="text-indent: 33pt; line-height: 1.25;">&#160;</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="6" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;"> June 30,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="6" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">June 30,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; padding-bottom: 2px;">
            <div style="text-indent: 33pt; line-height: 1.25;">&#160;</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2023</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2022</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2023</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2022</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25;">Total revenues</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">8,572</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">9,075</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">4,773</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">4,668</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%; padding-bottom: 2px;">
            <div style="text-align: justify; line-height: 1.25;">Total cost of revenues</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">6,609</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">6,502</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">3,636</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">3,555</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Gross profit</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">1,963</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">2,573</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">1,137</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">1,113</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%;">
            <div style="text-align: justify; line-height: 1.25;">&#160;</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25;">Research and development</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">4,126</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">4,599</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">2,024</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">2,191</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%;">
            <div style="line-height: 1.25;">Selling, general &amp; administrative</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">6,208</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">4,623</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">3,120</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">2,287</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25;">Other expenses</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">309</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">309</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%;">
            <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Total operating expenses</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25; font-weight: bold;">10,334</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25; font-weight: bold;">9,531</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25; font-weight: bold;">5,144</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25; font-weight: bold;">4,787</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%;">
            <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Operating loss</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25; font-weight: bold;">(8,371</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25; font-weight: bold;">(6,958</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25; font-weight: bold;">(4,007</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25; font-weight: bold;">(3,674</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25;">&#160;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">Financial income (expenses), net</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">5,611</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">(977</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">4,935</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">(676</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">Profit (loss) before taxes on income</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">(2,760</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">(7,935</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">928</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">(4,350</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25;">Taxes on income</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">(17</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">(8</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">(12</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">(4</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%; padding-bottom: 4px;">
            <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Net profit (loss)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-weight: bold;">(2,777</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-weight: bold;">(7,943</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-weight: bold;">916</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-weight: bold;">(4,354</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25;">&#160;</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">Foreign currency translation adjustments</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">(9</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">22</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">17</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Total comprehensive profit (loss)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">(2,786</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">(7,921</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">916</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">(4,337</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%;">
            <div style="text-align: justify; line-height: 1.25;">&#160;</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;"><u>Basic and diluted net profit (loss) per share:</u></div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-weight: bold;">(0.32</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">(1.79</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-weight: bold;">0.10</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">(0.92</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25; font-weight: bold;">&#160;</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; width: 52%; padding-bottom: 4px;">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Weighted average number of ordinary shares used in calculation basic and diluted net profit (loss) per share</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-weight: bold;">8,803</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-weight: bold;">4,440</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-weight: bold;">9,209</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-weight: bold;">4,734</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">MediWound, Ltd.</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">ADJUSTED EBITDA</div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">U.S. dollars in thousands</div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" class="cfttable" id="za027845f3ab249e0b6d223e9a49b4640" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

        <tr>
          <td valign="bottom" rowspan="1" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif;"></td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom;">&#160;</td>
          <td valign="bottom" colspan="6" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Six months ended</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom;">&#160;</td>
          <td valign="bottom" colspan="6" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Three months ended</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" rowspan="1" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; padding-bottom: 2px;">
            <div style="text-indent: 33pt; line-height: 1.25;">&#160;</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="6" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;"> June 30,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="6" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">June 30,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; padding-bottom: 2px;">
            <div style="text-indent: 33pt; line-height: 1.25;">&#160;</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2023</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2022</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2023</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2022</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif;">
            <div style="text-indent: 33pt; line-height: 1.25;">&#160;</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom;">&#160;</td>
          <td valign="bottom" colspan="6" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom;">&#160;</td>
          <td valign="bottom" colspan="6" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Net profit (loss) for the period</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">(2,777</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">(7,943</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">916</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">(4,354</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%;">
            <div style="text-align: justify; line-height: 1.25;">Adjustments:</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25;">Financial income (expenses), net</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">5,611</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">(977</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">4,935</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">(676</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%;">
            <div style="text-align: justify; line-height: 1.25;">Other expenses</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(309</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(309</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25;">Tax expenses</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">(17</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">(8</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">(12</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">(4</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" nowrap="nowrap" colspan="1" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%;">
            <div style="line-height: 1.25;">Depreciation and amortization</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(618</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(650</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(315</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(329</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" colspan="1" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25;">Share-based compensation expenses</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">(1,331</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">(597</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">(712</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">(252</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%; padding-bottom: 2px;">
            <div style="text-align: justify; line-height: 1.25;">Total adjustments</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">3,645</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">(2,541</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">3,896</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">(1,570</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Adjusted EBITDA</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">(6,422</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">(5,402</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">(2,980</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">(2,784</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">MediWound, Ltd.</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-weight: bold;">CONDENSED CONSOLIDATED STATEMENT OF CASH FLOW (UNAUDITED)</div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">U.S. dollars in thousands</div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" class="cfttable" id="z0005e34f6b2444768b1a6553e02ee85e" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom;">&#160;</td>
          <td valign="bottom" colspan="6" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Six months ended</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom;">&#160;</td>
          <td valign="bottom" colspan="6" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Three months ended</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="6" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;"> June 30,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="6" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">June 30,</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;"> 2023</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2022</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2023</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; border-bottom: #000000 solid 2px;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">2022</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;"><u>Cash Flows from Operating Activities:</u></div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; width: 52%;">
            <div style="line-height: 1.25;">Net income (loss)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25; font-weight: bold;">(2,777</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25; font-weight: bold;">(7,943</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25; font-weight: bold;">916</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25; font-weight: bold;">(4,354</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">Adjustments to reconcile net profit (loss) to net cash used in operating activities:</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; width: 52%;">
            <div style="line-height: 1.25;">Adjustments to profit and loss items:</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">Depreciation and amortization</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">618</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">650</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">315</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">329</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; width: 52%;">
            <div style="line-height: 1.25;">Share-based compensation</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">1,331</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">597</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">712</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">252</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">Revaluation of warrants accounted at fair value</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">(5,923</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">(4,990</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; width: 52%;">
            <div style="line-height: 1.25;">Revaluation of liabilities in respect of IIA grants</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">492</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">482</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">233</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">248</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">Revaluation of liabilities in respect of TEVA</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">241</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">272</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">119</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">135</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; width: 52%;">
            <div style="line-height: 1.25;">Revaluation of lease liabilities</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(22</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(152</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(9</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(138</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">Increase (decrease) in severance liability, net</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">67</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">55</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">(10</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">35</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; width: 52%;">
            <div style="line-height: 1.25;">Net financing income</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(1,005</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(11</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(759</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(11</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">Un-realized foreign currency loss</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">466</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">528</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">120</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">283</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; width: 52%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25; font-weight: bold;">(3,735</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25; font-weight: bold;">2,421</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25; font-weight: bold;">(4,269</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25; font-weight: bold;">1,133</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">Changes in asset and liability items:</div>
          </td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; width: 52%;">
            <div style="line-height: 1.25;">Decrease (increase) in trade receivables</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">6,115</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(2,024</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(707</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(1,445</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">Increase in inventories</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">(1,162</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">(747</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">(579</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">(37</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; width: 52%;">
            <div style="line-height: 1.25;">Decrease in other receivables</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">122</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">330</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">435</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">205</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">Increase (decrease) in trade payables and accrued expenses</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">(1,636</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="line-height: 1.25;"></font></div>
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">11</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="line-height: 1.25;"></font></div>
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">312</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(272</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; width: 52%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">Increase (decrease) in other payables and deferred revenues</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">(1,526</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">(1,367</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">(1,359</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">(484</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">1,913</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">(3,797</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">(1,898</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">(2,033</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; width: 52%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; width: 52%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">Net cash (used in) operating activities</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">(4,599</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">(9,319</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">(5,251</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">(5,254</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br>
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" class="cfttable" id="z476d102ad85447e8920e1617a7749af6" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

        <tr>
          <td valign="bottom" style="vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Cash Flows from Investment Activities:</u></div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman',Times,serif; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; width: 52%;">
            <div style="line-height: 1.25;">Purchase of property and equipment</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(2,570</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(298</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(1,065</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(138</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">Interest received</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">879</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">577</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">Investment in short term bank deposits, net</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">(31,830</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">(2,499</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">(25,590</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">(2,499</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; width: 52%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">Net cash used in investing activities</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">(33,521</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">(2,797</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">(26,078</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">(2,637</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; width: 52%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;"><u>Cash Flows from Financing Activities:</u></div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%;">
            <div style="line-height: 1.25;">Repayment of lease liabilities</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(334</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(350</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(157</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(172</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">Proceeds from (repayment of) issuance of shares and warrants, net</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">24,909</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">9,861</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">(248</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">(556</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%;">
            <div style="line-height: 1.25;">Repayments to IIA, net</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(310</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(162</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
            <div style="line-height: 1.25;">Repayment of liabilities in respect of TEVA</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">(417</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; width: 52%; padding-bottom: 4px;">
            <div style="line-height: 1.25; font-weight: bold;">Net cash provided by (used in) financing activities</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-weight: bold;">23,848</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-weight: bold;">9,349</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-weight: bold;">(405</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-weight: bold;">(728</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px;">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; width: 52%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: middle; font-family: 'Times New Roman',Times,serif; width: 52%;">
            <div style="line-height: 1.25; font-weight: bold;">Exchange rate differences on cash and cash equivalent balances</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25; font-weight: bold;">(457</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(550</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25; font-weight: bold;">(120</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%;">
            <div style="line-height: 1.25;">(303</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%;">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; width: 52%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">Increase (decrease) in cash and cash equivalents from continuing activities</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">(14,729</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">(3,317</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">(31,854</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">)</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">(8,922</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">)</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; width: 52%; padding-bottom: 2px;">
            <div style="line-height: 1.25;">Balance of cash and cash equivalents at the beginning of the period</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-weight: bold;">33,895</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">11,046</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-weight: bold;">51,020</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">16,651</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; font-family: 'Times New Roman',Times,serif; width: 52%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">Balance of cash and cash equivalents at the end of the period</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">19,166</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">7,729</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">19,166</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
          <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25; font-weight: bold;">7,729</div>
          </td>
          <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="font-family: 'Times New Roman',Times,serif; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
  </div>
  <font style="font-family: 'Times New Roman',Times,serif;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>3
<FILENAME>exhibit_99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--INTEGIX by Ez-XBRL--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full" xmlns:mdwd="http://mediwound.com/20230630" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0"  ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/><title>MediWound Ltd. - 1593984 - 2023</title></head><body>
        <div style="display:none">
        <ix:header><ix:hidden><ix:footnote id="FN20230811133219545" xml:lang="en-US">Restated to reflect 1:7 reverse ratio of shares</ix:footnote>
<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"  id="Fxbrl_20220804205853790" unitRef="USD"  xsi:nil="true"></ix:nonFraction><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20220101to20220630"  id="Fxbrl_20220804205858797" unitRef="USD"  xsi:nil="true"></ix:nonFraction><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"  id="Fxbrl_20230807111545632" unitRef="USD"  xsi:nil="true"></ix:nonFraction><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20220401to20220630"  id="Fxbrl_20230807111557608" unitRef="USD"  xsi:nil="true"></ix:nonFraction><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20220101to20221231"  id="Fxbrl_20230807164406322_xbrl_20220804205858797" unitRef="USD"  xsi:nil="true"></ix:nonFraction><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"  id="Fxbrl_20230807164406322_xbrl_20220804200911308_xbrl_20220726011223576" unitRef="USD"  xsi:nil="true"></ix:nonFraction><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"  id="Fxbrl_20230811011212291" unitRef="USD"  xsi:nil="true"></ix:nonFraction><ix:footnote id="FN20230811141517863" xml:lang="en-US">Represents less than $ 1.</ix:footnote>
<ix:nonFraction name="ifrs-full:ProceedsFromExerciseOfOptions" contextRef="C_20220101to20221231"  id="Fxbrl_20230807114925679_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_419" unitRef="USD"  xsi:nil="true"></ix:nonFraction><ix:nonFraction name="ifrs-full:ProceedsFromExerciseOfOptions" contextRef="C_20220401to20220630"  id="Fxbrl_20230807114925679_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_415" unitRef="USD"  xsi:nil="true"></ix:nonFraction><ix:nonFraction name="ifrs-full:ProceedsFromExerciseOfOptions" contextRef="C_20230401to20230630"  id="Fxbrl_20230807114925679_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_411" unitRef="USD"  xsi:nil="true"></ix:nonFraction><ix:nonFraction name="ifrs-full:ProceedsFromExerciseOfOptions" contextRef="C_20220101to20220630"  id="Fxbrl_20230807114925679_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_47" unitRef="USD"  xsi:nil="true"></ix:nonFraction><ix:nonFraction name="ifrs-full:ProceedsFromExerciseOfOptions" contextRef="C_20230101to20230630"  id="Fxbrl_20230807114925679_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_43" unitRef="USD"  xsi:nil="true"></ix:nonFraction></ix:hidden>
<ix:references>
        <link:schemaRef xlink:type="simple" xlink:href="mdwd-20230630.xsd"/>
        </ix:references><ix:resources><xbrli:context id="C_20230630"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220630"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230331"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230331_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230331_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230331_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230331_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230401to20230630"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220331"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220331_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220331_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220331_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220401to20220630"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20230630"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20220630"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220331_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230717_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentsEventMember_ifrsfullTypesOfInvestmentPropertyAxis_mdwdBiopharmaxGroupLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">mdwd:SubsequentsEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInvestmentPropertyAxis">mdwd:BiopharmaxGroupLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-07-17</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230716to20230717_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentsEventMember_ifrsfullTypesOfInvestmentPropertyAxis_mdwdBiopharmaxGroupLtdMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">mdwd:SubsequentsEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfInvestmentPropertyAxis">mdwd:BiopharmaxGroupLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-07-16</xbrli:startDate>
        <xbrli:endDate>2023-07-17</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230207_mdwdSaleOfStocksAxis_mdwdPublicOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="mdwd:SaleOfStocksAxis">mdwd:PublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-02-07</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230201to20230207_mdwdSaleOfStocksAxis_mdwdPublicOfferingMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="mdwd:SaleOfStocksAxis">mdwd:PublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-02-01</xbrli:startDate>
        <xbrli:endDate>2023-02-07</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndOfficersMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesAndOfficersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-02-01</xbrli:startDate>
        <xbrli:endDate>2023-02-15</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndOfficersMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesAndOfficersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-02-15</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndOfficersMember_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesAndOfficersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:RestrictedSharesUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-02-01</xbrli:startDate>
        <xbrli:endDate>2023-02-15</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230401to20230403_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdBoardMembersAndOfficersMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:BoardMembersAndOfficersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-04-03</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230403_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdBoardMembersAndOfficersMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:BoardMembersAndOfficersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-04-03</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230403_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdBoardMembersAndOfficersMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:BoardMembersAndOfficersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-04-03</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230531"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-05-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230531_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdEquityIncentivePlanMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2023-05-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230501to20230531"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-05-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20221231_deiLegalEntityAxis_mdwdUSDepartmentOfDefenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdwd:USDepartmentOfDefenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230401to20230430_deiLegalEntityAxis_mdwdUSDepartmentOfDefenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdwd:USDepartmentOfDefenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230101to20230630_ifrsfullBorrowingsByNameAxis_mdwdBardaMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mdwd:BardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230501to20230509_deiLegalEntityAxis_mdwdUSFoodAndDrugAdministrationMember_ifrsfullBorrowingsByNameAxis_mdwdBardaMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdwd:USFoodAndDrugAdministrationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mdwd:BardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-05-09</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20230501to20230509_ifrsfullBorrowingsByNameAxis_mdwdBardaMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001593984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mdwd:BardaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-05-09</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:unit id="NIS"><xbrli:measure>iso4217:ILS</xbrli:measure></xbrli:unit>
<xbrli:unit id="NIS_Per_Share"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:ILS</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit>
<xbrli:unit id="Patient"><xbrli:measure>mdwd:Patient</xbrli:measure></xbrli:unit>
<xbrli:unit id="Pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit>
<xbrli:unit id="SQFT"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit>
<xbrli:unit id="Share"><xbrli:measure>mdwd:Share</xbrli:measure></xbrli:unit>
<xbrli:unit id="Shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit>
<xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit>
<xbrli:unit id="USD_Per_Share"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit>
<ix:relationship fromRefs="Fxbrl_20230811005753137" toRefs="FN20230811133219545"/><ix:relationship fromRefs="Fxbrl_20230811005838682" toRefs="FN20230811133219545"/><ix:relationship fromRefs="Fxbrl_20230811005902765" toRefs="FN20230811133219545"/><ix:relationship fromRefs="Fxbrl_20230811104343178" toRefs="FN20230811133219545"/><ix:relationship fromRefs="Fxbrl_20220804205853790" toRefs="FN20230811141517863"/><ix:relationship fromRefs="Fxbrl_20220804205858797" toRefs="FN20230811141517863"/><ix:relationship fromRefs="Fxbrl_20230807111545632" toRefs="FN20230811141517863"/><ix:relationship fromRefs="Fxbrl_20230807111557608" toRefs="FN20230811141517863"/><ix:relationship fromRefs="Fxbrl_20230807164406322_xbrl_20220804205858797" toRefs="FN20230811141517863"/><ix:relationship fromRefs="Fxbrl_20230807164406322_xbrl_20220804200911308_xbrl_20220726011223576" toRefs="FN20230811141517863"/><ix:relationship fromRefs="Fxbrl_20230811011212291" toRefs="FN20230811141517863"/></ix:resources></ix:header></div><div><div style=""> <div><hr style="border:none;border-bottom:1px solid black;border-top:4px solid black;height:10px;color:#ffffff;background-color:#ffffff;text-align:center;margin-left:auto;margin-right:auto;text-align:center" /><div><div><div style="text-align:right;text-indent:72pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="text-decoration:underline">Exhibit 99.2</span></span></span></span></span></div><div style="line-height:1.25">&#160;</div></div><div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>MEDIWOUND LTD. AND ITS SUBSIDIARIES</span></span></span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS</span></span></span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>AS OF JUNE 30, 2023</span></span></span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>IN U.S. DOLLARS IN THOUSANDS</span></span></span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>UNAUDITED</span></span></span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>INDEX</span></span></span></span></div><div style="line-height:1.25">&#160;</div><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:86.36%;vertical-align:bottom;padding-bottom:2px">&#160;</td><td style="width:13.64%;vertical-align:bottom;text-align:center;border-bottom:2px solid rgb(0, 0, 0);font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Page</span></span></span></span></td></tr><tr><td style="width:86.36%;vertical-align:top">&#160;</td><td style="width:13.64%;vertical-align:top">&#160;</td></tr><tr><td style="width:86.36%;vertical-align:bottom"><div style="margin-left:2.85pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><a href="#Position_integixAnchor">Unaudited Condensed Interim Consolidated Statements of Financial Position</a></span></span></span></span></div></td><td style="width:13.64%;vertical-align:top"><div style="text-align:center;margin-left:2.85pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>F-2</span></span></span></span></div></td></tr><tr><td style="width:86.36%;vertical-align:top">&#160;</td><td style="width:13.64%;vertical-align:top">&#160;</td></tr><tr><td style="width:86.36%;vertical-align:top"><div style="margin-left:2.85pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><a href="#Loss_integixAnchor">Unaudited Condensed Interim Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss</a></span></span></span></span></div></td><td style="width:13.64%;vertical-align:top"><div style="text-align:center;margin-left:2.85pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>F-3</span></span></span></span></div></td></tr><tr><td style="width:86.36%;vertical-align:top">&#160;</td><td style="width:13.64%;vertical-align:top">&#160;</td></tr><tr><td style="width:86.36%;vertical-align:bottom"><div style="margin-left:2.85pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><a href="#Equity_integixAnchor">Unaudited Condensed Interim Consolidated Statements of Changes in Shareholders&#8217; Equity (Deficit)</a></span></span></span></span></div></td><td style="width:13.64%;vertical-align:top"><div style="text-align:center;margin-left:2.85pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>F-4 &#8211; F-5</span></span></span></span></div></td></tr><tr><td style="width:86.36%;vertical-align:top">&#160;</td><td style="width:13.64%;vertical-align:top">&#160;</td></tr><tr><td style="width:86.36%;vertical-align:bottom"><div style="margin-left:2.85pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><a href="#Flows_integixAnchor">Unaudited Condensed Interim Consolidated Statements of Cash Flows</a></span></span></span></span></div></td><td style="width:13.64%;vertical-align:top"><div style="text-align:center;margin-left:2.85pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>F-6 &#8211; F-7</span></span></span></span></div></td></tr><tr><td style="width:86.36%;vertical-align:top">&#160;</td><td style="width:13.64%;vertical-align:top">&#160;</td></tr><tr><td style="width:86.36%;vertical-align:bottom"><div style="margin-left:2.85pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><a href="#Notes_integixAnchor">Notes to Unaudited Condensed Interim Consolidated Financial Statements</a></span></span></span></span></div></td><td style="width:13.64%;vertical-align:bottom"><div style="text-align:center;margin-left:2.85pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>F-8 &#8211; F-11</span></span></span></span></div></td></tr></table><div style="line-height:1.25">&#160;</div><div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>- - - - - - - - - - - - -</span></span></span></span></div><div style="line-height:1.25">&#160;</div><div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div></div></div><div style="">
  <div style="margin-top:10pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">
    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><strong><span><span>MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></strong></span></span></span></span></span></span></p>
  </div>
  <div style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</div>
  <div>
    <div>
      <div style="line-height:1.25">
        <div style="line-height:1.25;font-weight:bold;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Unaudited Condensed Interim Consolidated Statements of Financial Position<span id="Position_integixAnchor" style="margin-top:0pt;margin-bottom:0pt"></span></span></span></div>
        <div style="line-height:1.25;font-weight:bold">
          <hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;margin-top:5pt;margin-bottom:5pt;text-align:center" />
        </div>
      </div>
      <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">U.S. dollars in thousands</span></span></div>
      <div style="text-align:justify;line-height:1.25;font-weight:bold">&#160;</div>
      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

          <tr>
            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 30,</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash and cash equivalents</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_43" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,166</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_47" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,729</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_411" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,895</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%" valign="bottom">
              <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Restricted deposits</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_53" name="ifrs-full:RestrictedCashAndCashEquivalents" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_57" name="ifrs-full:RestrictedCashAndCashEquivalents" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">168</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_511" name="ifrs-full:RestrictedCashAndCashEquivalents" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Short-term bank deposits</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210726110844571" name="ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31,956</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210726110919054" name="ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,509</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_611" name="ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%" valign="bottom">
              <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade receivables</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_73" name="ifrs-full:CurrentTradeReceivables" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,228</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_77" name="ifrs-full:CurrentTradeReceivables" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,759</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_711" name="ifrs-full:CurrentTradeReceivables" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,332</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Inventories</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_83" name="ifrs-full:Inventories" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,113</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_87" name="ifrs-full:Inventories" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,991</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_811" name="ifrs-full:Inventories" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,963</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
              <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other receivables</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_93" name="ifrs-full:OtherCurrentReceivables" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">590</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_97" name="ifrs-full:OtherCurrentReceivables" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">653</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_911" name="ifrs-full:OtherCurrentReceivables" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">650</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total current assets</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210805153502250_xbrl_20210716112257610_93" name="ifrs-full:CurrentAssets" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">58,053</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210805153502250_xbrl_20210716112257610_97" name="ifrs-full:CurrentAssets" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,809</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210805153502250_xbrl_20210716112257610_911" name="ifrs-full:CurrentAssets" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">45,840</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other receivables</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220725183617324" name="ifrs-full:OtherNoncurrentReceivables" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">277</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220725183653486" name="ifrs-full:OtherNoncurrentReceivables" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">230</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220725183637886" name="ifrs-full:OtherNoncurrentReceivables" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">364</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%" valign="bottom">
              <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property, plant and equipment, net</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_133" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,705</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_137" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,439</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_1311" name="ifrs-full:PropertyPlantAndEquipment" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,366</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Right of-use assets, net</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_143" name="ifrs-full:RightofuseAssets" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,133</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_147" name="ifrs-full:RightofuseAssets" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,364</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_1411" name="ifrs-full:RightofuseAssets" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,215</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
              <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Intangible assets, net</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_153" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">198</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_157" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">264</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_1511" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">231</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total non-current assets</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210726102408924" name="ifrs-full:NoncurrentAssets" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,313</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_173" name="ifrs-full:NoncurrentAssets" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,297</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_177" name="ifrs-full:NoncurrentAssets" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,176</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total assets</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210805153535386_xbrl_20210716112257610_93" name="ifrs-full:Assets" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">64,366</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210805153535386_xbrl_20210716112257610_97" name="ifrs-full:Assets" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,106</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210805153535386_xbrl_20210716112257610_911" name="ifrs-full:Assets" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">50,016</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current maturities of non-current liabilities</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_213" name="ifrs-full:CurrentLeaseLiabilities" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,961</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_217" name="ifrs-full:CurrentLeaseLiabilities" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,479</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_2111" name="ifrs-full:CurrentLeaseLiabilities" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,242</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%" valign="bottom">
              <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Trade payables and accrued expenses</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_223" name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,531</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_227" name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,877</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_2211" name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,656</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other payables</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_233" name="ifrs-full:OtherCurrentPayables" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,817</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_237" name="ifrs-full:OtherCurrentPayables" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,060</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_2311" name="ifrs-full:OtherCurrentPayables" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,159</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
              <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total current liabilities</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210726102959251_xbrl_20210716112257610_233" name="ifrs-full:CurrentLiabilities" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,309</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210726102959251_xbrl_20210716112257610_237" name="ifrs-full:CurrentLiabilities" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,416</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210726102959251_xbrl_20210716112257610_2311" name="ifrs-full:CurrentLiabilities" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,057</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%" valign="bottom">
              <div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Deferred revenues</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220725185154212" name="ifrs-full:RentDeferredIncomeClassifiedAsNoncurrent" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220725191008115" name="ifrs-full:RentDeferredIncomeClassifiedAsNoncurrent" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">61</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220725191032194" name="ifrs-full:RentDeferredIncomeClassifiedAsNoncurrent" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:middle;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Warrants</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230807104610196_xbrl_20220725185154212" name="ifrs-full:NoncurrentWarrantLiability" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,683</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230807104610196_xbrl_20220725191008115" name="ifrs-full:NoncurrentWarrantLiability" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230807104610196_xbrl_20220725191032194" name="ifrs-full:NoncurrentWarrantLiability" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,606</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:middle;width:64%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Liabilities in respect of IIA grants</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_283" name="ifrs-full:NoncurrentGovernmentGrants" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,806</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_287" name="ifrs-full:NoncurrentGovernmentGrants" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,131</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_2811" name="ifrs-full:NoncurrentGovernmentGrants" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,445</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liabilities in respect of TEVA</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_293" name="ifrs-full:OtherNoncurrentLiabilities" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,529</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_297" name="ifrs-full:OtherNoncurrentLiabilities" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,361</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_2911" name="ifrs-full:OtherNoncurrentLiabilities" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,788</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%" valign="bottom">
              <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Lease liabilities</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_313" name="mdwd:NoncurrentLeaseLiability" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">677</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_317" name="mdwd:NoncurrentLeaseLiability" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,053</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_3111" name="mdwd:NoncurrentLeaseLiability" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">846</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Severance pay liability, net</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_323" name="ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">433</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_327" name="ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">319</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_3211" name="ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">360</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
              <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total non-current liabilities</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210726102530177_xbrl_20210716112257610_323" name="ifrs-full:NoncurrentLiabilities" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,128</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210726102530177_xbrl_20210716112257610_327" name="ifrs-full:NoncurrentLiabilities" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,925</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210726102530177_xbrl_20210716112257610_3211" name="ifrs-full:NoncurrentLiabilities" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27,045</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
              <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total liabilities</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220725183852478" name="ifrs-full:Liabilities" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29,437</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220725225336460" name="ifrs-full:Liabilities" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,341</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220725204127469" name="ifrs-full:Liabilities" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">39,102</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%" valign="bottom">
              <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Shareholders' equity:</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ordinary shares of NIS <ix:nonFraction id="Fxbrl_20230811120745142" name="ifrs-full:ParValuePerShare" contextRef="C_20220630" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20230811120707313" name="ifrs-full:ParValuePerShare" contextRef="C_20221231" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20230811103934280" name="ifrs-full:ParValuePerShare" contextRef="C_20230630" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.01</ix:nonFraction></ix:nonFraction></ix:nonFraction> par value:</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%" valign="bottom">
              <div style="text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Authorized: <ix:nonFraction id="Fxbrl_20210805153830052" name="ifrs-full:NumberOfSharesAuthorised" contextRef="C_20230630" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">20,000,000 </ix:nonFraction>shares as of June 30, 2023, <ix:nonFraction id="Fxbrl_20230807104410495" name="ifrs-full:NumberOfSharesAuthorised" contextRef="C_20221231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">12,857,143 </ix:nonFraction>as of December 31, 2022; and <ix:nonFraction id="Fxbrl_20230807104419939" name="ifrs-full:NumberOfSharesAuthorised" contextRef="C_20220630" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">7,142,858 </ix:nonFraction>as of June 30, 2022; Issued and Outstanding:<span>&#160;</span><ix:nonFraction id="Fxbrl_20210726103615822" name="ifrs-full:NumberOfSharesOutstanding" contextRef="C_20230630" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20210726103539748" name="ifrs-full:NumberOfSharesIssued" contextRef="C_20230630" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">7,252,234 </ix:nonFraction></ix:nonFraction>as of June 30, 2023; <ix:nonFraction id="Fxbrl_20210726103713177" name="ifrs-full:NumberOfSharesOutstanding" contextRef="C_20221231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20210726103707094" name="ifrs-full:NumberOfSharesIssued" contextRef="C_20221231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">7,240,020 </ix:nonFraction></ix:nonFraction>as of December 31, 2022 and <ix:nonFraction id="Fxbrl_20210716120925440" name="ifrs-full:NumberOfSharesOutstanding" contextRef="C_20220630" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20210716120922887" name="ifrs-full:NumberOfSharesIssued" contextRef="C_20220630" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">4,734,774 </ix:nonFraction></ix:nonFraction>as of June 30, 2022</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210726102554936_xbrl_20210716112257610_323" name="ifrs-full:IssuedCapital" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">184</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210726102554936_xbrl_20210716112257610_327" name="ifrs-full:IssuedCapital" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">93</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210726102554936_xbrl_20210716112257610_3211" name="ifrs-full:IssuedCapital" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">143</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share premium</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_383" name="ifrs-full:SharePremium" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">205,642</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_387" name="ifrs-full:SharePremium" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">154,119</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_3811" name="ifrs-full:SharePremium" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">178,882</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%" valign="bottom">
              <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency translation adjustments</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230807104154280" name="ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreads" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">14</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716112257610_397" name="ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreads" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20210716112257610_3911" name="ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreads" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accumulated deficit</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20210716112257610_403" name="ifrs-full:RetainedEarnings" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">170,883</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20210716112257610_407" name="ifrs-full:RetainedEarnings" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">156,450</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20210716112257610_4011" name="ifrs-full:RetainedEarnings" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">168,106</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;padding-bottom:2px" valign="bottom">
              <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total equity (deficit)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220725190156165" name="ifrs-full:Equity" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">34,929</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230807104207402" name="ifrs-full:Equity" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,235</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220725204146028" name="ifrs-full:Equity" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,914</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:64%;padding-bottom:4px" valign="bottom">
              <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total liabilities and equity</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210805153704172_xbrl_20210716112257610_93" name="ifrs-full:EquityAndLiabilities" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">64,366</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210805153704172_xbrl_20210716112257610_97" name="ifrs-full:EquityAndLiabilities" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,106</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210805153704172_xbrl_20210716112257610_911" name="ifrs-full:EquityAndLiabilities" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">50,016</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>

      </table>
      <div style="line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying notes are an integral part of the interim financial statements.</span></span></div>
    </div>
  </div>
  <div>
    <div style="text-align:justify;line-height:1.25">
      <p style="margin:0pt">&#160;</p>
      <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:7pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 2</span></span></span></span></span></span></span></div><div><hr style="break-after:page;border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:0px" /></div></div><div style="text-align:left"><div><div><div style="margin-top:0px;margin-bottom:0pt;text-align:right"><p style="margin-top:10pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="font-weight:bold;color:rgb(0, 0, 0)">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></p></div></div></div></div><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
    </div>
  </div>
</div><div style="">
  <div>
    <div>
      <div>
        <div style="line-height:1.25">
          <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unaudited Condensed Interim Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss<span id="Loss_integixAnchor"></span></span></span></div>
          <div style="text-align:justify;line-height:1.25;font-weight:bold">
            <hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;margin-top:5pt;margin-bottom:5pt;text-align:center" />
          </div>
        </div>
        <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">U.S. dollars in thousands</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

            <tr>
              <td colspan="1" style="vertical-align:top;padding-left:9pt;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Six months ended</span></span></div>
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 30,</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Three months ended</span></span></div>
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 30,</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Year ended</span></span></div>
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;padding-left:9pt;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2023</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues from sale of products</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716123322526_33" name="ifrs-full:RevenueFromSaleOfGoods" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,358</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716123322526_37" name="ifrs-full:RevenueFromSaleOfGoods" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,771</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716123322526_311" name="ifrs-full:RevenueFromSaleOfGoods" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,206</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716123322526_315" name="ifrs-full:RevenueFromSaleOfGoods" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,669</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716123322526_319" name="ifrs-full:RevenueFromSaleOfGoods" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,347</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%" valign="bottom">
                <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues from development services</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124154186_xbrl_20210716123322526_33" name="ifrs-full:RevenueFromRenderingOfServices" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,149</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124154186_xbrl_20210716123322526_37" name="ifrs-full:RevenueFromRenderingOfServices" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,866</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124154186_xbrl_20210716123322526_311" name="ifrs-full:RevenueFromRenderingOfServices" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,534</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124154186_xbrl_20210716123322526_315" name="ifrs-full:RevenueFromRenderingOfServices" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,777</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124154186_xbrl_20210716123322526_319" name="ifrs-full:RevenueFromRenderingOfServices" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,943</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Revenues from license agreements</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124304306_xbrl_20210716123322526_33" name="ifrs-full:LicenceFeeIncome" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">65</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124304306_xbrl_20210716123322526_37" name="ifrs-full:LicenceFeeIncome" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">438</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124304306_xbrl_20210716123322526_311" name="ifrs-full:LicenceFeeIncome" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124304306_xbrl_20210716123322526_315" name="ifrs-full:LicenceFeeIncome" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">222</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124304306_xbrl_20210716123322526_319" name="ifrs-full:LicenceFeeIncome" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,206</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%" valign="bottom">
                <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total revenues</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124308513_xbrl_20210716123322526_33" name="ifrs-full:Revenue" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,572</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124308513_xbrl_20210716123322526_37" name="ifrs-full:Revenue" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,075</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124308513_xbrl_20210716123322526_311" name="ifrs-full:Revenue" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,773</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124308513_xbrl_20210716123322526_315" name="ifrs-full:Revenue" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,668</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124308513_xbrl_20210716123322526_319" name="ifrs-full:Revenue" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,496</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%" valign="bottom">
                <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost of revenues from sale of products</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220725183352579" name="ifrs-full:CostOfMerchandiseSold" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,436</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220725183414122" name="ifrs-full:CostOfMerchandiseSold" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,539</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220725183435472" name="ifrs-full:CostOfMerchandiseSold" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">628</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220725183445820" name="ifrs-full:CostOfMerchandiseSold" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,148</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220725183512382" name="ifrs-full:CostOfMerchandiseSold" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,184</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost of revenues from development services</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220725183528211" name="ifrs-full:ServicesExpense" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,170</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220725183633645" name="ifrs-full:ServicesExpense" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,932</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220725183628926" name="ifrs-full:ServicesExpense" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,005</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220725183620249" name="ifrs-full:ServicesExpense" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,391</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220725183548595" name="ifrs-full:ServicesExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,829</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:2px" valign="bottom">
                <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cost of revenues from license agreements</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220725183706414" name="mdwd:CostOfLicenseAgreements" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220725183709901" name="mdwd:CostOfLicenseAgreements" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220725183716764" name="mdwd:CostOfLicenseAgreements" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220725183719713" name="mdwd:CostOfLicenseAgreements" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220725183554874" name="mdwd:CostOfLicenseAgreements" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">318</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total cost of revenues</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124310657_xbrl_20210716123322526_33" name="ifrs-full:CostOfSales" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,609</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124310657_xbrl_20210716123322526_37" name="ifrs-full:CostOfSales" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,502</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124310657_xbrl_20210716123322526_311" name="ifrs-full:CostOfSales" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,636</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124310657_xbrl_20210716123322526_315" name="ifrs-full:CostOfSales" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,555</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124310657_xbrl_20210716123322526_319" name="ifrs-full:CostOfSales" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,331</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Gross profit</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124313801_xbrl_20210716123322526_33" name="ifrs-full:GrossProfit" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,963</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124313801_xbrl_20210716123322526_37" name="ifrs-full:GrossProfit" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,573</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124313801_xbrl_20210716123322526_311" name="ifrs-full:GrossProfit" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,137</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124313801_xbrl_20210716123322526_315" name="ifrs-full:GrossProfit" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,113</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124313801_xbrl_20210716123322526_319" name="ifrs-full:GrossProfit" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,165</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Research and development</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210726102137309_xbrl_20210716124313801_xbrl_20210716123322526_33" name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,126</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210726102137309_xbrl_20210716124313801_xbrl_20210716123322526_37" name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,599</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210726102137309_xbrl_20210716124313801_xbrl_20210716123322526_311" name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,024</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210726102137309_xbrl_20210716124313801_xbrl_20210716123322526_315" name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,191</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210726102137309_xbrl_20210716124313801_xbrl_20210716123322526_319" name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,181</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%" valign="bottom">
                <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Selling and marketing</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124325241_xbrl_20210716123322526_33" name="ifrs-full:SalesAndMarketingExpense" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,438</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124325241_xbrl_20210716123322526_37" name="ifrs-full:SalesAndMarketingExpense" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,854</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124325241_xbrl_20210716123322526_311" name="ifrs-full:SalesAndMarketingExpense" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,332</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124325241_xbrl_20210716123322526_315" name="ifrs-full:SalesAndMarketingExpense" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">935</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124325241_xbrl_20210716123322526_319" name="ifrs-full:SalesAndMarketingExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,725</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General and administrative</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124327322_xbrl_20210716123322526_33" name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,770</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124327322_xbrl_20210716123322526_37" name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,769</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124327322_xbrl_20210716123322526_311" name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,788</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124327322_xbrl_20210716123322526_315" name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,352</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124327322_xbrl_20210716123322526_319" name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,920</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:2px" valign="bottom">
                <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other expenses</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804191525677_xbrl_20210716124327322_xbrl_20210716123322526_33" name="ifrs-full:OtherExpenseByFunction" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804191525677_xbrl_20210716124327322_xbrl_20210716123322526_37" name="ifrs-full:OtherExpenseByFunction" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">309</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804191525677_xbrl_20210716124327322_xbrl_20210716123322526_311" name="ifrs-full:OtherExpenseByFunction" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804191525677_xbrl_20210716124327322_xbrl_20210716123322526_315" name="ifrs-full:OtherExpenseByFunction" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">309</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804191525677_xbrl_20210716124327322_xbrl_20210716123322526_319" name="ifrs-full:OtherExpenseByFunction" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">684</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total operating expenses</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124333082_xbrl_20210716123322526_33" name="ifrs-full:OperatingExpense" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,334</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124333082_xbrl_20210716123322526_37" name="ifrs-full:OperatingExpense" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,531</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124333082_xbrl_20210716123322526_311" name="ifrs-full:OperatingExpense" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,144</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124333082_xbrl_20210716123322526_315" name="ifrs-full:OperatingExpense" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,787</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124333082_xbrl_20210716123322526_319" name="ifrs-full:OperatingExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,510</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating loss</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20210805160008519_xbrl_20210716124333082_xbrl_20210716123322526_33" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">8,371</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20210805160008519_xbrl_20210716124333082_xbrl_20210716123322526_37" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">6,958</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20210805160008519_xbrl_20210716124333082_xbrl_20210716123322526_311" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">4,007</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20210805160008519_xbrl_20210716124333082_xbrl_20210716123322526_315" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">3,674</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20210805160008519_xbrl_20210716124333082_xbrl_20210716123322526_319" name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">8,345</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial income</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124337921_xbrl_20210716123322526_33" name="ifrs-full:FinanceIncome" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,480</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124337921_xbrl_20210716123322526_37" name="ifrs-full:FinanceIncome" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124337921_xbrl_20210716123322526_311" name="ifrs-full:FinanceIncome" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,828</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124337921_xbrl_20210716123322526_315" name="ifrs-full:FinanceIncome" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124337921_xbrl_20210716123322526_319" name="ifrs-full:FinanceIncome" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">461</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:2px" valign="bottom">
                <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial expenses</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20210716124340706_xbrl_20210716123322526_33" name="ifrs-full:FinanceCosts" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,869</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20210716124340706_xbrl_20210716123322526_37" name="ifrs-full:FinanceCosts" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">988</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20210716124340706_xbrl_20210716123322526_311" name="ifrs-full:FinanceCosts" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">893</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20210716124340706_xbrl_20210716123322526_315" name="ifrs-full:FinanceCosts" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">687</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20210716124340706_xbrl_20210716123322526_319" name="ifrs-full:FinanceCosts" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,637</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financing income (expenses), net</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220725190414450" name="mdwd:FinanceIncomeExpenseNet" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,611</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220725190434660" name="mdwd:FinanceIncomeExpenseNet" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">977</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220725190505672" name="mdwd:FinanceIncomeExpenseNet" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,935</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220725190517131" name="mdwd:FinanceIncomeExpenseNet" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">676</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220725190532031" name="mdwd:FinanceIncomeExpenseNet" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">11,176</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Profit (loss) before taxes on income</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20210726103206944_xbrl_20210716124337921_xbrl_20210716123322526_33" name="ifrs-full:ProfitLossBeforeTax" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,760</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20210726103206944_xbrl_20210716124337921_xbrl_20210716123322526_37" name="ifrs-full:ProfitLossBeforeTax" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">7,935</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210726103206944_xbrl_20210716124337921_xbrl_20210716123322526_311" name="ifrs-full:ProfitLossBeforeTax" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">928</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20210726103206944_xbrl_20210716124337921_xbrl_20210716123322526_315" name="ifrs-full:ProfitLossBeforeTax" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">4,350</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20210726103206944_xbrl_20210716124337921_xbrl_20210716123322526_319" name="ifrs-full:ProfitLossBeforeTax" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,521</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">
                <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Taxes on income</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220725222501270_xbrl_20210726103209193_xbrl_20210716124337921_xbrl_20210716123322526_315" name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220725222501270_xbrl_20210726103337085" name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220725222501270_xbrl_20210726103209193_xbrl_20210716124337921_xbrl_20210716123322526_319" name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220725222501270_xbrl_20210726103354908" name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220725222501270_xbrl_20210726103409366" name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">78</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:4px" valign="bottom">
                <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;Net profit (loss)</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20210726103237527_xbrl_20210716124337921_xbrl_20210716123322526_33" name="ifrs-full:ProfitLoss" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,777</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20210726103237527_xbrl_20210716124337921_xbrl_20210716123322526_37" name="ifrs-full:ProfitLoss" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">7,943</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210726103237527_xbrl_20210716124337921_xbrl_20210716123322526_311" name="ifrs-full:ProfitLoss" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">916</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20210726103237527_xbrl_20210716124337921_xbrl_20210716123322526_315" name="ifrs-full:ProfitLoss" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">4,354</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20210726103237527_xbrl_20210716124337921_xbrl_20210716123322526_319" name="ifrs-full:ProfitLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,599</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%" valign="bottom">
                <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other comprehensive income:</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency translation adjustments</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230807100443673" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124351857_xbrl_20210716123322526_37" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">22</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210726104832566" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804191745488" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">17</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210716124351857_xbrl_20210716123322526_319" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">14</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total comprehensive profit (loss)</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20210726103241224_xbrl_20210716124337921_xbrl_20210716123322526_33" name="ifrs-full:ComprehensiveIncome" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,786</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20210726103241224_xbrl_20210716124337921_xbrl_20210716123322526_37" name="ifrs-full:ComprehensiveIncome" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">7,921</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20210726103241224_xbrl_20210716124337921_xbrl_20210716123322526_311" name="ifrs-full:ComprehensiveIncome" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">916</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20210726103241224_xbrl_20210716124337921_xbrl_20210716123322526_315" name="ifrs-full:ComprehensiveIncome" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">4,337</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20210726103241224_xbrl_20210716124337921_xbrl_20210716123322526_319" name="ifrs-full:ComprehensiveIncome" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,585</ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss per share data:</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:4px" valign="bottom">
                <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Basic and diluted net profit (loss) per share - USD</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230807164026424" name="ifrs-full:DilutedEarningsLossPerShare" contextRef="C_20230101to20230630" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-"><ix:nonFraction id="Fxbrl_20210726103243244_xbrl_20210716124337921_xbrl_20210716123322526_33" name="ifrs-full:BasicEarningsLossPerShare" contextRef="C_20230101to20230630" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">0.32</ix:nonFraction></ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*(<ix:nonFraction id="Fxbrl_s_20230811005753136" name="ifrs-full:DilutedEarningsLossPerShare" contextRef="C_20220101to20220630" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-"><ix:nonFraction id="Fxbrl_20230811005753137" name="ifrs-full:BasicEarningsLossPerShare" contextRef="C_20220101to20220630" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">1.79</ix:nonFraction></ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230807164112851" name="ifrs-full:DilutedEarningsLossPerShare" contextRef="C_20230401to20230630" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20210726103243244_xbrl_20210716124337921_xbrl_20210716123322526_311" name="ifrs-full:BasicEarningsLossPerShare" contextRef="C_20230401to20230630" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.10</ix:nonFraction></ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*(<ix:nonFraction id="Fxbrl_s_20230811005838682" name="ifrs-full:DilutedEarningsLossPerShare" contextRef="C_20220401to20220630" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-"><ix:nonFraction id="Fxbrl_20230811005838682" name="ifrs-full:BasicEarningsLossPerShare" contextRef="C_20220401to20220630" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">0.92</ix:nonFraction></ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230807164157083" name="ifrs-full:DilutedEarningsLossPerShare" contextRef="C_20220101to20221231" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-"><ix:nonFraction id="Fxbrl_20210726103243244_xbrl_20210716124337921_xbrl_20210716123322526_319" name="ifrs-full:BasicEarningsLossPerShare" contextRef="C_20220101to20221231" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal" sign="-">3.93</ix:nonFraction></ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-align:justify;text-indent:-11.35pt;margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of shares used in calculating basic and diluted net loss per share</span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230807164243675" name="ifrs-full:AdjustedWeightedAverageShares" contextRef="C_20230101to20230630" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20220725175133735" name="ifrs-full:WeightedAverageShares" contextRef="C_20230101to20230630" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">8,803</ix:nonFraction></ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*<ix:nonFraction id="Fxbrl_s_20230811104343177" name="ifrs-full:AdjustedWeightedAverageShares" contextRef="C_20220101to20220630" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20230811104343178" name="ifrs-full:WeightedAverageShares" contextRef="C_20220101to20220630" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">4,440</ix:nonFraction></ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230807164300115" name="ifrs-full:AdjustedWeightedAverageShares" contextRef="C_20230401to20230630" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20220725175207243" name="ifrs-full:WeightedAverageShares" contextRef="C_20230401to20230630" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">9,209</ix:nonFraction></ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*<ix:nonFraction id="Fxbrl_s_20230811005902765" name="ifrs-full:AdjustedWeightedAverageShares" contextRef="C_20220401to20220630" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20230811005902765" name="ifrs-full:WeightedAverageShares" contextRef="C_20220401to20220630" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">4,734</ix:nonFraction></ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230807164316251" name="ifrs-full:AdjustedWeightedAverageShares" contextRef="C_20220101to20221231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="Fxbrl_20220725175224909" name="ifrs-full:WeightedAverageShares" contextRef="C_20220101to20221231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">4,987</ix:nonFraction></ix:nonFraction></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>

        </table>
        <div style="text-align:justify;line-height:1.25">&#160;</div>
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">*Restated to reflect 1:7 reverse ratio of shares</span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying notes are an integral part of the interim consolidated financial statements.</span></span></div>
      </div>
    </div>
    <div style="line-height:1.25">
      <p style="margin:0pt">&#160;</p>
      <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:7pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 3</span></span></span></span></span></span></span></div><div><hr style="break-after:page;border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:0px" /></div></div><div style="text-align:left"><div><div><div style="margin-top:0px;margin-bottom:0pt;text-align:right"><p style="margin-top:10pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="font-weight:bold;color:rgb(0, 0, 0)">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></p></div></div></div></div><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
    </div>
  </div>
</div><div style="">
  <div>
    <div>
      <div style="line-height:1.25">
        <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unaudited Condensed Interim Consolidated Statements of Changes in Shareholders&#8217; Equity<span id="Equity_integixAnchor"></span> (Deficit)</span></span></div>
        <div style="text-align:justify;line-height:1.25;font-weight:bold">
          <hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;margin-top:5pt;margin-bottom:5pt;text-align:center" />
        </div>
      </div>
      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">U.S. dollars in thousands</span></span></div>
      <div style="line-height:1.25">&#160;</div>
      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

          <tr>
            <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share capital</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share premium</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency translation reserve</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accumulated</span></span></div>
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">deficit</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
              <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">equity (deficit)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:middle;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of April 1, 2023</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804194401541_xbrl_20210805162349215_xbrl_20210726103916501_xbrl_20210726103844427_xbrl_20210716145820874_xbrl_20210716144837125_23" name="ifrs-full:Equity" contextRef="C_20230331_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">183</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804194401541_xbrl_20210805162349215_xbrl_20210726103916501_xbrl_20210726103844427_xbrl_20210716145820874_xbrl_20210716144837125_27" name="ifrs-full:Equity" contextRef="C_20230331_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">204,930</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220804194401541_xbrl_20210805162349215_xbrl_20210726103916501_xbrl_20210726103844427_xbrl_20210716145820874_xbrl_20210716144837125_211" name="ifrs-full:Equity" contextRef="C_20230331_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">14</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220804194401541_xbrl_20210805162349215_xbrl_20210726103916501_xbrl_20210726103844427_xbrl_20210716145820874_xbrl_20210716144837125_215" name="ifrs-full:Equity" contextRef="C_20230331_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">171,799</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804194401541_xbrl_20210805162349215_xbrl_20210726103916501_xbrl_20210726103844427_xbrl_20210716145820874_xbrl_20210716144837125_219" name="ifrs-full:Equity" contextRef="C_20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,300</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Profit for the period</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804194419581_xbrl_20220726010534919" name="ifrs-full:ProfitLoss" contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804194419581_xbrl_20220726010540999" name="ifrs-full:ProfitLoss" contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804194419581_xbrl_20220726010546988" name="ifrs-full:ProfitLoss" contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804194419581_xbrl_20210805162426882_xbrl_20210726103505618_xbrl_20210716150154169_xbrl_20210716145835728_xbrl_20210716144837125_415" name="ifrs-full:ProfitLoss" contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">916</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804194419581_xbrl_20210805162426882_xbrl_20210726103505618_xbrl_20210716150154169_xbrl_20210716145835728_xbrl_20210716144837125_419" name="ifrs-full:ProfitLoss" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">916</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:40%;padding-bottom:2px" valign="bottom">
              <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other comprehensive income</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804194437283_xbrl_20220726010951571" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804194437283_xbrl_20220726011000691" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804194437283_xbrl_20210805162907744_xbrl_20210726103505630_xbrl_20210716150923612_xbrl_20210716145820903_xbrl_20210716144837125_511" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero" sign="-">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804194437283_xbrl_20220726011003910" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804194437283_xbrl_20210805162907744_xbrl_20210726103505630_xbrl_20210716150923612_xbrl_20210716145820903_xbrl_20210716144837125_519" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero" sign="-">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total comprehensive income</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804194513119_xbrl_20220726010613077" name="ifrs-full:ComprehensiveIncome" contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804194513119_xbrl_20220726010619109" name="ifrs-full:ComprehensiveIncome" contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804194513119_xbrl_20210805162633992_xbrl_20210726103820235_xbrl_20210716144837125_611" name="ifrs-full:ComprehensiveIncome" contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804194513119_xbrl_20210805162633992_xbrl_20210726103820235_xbrl_20210716144837125_615" name="ifrs-full:ComprehensiveIncome" contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">916</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804194513119_xbrl_20210805162633992_xbrl_20210726103820235_xbrl_20210716144837125_619" name="ifrs-full:ComprehensiveIncome" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">916</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:40%" valign="bottom">
              <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuance expenses, see Note 3</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804204701105_xbrl_20220804195959675_xbrl_20220726010731719" name="ifrs-full:ShareIssueRelatedCost" contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804204701105_xbrl_20220804195959675_xbrl_20210805162426893_xbrl_20210726103505658_xbrl_20210716151223357_xbrl_20210716145820919_xbrl_20210716144837125_87" name="ifrs-full:ShareIssueRelatedCost" contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804204701105_xbrl_20220804195959675_xbrl_20220726010737773" name="ifrs-full:ShareIssueRelatedCost" contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804204701105_xbrl_20220804195959675_xbrl_20220726010742299" name="ifrs-full:ShareIssueRelatedCost" contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804204701105_xbrl_20220804195959675_xbrl_20210805162426893_xbrl_20210726103505658_xbrl_20210716151223357_xbrl_20210716145820919_xbrl_20210716144837125_819" name="ifrs-full:ShareIssueRelatedCost" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise of options</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804203216763" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804195919524" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804194601328_xbrl_20220726011042902" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804194601328_xbrl_20220726011052629" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804203226556" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:40%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804195959675_xbrl_20220726010731719" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804195959675_xbrl_20210805162426893_xbrl_20210726103505658_xbrl_20210716151223357_xbrl_20210716145820919_xbrl_20210716144837125_87" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">712</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804195959675_xbrl_20220726010737773" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804195959675_xbrl_20220726010742299" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804195959675_xbrl_20210805162426893_xbrl_20210726103505658_xbrl_20210716151223357_xbrl_20210716145820919_xbrl_20210716144837125_819" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">712</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of June 30, 2023 (unaudited)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200040800_xbrl_20220725181900025_xbrl_20210805162426907_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_23" name="ifrs-full:Equity" contextRef="C_20230630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">184</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200040800_xbrl_20220725181900025_xbrl_20210805162426907_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_27" name="ifrs-full:Equity" contextRef="C_20230630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">205,642</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230807103014560" name="ifrs-full:Equity" contextRef="C_20230630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">14</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220804200040800_xbrl_20220725181900025_xbrl_20210805162426907_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_215" name="ifrs-full:Equity" contextRef="C_20230630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">170,883</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200040800_xbrl_20220725181900025_xbrl_20210805162426907_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_219" name="ifrs-full:Equity" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">34,929</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>

      </table>
      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

          <tr>
            <td style="vertical-align:middle;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of April 1, 2022</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230807110720967" name="ifrs-full:Equity" contextRef="C_20220331_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">93</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200204394_xbrl_20220725173724728_xbrl_20210805162715251_xbrl_20210726103844427_xbrl_20210716145820874_xbrl_20210716144837125_27" name="ifrs-full:Equity" contextRef="C_20220331_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">153,962</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220804200204394_xbrl_20220725173724728_xbrl_20210805162715251_xbrl_20210726103844427_xbrl_20210716145820874_xbrl_20210716144837125_211" name="ifrs-full:Equity" contextRef="C_20220331_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">14</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220804200204394_xbrl_20220725173724728_xbrl_20210805162715251_xbrl_20210726103844427_xbrl_20210716145820874_xbrl_20210716144837125_215" name="ifrs-full:Equity" contextRef="C_20220331_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">152,096</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200204394_xbrl_20220725173724728_xbrl_20210805162715251_xbrl_20210726103844427_xbrl_20210716145820874_xbrl_20210716144837125_219" name="ifrs-full:Equity" contextRef="C_20220331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,945</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss for the period</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200219505_xbrl_20220726010751147" name="ifrs-full:ProfitLoss" contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200219505_xbrl_20220726010757650" name="ifrs-full:ProfitLoss" contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200219505_xbrl_20220726010801530" name="ifrs-full:ProfitLoss" contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220804200219505_xbrl_20220725173739413_xbrl_20210805162742179_xbrl_20210726103844444_xbrl_20210716145835728_xbrl_20210716144837125_415" name="ifrs-full:ProfitLoss" contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">4,354</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220804200219505_xbrl_20220725173739413_xbrl_20210805162742179_xbrl_20210726103844444_xbrl_20210716145835728_xbrl_20210716144837125_419" name="ifrs-full:ProfitLoss" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">4,354</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:40%;padding-bottom:2px" valign="bottom">
              <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other comprehensive income</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200242228_xbrl_20220726010807761" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200242228_xbrl_20220726010813554" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200242228_xbrl_20220725173759919_xbrl_20210805162715279_xbrl_20210726103844451_xbrl_20210716145820903_xbrl_20210716144837125_511" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">17</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200242228_xbrl_20220726010823921" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200242228_xbrl_20220725173759919_xbrl_20210805162715279_xbrl_20210726103844451_xbrl_20210716145820903_xbrl_20210716144837125_519" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">17</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total comprehensive Income (loss)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200303307_xbrl_20220726011206594" name="ifrs-full:ComprehensiveIncome" contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200303307_xbrl_20220726011214615" name="ifrs-full:ComprehensiveIncome" contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200303307_xbrl_20220725182607499_xbrl_20210805162907757_xbrl_20210726103505639_xbrl_20210716151159324_xbrl_20210716145845544_xbrl_20210716144837125_611" name="ifrs-full:ComprehensiveIncome" contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220804200303307_xbrl_20220725182607499_xbrl_20210805162907757_xbrl_20210726103505639_xbrl_20210716151159324_xbrl_20210716145845544_xbrl_20210716144837125_615" name="ifrs-full:ComprehensiveIncome" contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">4,354</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220804200303307_xbrl_20220725182607499_xbrl_20210805162907757_xbrl_20210726103505639_xbrl_20210716151159324_xbrl_20210716145845544_xbrl_20210716144837125_619" name="ifrs-full:ComprehensiveIncome" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">4,337</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:40%" valign="bottom">
              <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuance expenses, see Note 3</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230807105953383_xbrl_20220804204701105_xbrl_20220804195959675_xbrl_20220726010731719" name="ifrs-full:ShareIssueRelatedCost" contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230807111456280" name="ifrs-full:ShareIssueRelatedCost" contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">95</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230807105953383_xbrl_20220804204701105_xbrl_20220804195959675_xbrl_20220726010737773" name="ifrs-full:ShareIssueRelatedCost" contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230807105953383_xbrl_20220804204701105_xbrl_20220804195959675_xbrl_20220726010742299" name="ifrs-full:ShareIssueRelatedCost" contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230807111504799" name="ifrs-full:ShareIssueRelatedCost" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">95</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise of options</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<span style="-sec-ix-hidden:Fxbrl_20230807111545632">*</span></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200732492_xbrl_20220726010845363" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200732492_xbrl_20220726010853214" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200732492_xbrl_20220726010857927" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<span style="-sec-ix-hidden:Fxbrl_20230807111557608">*</span></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:40%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200757567_xbrl_20220726010905573" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200757567_xbrl_20220725173937130_xbrl_20210805162715292_xbrl_20210726103844475_xbrl_20210716145820919_xbrl_20210716144837125_87" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">252</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200757567_xbrl_20220726010911443" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200757567_xbrl_20220726010921099" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200757567_xbrl_20220725173937130_xbrl_20210805162715292_xbrl_20210726103844475_xbrl_20210716145820919_xbrl_20210716144837125_819" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">252</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="text-align:justify;text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of June 30, 2022 (unaudited)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200811104_xbrl_20220725173957369_xbrl_20210805162715305_xbrl_20210726103905588_xbrl_20210726103844427_xbrl_20210716145820874_xbrl_20210716144837125_23" name="ifrs-full:Equity" contextRef="C_20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">93</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200811104_xbrl_20220725173957369_xbrl_20210805162715305_xbrl_20210726103905588_xbrl_20210726103844427_xbrl_20210716145820874_xbrl_20210716144837125_27" name="ifrs-full:Equity" contextRef="C_20220630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">154,119</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200811104_xbrl_20220725173957369_xbrl_20210805162715305_xbrl_20210726103905588_xbrl_20210726103844427_xbrl_20210716145820874_xbrl_20210716144837125_211" name="ifrs-full:Equity" contextRef="C_20220630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220804200811104_xbrl_20220725173957369_xbrl_20210805162715305_xbrl_20210726103905588_xbrl_20210726103844427_xbrl_20210716145820874_xbrl_20210716144837125_215" name="ifrs-full:Equity" contextRef="C_20220630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">156,450</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230807103054329" name="ifrs-full:Equity" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,235</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>

      </table>&#160;<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(*)&#160;&#160;&#160;&#160;&#160;&#160; Represents less than $ 1.</span></span></div>
      <div style="text-align:justify;line-height:1.25">&#160;</div>
      <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying notes are an integral part of the interim consolidated financial statements.</span></span></div>
    </div>
  </div>
  <div style="text-align:justify;line-height:1.25">
    <div>
      <div>
        <div style="text-align:justify;line-height:1.25">
          <p style="margin:0pt">&#160;</p>
          <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:7pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 4</span></span></span></span></span></span></span></div><div><hr style="break-after:page;border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:0px" /></div></div><div style="text-align:left"><div><div><div style="margin-top:0px;margin-bottom:0pt;text-align:right"><p style="margin-top:10pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="font-weight:bold;color:rgb(0, 0, 0)">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></p></div></div></div></div><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
        </div>
        <div style="line-height:1.25">
          <div style="text-align:justify;line-height:1.25;font-weight:bold">
            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Unaudited Condensed Interim Consolidated Statements of Changes in Shareholders&#8217; Equity (Deficit)</span></span></p>
          </div>
        </div>
        <div>
          <div>
            <div style="line-height:1.25">
              <div style="text-align:justify;line-height:1.25;font-weight:bold">
                <hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;margin-top:5pt;margin-bottom:5pt;text-align:center" />
              </div>
            </div>
            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">U.S. dollars in thousands</span></span></div>
            <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

                <tr>
                  <td colspan="1" style="vertical-align:top;padding-left:9pt;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share capital</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share premium</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Foreign currency translation reserve</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accumulated</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">deficit</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">equity (deficit)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2022 (audited)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911213_xbrl_20220725181317026_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_23" name="ifrs-full:Equity" contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">143</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911213_xbrl_20220725181317026_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_27" name="ifrs-full:Equity" contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">178,882</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220804200911213_xbrl_20220725181317026_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_211" name="ifrs-full:Equity" contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220804200911213_xbrl_20220725181317026_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_215" name="ifrs-full:Equity" contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">168,106</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911213_xbrl_20220725181317026_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_219" name="ifrs-full:Equity" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,914</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:40%" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss for the period</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911130_xbrl_20220726010936179" name="ifrs-full:ProfitLoss" contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911130_xbrl_20220726010943050" name="ifrs-full:ProfitLoss" contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911130_xbrl_20220726010946073" name="ifrs-full:ProfitLoss" contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220804200911130_xbrl_20210805162907731_xbrl_20210726103505618_xbrl_20210716150154169_xbrl_20210716145835728_xbrl_20210716144837125_415" name="ifrs-full:ProfitLoss" contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,777</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220804200911130_xbrl_20210805162907731_xbrl_20210726103505618_xbrl_20210716150154169_xbrl_20210716145835728_xbrl_20210716144837125_419" name="ifrs-full:ProfitLoss" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,777</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other comprehensive (loss)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911142_xbrl_20220726010951571" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911142_xbrl_20220726011000691" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230807112358119" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911142_xbrl_20220726011003910" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230807140236151" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:40%" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total comprehensive (loss)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911154_xbrl_20220726011011047" name="ifrs-full:ComprehensiveIncome" contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911154_xbrl_20220726011017500" name="ifrs-full:ComprehensiveIncome" contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230807112347815" name="ifrs-full:ComprehensiveIncome" contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">9</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220804200911154_xbrl_20210805162907757_xbrl_20210726103505639_xbrl_20210716151159324_xbrl_20210716145845544_xbrl_20210716144837125_615" name="ifrs-full:ComprehensiveIncome" contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,777</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220804200911154_xbrl_20210805162907757_xbrl_20210726103505639_xbrl_20210716151159324_xbrl_20210716145845544_xbrl_20210716144837125_619" name="ifrs-full:ComprehensiveIncome" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,786</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuance of ordinary shares, net of issuance expenses (see Note 3)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804201533828_xbrl_20220725182104960" name="ifrs-full:IssueOfEquity" contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804201533828_xbrl_20220725182054265_xbrl_20220725181931129_xbrl_20210805162633992_xbrl_20210726103820235_xbrl_20210716144837125_615" name="ifrs-full:IssueOfEquity" contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,429</ix:nonFraction></span></span></strong></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804201533828_xbrl_20220726011028297" name="ifrs-full:IssueOfEquity" contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804201533828_xbrl_20220726011031293" name="ifrs-full:IssueOfEquity" contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804201533828_xbrl_20220725182054265_xbrl_20220725181931129_xbrl_20210805162633992_xbrl_20210726103820235_xbrl_20210716144837125_619" name="ifrs-full:IssueOfEquity" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,469</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:40%" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise of options</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804205734843" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804205739952" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911171_xbrl_20220726011042902" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911171_xbrl_20220726011052629" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804205747127" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911179_xbrl_20220726011059298" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911179_xbrl_20210805162907776_xbrl_20210726103505658_xbrl_20210716151223357_xbrl_20210716145820919_xbrl_20210716144837125_87" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,331</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911179_xbrl_20220726011110899" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911179_xbrl_20220726011114078" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911179_xbrl_20210805162907776_xbrl_20210726103505658_xbrl_20210716151223357_xbrl_20210716145820919_xbrl_20210716144837125_819" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,331</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of June 30, 2023 (unaudited)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911197_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_23" name="ifrs-full:Equity" contextRef="C_20230630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">184</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911197_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_27" name="ifrs-full:Equity" contextRef="C_20230630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">205,642</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230807112331639" name="ifrs-full:Equity" contextRef="C_20230630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">14</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220804200911197_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_215" name="ifrs-full:Equity" contextRef="C_20230630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">170,883</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911197_xbrl_20220725193210582" name="ifrs-full:Equity" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">34,929</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:4px" valign="bottom">
                    <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2021 (audited)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911447_xbrl_20220725182314592_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_23" name="ifrs-full:Equity" contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">75</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911447_xbrl_20220725182314592_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_27" name="ifrs-full:Equity" contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">143,869</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220804200911447_xbrl_20220725182314592_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_211" name="ifrs-full:Equity" contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220804200911447_xbrl_20220725182314592_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_215" name="ifrs-full:Equity" contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">148,507</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230807140310911" name="ifrs-full:Equity" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">4,582</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:40%" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss for the period</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911250_xbrl_20220726011122465" name="ifrs-full:ProfitLoss" contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911250_xbrl_20220726011132381" name="ifrs-full:ProfitLoss" contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911250_xbrl_20220726011135513" name="ifrs-full:ProfitLoss" contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220804200911250_xbrl_20220725182637766_xbrl_20210805162907731_xbrl_20210726103505618_xbrl_20210716150154169_xbrl_20210716145835728_xbrl_20210716144837125_415" name="ifrs-full:ProfitLoss" contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">7,943</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220804200911250_xbrl_20220725182637766_xbrl_20210805162907731_xbrl_20210726103505618_xbrl_20210716150154169_xbrl_20210716145835728_xbrl_20210716144837125_419" name="ifrs-full:ProfitLoss" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">7,943</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other comprehensive income</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911268_xbrl_20220726011149344" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911268_xbrl_20220726011155262" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911268_xbrl_20220725182708825_xbrl_20210805162907744_xbrl_20210726103505630_xbrl_20210716150923612_xbrl_20210716145820903_xbrl_20210716144837125_511" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">22</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911268_xbrl_20220726011159642" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911268_xbrl_20220725182708825_xbrl_20210805162907744_xbrl_20210726103505630_xbrl_20210716150923612_xbrl_20210716145820903_xbrl_20210716144837125_519" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">22</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:40%" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total comprehensive income (loss)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911287_xbrl_20220726011206594" name="ifrs-full:ComprehensiveIncome" contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911287_xbrl_20220726011214615" name="ifrs-full:ComprehensiveIncome" contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911287_xbrl_20220725182607499_xbrl_20210805162907757_xbrl_20210726103505639_xbrl_20210716151159324_xbrl_20210716145845544_xbrl_20210716144837125_611" name="ifrs-full:ComprehensiveIncome" contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220804200911287_xbrl_20220725182607499_xbrl_20210805162907757_xbrl_20210726103505639_xbrl_20210716151159324_xbrl_20210716145845544_xbrl_20210716144837125_615" name="ifrs-full:ComprehensiveIncome" contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">7,943</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220804200911287_xbrl_20220725182607499_xbrl_20210805162907757_xbrl_20210726103505639_xbrl_20210716151159324_xbrl_20210716145845544_xbrl_20210716144837125_619" name="ifrs-full:ComprehensiveIncome" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">7,921</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuance of ordinary shares, net of issuance expenses (see Note 3)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230807105825648_xbrl_20220804201533828_xbrl_20220725182104960" name="ifrs-full:IssueOfEquity" contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230807105825648_xbrl_20220804201533828_xbrl_20220725182054265_xbrl_20220725181931129_xbrl_20210805162633992_xbrl_20210726103820235_xbrl_20210716144837125_615" name="ifrs-full:IssueOfEquity" contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,653</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230807105825648_xbrl_20220804201533828_xbrl_20220726011028297" name="ifrs-full:IssueOfEquity" contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230807105825648_xbrl_20220804201533828_xbrl_20220726011031293" name="ifrs-full:IssueOfEquity" contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230807105825648_xbrl_20220804201533828_xbrl_20220725182054265_xbrl_20220725181931129_xbrl_20210805162633992_xbrl_20210726103820235_xbrl_20210716144837125_619" name="ifrs-full:IssueOfEquity" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,671</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:40%" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise of options</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<span style="-sec-ix-hidden:Fxbrl_20220804205853790">*</span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911308_xbrl_20220726011223576" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911308_xbrl_20220726011230580" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911308_xbrl_20220726011233993" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<span style="-sec-ix-hidden:Fxbrl_20220804205858797">*</span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911319_xbrl_20220726011240408" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911319_xbrl_20220725182444873_xbrl_20210805162907776_xbrl_20210726103505658_xbrl_20210716151223357_xbrl_20210716145820919_xbrl_20210716144837125_87" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">597</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911319_xbrl_20220726011246769" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911319_xbrl_20220726011250232" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911319_xbrl_20220725182444873_xbrl_20210805162907776_xbrl_20210726103505658_xbrl_20210716151223357_xbrl_20210716145820919_xbrl_20210716144837125_819" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">597</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of June 30, 2022 (unaudited)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911338_xbrl_20220725182308741_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_23" name="ifrs-full:Equity" contextRef="C_20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">93</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911338_xbrl_20220725182308741_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_27" name="ifrs-full:Equity" contextRef="C_20220630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">154,119</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911338_xbrl_20220725182308741_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_211" name="ifrs-full:Equity" contextRef="C_20220630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220804200911338_xbrl_20220725182308741_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_215" name="ifrs-full:Equity" contextRef="C_20220630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">156,450</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230807141756506" name="ifrs-full:Equity" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,235</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:bottom;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2021 (audited)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804201102031_xbrl_20220725182311049_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_23" name="ifrs-full:Equity" contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">75</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804201102031_xbrl_20220725182311049_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_27" name="ifrs-full:Equity" contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">143,869</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220804201102031_xbrl_20220725182311049_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_211" name="ifrs-full:Equity" contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220804201102031_xbrl_20220725182311049_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_215" name="ifrs-full:Equity" contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">148,507</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20230807112948167" name="ifrs-full:Equity" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">4,582</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:40%" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss for the period</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911374_xbrl_20220726011257799" name="ifrs-full:ProfitLoss" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911374_xbrl_20220726011307287" name="ifrs-full:ProfitLoss" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911374_xbrl_20220726011310153" name="ifrs-full:ProfitLoss" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220804200911374_xbrl_20220725182640742_xbrl_20210805162907731_xbrl_20210726103505618_xbrl_20210716150154169_xbrl_20210716145835728_xbrl_20210716144837125_415" name="ifrs-full:ProfitLoss" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,599</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220804200911374_xbrl_20220725182640742_xbrl_20210805162907731_xbrl_20210726103505618_xbrl_20210716150154169_xbrl_20210716145835728_xbrl_20210716144837125_419" name="ifrs-full:ProfitLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,599</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other comprehensive income</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911392_xbrl_20220726011317028" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911392_xbrl_20220726011322488" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911392_xbrl_20220725182713730_xbrl_20210805162907744_xbrl_20210726103505630_xbrl_20210716150923612_xbrl_20210716145820903_xbrl_20210716144837125_511" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">14</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911392_xbrl_20220726011325504" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911392_xbrl_20220725182713730_xbrl_20210805162907744_xbrl_20210726103505630_xbrl_20210716150923612_xbrl_20210716145820903_xbrl_20210716144837125_519" name="ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">14</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:40%" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total comprehensive loss</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911408_xbrl_20220726011333568" name="ifrs-full:ComprehensiveIncome" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911408_xbrl_20220725182613379_xbrl_20210805162907757_xbrl_20210726103505639_xbrl_20210716151159324_xbrl_20210716145845544_xbrl_20210716144837125_611" name="ifrs-full:ComprehensiveIncome" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220804200911408_xbrl_20220725182613379_xbrl_20210805162907757_xbrl_20210726103505639_xbrl_20210716151159324_xbrl_20210716145845544_xbrl_20210716144837125_615" name="ifrs-full:ComprehensiveIncome" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,599</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220804200911408_xbrl_20220725182613379_xbrl_20210805162907757_xbrl_20210726103505639_xbrl_20210716151159324_xbrl_20210716145845544_xbrl_20210716144837125_619" name="ifrs-full:ComprehensiveIncome" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,585</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise of options</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<span style="-sec-ix-hidden:Fxbrl_20230811011212291">*</span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<span style="-sec-ix-hidden:Fxbrl_20230807164406322_xbrl_20220804200911308_xbrl_20220726011223576">*</span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230807164406322_xbrl_20220804200911308_xbrl_20220726011230580" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230807164406322_xbrl_20220804200911308_xbrl_20220726011233993" name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<span style="-sec-ix-hidden:Fxbrl_20230807164406322_xbrl_20220804205858797">*</span></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:40%" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuance of ordinary shares, net of issuance expenses</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230807105833497_xbrl_20220804201533828_xbrl_20220725182104960" name="ifrs-full:IssueOfEquity" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230807105833497_xbrl_20220804201533828_xbrl_20220725182054265_xbrl_20220725181931129_xbrl_20210805162633992_xbrl_20210726103820235_xbrl_20210716144837125_615" name="ifrs-full:IssueOfEquity" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,389</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230807105833497_xbrl_20220804201533828_xbrl_20220726011028297" name="ifrs-full:IssueOfEquity" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230807105833497_xbrl_20220804201533828_xbrl_20220726011031293" name="ifrs-full:IssueOfEquity" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230807105833497_xbrl_20220804201533828_xbrl_20220725182054265_xbrl_20220725181931129_xbrl_20210805162633992_xbrl_20210726103820235_xbrl_20210716144837125_619" name="ifrs-full:IssueOfEquity" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,429</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise of pre-funded warrants</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230807110509789_xbrl_20230807105833497_xbrl_20220804201533828_xbrl_20220725182104960" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230807110509789_xbrl_20230807105833497_xbrl_20220804201533828_xbrl_20220725182054265_xbrl_20220725181931129_xbrl_20210805162633992_xbrl_20210726103820235_xbrl_20210716144837125_615" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,678</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230807110509789_xbrl_20230807105833497_xbrl_20220804201533828_xbrl_20220726011028297" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230807110509789_xbrl_20230807105833497_xbrl_20220804201533828_xbrl_20220726011031293" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20230807110509789_xbrl_20230807105833497_xbrl_20220804201533828_xbrl_20220725182054265_xbrl_20220725181931129_xbrl_20210805162633992_xbrl_20210726103820235_xbrl_20210716144837125_619" name="ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,706</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:2px" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911433_xbrl_20220726011400608" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911433_xbrl_20220725182440873_xbrl_20210805162907776_xbrl_20210726103505658_xbrl_20210716151223357_xbrl_20210716145820919_xbrl_20210716144837125_87" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,946</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911433_xbrl_20220726011406088" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911433_xbrl_20220726011408975" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200911433_xbrl_20220725182440873_xbrl_20210805162907776_xbrl_20210726103505658_xbrl_20210716151223357_xbrl_20210716145820919_xbrl_20210716144837125_819" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,946</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:4px" valign="bottom">
                    <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance as of December 31, 2022 (audited)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200950679_xbrl_20220725182314592_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_23" name="ifrs-full:Equity" contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">143</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200950679_xbrl_20220725182314592_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_27" name="ifrs-full:Equity" contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">178,882</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220804200950679_xbrl_20220725182314592_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_211" name="ifrs-full:Equity" contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220804200950679_xbrl_20220725182314592_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_215" name="ifrs-full:Equity" contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">168,106</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220804200950679_xbrl_20220725182314592_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_219" name="ifrs-full:Equity" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,914</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>

            </table>
            <div style="text-align:justify;line-height:1.25">&#160;</div>
            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(*)&#160;&#160;&#160;&#160;&#160;&#160; Represents less than $ 1.</span></span></div>
            <div style="text-align:justify;line-height:1.25">&#160;</div>
            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying notes are an integral part of the interim consolidated financial statements.</span></span></div>
          </div>
        </div>
        <div style="text-align:justify;line-height:1.25">
          <p style="margin:0pt">&#160;</p>
          <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:7pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 5</span></span></span></span></span></span></span></div><div><hr style="break-after:page;border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:0px" /></div></div><div style="text-align:left"><div><div><div style="margin-top:0px;margin-bottom:0pt;text-align:right"><p style="margin-top:10pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="font-weight:bold;color:rgb(0, 0, 0)">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></p></div></div></div></div><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
        </div>
      </div>
    </div>
  </div>
</div><div style="">
  <div>
    <div>
      <div>
        <div style="line-height:1.25">
          <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Unaudited Condensed Interim Consolidated Statements of Cash Flows<span id="Flows_integixAnchor"></span></span></span></span></div>
          <div style="text-align:justify;line-height:1.25;font-weight:bold">
            <hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;margin-top:5pt;margin-bottom:5pt;text-align:center" />
          </div>
        </div>
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>U.S. dollars in thousands</span></span></span></div>
        <div style="line-height:1.25">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

            <tr>
              <td colspan="1" style="vertical-align:top;padding-left:9pt;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Six months ended</span></span></span></div>
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>June 30,</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Three months ended</span></span></span></div>
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>June 30,</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Year ended December 31,</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;padding-left:9pt;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>2023</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>2022</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>2023</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>2022</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>2022</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="text-decoration:underline">Cash flows from operating activities:</span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;padding-left:9pt;width:40%;padding-bottom:2px" valign="bottom">
                <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Net income (loss)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20210716153321700_xbrl_20210716153257620_xbrl_20210716153212506_43" name="ifrs-full:ProfitLoss" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,777</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20210726131029374" name="ifrs-full:ProfitLoss" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">7,943</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210726105355449" name="ifrs-full:ProfitLoss" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">916</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20210726095130879" name="ifrs-full:ProfitLoss" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">4,354</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20210726112027429" name="ifrs-full:ProfitLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">19,599</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;padding-left:9pt;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;padding-left:9pt;width:40%" valign="bottom">
                <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Adjustments to reconcile net income (loss) to net cash used in operating activities:</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;padding-left:9pt;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;padding-left:9pt;width:40%" valign="bottom">
                <div style="text-indent:-10pt;margin-left:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Adjustments to profit and loss items:</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:bottom;padding-left:9pt;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-indent:-10pt;margin-left:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Depreciation and amortization</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153328165_xbrl_20210716153257620_xbrl_20210716153212506_43" name="ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">618</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153328165_xbrl_20210716153257620_xbrl_20210716153212506_47" name="ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">650</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153328165_xbrl_20210716153257620_xbrl_20210716153212506_411" name="ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">315</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153328165_xbrl_20210716153257620_xbrl_20210716153212506_415" name="ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">329</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153328165_xbrl_20210716153257620_xbrl_20210716153212506_419" name="ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,272</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:bottom;padding-left:9pt;width:40%" valign="bottom">
                <div style="text-indent:-10pt;margin-left:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Share-based compensation</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_43" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,331</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_47" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">597</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_411" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">712</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_415" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">252</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_419" name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,946</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:bottom;padding-left:9pt;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-indent:-10pt;margin-left:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Revaluation of warrants accounted at fair value</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20230807102241950_xbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_43" name="mdwd:RevaluationOfWarrantsAccountedAtFairValue" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,923</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20230807102241950_xbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_47" name="mdwd:RevaluationOfWarrantsAccountedAtFairValue" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20230807102241950_xbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_411" name="mdwd:RevaluationOfWarrantsAccountedAtFairValue" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,990</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20230807102241950_xbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_415" name="mdwd:RevaluationOfWarrantsAccountedAtFairValue" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20230807102241950_xbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_419" name="mdwd:RevaluationOfWarrantsAccountedAtFairValue" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">8,977</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:bottom;padding-left:9pt;width:40%" valign="bottom">
                <div style="text-indent:-10pt;margin-left:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Issuance expenses of warrants through profit and loss</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20230807102243878_xbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_43" name="mdwd:AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20230807102243878_xbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_47" name="mdwd:AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20230807102243878_xbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_411" name="mdwd:AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20230807102243878_xbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_415" name="mdwd:AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20230807102243878_xbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_419" name="mdwd:AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,911</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:bottom;padding-left:9pt;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-indent:-10pt;margin-left:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Revaluation of liabilities in respect of IIA grants</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153332948_xbrl_20210716153257620_xbrl_20210716153212506_43" name="mdwd:RevaluationOfLiabilitiesInRespectOfGrants" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">492</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153332948_xbrl_20210716153257620_xbrl_20210716153212506_47" name="mdwd:RevaluationOfLiabilitiesInRespectOfGrants" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">482</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153332948_xbrl_20210716153257620_xbrl_20210716153212506_411" name="mdwd:RevaluationOfLiabilitiesInRespectOfGrants" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">233</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153332948_xbrl_20210716153257620_xbrl_20210716153212506_415" name="mdwd:RevaluationOfLiabilitiesInRespectOfGrants" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">248</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20230807105852423" name="mdwd:RevaluationOfLiabilitiesInRespectOfGrants" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">132</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;padding-left:9pt;width:40%" valign="bottom">
                <div style="text-indent:-10pt;margin-left:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Revaluation of liabilities in respect of TEVA</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20230807102257423_xbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_43" name="mdwd:RevaluationOfLiabilitiesInRespectOfTeva" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">241</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20230807102257423_xbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_47" name="mdwd:RevaluationOfLiabilitiesInRespectOfTeva" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">272</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20230807102257423_xbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_411" name="mdwd:RevaluationOfLiabilitiesInRespectOfTeva" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">119</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20230807102257423_xbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_415" name="mdwd:RevaluationOfLiabilitiesInRespectOfTeva" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">135</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20230807102257423_xbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_419" name="mdwd:RevaluationOfLiabilitiesInRespectOfTeva" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">533</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;padding-left:9pt;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-indent:-10pt;margin-left:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Revaluation of lease liabilities</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20220725190439309" name="mdwd:RevaluationOfLeaseLiabilities" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20230807105705827" name="mdwd:RevaluationOfLeaseLiabilities" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">152</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20220725190507709" name="mdwd:RevaluationOfLeaseLiabilities" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20230807105841079" name="mdwd:RevaluationOfLeaseLiabilities" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">138</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20230807105859758" name="mdwd:RevaluationOfLeaseLiabilities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">109</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;padding-left:9pt;width:40%" valign="bottom">
                <div style="text-indent:-10pt;margin-left:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Increase (decrease) in severance pay liability, net</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210726100109446" name="ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">67</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20220725190609462" name="ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">55</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20230807105719939" name="ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">10</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153343060_xbrl_20210716153257620_xbrl_20210716153212506_415" name="ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">35</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153343060_xbrl_20210716153257620_xbrl_20210716153212506_419" name="ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">109</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;padding-left:9pt;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-indent:-10pt;margin-left:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Net financing income</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20210716153345828_xbrl_20210716153257620_xbrl_20210716153212506_43" name="ifrs-full:AdjustmentsForFinanceIncomeCost" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,005</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20210716153345828_xbrl_20210716153257620_xbrl_20210716153212506_47" name="ifrs-full:AdjustmentsForFinanceIncomeCost" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20220725190634806" name="ifrs-full:AdjustmentsForFinanceIncomeCost" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">759</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20230807105832831" name="ifrs-full:AdjustmentsForFinanceIncomeCost" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20210716153345828_xbrl_20210716153257620_xbrl_20210716153212506_419" name="ifrs-full:AdjustmentsForFinanceIncomeCost" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">74</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;padding-left:9pt;width:40%;padding-bottom:2px" valign="bottom">
                <div style="text-indent:-10pt;margin-left:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Un-realized foreign currency loss</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210726112501750" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">466</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20220725191200728" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">528</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153347948_xbrl_20210716153257620_xbrl_20210716153212506_411" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">120</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210726112629145" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">283</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153347948_xbrl_20210716153257620_xbrl_20210716153212506_419" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">525</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;padding-left:9pt;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20230807105623029" name="ifrs-full:AdjustmentsForReconcileProfitLoss" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">3,735</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153350142_xbrl_20210716153257620_xbrl_20210716153212506_47" name="ifrs-full:AdjustmentsForReconcileProfitLoss" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,421</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20230807105731252" name="ifrs-full:AdjustmentsForReconcileProfitLoss" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">4,269</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153350142_xbrl_20210716153257620_xbrl_20210716153212506_415" name="ifrs-full:AdjustmentsForReconcileProfitLoss" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,133</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153350142_xbrl_20210716153257620_xbrl_20210716153212506_419" name="ifrs-full:AdjustmentsForReconcileProfitLoss" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,958</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;padding-left:9pt;width:40%" valign="bottom">
                <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Changes in asset and liability items:</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:bottom;padding-left:9pt;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-indent:-10pt;margin-left:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Decrease (increase) in trade receivables</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20220725191253189" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,115</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20230807105652603" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,024</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20220725191311342" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">707</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20230807105825740" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,445</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20230807105917686" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">7,582</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;padding-left:9pt;width:40%" valign="bottom">
                <div style="text-indent:-10pt;margin-left:21.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Increase in inventories</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20220725191327749" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,162</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20230807105645859" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">747</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20220725191340709" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">579</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20230807105819372" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">37</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20230807110024376" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">721</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:bottom;padding-left:9pt;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-indent:-10pt;margin-left:21.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Decrease in other receivables</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153356166_xbrl_20210716153257620_xbrl_20210716153212506_43" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">122</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210726113603315" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">330</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153356166_xbrl_20210716153257620_xbrl_20210716153212506_411" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">435</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210726113612210" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">205</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210726113620306" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">364</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;padding-left:9pt;width:40%" valign="bottom">
                <div style="text-indent:-10pt;margin-left:21.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Increase (decrease) in trade payables and accrued expenses</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20230807105634171" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,636</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210726113947029" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20220725191412516" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">312</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20230807105809964" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">272</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210726113922821" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">414</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;padding-left:9pt;width:40%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">
                <div style="text-indent:-10pt;margin-left:21.35pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Increase (decrease) in other payables and deferred revenues</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20210726114139269" name="mdwd:AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,526</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20220725191435632" name="mdwd:AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,367</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20210726114147954" name="mdwd:AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,359</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20220725192637042" name="mdwd:AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">484</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20220725192651617" name="mdwd:AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">281</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;padding-left:9pt;width:40%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20220725192742457" name="mdwd:AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,913</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20230807111039091" name="mdwd:AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">3,797</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20220725192758962" name="mdwd:AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,898</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20230807105801631" name="mdwd:AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,033</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20230807110108148" name="mdwd:AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">7,244</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;padding-left:9pt;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;padding-left:9pt;width:40%;padding-bottom:2px" valign="bottom">
                <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Net cash (used in) operating activities</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20210716153413812_xbrl_20210716153257620_xbrl_20210716153212506_43" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">4,599</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20210726115928284" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">9,319</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20210716153413812_xbrl_20210716153257620_xbrl_20210716153212506_411" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5,251</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20210726115939736" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5,254</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20210726115948143" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">11,885</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
            </tr>

        </table>&#160;<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>The accompanying notes are an integral part of the interim consolidated financial statements.</span></span></span></div>
      </div>
    </div>
    <div style="line-height:1.25">
      <p style="margin:0pt">&#160;</p>
      <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:7pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 6</span></span></span></span></span></span></span></div><div><hr style="break-after:page;border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:4px;margin-bottom:0px" /></div></div><div style="text-align:left"><div><div><div style="margin-top:0px;margin-bottom:0pt;text-align:right"><p style="margin-top:10pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="font-weight:bold;color:rgb(0, 0, 0)">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></p></div></div></div></div><p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</p>
    </div>
    <div>
      <div>
        <div style="line-height:1.25">
          <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Unaudited Condensed Interim Consolidated Statements of Cash Flows</span></span></span></div>
          <div style="text-align:justify;line-height:1.25;font-weight:bold">
            <hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;margin-top:5pt;margin-bottom:5pt;text-align:center" />
          </div>
        </div>
        <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>U.S. dollars in thousands</span></span></span></div>
        <div style="line-height:1.25;font-weight:bold">&#160;</div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

            <tr>
              <td colspan="1" style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Six months ended</span></span></span></div>
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>June 30,</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Three months ended</span></span></span></div>
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>June 30,</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Year ended December 31,</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>2023</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>2022</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>2023</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>2022</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>2022</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="text-decoration:underline">Cash Flows from Investing Activities:</span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
              <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-indent:4.2pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Purchase of property and equipment</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20210716153257620_xbrl_20210716153212506_43" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,570</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20210716153257620_xbrl_20210716153212506_47" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">298</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20210716153257620_xbrl_20210716153212506_411" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,065</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20210716153257620_xbrl_20210716153212506_415" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">138</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20210716153257620_xbrl_20210716153212506_419" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">555</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%" valign="bottom">
                <div style="text-indent:4.2pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Interest received</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153417028_xbrl_20210716153257620_xbrl_20210716153212506_43" name="ifrs-full:InterestReceivedClassifiedAsInvestingActivities" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">879</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153417028_xbrl_20210716153257620_xbrl_20210716153212506_47" name="ifrs-full:InterestReceivedClassifiedAsInvestingActivities" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210726120225212" name="ifrs-full:InterestReceivedClassifiedAsInvestingActivities" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">577</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153417028_xbrl_20210716153257620_xbrl_20210716153212506_415" name="ifrs-full:InterestReceivedClassifiedAsInvestingActivities" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153417028_xbrl_20210716153257620_xbrl_20210716153212506_419" name="ifrs-full:InterestReceivedClassifiedAsInvestingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">74</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-indent:4.2pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Investment in short term bank deposits, net</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20220725193000184" name="ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">31,830</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20230807120316315" name="ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,499</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20210716153419069_xbrl_20210716153257620_xbrl_20210716153212506_411" name="ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">25,590</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20220725193146197" name="ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,499</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153419069_xbrl_20210716153257620_xbrl_20210716153212506_419" name="ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Net cash used in investing activities</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20220725193158809" name="ifrs-full:CashFlowsFromUsedInInvestingActivitiesContinuingOperations" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">33,521</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20230807120326674" name="ifrs-full:CashFlowsFromUsedInInvestingActivitiesContinuingOperations" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,797</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20210726121036886" name="ifrs-full:CashFlowsFromUsedInInvestingActivitiesContinuingOperations" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">26,078</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20220725193224511" name="ifrs-full:CashFlowsFromUsedInInvestingActivitiesContinuingOperations" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">2,637</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20230807120336153" name="ifrs-full:CashFlowsFromUsedInInvestingActivitiesContinuingOperations" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">481</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="text-decoration:underline">Cash Flows from Financing Activities:</span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-indent:4.2pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Repayment of leases liabilities</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_43" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">334</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_47" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">350</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_411" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">157</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_415" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">172</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_419" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">701</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%" valign="bottom">
                <div style="text-indent:4.2pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Proceeds from exercise of options</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<span style="-sec-ix-hidden:Fxbrl_20230807114925679_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_43">*</span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<span style="-sec-ix-hidden:Fxbrl_20230807114925679_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_47">*</span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<span style="-sec-ix-hidden:Fxbrl_20230807114925679_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_411">*</span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<span style="-sec-ix-hidden:Fxbrl_20230807114925679_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_415">*</span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<span style="-sec-ix-hidden:Fxbrl_20230807114925679_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_419">*</span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-indent:4.2pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Proceeds from exercise of pre-funded warrants</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20230807114928344_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_43" name="ifrs-full:ProceedsFromExerciseOfWarrants" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20230807114928344_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_47" name="ifrs-full:ProceedsFromExerciseOfWarrants" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20230807114928344_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_411" name="ifrs-full:ProceedsFromExerciseOfWarrants" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20230807114928344_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_415" name="ifrs-full:ProceedsFromExerciseOfWarrants" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20230807114928344_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_419" name="ifrs-full:ProceedsFromExerciseOfWarrants" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%" valign="bottom">
                <div style="text-indent:4.2pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Proceeds from (Repayment of) issuance of shares and warrants, net</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20230811014007588" name="mdwd:RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">24,909</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20230811014016505" name="mdwd:RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">9,861</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20230811014019140" name="mdwd:RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">248</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20230811014022090" name="mdwd:RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">556</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20230811014025058" name="mdwd:RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">38,380</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-indent:4.2pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Repayment of IIA grants, net</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20210805171548721_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_43" name="mdwd:RepaymentFromGrants" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">310</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20210805171548721_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_47" name="mdwd:RepaymentFromGrants" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">162</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210805171548721_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_411" name="mdwd:RepaymentFromGrants" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210805171548721_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_415" name="mdwd:RepaymentFromGrants" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20210805171548721_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_419" name="mdwd:RepaymentFromGrants" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">258</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:2px" valign="bottom">
                <div style="margin-left:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Repayment of liabilities in respect of TEVA</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20230807114936719_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_43" name="mdwd:RepaymentOfLiabilitiesInRespectOfTeva" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">417</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20230807114936719_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_47" name="mdwd:RepaymentOfLiabilitiesInRespectOfTeva" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20230807114936719_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_411" name="mdwd:RepaymentOfLiabilitiesInRespectOfTeva" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20230807114936719_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_415" name="mdwd:RepaymentOfLiabilitiesInRespectOfTeva" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20230807114936719_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_419" name="mdwd:RepaymentOfLiabilitiesInRespectOfTeva" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,667</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:2px" valign="bottom">
                <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Net cash provided by (used in) financing activities</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153439236_xbrl_20210716153257620_xbrl_20210716153212506_43" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,848</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153439236_xbrl_20210716153257620_xbrl_20210716153212506_47" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,349</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20210716153439236_xbrl_20210716153257620_xbrl_20210716153212506_411" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">405</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20210726121603510" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">728</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153439236_xbrl_20210716153257620_xbrl_20210716153212506_419" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">35,764</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:2px" valign="bottom">
                <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Exchange rate differences on cash and cash equivalent balances</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20220725195249758" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">457</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20230807120520323" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">550</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20220725195317273" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">120</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20230807120526776" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">303</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20230807120533068" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">549</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%" valign="bottom">
                <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Increase (decrease) in cash and cash equivalents</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20210726122051717" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">14,729</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20220725195333303" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">3,317</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20210726122144986" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">31,854</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(<ix:nonFraction id="Fxbrl_20220725195344490" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">8,922</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20220725195510182" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,849</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:2px" valign="bottom">
                <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Balance of cash and cash equivalents at the beginning of the period</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153449900_xbrl_20210716153257620_xbrl_20210716153212506_43" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,895</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153449900_xbrl_20210716153257620_xbrl_20210716153212506_47" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,046</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153449900_xbrl_20210716153257620_xbrl_20210716153212506_411" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20230331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">51,020</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20230530171912645" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20220331" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,651</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153449900_xbrl_20210716153257620_xbrl_20210716153212506_419" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20211231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,046</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:4px" valign="bottom">
                <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Balance of cash and cash equivalents at the end of the period</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153452373_xbrl_20210716153257620_xbrl_20210716153212506_43" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,166</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153452373_xbrl_20210716153257620_xbrl_20210716153212506_47" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,729</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153452373_xbrl_20210716153257620_xbrl_20210716153212506_411" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,166</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153452373_xbrl_20210716153257620_xbrl_20210716153212506_415" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,729</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210716153452373_xbrl_20210716153257620_xbrl_20210716153212506_419" name="ifrs-full:CashAndCashEquivalents" contextRef="C_20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,895</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%" valign="bottom">
                <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="text-decoration:underline">Supplement disclosure of Non-cash transactions:</span></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="vertical-align:top;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="text-indent:-10pt;margin-left:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>ROU asset, net recognized with corresponding lease liability</span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210805171624139_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_43" name="ifrs-full:RightofuseAssetsIncreaseDecreaseInRevaluationSurplus" contextRef="C_20230101to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">154</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210805171624139_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_47" name="ifrs-full:RightofuseAssetsIncreaseDecreaseInRevaluationSurplus" contextRef="C_20220101to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">43</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210805171624139_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_411" name="ifrs-full:RightofuseAssetsIncreaseDecreaseInRevaluationSurplus" contextRef="C_20230401to20230630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">102</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210805171624139_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_415" name="ifrs-full:RightofuseAssetsIncreaseDecreaseInRevaluationSurplus" contextRef="C_20220401to20220630" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">43</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
              <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonFraction id="Fxbrl_20210805171624139_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_419" name="ifrs-full:RightofuseAssetsIncreaseDecreaseInRevaluationSurplus" contextRef="C_20220101to20221231" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">117</ix:nonFraction></span></span></span></div>
              </td>
              <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            </tr>

        </table>
        <div style="line-height:1.25">&#160;</div>
        <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>The accompanying notes are an integral part of the interim consolidated financial statements.</span></span></span></div>
      </div>
    </div>
    <div style="text-align:justify;line-height:1.25">
      <p style="margin-top:0px;margin-bottom:0px">&#160;</p>
      <p style="text-align:center;margin-top:6pt;margin-bottom:4pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>F - 7</span></span></span></span></span></span></span></span></span></p>
    </div>
  </div>
  <hr style="page-break-after:always;border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:0pt;margin-bottom:0pt" />
</div><div style="">
  <div style="line-height:1.25">
    <div style="margin-top:0pt;margin-bottom:0pt;text-align:right">
      <p style="margin-top:10pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:10pt;font-weight:bold;color:rgb(0, 0, 0)">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></p>
    </div>
    <p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
    <div>
      <div style="margin-top:0pt;margin-bottom:0pt;text-align:justify">
        <p style="margin-top:0pt;margin-bottom:6pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span id="Notes_integixAnchor"><span id="NotestoUnauditedCondensedInterimConsolidatedFinancialStatements_integixAnchor"><span style="font-family:Times New Roman, Times, serif;font-size:10pt"><strong>Notes to Unaudited Condensed Interim Consolidated Financial Statements&#160;</strong></span></span></span></p>
        <hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;margin-top:5pt;margin-bottom:5pt;text-align:center" />
      </div>
    </div>
    <div style="margin-top:4pt;margin-bottom:11pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-family:Times New Roman, Times, serif;font-size:10pt;font-style:normal;color:rgb(0, 0, 0);line-height:1;font-weight:bold">U.S. dollars in thousands</span></div>
  </div>
  <ix:nonNumeric id="Fxbrl_20220725183253877" name="ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" contextRef="C_20230101to20230630" escape="true">
    <div>
      <div>
        <div>
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:56.7pt;vertical-align:top;font-weight:bold">Note 1:</td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold">General</div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:57.3pt">&#160;</td>
                  <td style="width:27.75pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold">a.</td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-weight:bold">Description of the Company and its operations:</div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-weight:bold">
                      <div style="line-height:1.25;font-weight:normal">MediWound Ltd. Was incorporated in Israel. The Company which is located in Yavne, Israel (The "Company" or "MediWound"), is biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, bio-therapeutic, non-surgical solutions for tissue repair and regeneration. The Company&#8217;s strategy leverages its breakthrough enzymatic technology platform into diversified portfolio of biotherapeutics across multiple indications to pioneer solutions for unmet medical needs.<span style="font-size:12pt;color:rgb(61, 61, 100)">&#160;</span> The Company&#8217;s current portfolio is focused on next-generation protein-based therapies for burn care, wound care and tissue repair.<br /><span style="font-weight:normal">&#160;</span></div>
                      <div style="line-height:1.25;font-weight:normal">The Company's first innovative biopharmaceutical product, NexoBrid, has received in December 2022, an approval from the U.S. Food and Drug Administration (&#8220;FDA&#8221;) and marketing approval in each of India, Switzerland and Japan. In addition it has a marketing authorization from the European Medicines Agency (&#8220;EMA&#8221;) and regulatory agencies in other international markets for removal of dead or damaged tissue, known as eschar, in adults with deep partial and full thickness thermal burns.<br /><span style="font-weight:normal">&#160;</span></div>
                      <div style="line-height:1.25;font-weight:normal">The Company commercialize NexoBrid globally through multiple sales channels.</div>
                    </div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:102.45pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top">&#8226;</td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div>The Company sell NexoBrid to burn centers in the European Union, United Kingdom and Israel, primarily through its commercial organizations.</div>
                  </td>
                </tr>

            </table>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:102.45pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top">&#8226;</td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div>The Company have established local distribution channels in multiple international markets, focusing on Asia Pacific, EMEA, CEE and LATAM, which local distributors are also responsible for obtaining local marketing authorization within the relevant territories.</div>
                  </td>
                </tr>

            </table>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:102.5pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top">&#8226;</td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div>In the United States, the Company entered into exclusive license and supply agreements with Vericel Corporation (&#8220;Vericel&#8221;) to commercialize NexoBrid in North America upon FDA approval.</div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:57.3pt">&#160;</td>
                    <td style="width:27.75pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;</td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div style="font-weight:bold">
                        <div style="line-height:1.25;font-weight:normal">
                          <div style="line-height:1.25">The Company&#8217;s second investigational next-generation enzymatic therapy product, EscharEx, a topical biological drug being developed for debridement of chronic and other hard-to-heal wounds, is currently under discussions with the FDA regarding the pivotal Phase 3 study design.</div>
                          <div style="line-height:1.25">&#160;</div>
                          <div style="line-height:1.25;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);margin-bottom:10pt">The third clinical-stage innovative product candidate, MW005, is a topical applied biological drug candidate for the treatment of non-melanoma skin cancers. A U.S. phase 1/2 study of MW005 for the treatment of low-risk basal cell carcinoma (BCC) was initiated in July 2021, and an investigator-initiated phase II trial of MW005 in non-melanoma skin cancer is being conducted in parallel in Israel. In December 2022, the Company announced final positive results from the study. Based on the positive results, The Company plan to continue enrolling patients in its Phase 1/2 study.</div>
                        </div>
                      </div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div><ix:exclude>
          <div style="line-height:1.25">
            <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 8</span></span></span></span></span></span></span></span></span></div><div><hr style="page-break-after:always;border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:6px;margin-bottom:6px" /></div></div><div style="text-align:left"><div><div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right"><p style="margin-top:10pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="font-weight:bold;color:rgb(0, 0, 0);margin-top:10pt">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></p></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify;margin-top:0pt;margin-bottom:0pt"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:6pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><strong>Notes to Unaudited Condensed Interim Consolidated Financial Statements&#160;</strong></span></span></span></span></p><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;margin-top:5pt;margin-bottom:5pt;text-align:center" /></div></div><div style="text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:4pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands </span></span></span></span></span></span></span></span></span></span></div></div></div></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div>
          </div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:56.7pt;vertical-align:top;font-weight:bold;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Note 1:</span></span></td>
                <td style="width:auto;vertical-align:top">
                  <div style="font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">General (Cont.)</span></span></div>
                </td>
              </tr>
              <tr>
                <td style="width:56.7pt;vertical-align:top;font-weight:bold;margin-top:0pt;margin-bottom:0pt">&#160;</td>
                <td style="width:auto;vertical-align:top">&#160;</td>
              </tr>

          </table>
        </ix:exclude></div>
        <div>
          <div>
            <div style="margin-top:0px">
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:57.3pt">&#160;</td>
                    <td style="width:27.75pt;vertical-align:top;font-weight:bold"><span style="font-family:Times New Roman,Times,serif">b.</span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div><span style="font-family:Times New Roman,Times,serif">The Company's securities are listed for trading on NASDAQ since March 2014.</span></div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:57.3pt">&#160;</td>
                  <td style="width:27.75pt;vertical-align:top;font-weight:bold"><span style="font-family:Times New Roman,Times,serif">c.</span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-family:Times New Roman,Times,serif">The Company has three wholly owned subsidiaries: MediWound Germany GmbH, acting as Europe (&#8220;EU&#8221;) marketing authorization holder and EU sales and marketing arm, and MediWound UK Limited and MediWound US, Inc. which are currently inactive companies.</span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:57.3pt">&#160;</td>
                  <td style="width:27.75pt;vertical-align:top;font-weight:bold"><span style="font-family:Times New Roman,Times,serif">d.</span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-family:Times New Roman,Times,serif">The Company awarded two contracts with the U.S. Biomedical Advanced Research and Development Authority ("BARDA") valued at up to $<ix:nonFraction id="Fxbrl_20230811093412429" name="mdwd:ContractAmountForResearchDevelopmentAndManufacturing" contextRef="C_20230101to20230630_ifrsfullBorrowingsByNameAxis_mdwdBardaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">209,000</ix:nonFraction> for the advancement of the development, manufacturing and emergency readiness for NexoBrid deployment as well as the procurement of NexoBrid as a medical countermeasure as part of BARDA preparedness for mass casualty events.</span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On May 9, 2023 BARDA has awarded an additional $<ix:nonFraction id="Fxbrl_20230811094644882" name="mdwd:AdditionalProceedsFromFunding" contextRef="C_20230501to20230509_ifrsfullBorrowingsByNameAxis_mdwdBardaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,000</ix:nonFraction> to the Company. The supplemental funding will support $<ix:nonFraction id="Fxbrl_20230811094030718" name="mdwd:ContractAmountForResearchDevelopmentAndManufacturing" contextRef="C_20230501to20230509_deiLegalEntityAxis_mdwdUSFoodAndDrugAdministrationMember_ifrsfullBorrowingsByNameAxis_mdwdBardaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,000</ix:nonFraction> R&#38;D activities and $<ix:nonFraction id="Fxbrl_20230811094911752" name="mdwd:ReplenishmentAmount" contextRef="C_20230501to20230509_deiLegalEntityAxis_mdwdUSFoodAndDrugAdministrationMember_ifrsfullBorrowingsByNameAxis_mdwdBardaMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,000</ix:nonFraction> replenishment of expired product previously procured for emergency preparedness, the pediatric indication sBLA submission to the U.S. Food and Drug Administration (FDA), and enrollment of an additional <ix:nonFraction id="Fxbrl_20230811094900063" name="mdwd:NumberOfPatients" contextRef="C_20230501to20230509_deiLegalEntityAxis_mdwdUSFoodAndDrugAdministrationMember_ifrsfullBorrowingsByNameAxis_mdwdBardaMember" unitRef="Patient" decimals="INF" format="ixt:num-dot-decimal">50</ix:nonFraction> patients in the ongoing expanded access treatment protocol (NEXT).</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:57.3pt">&#160;</td>
                  <td style="width:27.75pt;vertical-align:top;color:#000000;font-weight:bold"><span style="font-family:Times New Roman,Times,serif">e.</span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="color:#000000"><span style="font-family:Times New Roman,Times,serif">Our Partner, Vericel Corporation Inc. (&#8220;<span style="font-weight:bold">Vericel</span>&#8221;) has received the first lot of NexoBrid&#174; finished product from the company for the U.S. commercial market in June 2023, which currently is warehoused at Vericel&#8217;s third-party logistics distributor. Although this NexoBrid finished product batch has met all required release criteria for distribution in the U.S., Vericel is unable to release this product into the commercial channel at this time due to a deviation associated with a third-party testing lab used during the manufacturing process. A detailed risk assessment prepared by the Company and Vericel has concluded that the deviation presents no incremental risk to the finished product&#8217;s quality and safety, and the company actively engaged with Vericel and the U.S. Food and Drug Administration (FDA) to address this matter. Future manufacturing of NexoBrid drug product for the U.S. market will not be impacted because the at-issue test will be conducted directly by the Company. As the FDA has not yet authorized the commercial release of the finished product affected by the deviation, the company is currently preparing for a production campaign scheduled to begin in September 2023.</span></div>
                  </td>
                </tr>

            </table>
            <div style="text-align:justify;margin-left:63.85pt;line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:57.3pt">&#160;</td>
                  <td style="width:27.75pt;vertical-align:top;font-weight:bold"><span style="font-family:Times New Roman,Times,serif">f.</span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-family:Times New Roman,Times,serif">In 2022 the Company engaged with the U.S. Department of Defense (DoD), through the Medical Technology Enterprise Consortium (MTEC), for a $<ix:nonFraction id="Fxbrl_20230807130321124" name="mdwd:ContractWithCustomers" contextRef="C_20220101to20221231_deiLegalEntityAxis_mdwdUSDepartmentOfDefenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,800 </ix:nonFraction>contract for the development of NexoBrid as a non-surgical solution for field-care burn treatment for the U.S. Army. This contract was amended in April 2023 to extend the total value, up to a total amount of $<ix:nonFraction id="Fxbrl_20230807130333507" name="mdwd:ContractWithCustomers" contextRef="C_20230401to20230430_deiLegalEntityAxis_mdwdUSDepartmentOfDefenseMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,700</ix:nonFraction>.</span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
          </div>
        </div>
      </div>
    </div>
  </ix:nonNumeric>
  <div style="line-height:1.25">
    <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 9</span></span></span></span></span></span></span></span></span></div><div><hr style="page-break-after:always;border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:6px;margin-bottom:6px" /></div></div><div style="text-align:left"><div><div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right"><p style="margin-top:10pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="font-weight:bold;color:rgb(0, 0, 0);margin-top:10pt">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></p></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify;margin-top:0pt;margin-bottom:0pt"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:6pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><strong>Notes to Unaudited Condensed Interim Consolidated Financial Statements&#160;</strong></span></span></span></span></p><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;margin-top:5pt;margin-bottom:5pt;text-align:center" /></div></div><div style="text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:4pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands </span></span></span></span></span></span></span></span></span></span></div></div></div></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div>
  </div>
</div><div style="">
  <div>
    <div>
      <div>
        <div>
          <div>
            <div>
              <ix:nonNumeric id="Fxbrl_20220725172057415" name="ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" contextRef="C_20230101to20230630" escape="true">
                <div>
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span>Note 2:</span></span></span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span>S</span></span></span></span><strong><span style="line-height:110%">ignificant Accounting Policies</span></strong></span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold">&#160;</td>
                          <td style="width:auto;vertical-align:top;text-align:justify">&#160;</td>
                        </tr>
                        <tr>
                          <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold">&#160;</td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">The following accounting policies have been applied consistently in the financial statements for all periods presented unless otherwise stated.</span></p>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>
                    <ix:nonNumeric id="Fxbrl_20210805180246968" name="ifrs-full:DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements" contextRef="C_20230101to20230630" escape="true">
                      <div>
                        <div>
                          <table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt">

                              <tr style="vertical-align:top">
                                <td style="width:57pt">&#160;</td>
                                <td style="vertical-align:top;width:27pt">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">a.</span></span></span></span></span></div>
                                </td>
                                <td style="vertical-align:top;width:auto">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Basis of presentation of financial statements:</span></span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:57pt">&#160;</td>
                                <td style="vertical-align:top;width:27pt">&#160;</td>
                                <td style="vertical-align:top;width:auto">&#160;</td>
                              </tr>
                              <tr>
                                <td style="width:57pt">&#160;</td>
                                <td style="vertical-align:top;width:27pt">&#160;</td>
                                <td style="vertical-align:top;width:auto">
                                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">These financial statements have been prepared in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board ("IASB").</span></p>
                                </td>
                              </tr>

                          </table>
                        </div>
                      </div>
                    </ix:nonNumeric>
                    <div style="line-height:1.25">&#160;</div>
                    <ix:nonNumeric id="Fxbrl_20210805180300927" name="mdwd:DescriptionOfOtherAccountingPoliciesBasisOfPreparationOfInterimConsolidatedFinancialStatementsExplanatory" contextRef="C_20230101to20230630" escape="true">
                      <div>
                        <div>
                          <table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt">

                              <tr style="vertical-align:top">
                                <td style="width:57pt">&#160;</td>
                                <td style="vertical-align:top;width:27pt">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">b.</span></span></span></span></span></div>
                                </td>
                                <td style="vertical-align:top;width:auto">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Basis of preparation of the interim consolidated financial statements:</span></span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:57pt">&#160;</td>
                                <td style="vertical-align:top;width:27pt">&#160;</td>
                                <td style="vertical-align:top;width:auto">&#160;</td>
                              </tr>
                              <tr>
                                <td style="width:57pt">&#160;</td>
                                <td style="vertical-align:top;width:27pt">&#160;</td>
                                <td style="vertical-align:top;width:auto">
                                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">The interim condensed consolidated financial statements for the six and three months ended June 30, 2023&#160;have been prepared in accordance with IAS 34 "Interim Financial Reporting".</span></p>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:57pt">&#160;</td>
                                <td style="vertical-align:top;width:27pt">&#160;</td>
                                <td style="vertical-align:top;width:auto">&#160;</td>
                              </tr>
                              <tr>
                                <td style="width:57pt">&#160;</td>
                                <td style="vertical-align:top;width:27pt">&#160;</td>
                                <td style="vertical-align:top;width:auto">
                                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">The interim condensed consolidated financial statements do not include all the information and disclosures required in the annual financial statements, and should be read in conjunction with the Company's annual financial statements as of December 31, 2022 that were included in the Annual Report on Form 20-F filed on March 16, 2023.</span></p>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:57pt">&#160;</td>
                                <td style="vertical-align:top;width:27pt">&#160;</td>
                                <td style="vertical-align:top;width:auto">&#160;</td>
                              </tr>
                              <tr>
                                <td style="width:57pt">&#160;</td>
                                <td style="vertical-align:top;width:27pt">&#160;</td>
                                <td style="vertical-align:top;width:auto">
                                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">The accounting policies adopted in the preparation of the interim condensed consolidated financial statements are consistent with those followed in the preparation of the Company&#8217;s annual consolidated financial statements for the year ended December 31, 2022 that were included in the Annual Report on Form 20-F filed on March 16, 2023.&#160;</span></p>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:57pt">&#160;</td>
                                <td style="vertical-align:top;width:27pt">&#160;</td>
                                <td style="vertical-align:top;width:auto">&#160;</td>
                              </tr>

                          </table>
                        </div>
                      </div>
                    </ix:nonNumeric>
                  </div>
                </div>
              </ix:nonNumeric>
            </div>
          </div>
        </div>
      </div>
    </div>
  </div>
</div><div style="">
  <div>
    <div>
      <div>
        <div>
          <div>
            <div>
              <div>
                <div>
                  <div>
                    <div>
                      <div>
                        <div>
                          <ix:nonNumeric id="Fxbrl_20230811021241930" name="ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" contextRef="C_20230101to20230630" escape="true">
                            <div style="margin-top:0pt;margin-bottom:0pt">
                              <div style="margin-top:0pt;margin-bottom:0pt">
                                <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;margin-top:0pt;margin-bottom:0pt">

                                    <tr style="vertical-align:top;margin-top:0pt;margin-bottom:0pt">
                                      <td style="text-align:right;vertical-align:top;width:56.7pt;margin-top:0pt;margin-bottom:0pt">
                                        <div style="text-align:left;line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold;margin-top:0pt;margin-bottom:0pt">Note 3:</span></div>
                                      </td>
                                      <td style="text-align:left;vertical-align:top;width:auto;margin-top:0pt;margin-bottom:0pt">
                                        <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold;margin-top:0pt;margin-bottom:0pt">Equity</span></div>
                                      </td>
                                    </tr>

                                </table>
                              </div>
                              <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
                              <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">

                                  <tr style="margin-top:0pt;margin-bottom:0pt">
                                    <td style="width:56.7pt;margin-top:0pt;margin-bottom:0pt">&#160;</td>
                                    <td style="width:18pt;vertical-align:top;font-weight:bold;margin-top:0pt;margin-bottom:0pt">1.</td>
                                    <td style="width:auto;vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt">
                                      <div style="margin-top:0pt;margin-bottom:0pt">On February 7, 2023, the Company completed a public offering of <ix:nonFraction id="Fxbrl_20230807123402491" name="ifrs-full:NumberOfSharesIssued" contextRef="C_20230207_mdwdSaleOfStocksAxis_mdwdPublicOfferingMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">1,964,286 </ix:nonFraction>new ordinary shares which were issued in consideration to offering price of $<ix:nonFraction id="Fxbrl_20230807123447913" name="ifrs-full:ParValuePerShare" contextRef="C_20230207_mdwdSaleOfStocksAxis_mdwdPublicOfferingMember" unitRef="USD_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">14.0 </ix:nonFraction>per share. The gross proceeds were $<ix:nonFraction id="Fxbrl_20230807124926726" name="ifrs-full:ProceedsFromIssuingShares" contextRef="C_20230201to20230207_mdwdSaleOfStocksAxis_mdwdPublicOfferingMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27,500</ix:nonFraction>, before deducting commissions and other offering expenses in the amount of $<ix:nonFraction id="Fxbrl_20230811100933146" name="ifrs-full:ShareIssueRelatedCost" contextRef="C_20230201to20230207_mdwdSaleOfStocksAxis_mdwdPublicOfferingMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,031</ix:nonFraction>.</div>
                                    </td>
                                  </tr>

                              </table>
                              <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
                              <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">

                                  <tr style="margin-top:0pt;margin-bottom:0pt">
                                    <td style="width:56.7pt;margin-top:0pt;margin-bottom:0pt">&#160;</td>
                                    <td style="width:18pt;vertical-align:top;font-weight:bold;margin-top:0pt;margin-bottom:0pt">2.</td>
                                    <td style="width:auto;vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt">
                                      <div style="margin-top:0pt;margin-bottom:0pt">On February 15, 2023, the Company granted to its employees and officers <ix:nonFraction id="Fxbrl_20230807125153248" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndOfficersMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">130,600 </ix:nonFraction>share options for an exercise price of $<ix:nonFraction id="Fxbrl_20230807125845831" name="mdwd:ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare" contextRef="C_20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndOfficersMember" unitRef="USD_Per_Share" scale="0" decimals="3" format="ixt:num-dot-decimal">13.32 </ix:nonFraction>per share and <ix:nonFraction id="Fxbrl_20230807125926325" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" contextRef="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndOfficersMember_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">9,100 </ix:nonFraction>RSUs. The share options vest over a period of <ix:nonNumeric id="Fxbrl_20230811101057353" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" contextRef="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndOfficersMember">4 years</ix:nonNumeric>. The total value was estimated at $<ix:nonFraction id="Fxbrl_20230807131315417" name="mdwd:StockOptionValue" contextRef="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndOfficersMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,129</ix:nonFraction>.</div>
                                    </td>
                                  </tr>

                              </table>
                              <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
                              <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">

                                  <tr style="margin-top:0pt;margin-bottom:0pt">
                                    <td style="width:56.7pt;margin-top:0pt;margin-bottom:0pt">&#160;</td>
                                    <td style="width:18pt;vertical-align:top;font-weight:bold;margin-top:0pt;margin-bottom:0pt">3.</td>
                                    <td style="width:auto;vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt">
                                      <div style="margin-top:0pt;margin-bottom:0pt">On April 3, 2023, the Company granted to its board members and officers <ix:nonFraction id="Fxbrl_20230807132607028" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="C_20230401to20230403_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdBoardMembersAndOfficersMember" unitRef="Share" decimals="INF" format="ixt:num-dot-decimal">160,400 </ix:nonFraction>share options for an exercise price of $<ix:nonFraction id="Fxbrl_20230807132643606" name="mdwd:ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare" contextRef="C_20230403_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdBoardMembersAndOfficersMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember" unitRef="USD_Per_Share" scale="0" decimals="3" format="ixt:num-dot-decimal">11.89 </ix:nonFraction>and $<ix:nonFraction id="Fxbrl_20230807132651045" name="mdwd:ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare" contextRef="C_20230403_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdBoardMembersAndOfficersMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember" unitRef="USD_Per_Share" scale="0" decimals="3" format="ixt:num-dot-decimal">11.91 </ix:nonFraction>per share. The grants to the directors and CEO were subject to the approval of the shareholders&#8217; meeting held on May, 2023. The share options vest over a period of <ix:nonNumeric id="Fxbrl_20230807132809388" name="ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" contextRef="C_20230401to20230403_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdBoardMembersAndOfficersMember">1-4 years</ix:nonNumeric> and the total value was estimated at $<ix:nonFraction id="Fxbrl_20230807132832899" name="mdwd:StockOptionValue" contextRef="C_20230401to20230403_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdBoardMembersAndOfficersMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">884</ix:nonFraction>.</div>
                                    </td>
                                  </tr>

                              </table>
                              <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
                              <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">

                                  <tr style="margin-top:0pt;margin-bottom:0pt">
                                    <td style="width:56.7pt;margin-top:0pt;margin-bottom:0pt">&#160;</td>
                                    <td style="width:18pt;vertical-align:top;font-weight:bold;margin-top:0pt;margin-bottom:0pt">4.</td>
                                    <td style="width:auto;vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt">
                                      <div style="margin-bottom:10pt;margin-top:0pt">On May 31, 2023 the Shareholders of the Company approved an amendment to Article 6 of the Company&#8217;s Amended and Restated Articles of Association, which increased the Company&#8217;s authorized share capital from <ix:nonFraction id="Fxbrl_20230811101339577" name="mdwd:AuthorizedShareCapital" contextRef="C_20230531" unitRef="NIS" scale="3" decimals="-3" format="ixt:num-dot-decimal">900,000</ix:nonFraction> NIS consisting of <ix:nonFraction id="Fxbrl_20230807133505406" name="ifrs-full:NumberOfSharesIssued" contextRef="C_20230531" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">12,857,143 </ix:nonFraction>ordinary shares par value NIS <ix:nonFraction id="Fxbrl_20230811101400427" name="ifrs-full:ParValuePerShare" contextRef="C_20230531" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.07</ix:nonFraction> to NIS <ix:nonFraction id="Fxbrl_20230807135404503" name="mdwd:IncreaseInAuthorizedShareCapital" contextRef="C_20230531" unitRef="NIS" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,400,000</ix:nonFraction>, consisting of <ix:nonFraction id="Fxbrl_20230811101349394" name="mdwd:IncreaseInSharesIssued" contextRef="C_20230531" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">20,000,000</ix:nonFraction> ordinary shares, par value NIS <ix:nonFraction id="Fxbrl_20230811101357361" name="mdwd:IncreaseInPricePerShareOfSharesIssued" contextRef="C_20230531" unitRef="NIS_Per_Share" scale="0" decimals="2" format="ixt:num-dot-decimal">0.07</ix:nonFraction> per share.</div>
                                    </td>
                                  </tr>

                              </table>
                              <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
                                <div style="margin-top:0pt;margin-bottom:0pt">
                                  <div style="margin-top:0pt;margin-bottom:0pt"><ix:exclude>
                                    <div style="margin-top:0pt;margin-bottom:0pt;text-align:left"><div style="text-align:center;margin-top:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 10</span></span></span></span></span></span></span></span></span></div><div><hr style="page-break-after:always;border-width:0px;clear:both;width:100%;height:2px;color:#000000;background-color:#000000;margin-top:6px;margin-bottom:6px" /></div></div><div style="text-align:left"><div><div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right"><p style="margin-top:10pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="font-weight:bold;color:rgb(0, 0, 0);margin-top:10pt">MEDIWOUND&#160;LTD. AND ITS SUBSIDIARIES</span></span></span></p></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div><div><div style="text-align:justify;margin-top:0pt;margin-bottom:0pt"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:6pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><strong>Notes to Unaudited Condensed Interim Consolidated Financial Statements&#160;</strong></span></span></span></span></p><hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;margin-top:5pt;margin-bottom:5pt;text-align:center" /></div></div><div style="text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:4pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span><span style="color:rgb(0, 0, 0);font-style:normal;font-weight:400;line-height:1"><span style="line-height:1"><span style="line-height:1"><span style="font-weight:bold">U.S. dollars in thousands </span></span></span></span></span></span></span></span></span></span></div></div></div></div><div style="margin-top:0pt;margin-bottom:0pt;text-align:right">&#160;</div>
                                    <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;margin-top:0pt;margin-bottom:0pt">

                                        <tr style="vertical-align:top;margin-top:0pt;margin-bottom:0pt">
                                          <td style="text-align:right;vertical-align:top;width:56.7pt;margin-top:0pt;margin-bottom:0pt">
                                            <div style="text-align:left;line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold;margin-top:0pt;margin-bottom:0pt">Note 3:</span></div>
                                          </td>
                                          <td style="vertical-align:top;width:auto;margin-top:0pt;margin-bottom:0pt">
                                            <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold;margin-top:0pt;margin-bottom:0pt">Equity</span>&#160;<span style="font-weight:bold;margin-top:0pt;margin-bottom:0pt">(Cont.)</span></div>
                                          </td>
                                        </tr>
                                        <tr>
                                          <td style="text-align:right;vertical-align:top;width:56.7pt;margin-top:0pt;margin-bottom:0pt">&#160;</td>
                                          <td style="vertical-align:top;width:auto;margin-top:0pt;margin-bottom:0pt">&#160;</td>
                                        </tr>

                                    </table>
                                  </ix:exclude></div>
                                </div>
                              </div>
                              <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">

                                  <tr style="margin-top:0pt;margin-bottom:0pt">
                                    <td style="width:56.7pt;margin-top:0pt;margin-bottom:0pt">&#160;</td>
                                    <td style="width:18pt;vertical-align:top;font-weight:bold;margin-top:0pt;margin-bottom:0pt">5.</td>
                                    <td style="width:auto;vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt">
                                      <div style="margin-top:0pt;margin-bottom:0pt">On May 31, 2023 the Shareholders of the Company approved the increase by <ix:nonFraction id="Fxbrl_20230807140002045" name="mdwd:NumberOfShareAvailableForIssuance" contextRef="C_20230531_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdEquityIncentivePlanMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">1,000,000 </ix:nonFraction>in the number of ordinary shares available for issuance under the Company&#8217;s 2014 Equity Incentive Plan.</div>
                                    </td>
                                  </tr>

                              </table>
                              <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
                              <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">

                                  <tr style="margin-top:0pt;margin-bottom:0pt">
                                    <td style="width:56.7pt;margin-top:0pt;margin-bottom:0pt">&#160;</td>
                                    <td style="width:18pt;vertical-align:top;font-weight:bold;margin-top:0pt;margin-bottom:0pt">6.</td>
                                    <td style="width:auto;vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt">
                                      <div style="margin-top:0pt;margin-bottom:0pt">On May 31, 2023 the Shareholders of the Company approved the extension to the exercise period of options which were granted to the company&#8217;s directors on April 23, 2020 for an additional <ix:nonNumeric id="Fxbrl_20230811100607158" name="mdwd:ExtensionPeriodForOptionsExercised" contextRef="C_20230501to20230531" format="ixt-sec:durwordsen">five years</ix:nonNumeric>, until April 23, 2030. According to this extension, an expense of $<ix:nonFraction id="Fxbrl_20230811100623146" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" contextRef="C_20230501to20230531" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">146</ix:nonFraction> was recognized.<p style="margin:0pt">&#160;</p>
                                      </div>
                                    </td>
                                  </tr>

                              </table>
                            </div>
                          </ix:nonNumeric>
                        </div>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
  </div>
</div><div style="">
  <div style="margin-top:0pt;margin-bottom:0pt">
    <div style="margin-top:0pt;margin-bottom:0pt">
      <div style="margin-top:0pt;margin-bottom:0pt">
        <div style="margin-top:0pt;margin-bottom:0pt">
          <div style="margin-top:0pt;margin-bottom:0pt">
            <div style="margin-top:0pt;margin-bottom:0pt">
              <div style="margin-top:0pt;margin-bottom:0pt">
                <div style="margin-top:0pt;margin-bottom:0pt">
                  <div style="margin-top:0pt;margin-bottom:0pt">
                    <div style="margin-top:0pt;margin-bottom:0pt">
                      <ix:nonNumeric id="Fxbrl_20230807111535655" name="ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory" contextRef="C_20230101to20230630" escape="true">
                        <div style="margin-top:0pt;margin-bottom:0pt">
                          <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">

                              <tr style="margin-top:0pt;margin-bottom:0pt">
                                <td style="margin-top:0pt;margin-bottom:0pt">
                                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold;margin-top:0pt;margin-bottom:0pt">Note&#160;4:</span></span></span></span></span></span></span></p>
                                </td>
                                <td colspan="3" rowspan="1" style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;margin-top:0pt;margin-bottom:0pt">
                                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><strong style="margin-top:0pt;margin-bottom:0pt"><span style="line-height:110%;margin-top:0pt;margin-bottom:0pt">Subsequent events</span></strong></span></span></span></span></span></span></p>
                                </td>
                              </tr>
                              <tr style="margin-top:0pt;margin-bottom:0pt">
                                <td style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;margin-top:0pt;margin-bottom:0pt;width:56pt">&#160;</td>
                                <td style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:18pt">&#160;</td>
                                <td style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:auto">&#160;</td>
                              </tr>
                              <tr style="margin-top:0pt;margin-bottom:0pt">
                                <td style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;margin-top:0pt;margin-bottom:0pt;width:56pt">&#160;</td>
                                <td style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:18pt">
                                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><strong style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">1.</span></strong></span></span></span></span></p>
                                </td>
                                <td style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:auto">
                                  <div style="margin-top:0pt;margin-bottom:0pt">
                                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">On July 17, 2023 the company signed a turnkey scale-up agreement with Biopharmax Group Ltd. This strategic agreement is designed to bolster the company&#8217;s manufacturing infrastructure to support our long-term growth trajectory. &#160;The objective of this agreement is to establish, commission, and validate a cutting-edge, sterile, and GMP-compliant manufacturing facility. The venture aims to increase our production capacity significantly, projected to expand to six times the current capacity, aligning with our strategic plan to meet the escalating global demand for NexoBrid.</span></span></span></span></p>
                                  </div>
                                </td>
                              </tr>
                              <tr style="margin-top:0pt;margin-bottom:0pt">
                                <td colspan="1" style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;margin-top:0pt;margin-bottom:0pt;width:56pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">&#160;</span></span></span></span></td>
                                <td colspan="1" style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:18pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">&#160;</span></span></span></span></td>
                                <td colspan="1" style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:auto"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">&#160;</span></span></span></span></td>
                              </tr>
                              <tr style="margin-top:0pt;margin-bottom:0pt">
                                <td colspan="1" style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;margin-top:0pt;margin-bottom:0pt;width:56pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">&#160;</span></span></span></span></td>
                                <td colspan="1" style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:18pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">&#160;</span></span></span></span></td>
                                <td colspan="1" style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:auto"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">The new facility, equipped with fully operational clean rooms, will be exclusively designed for NexoBrid production. It will comply with stringent regulations from the GMP, FDA, EMA, Israeli Ministry of Health, and relevant Israeli regulatory bodies. An estimated $<ix:nonFraction id="Fxbrl_20230807144738138" name="ifrs-full:InvestmentProperty" contextRef="C_20230717_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentsEventMember_ifrsfullTypesOfInvestmentPropertyAxis_mdwdBiopharmaxGroupLtdMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,000</ix:nonFraction>&#160;will be invested in the project, set for completion by mid-2024, with full-scale manufacturing expected to commence in 2025.</span></span>
                                  <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
                                  <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">The Scale-up Agreement encompasses various standard provisions, including those related to reporting, compliance, guarantees, representations, liability, insurance, confidentiality, and ownership.</span></span></span></span></p>
                                </td>
                              </tr>
                              <tr style="margin-top:0pt;margin-bottom:0pt">
                                <td colspan="1" style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;margin-top:0pt;margin-bottom:0pt;width:56pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">&#160;</span></span></span></span></td>
                                <td colspan="1" style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:18pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">&#160;</span></span></span></span></td>
                                <td colspan="1" style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:auto"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">&#160;</span></span></span></span></td>
                              </tr>
                              <tr style="margin-top:0pt;margin-bottom:0pt">
                                <td colspan="1" style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;margin-top:0pt;margin-bottom:0pt;width:56pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">&#160;</span></span></span></span></span></span></td>
                                <td colspan="1" style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:18pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong style="margin-top:0pt;margin-bottom:0pt">2.</strong></span></span></td>
                                <td colspan="1" style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:auto">
                                  <p style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Alongside entering the Scale-up Agreement, the company has also secured a new lease agreement with the current property owner. This agreement allows the company to continue the utilization of our existing facilities and the planned manufacturing site. This property, located in Yavne, Israel, serves as the base for the company&#8217;s administrative headquarters, research and development laboratories, and manufacturing plant. The duration of the lease extends until 2035, with an option for a further three-year extension until 2038. In parallel the existing sub lease agreement with Clal Life Science L.P. and the company was terminated.</span></span></p>
                                  <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
                                  <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">The property, measuring approximately <ix:nonFraction id="Fxbrl_20230807144807112" name="mdwd:AreaOfLand" contextRef="C_20230716to20230717_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentsEventMember_ifrsfullTypesOfInvestmentPropertyAxis_mdwdBiopharmaxGroupLtdMember" unitRef="SQFT" scale="0" decimals="0" format="ixt:num-dot-decimal">32,500</ix:nonFraction> square feet, will encompass the new manufacturing facility. As per the Lease Agreement, the annual rent is set at approximately $<ix:nonFraction id="Fxbrl_20230807144900801" name="ifrs-full:RentalExpense" contextRef="C_20230716to20230717_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentsEventMember_ifrsfullTypesOfInvestmentPropertyAxis_mdwdBiopharmaxGroupLtdMember" unitRef="USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">625</ix:nonFraction>. This rent is indexed to the Israeli Consumer Price Index and will see a staged increase of <ix:nonFraction id="Fxbrl_20230807144911817" name="mdwd:IncreaseInRentAsPercentageInEveryThreeYear" contextRef="C_20230716to20230717_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentsEventMember_ifrsfullTypesOfInvestmentPropertyAxis_mdwdBiopharmaxGroupLtdMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">6</ix:nonFraction>% every three years.</span></span></span></span></span></span></p>
                                </td>
                              </tr>

                          </table>
                        </div>
                      </ix:nonNumeric>
                      <p style="margin:0pt">&#160;</p>
                      <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:4pt;margin-bottom:4pt;text-align:center"><span style="font-family:Times New Roman, Times, serif;font-size:10pt;color:rgb(0, 0, 0);font-style:normal;font-weight:400"><span><span><span style="color:#000000;font-weight:normal;font-style:normal">F - 11</span></span></span></span></p>
                      <hr style="border:none;border-bottom:4px solid black;border-top:1px solid black;height:10px;width:100%;color:#ffffff;background-color:#ffffff;text-align:center;margin-left:auto;margin-right:auto;margin-top:0pt;text-align:center" />
                      <div style="text-align:left">&#160;</div>
                    </div>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
  </div>
</div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>mdwd-20230630.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<schema xmlns:mdwd="http://mediwound.com/20230630" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" targetNamespace="http://mediwound.com/20230630" elementFormDefault="qualified">
  <!-- INTEGIX by Ez-XBRL -->
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"/>
  <import namespace="http://xbrl.sec.gov/naics/2022" schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd"/>
  <import namespace="http://xbrl.sec.gov/stpr/2022" schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"/>
  <import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd"/>
  <import namespace="http://xbrl.sec.gov/exch/2022" schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd"/>
  <import namespace="http://xbrl.sec.gov/sic/2022" schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd"/>
  <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd"/>
  <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd"/>
  <import namespace="https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full" schemaLocation="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd"/>
  <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <import namespace="http://xbrl.org/2020/extensible-enumerations-2.0" schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://mediwound.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>0001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets" id="CondensedInterimConsolidatedBalanceSheets">
        <link:definition>0002 - Statement - Unaudited Condensed Interim Consolidated Statements of Financial Position</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheetsParenthetical" id="CondensedInterimConsolidatedBalanceSheetsParenthetical">
        <link:definition>0003 - Statement - Unaudited Condensed Interim Consolidated Statements of Financial Position (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss" id="CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss">
        <link:definition>0004 - Statement - Unaudited Condensed Interim Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfChangesInShareholdersEquity" id="CondensedInterimConsolidatedStatementsOfChangesInShareholdersEquity">
        <link:definition>0005 - Statement - Unaudited Condensed Interim Consolidated Statements of Changes in Shareholders' Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows" id="CondensedInterimConsolidatedStatementsOfCashFlows">
        <link:definition>0006 - Statement - Unaudited Condensed Interim Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/General" id="General">
        <link:definition>0007 - Disclosure - General</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/SignificantAccountingPolicies" id="SignificantAccountingPolicies">
        <link:definition>0008 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/Equity" id="Equity">
        <link:definition>0009 - Disclosure - Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/SubsequentEvents" id="SubsequentEvents">
        <link:definition>0010 - Disclosure - Subsequent events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/SignificantAccountingPoliciesPolicies" id="SignificantAccountingPoliciesPolicies">
        <link:definition>0011 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/GENERALTextual" id="GENERALTextual">
        <link:definition>0012 - Disclosure - General (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/EquityDetails" id="EquityDetails">
        <link:definition>0014 - Disclosure - Equity (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://mediwound.com/role/SubsequentEventsNarrativeDetails" id="SubsequentEventsNarrativeDetails">
        <link:definition>0015 - Disclosure - Subsequent events (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="mdwd-20230630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="mdwd-20230630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="mdwd-20230630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="mdwd-20230630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
    </appinfo>
  </annotation>
  <element name="AdditionalProceedsFromFunding" id="mdwd_AdditionalProceedsFromFunding" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems" id="mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue" id="mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss" id="mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AdjustmentsMember" id="mdwd_AdjustmentsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AdjustmentsToReconcileNetLossToNetCashUsedInContinuingOperatingActivitiesAbstract" id="mdwd_AdjustmentsToReconcileNetLossToNetCashUsedInContinuingOperatingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AreaOfLand" id="mdwd_AreaOfLand" type="dtr-types:areaItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AuthorizedShareCapital" id="mdwd_AuthorizedShareCapital" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="BardaMember" id="mdwd_BardaMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BasicAndDilutedEarningsLossPerShare" id="mdwd_BasicAndDilutedEarningsLossPerShare" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BasicAndDilutedNetProfitLossPerShare" id="mdwd_BasicAndDilutedNetProfitLossPerShare" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BiomedicalAdvancedResearchAndDevelopmentAuthorityMember" id="mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BiopharmaxGroupLtdMember" id="mdwd_BiopharmaxGroupLtdMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BoardMembersAndOfficersMember" id="mdwd_BoardMembersAndOfficersMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="CertainEntitiesAffiliatedWithCbiMember" id="mdwd_CertainEntitiesAffiliatedWithCbiMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ChangesInAssetAndLiabilityItemsAbstract" id="mdwd_ChangesInAssetAndLiabilityItemsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ChiefExecutiveOfficersMember" id="mdwd_ChiefExecutiveOfficersMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ContractAmountForResearchDevelopmentAndManufacturing" id="mdwd_ContractAmountForResearchDevelopmentAndManufacturing" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ContractTerm" id="mdwd_ContractTerm" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ContractWithCustomers" id="mdwd_ContractWithCustomers" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="CostOfLicenseAgreements" id="mdwd_CostOfLicenseAgreements" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CumulativeEffectAdjustmentOnAccumulatedDeficitAsResultOfAdoptingIfrsFifteen" id="mdwd_CumulativeEffectAdjustmentOnAccumulatedDeficitAsResultOfAdoptingIfrsFifteen" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="DescriptionOfAccountingPolicyForShorttermBankDepositsExplanatory" id="mdwd_DescriptionOfAccountingPolicyForShorttermBankDepositsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfOtherAccountingPoliciesBasisOfPreparationOfInterimConsolidatedFinancialStatementsExplanatory" id="mdwd_DescriptionOfOtherAccountingPoliciesBasisOfPreparationOfInterimConsolidatedFinancialStatementsExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DescriptionOfOtherAccountingPoliciesChangesInSignificantAccountingPoliciesExplanatory" id="mdwd_DescriptionOfOtherAccountingPoliciesChangesInSignificantAccountingPoliciesExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfFinancialPositionExplanatory" id="mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfFinancialPositionExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfProfitOrLossExplanatory" id="mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfProfitOrLossExplanatory" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfGeneralInformationAbstract" id="mdwd_DisclosureOfGeneralInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DisclosureOfSignificantAccountingPoliciesAbstract" id="mdwd_DisclosureOfSignificantAccountingPoliciesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DocumentAndEntityInformationAbstract" id="mdwd_DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EmployeesAndOfficersMember" id="mdwd_EmployeesAndOfficersMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="Equity1" id="mdwd_Equity1" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="EquityIncentivePlanMember" id="mdwd_EquityIncentivePlanMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EventsAfterReportingPeriodMember" id="mdwd_EventsAfterReportingPeriodMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExerciseOfRsuOption" id="mdwd_ExerciseOfRsuOption" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ExtensionPeriodForOptionsExercised" id="mdwd_ExtensionPeriodForOptionsExercised" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="FinanceIncomeExpenseNet" id="mdwd_FinanceIncomeExpenseNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseInAuthorizedShareCapital" id="mdwd_IncreaseInAuthorizedShareCapital" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseInPricePerShareOfSharesIssued" id="mdwd_IncreaseInPricePerShareOfSharesIssued" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncreaseInRentAsPercentageInEveryThreeYear" id="mdwd_IncreaseInRentAsPercentageInEveryThreeYear" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncreaseInSharesIssued" id="mdwd_IncreaseInSharesIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IncrementalInterestRatesOfLeaseLiability" id="mdwd_IncrementalInterestRatesOfLeaseLiability" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IssueOfEquityShares" id="mdwd_IssueOfEquityShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LeaseExpenses" id="mdwd_LeaseExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="MedicalTechnologyEnterpriseConsortiumMember" id="mdwd_MedicalTechnologyEnterpriseConsortiumMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NetProceedsFromIssueOfOrdinaryShares" id="mdwd_NetProceedsFromIssueOfOrdinaryShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="NexoBridMember" id="mdwd_NexoBridMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NonCashTransactionsAbstract" id="mdwd_NonCashTransactionsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NoncurrentLeaseLiability" id="mdwd_NoncurrentLeaseLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="NumberOfOrdinarySharesIssuable" id="mdwd_NumberOfOrdinarySharesIssuable" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfPatients" id="mdwd_NumberOfPatients" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfRestrictedShareUnits" id="mdwd_NumberOfRestrictedShareUnits" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfShareAvailableForIssuance" id="mdwd_NumberOfShareAvailableForIssuance" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesUsedInCalculatingBasicAndDilutedProfitLossPerShare" id="mdwd_NumberOfSharesUsedInCalculatingBasicAndDilutedProfitLossPerShare" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ParticipationsByBardaAndIia" id="mdwd_ParticipationsByBardaAndIia" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PolyHealLtdMember" id="mdwd_PolyHealLtdMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ProceedsFromAdditionalFunding" id="mdwd_ProceedsFromAdditionalFunding" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromAdditionalProcurement" id="mdwd_ProceedsFromAdditionalProcurement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromGrants" id="mdwd_ProceedsFromGrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromIssuingAdditionalShares" id="mdwd_ProceedsFromIssuingAdditionalShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromProcurement" id="mdwd_ProceedsFromProcurement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromRepaymentOfIssuingShares" id="mdwd_ProceedsFromRepaymentOfIssuingShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PublicOfferingMember" id="mdwd_PublicOfferingMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RepaymentFromGrants" id="mdwd_RepaymentFromGrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RepaymentOfLiabilitiesInRespectOfTeva" id="mdwd_RepaymentOfLiabilitiesInRespectOfTeva" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet" id="mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ReplenishmentAmount" id="mdwd_ReplenishmentAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ResearchAndDevelopmentExpenseGross" id="mdwd_ResearchAndDevelopmentExpenseGross" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RestrictedSharesUnitsMember" id="mdwd_RestrictedSharesUnitsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="RevaluationOfLeaseLiabilities" id="mdwd_RevaluationOfLeaseLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RevaluationOfLiabilitiesInRespectOfGrants" id="mdwd_RevaluationOfLiabilitiesInRespectOfGrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RevaluationOfLiabilitiesInRespectOfTeva" id="mdwd_RevaluationOfLiabilitiesInRespectOfTeva" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RevaluationOfWarrantsAccountedAtFairValue" id="mdwd_RevaluationOfWarrantsAccountedAtFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="SaleOfStocksAxis" id="mdwd_SaleOfStocksAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" nillable="true"/>
  <element name="SaleOfStocksDomain" id="mdwd_SaleOfStocksDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare" id="mdwd_ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SharesIssuedPriceInInitialPublicOffering" id="mdwd_SharesIssuedPriceInInitialPublicOffering" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StatementsLineItems" id="mdwd_StatementsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StatementsTableTable" id="mdwd_StatementsTableTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" nillable="true"/>
  <element name="StockOptionsMember" id="mdwd_StockOptionsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockOptionValue" id="mdwd_StockOptionValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="SubsequentsEventMember" id="mdwd_SubsequentsEventMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SupplementalFunding" id="mdwd_SupplementalFunding" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="TevaMember" id="mdwd_TevaMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UnderwritingDiscounts" id="mdwd_UnderwritingDiscounts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="USDepartmentOfDefenseMember" id="mdwd_USDepartmentOfDefenseMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="USFoodAndDrugAdministrationMember" id="mdwd_USFoodAndDrugAdministrationMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="VericelMember" id="mdwd_VericelMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>5
<FILENAME>mdwd-20230630_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="mdwd-20230630.xsd#CondensedInterimConsolidatedBalanceSheets" roleURI="http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20230630.xsd#CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss" roleURI="http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20230630.xsd#CondensedInterimConsolidatedStatementsOfCashFlows" roleURI="http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"/>
  <calculationLink xlink:type="extended" xlink:role="http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents" xlink:label="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherCurrentReceivables" xlink:label="loc_ifrs-full_OtherCurrentReceivables_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RestrictedCashAndCashEquivalents" xlink:label="loc_ifrs-full_RestrictedCashAndCashEquivalents_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentAssets_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherNoncurrentReceivables" xlink:label="loc_ifrs-full_OtherNoncurrentReceivables_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherCurrentPayables" xlink:label="loc_ifrs-full_OtherCurrentPayables_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-full_NoncurrentLiabilities_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentGovernmentGrants" xlink:label="loc_ifrs-full_NoncurrentGovernmentGrants_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentWarrantLiability" xlink:label="loc_ifrs-full_NoncurrentWarrantLiability_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherNoncurrentLiabilities" xlink:label="loc_ifrs-full_OtherNoncurrentLiabilities_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:label="loc_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_21"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_NoncurrentLeaseLiability" xlink:label="loc_mdwd_NoncurrentLeaseLiability_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RentDeferredIncomeClassifiedAsNoncurrent" xlink:label="loc_ifrs-full_RentDeferredIncomeClassifiedAsNoncurrent_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SharePremium" xlink:label="loc_ifrs-full_SharePremium_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads" xlink:label="loc_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_29"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_0" xlink:to="loc_ifrs-full_CurrentAssets_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_1" xlink:to="loc_ifrs-full_CashAndCashEquivalents_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_1" xlink:to="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_1" xlink:to="loc_ifrs-full_CurrentTradeReceivables_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_1" xlink:to="loc_ifrs-full_Inventories_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_1" xlink:to="loc_ifrs-full_OtherCurrentReceivables_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_1" xlink:to="loc_ifrs-full_RestrictedCashAndCashEquivalents_6" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_0" xlink:to="loc_ifrs-full_NoncurrentAssets_8" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_8" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_8" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_8" xlink:to="loc_ifrs-full_RightofuseAssets_9" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_8" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_10" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_8" xlink:to="loc_ifrs-full_OtherNoncurrentReceivables_11" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAndLiabilities_13" xlink:to="loc_ifrs-full_Liabilities_14" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Liabilities_14" xlink:to="loc_ifrs-full_CurrentLiabilities_14" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_14" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_14" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_14" xlink:to="loc_ifrs-full_OtherCurrentPayables_15" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_14" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_16" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Liabilities_14" xlink:to="loc_ifrs-full_NoncurrentLiabilities_18" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_18" xlink:to="loc_ifrs-full_NoncurrentGovernmentGrants_18" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_18" xlink:to="loc_ifrs-full_NoncurrentWarrantLiability_19" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_18" xlink:to="loc_ifrs-full_OtherNoncurrentLiabilities_20" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_18" xlink:to="loc_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_21" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_18" xlink:to="loc_mdwd_NoncurrentLeaseLiability_22" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_18" xlink:to="loc_ifrs-full_RentDeferredIncomeClassifiedAsNoncurrent_23" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAndLiabilities_13" xlink:to="loc_ifrs-full_Equity_26" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_26" xlink:to="loc_ifrs-full_IssuedCapital_26" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_26" xlink:to="loc_ifrs-full_SharePremium_27" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_26" xlink:to="loc_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads_28" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_26" xlink:to="loc_ifrs-full_RetainedEarnings_29" order="30" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-full_GrossProfit_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LicenceFeeIncome" xlink:label="loc_ifrs-full_LicenceFeeIncome_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RevenueFromRenderingOfServices" xlink:label="loc_ifrs-full_RevenueFromRenderingOfServices_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CostOfMerchandiseSold" xlink:label="loc_ifrs-full_CostOfMerchandiseSold_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ServicesExpense" xlink:label="loc_ifrs-full_ServicesExpense_6"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_CostOfLicenseAgreements" xlink:label="loc_mdwd_CostOfLicenseAgreements_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OperatingExpense" xlink:label="loc_ifrs-full_OperatingExpense_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_10"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ResearchAndDevelopmentExpenseGross" xlink:label="loc_mdwd_ResearchAndDevelopmentExpenseGross_10"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ParticipationsByBardaAndIia" xlink:label="loc_mdwd_ParticipationsByBardaAndIia_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SalesAndMarketingExpense" xlink:label="loc_ifrs-full_SalesAndMarketingExpense_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherExpenseByFunction" xlink:label="loc_ifrs-full_OtherExpenseByFunction_15"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_FinanceIncomeExpenseNet" xlink:label="loc_mdwd_FinanceIncomeExpenseNet_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" xlink:label="loc_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_24"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome_0" xlink:to="loc_ifrs-full_ProfitLoss_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_1" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_1" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_1" xlink:to="loc_ifrs-full_GrossProfit_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_GrossProfit_1" xlink:to="loc_ifrs-full_Revenue_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Revenue_1" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoods_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Revenue_1" xlink:to="loc_ifrs-full_LicenceFeeIncome_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Revenue_1" xlink:to="loc_ifrs-full_RevenueFromRenderingOfServices_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_GrossProfit_1" xlink:to="loc_ifrs-full_CostOfSales_5" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CostOfSales_5" xlink:to="loc_ifrs-full_CostOfMerchandiseSold_5" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CostOfSales_5" xlink:to="loc_ifrs-full_ServicesExpense_6" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CostOfSales_5" xlink:to="loc_mdwd_CostOfLicenseAgreements_7" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_1" xlink:to="loc_ifrs-full_OperatingExpense_10" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OperatingExpense_10" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_10" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ResearchAndDevelopmentExpense_10" xlink:to="loc_mdwd_ResearchAndDevelopmentExpenseGross_10" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ResearchAndDevelopmentExpense_10" xlink:to="loc_mdwd_ParticipationsByBardaAndIia_11" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OperatingExpense_10" xlink:to="loc_ifrs-full_SalesAndMarketingExpense_13" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OperatingExpense_10" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_14" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OperatingExpense_10" xlink:to="loc_ifrs-full_OtherExpenseByFunction_15" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_1" xlink:to="loc_mdwd_FinanceIncomeExpenseNet_18" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdwd_FinanceIncomeExpenseNet_18" xlink:to="loc_ifrs-full_FinanceIncome_18" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdwd_FinanceIncomeExpenseNet_18" xlink:to="loc_ifrs-full_FinanceCosts_19" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_1" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_22" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome_0" xlink:to="loc_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_24" order="10" use="optional" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems" xlink:label="loc_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue" xlink:label="loc_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_7"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfGrants" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_7"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RevaluationOfLeaseLiabilities" xlink:label="loc_mdwd_RevaluationOfLeaseLiabilities_8"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RevaluationOfWarrantsAccountedAtFairValue" xlink:label="loc_mdwd_RevaluationOfWarrantsAccountedAtFairValue_9"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss" xlink:label="loc_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_11"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfTeva" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfTeva_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForFinanceIncomeCost" xlink:label="loc_ifrs-full_AdjustmentsForFinanceIncomeCost_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" xlink:label="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromExerciseOfOptions" xlink:label="loc_ifrs-full_ProceedsFromExerciseOfOptions_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromExerciseOfWarrants" xlink:label="loc_ifrs-full_ProceedsFromExerciseOfWarrants_26"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet" xlink:label="loc_mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet_27"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RepaymentFromGrants" xlink:label="loc_mdwd_RepaymentFromGrants_28"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RepaymentOfLiabilitiesInRespectOfTeva" xlink:label="loc_mdwd_RepaymentOfLiabilitiesInRespectOfTeva_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_31"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xlink:to="loc_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_1" xlink:to="loc_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_1" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_1" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_1" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_1" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xlink:to="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_7" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_7" xlink:to="loc_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_7" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_7" xlink:to="loc_mdwd_RevaluationOfLeaseLiabilities_8" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_7" xlink:to="loc_mdwd_RevaluationOfWarrantsAccountedAtFairValue_9" order="20" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_7" xlink:to="loc_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss_10" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_7" xlink:to="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_11" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_7" xlink:to="loc_mdwd_RevaluationOfLiabilitiesInRespectOfTeva_12" order="50" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_7" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_13" order="60" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_7" xlink:to="loc_ifrs-full_AdjustmentsForFinanceIncomeCost_14" order="70" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_7" xlink:to="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_15" order="80" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_7" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_16" order="90" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xlink:to="loc_ifrs-full_ProfitLoss_18" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_20" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_20" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_20" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_20" xlink:to="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_21" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_20" xlink:to="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_22" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_24" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_24" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_24" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_24" xlink:to="loc_ifrs-full_ProceedsFromExerciseOfOptions_25" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_24" xlink:to="loc_ifrs-full_ProceedsFromExerciseOfWarrants_26" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_24" xlink:to="loc_mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet_27" order="30" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_24" xlink:to="loc_mdwd_RepaymentFromGrants_28" order="40" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_24" xlink:to="loc_mdwd_RepaymentOfLiabilitiesInRespectOfTeva_29" order="50" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0" xlink:to="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_31" order="30" use="optional" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>mdwd-20230630_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="mdwd-20230630.xsd#CondensedInterimConsolidatedStatementsOfChangesInShareholdersEquity" roleURI="http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfChangesInShareholdersEquity"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20230630.xsd#EquityDetails" roleURI="http://mediwound.com/role/EquityDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20230630.xsd#GENERALTextual" roleURI="http://mediwound.com/role/GENERALTextual"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20230630.xsd#SubsequentEventsNarrativeDetails" roleURI="http://mediwound.com/role/SubsequentEventsNarrativeDetails"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll"/>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfChangesInShareholdersEquity">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SharePremiumMember" xlink:label="loc_ifrs-full_SharePremiumMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" xlink:label="loc_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-full_RetainedEarningsMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" xlink:label="loc_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_17"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_EquityMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_1" xlink:to="loc_ifrs-full_IssuedCapitalMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_1" xlink:to="loc_ifrs-full_SharePremiumMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_1" xlink:to="loc_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityMember_1" xlink:to="loc_ifrs-full_RetainedEarningsMember_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_EquityMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_Equity_9" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_ProfitLoss_10" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_11" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_ComprehensiveIncome_12" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_ShareIssueRelatedCost_13" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IssueOfEquity_14" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_15" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_16" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_0" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_17" order="90" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/EquityDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_EquityIncentivePlanMember" xlink:label="loc_mdwd_EquityIncentivePlanMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_EmployeesAndOfficersMember" xlink:label="loc_mdwd_EmployeesAndOfficersMember_5"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_BoardMembersAndOfficersMember" xlink:label="loc_mdwd_BoardMembersAndOfficersMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_10"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RestrictedSharesUnitsMember" xlink:label="loc_mdwd_RestrictedSharesUnitsMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_Default"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_SaleOfStocksAxis" xlink:label="loc_mdwd_SaleOfStocksAxis_14"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_SaleOfStocksDomain" xlink:label="loc_mdwd_SaleOfStocksDomain_14"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_PublicOfferingMember" xlink:label="loc_mdwd_PublicOfferingMember_14"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_SaleOfStocksDomain" xlink:label="loc_mdwd_SaleOfStocksDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_28"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare" xlink:label="loc_mdwd_ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_30"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_StockOptionValue" xlink:label="loc_mdwd_StockOptionValue_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_32"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AuthorizedShareCapital" xlink:label="loc_mdwd_AuthorizedShareCapital_33"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_IncreaseInAuthorizedShareCapital" xlink:label="loc_mdwd_IncreaseInAuthorizedShareCapital_34"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_IncreaseInSharesIssued" xlink:label="loc_mdwd_IncreaseInSharesIssued_35"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_IncreaseInPricePerShareOfSharesIssued" xlink:label="loc_mdwd_IncreaseInPricePerShareOfSharesIssued_36"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_NumberOfShareAvailableForIssuance" xlink:label="loc_mdwd_NumberOfShareAvailableForIssuance_37"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ExtensionPeriodForOptionsExercised" xlink:label="loc_mdwd_ExtensionPeriodForOptionsExercised_38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_39"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" xlink:to="loc_mdwd_EquityIncentivePlanMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_5" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5" xlink:to="loc_mdwd_EmployeesAndOfficersMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_5" xlink:to="loc_mdwd_BoardMembersAndOfficersMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_5" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_10" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_10" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_10" xlink:to="loc_mdwd_RestrictedSharesUnitsMember_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_10" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_mdwd_SaleOfStocksAxis_14" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_mdwd_SaleOfStocksAxis_14" xlink:to="loc_mdwd_SaleOfStocksDomain_14" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mdwd_SaleOfStocksDomain_14" xlink:to="loc_mdwd_PublicOfferingMember_14" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_mdwd_SaleOfStocksAxis_14" xlink:to="loc_mdwd_SaleOfStocksDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_RangeAxis_18" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_18" xlink:to="loc_ifrs-full_RangesMember_18" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_18" xlink:to="loc_ifrs-full_BottomOfRangeMember_18" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesMember_18" xlink:to="loc_ifrs-full_TopOfRangeMember_19" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_18" xlink:to="loc_ifrs-full_RangesMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_NumberOfSharesIssued_24" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_ParValuePerShare_25" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_26" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_27" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_ShareIssueRelatedCost_28" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_mdwd_ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare_29" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_30" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_mdwd_StockOptionValue_31" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_32" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_mdwd_AuthorizedShareCapital_33" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_mdwd_IncreaseInAuthorizedShareCapital_34" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_mdwd_IncreaseInSharesIssued_35" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_mdwd_IncreaseInPricePerShareOfSharesIssued_36" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_mdwd_NumberOfShareAvailableForIssuance_37" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_mdwd_ExtensionPeriodForOptionsExercised_38" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_39" order="160" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/GENERALTextual">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_USFoodAndDrugAdministrationMember" xlink:label="loc_mdwd_USFoodAndDrugAdministrationMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_USDepartmentOfDefenseMember" xlink:label="loc_mdwd_USDepartmentOfDefenseMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_6"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_BardaMember" xlink:label="loc_mdwd_BardaMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_Default"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ContractAmountForResearchDevelopmentAndManufacturing" xlink:label="loc_mdwd_ContractAmountForResearchDevelopmentAndManufacturing_11"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AdditionalProceedsFromFunding" xlink:label="loc_mdwd_AdditionalProceedsFromFunding_12"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ReplenishmentAmount" xlink:label="loc_mdwd_ReplenishmentAmount_13"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_NumberOfPatients" xlink:label="loc_mdwd_NumberOfPatients_14"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ContractWithCustomers" xlink:label="loc_mdwd_ContractWithCustomers_15"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1" xlink:to="loc_dei_LegalEntityAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1" xlink:to="loc_dei_EntityDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_1" xlink:to="loc_mdwd_USFoodAndDrugAdministrationMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_1" xlink:to="loc_mdwd_USDepartmentOfDefenseMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1" xlink:to="loc_dei_EntityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_6" xlink:to="loc_ifrs-full_BorrowingsByNameMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameMember_6" xlink:to="loc_mdwd_BardaMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_6" xlink:to="loc_ifrs-full_BorrowingsByNameMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_mdwd_ContractAmountForResearchDevelopmentAndManufacturing_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_mdwd_AdditionalProceedsFromFunding_12" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_mdwd_ReplenishmentAmount_13" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_mdwd_NumberOfPatients_14" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xlink:to="loc_mdwd_ContractWithCustomers_15" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://mediwound.com/role/SubsequentEventsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_SubsequentsEventMember" xlink:label="loc_mdwd_SubsequentsEventMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TypesOfInvestmentPropertyAxis" xlink:label="loc_ifrs-full_TypesOfInvestmentPropertyAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InvestmentPropertyMember" xlink:label="loc_ifrs-full_InvestmentPropertyMember_5"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_BiopharmaxGroupLtdMember" xlink:label="loc_mdwd_BiopharmaxGroupLtdMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InvestmentPropertyMember" xlink:label="loc_ifrs-full_InvestmentPropertyMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InvestmentProperty" xlink:label="loc_ifrs-full_InvestmentProperty_10"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AreaOfLand" xlink:label="loc_mdwd_AreaOfLand_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RentalExpense" xlink:label="loc_ifrs-full_RentalExpense_12"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_IncreaseInRentAsPercentageInEveryThreeYear" xlink:label="loc_mdwd_IncreaseInRentAsPercentageInEveryThreeYear_13"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" xlink:to="loc_ifrs-full_NonadjustingEventsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsMember_1" xlink:to="loc_mdwd_SubsequentsEventMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" xlink:to="loc_ifrs-full_NonadjustingEventsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_TypesOfInvestmentPropertyAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfInvestmentPropertyAxis_5" xlink:to="loc_ifrs-full_InvestmentPropertyMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_InvestmentPropertyMember_5" xlink:to="loc_mdwd_BiopharmaxGroupLtdMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfInvestmentPropertyAxis_5" xlink:to="loc_ifrs-full_InvestmentPropertyMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ifrs-full_InvestmentProperty_10" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_mdwd_AreaOfLand_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_ifrs-full_RentalExpense_12" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xlink:to="loc_mdwd_IncreaseInRentAsPercentageInEveryThreeYear_13" order="40" use="optional"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>mdwd-20230630_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare_5"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_BasicAndDilutedNetProfitLossPerShare" xlink:label="loc_mdwd_BasicAndDilutedNetProfitLossPerShare_6"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_BasicAndDilutedNetProfitLossPerShare" xlink:label="loc_mdwd_BasicAndDilutedNetProfitLossPerShare_7"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_BasicAndDilutedNetProfitLossPerShare" xlink:label="loc_mdwd_BasicAndDilutedNetProfitLossPerShare_8"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_BasicAndDilutedNetProfitLossPerShare" xlink:label="loc_mdwd_BasicAndDilutedNetProfitLossPerShare_9"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_BasicAndDilutedNetProfitLossPerShare" xlink:label="loc_mdwd_BasicAndDilutedNetProfitLossPerShare_10"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_BasicAndDilutedNetProfitLossPerShare" xlink:label="loc_mdwd_BasicAndDilutedNetProfitLossPerShare_11"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AdditionalProceedsFromFunding" xlink:label="loc_mdwd_AdditionalProceedsFromFunding_12"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AdditionalProceedsFromFunding" xlink:label="loc_mdwd_AdditionalProceedsFromFunding_13"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AdditionalProceedsFromFunding" xlink:label="loc_mdwd_AdditionalProceedsFromFunding_14"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems" xlink:label="loc_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_15"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems" xlink:label="loc_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_16"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems" xlink:label="loc_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_17"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems" xlink:label="loc_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_18"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue" xlink:label="loc_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_19"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue" xlink:label="loc_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_20"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue" xlink:label="loc_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_21"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue" xlink:label="loc_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_22"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss" xlink:label="loc_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss_23"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss" xlink:label="loc_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss_24"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss" xlink:label="loc_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss_25"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AdjustmentsMember" xlink:label="loc_mdwd_AdjustmentsMember_26"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AreaOfLand" xlink:label="loc_mdwd_AreaOfLand_27"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AreaOfLand" xlink:label="loc_mdwd_AreaOfLand_28"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AreaOfLand" xlink:label="loc_mdwd_AreaOfLand_29"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AuthorizedShareCapital" xlink:label="loc_mdwd_AuthorizedShareCapital_30"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AuthorizedShareCapital" xlink:label="loc_mdwd_AuthorizedShareCapital_31"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AuthorizedShareCapital" xlink:label="loc_mdwd_AuthorizedShareCapital_32"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AuthorizedShareCapital" xlink:label="loc_mdwd_AuthorizedShareCapital_33"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AuthorizedShareCapital" xlink:label="loc_mdwd_AuthorizedShareCapital_34"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_BardaMember" xlink:label="loc_mdwd_BardaMember_35"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_BardaMember" xlink:label="loc_mdwd_BardaMember_36"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_BardaMember" xlink:label="loc_mdwd_BardaMember_37"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_BasicAndDilutedEarningsLossPerShare" xlink:label="loc_mdwd_BasicAndDilutedEarningsLossPerShare_38"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_BasicAndDilutedEarningsLossPerShare" xlink:label="loc_mdwd_BasicAndDilutedEarningsLossPerShare_39"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_BasicAndDilutedEarningsLossPerShare" xlink:label="loc_mdwd_BasicAndDilutedEarningsLossPerShare_40"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_BasicAndDilutedEarningsLossPerShare" xlink:label="loc_mdwd_BasicAndDilutedEarningsLossPerShare_41"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember" xlink:label="loc_mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_42"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_BiopharmaxGroupLtdMember" xlink:label="loc_mdwd_BiopharmaxGroupLtdMember_43"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_BiopharmaxGroupLtdMember" xlink:label="loc_mdwd_BiopharmaxGroupLtdMember_44"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_BiopharmaxGroupLtdMember" xlink:label="loc_mdwd_BiopharmaxGroupLtdMember_45"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_BoardMembersAndOfficersMember" xlink:label="loc_mdwd_BoardMembersAndOfficersMember_46"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_BoardMembersAndOfficersMember" xlink:label="loc_mdwd_BoardMembersAndOfficersMember_47"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_BoardMembersAndOfficersMember" xlink:label="loc_mdwd_BoardMembersAndOfficersMember_48"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_CertainEntitiesAffiliatedWithCbiMember" xlink:label="loc_mdwd_CertainEntitiesAffiliatedWithCbiMember_49"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_CertainEntitiesAffiliatedWithCbiMember" xlink:label="loc_mdwd_CertainEntitiesAffiliatedWithCbiMember_50"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_CertainEntitiesAffiliatedWithCbiMember" xlink:label="loc_mdwd_CertainEntitiesAffiliatedWithCbiMember_51"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ChiefExecutiveOfficersMember" xlink:label="loc_mdwd_ChiefExecutiveOfficersMember_52"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ContractAmountForResearchDevelopmentAndManufacturing" xlink:label="loc_mdwd_ContractAmountForResearchDevelopmentAndManufacturing_53"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ContractAmountForResearchDevelopmentAndManufacturing" xlink:label="loc_mdwd_ContractAmountForResearchDevelopmentAndManufacturing_54"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ContractAmountForResearchDevelopmentAndManufacturing" xlink:label="loc_mdwd_ContractAmountForResearchDevelopmentAndManufacturing_55"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ContractTerm" xlink:label="loc_mdwd_ContractTerm_56"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ContractTerm" xlink:label="loc_mdwd_ContractTerm_57"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ContractWithCustomers" xlink:label="loc_mdwd_ContractWithCustomers_58"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ContractWithCustomers" xlink:label="loc_mdwd_ContractWithCustomers_59"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ContractWithCustomers" xlink:label="loc_mdwd_ContractWithCustomers_60"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_CostOfLicenseAgreements" xlink:label="loc_mdwd_CostOfLicenseAgreements_61"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_CostOfLicenseAgreements" xlink:label="loc_mdwd_CostOfLicenseAgreements_62"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_CostOfLicenseAgreements" xlink:label="loc_mdwd_CostOfLicenseAgreements_63"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_CumulativeEffectAdjustmentOnAccumulatedDeficitAsResultOfAdoptingIfrsFifteen" xlink:label="loc_mdwd_CumulativeEffectAdjustmentOnAccumulatedDeficitAsResultOfAdoptingIfrsFifteen_64"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_CumulativeEffectAdjustmentOnAccumulatedDeficitAsResultOfAdoptingIfrsFifteen" xlink:label="loc_mdwd_CumulativeEffectAdjustmentOnAccumulatedDeficitAsResultOfAdoptingIfrsFifteen_65"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_DescriptionOfAccountingPolicyForShorttermBankDepositsExplanatory" xlink:label="loc_mdwd_DescriptionOfAccountingPolicyForShorttermBankDepositsExplanatory_66"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_DescriptionOfAccountingPolicyForShorttermBankDepositsExplanatory" xlink:label="loc_mdwd_DescriptionOfAccountingPolicyForShorttermBankDepositsExplanatory_67"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_DescriptionOfAccountingPolicyForShorttermBankDepositsExplanatory" xlink:label="loc_mdwd_DescriptionOfAccountingPolicyForShorttermBankDepositsExplanatory_68"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_DescriptionOfOtherAccountingPoliciesBasisOfPreparationOfInterimConsolidatedFinancialStatementsExplanatory" xlink:label="loc_mdwd_DescriptionOfOtherAccountingPoliciesBasisOfPreparationOfInterimConsolidatedFinancialStatementsExplanatory_69"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_DescriptionOfOtherAccountingPoliciesBasisOfPreparationOfInterimConsolidatedFinancialStatementsExplanatory" xlink:label="loc_mdwd_DescriptionOfOtherAccountingPoliciesBasisOfPreparationOfInterimConsolidatedFinancialStatementsExplanatory_70"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_DescriptionOfOtherAccountingPoliciesBasisOfPreparationOfInterimConsolidatedFinancialStatementsExplanatory" xlink:label="loc_mdwd_DescriptionOfOtherAccountingPoliciesBasisOfPreparationOfInterimConsolidatedFinancialStatementsExplanatory_71"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_DescriptionOfOtherAccountingPoliciesChangesInSignificantAccountingPoliciesExplanatory" xlink:label="loc_mdwd_DescriptionOfOtherAccountingPoliciesChangesInSignificantAccountingPoliciesExplanatory_72"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_DescriptionOfOtherAccountingPoliciesChangesInSignificantAccountingPoliciesExplanatory" xlink:label="loc_mdwd_DescriptionOfOtherAccountingPoliciesChangesInSignificantAccountingPoliciesExplanatory_73"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfFinancialPositionExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfFinancialPositionExplanatory_74"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfFinancialPositionExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfFinancialPositionExplanatory_75"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfProfitOrLossExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfProfitOrLossExplanatory_76"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfProfitOrLossExplanatory" xlink:label="loc_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfProfitOrLossExplanatory_77"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_EmployeesAndOfficersMember" xlink:label="loc_mdwd_EmployeesAndOfficersMember_78"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_EmployeesAndOfficersMember" xlink:label="loc_mdwd_EmployeesAndOfficersMember_79"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_EmployeesAndOfficersMember" xlink:label="loc_mdwd_EmployeesAndOfficersMember_80"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_Equity1" xlink:label="loc_mdwd_Equity1_81"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_Equity1" xlink:label="loc_mdwd_Equity1_82"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_Equity1" xlink:label="loc_mdwd_Equity1_83"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_EquityIncentivePlanMember" xlink:label="loc_mdwd_EquityIncentivePlanMember_84"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_EquityIncentivePlanMember" xlink:label="loc_mdwd_EquityIncentivePlanMember_85"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_EquityIncentivePlanMember" xlink:label="loc_mdwd_EquityIncentivePlanMember_86"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_EventsAfterReportingPeriodMember" xlink:label="loc_mdwd_EventsAfterReportingPeriodMember_87"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_EventsAfterReportingPeriodMember" xlink:label="loc_mdwd_EventsAfterReportingPeriodMember_88"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_EventsAfterReportingPeriodMember" xlink:label="loc_mdwd_EventsAfterReportingPeriodMember_89"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ExerciseOfRsuOption" xlink:label="loc_mdwd_ExerciseOfRsuOption_90"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ExerciseOfRsuOption" xlink:label="loc_mdwd_ExerciseOfRsuOption_91"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ExerciseOfRsuOption" xlink:label="loc_mdwd_ExerciseOfRsuOption_92"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ExerciseOfRsuOption" xlink:label="loc_mdwd_ExerciseOfRsuOption_93"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ExtensionPeriodForOptionsExercised" xlink:label="loc_mdwd_ExtensionPeriodForOptionsExercised_94"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ExtensionPeriodForOptionsExercised" xlink:label="loc_mdwd_ExtensionPeriodForOptionsExercised_95"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ExtensionPeriodForOptionsExercised" xlink:label="loc_mdwd_ExtensionPeriodForOptionsExercised_96"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_FinanceIncomeExpenseNet" xlink:label="loc_mdwd_FinanceIncomeExpenseNet_97"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_FinanceIncomeExpenseNet" xlink:label="loc_mdwd_FinanceIncomeExpenseNet_98"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_FinanceIncomeExpenseNet" xlink:label="loc_mdwd_FinanceIncomeExpenseNet_99"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_IncreaseInAuthorizedShareCapital" xlink:label="loc_mdwd_IncreaseInAuthorizedShareCapital_100"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_IncreaseInAuthorizedShareCapital" xlink:label="loc_mdwd_IncreaseInAuthorizedShareCapital_101"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_IncreaseInAuthorizedShareCapital" xlink:label="loc_mdwd_IncreaseInAuthorizedShareCapital_102"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_IncreaseInPricePerShareOfSharesIssued" xlink:label="loc_mdwd_IncreaseInPricePerShareOfSharesIssued_103"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_IncreaseInPricePerShareOfSharesIssued" xlink:label="loc_mdwd_IncreaseInPricePerShareOfSharesIssued_104"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_IncreaseInPricePerShareOfSharesIssued" xlink:label="loc_mdwd_IncreaseInPricePerShareOfSharesIssued_105"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_IncreaseInRentAsPercentageInEveryThreeYear" xlink:label="loc_mdwd_IncreaseInRentAsPercentageInEveryThreeYear_106"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_IncreaseInRentAsPercentageInEveryThreeYear" xlink:label="loc_mdwd_IncreaseInRentAsPercentageInEveryThreeYear_107"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_IncreaseInRentAsPercentageInEveryThreeYear" xlink:label="loc_mdwd_IncreaseInRentAsPercentageInEveryThreeYear_108"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_IncreaseInSharesIssued" xlink:label="loc_mdwd_IncreaseInSharesIssued_109"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_IncreaseInSharesIssued" xlink:label="loc_mdwd_IncreaseInSharesIssued_110"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_IncreaseInSharesIssued" xlink:label="loc_mdwd_IncreaseInSharesIssued_111"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_IncrementalInterestRatesOfLeaseLiability" xlink:label="loc_mdwd_IncrementalInterestRatesOfLeaseLiability_112"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_IncrementalInterestRatesOfLeaseLiability" xlink:label="loc_mdwd_IncrementalInterestRatesOfLeaseLiability_113"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_IssueOfEquityShares" xlink:label="loc_mdwd_IssueOfEquityShares_114"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_IssueOfEquityShares" xlink:label="loc_mdwd_IssueOfEquityShares_115"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_LeaseExpenses" xlink:label="loc_mdwd_LeaseExpenses_116"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_LeaseExpenses" xlink:label="loc_mdwd_LeaseExpenses_117"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_MedicalTechnologyEnterpriseConsortiumMember" xlink:label="loc_mdwd_MedicalTechnologyEnterpriseConsortiumMember_118"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_MedicalTechnologyEnterpriseConsortiumMember" xlink:label="loc_mdwd_MedicalTechnologyEnterpriseConsortiumMember_119"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_MedicalTechnologyEnterpriseConsortiumMember" xlink:label="loc_mdwd_MedicalTechnologyEnterpriseConsortiumMember_120"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_NetProceedsFromIssueOfOrdinaryShares" xlink:label="loc_mdwd_NetProceedsFromIssueOfOrdinaryShares_121"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_NetProceedsFromIssueOfOrdinaryShares" xlink:label="loc_mdwd_NetProceedsFromIssueOfOrdinaryShares_122"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_NexoBridMember" xlink:label="loc_mdwd_NexoBridMember_123"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_NoncurrentLeaseLiability" xlink:label="loc_mdwd_NoncurrentLeaseLiability_124"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_NoncurrentLeaseLiability" xlink:label="loc_mdwd_NoncurrentLeaseLiability_125"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_NoncurrentLeaseLiability" xlink:label="loc_mdwd_NoncurrentLeaseLiability_126"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_NumberOfOrdinarySharesIssuable" xlink:label="loc_mdwd_NumberOfOrdinarySharesIssuable_127"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_NumberOfOrdinarySharesIssuable" xlink:label="loc_mdwd_NumberOfOrdinarySharesIssuable_128"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_NumberOfOrdinarySharesIssuable" xlink:label="loc_mdwd_NumberOfOrdinarySharesIssuable_129"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_NumberOfPatients" xlink:label="loc_mdwd_NumberOfPatients_130"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_NumberOfPatients" xlink:label="loc_mdwd_NumberOfPatients_131"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_NumberOfPatients" xlink:label="loc_mdwd_NumberOfPatients_132"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_NumberOfRestrictedShareUnits" xlink:label="loc_mdwd_NumberOfRestrictedShareUnits_133"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_NumberOfRestrictedShareUnits" xlink:label="loc_mdwd_NumberOfRestrictedShareUnits_134"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_NumberOfRestrictedShareUnits" xlink:label="loc_mdwd_NumberOfRestrictedShareUnits_135"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_NumberOfShareAvailableForIssuance" xlink:label="loc_mdwd_NumberOfShareAvailableForIssuance_136"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_NumberOfShareAvailableForIssuance" xlink:label="loc_mdwd_NumberOfShareAvailableForIssuance_137"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_NumberOfShareAvailableForIssuance" xlink:label="loc_mdwd_NumberOfShareAvailableForIssuance_138"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_NumberOfSharesUsedInCalculatingBasicAndDilutedProfitLossPerShare" xlink:label="loc_mdwd_NumberOfSharesUsedInCalculatingBasicAndDilutedProfitLossPerShare_139"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_NumberOfSharesUsedInCalculatingBasicAndDilutedProfitLossPerShare" xlink:label="loc_mdwd_NumberOfSharesUsedInCalculatingBasicAndDilutedProfitLossPerShare_140"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_NumberOfSharesUsedInCalculatingBasicAndDilutedProfitLossPerShare" xlink:label="loc_mdwd_NumberOfSharesUsedInCalculatingBasicAndDilutedProfitLossPerShare_141"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ParticipationsByBardaAndIia" xlink:label="loc_mdwd_ParticipationsByBardaAndIia_142"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ParticipationsByBardaAndIia" xlink:label="loc_mdwd_ParticipationsByBardaAndIia_143"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_PolyHealLtdMember" xlink:label="loc_mdwd_PolyHealLtdMember_144"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_PolyHealLtdMember" xlink:label="loc_mdwd_PolyHealLtdMember_145"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ProceedsFromAdditionalFunding" xlink:label="loc_mdwd_ProceedsFromAdditionalFunding_146"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ProceedsFromAdditionalFunding" xlink:label="loc_mdwd_ProceedsFromAdditionalFunding_147"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ProceedsFromAdditionalProcurement" xlink:label="loc_mdwd_ProceedsFromAdditionalProcurement_148"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ProceedsFromAdditionalProcurement" xlink:label="loc_mdwd_ProceedsFromAdditionalProcurement_149"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ProceedsFromGrants" xlink:label="loc_mdwd_ProceedsFromGrants_150"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ProceedsFromGrants" xlink:label="loc_mdwd_ProceedsFromGrants_151"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ProceedsFromGrants" xlink:label="loc_mdwd_ProceedsFromGrants_152"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ProceedsFromIssuingAdditionalShares" xlink:label="loc_mdwd_ProceedsFromIssuingAdditionalShares_153"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ProceedsFromIssuingAdditionalShares" xlink:label="loc_mdwd_ProceedsFromIssuingAdditionalShares_154"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ProceedsFromIssuingAdditionalShares" xlink:label="loc_mdwd_ProceedsFromIssuingAdditionalShares_155"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ProceedsFromProcurement" xlink:label="loc_mdwd_ProceedsFromProcurement_156"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ProceedsFromProcurement" xlink:label="loc_mdwd_ProceedsFromProcurement_157"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ProceedsFromRepaymentOfIssuingShares" xlink:label="loc_mdwd_ProceedsFromRepaymentOfIssuingShares_158"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ProceedsFromRepaymentOfIssuingShares" xlink:label="loc_mdwd_ProceedsFromRepaymentOfIssuingShares_159"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ProceedsFromRepaymentOfIssuingShares" xlink:label="loc_mdwd_ProceedsFromRepaymentOfIssuingShares_160"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ProceedsFromRepaymentOfIssuingShares" xlink:label="loc_mdwd_ProceedsFromRepaymentOfIssuingShares_161"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_PublicOfferingMember" xlink:label="loc_mdwd_PublicOfferingMember_162"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_PublicOfferingMember" xlink:label="loc_mdwd_PublicOfferingMember_163"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_PublicOfferingMember" xlink:label="loc_mdwd_PublicOfferingMember_164"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RepaymentFromGrants" xlink:label="loc_mdwd_RepaymentFromGrants_165"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RepaymentFromGrants" xlink:label="loc_mdwd_RepaymentFromGrants_166"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RepaymentFromGrants" xlink:label="loc_mdwd_RepaymentFromGrants_167"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RepaymentFromGrants" xlink:label="loc_mdwd_RepaymentFromGrants_168"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RepaymentOfLiabilitiesInRespectOfTeva" xlink:label="loc_mdwd_RepaymentOfLiabilitiesInRespectOfTeva_169"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RepaymentOfLiabilitiesInRespectOfTeva" xlink:label="loc_mdwd_RepaymentOfLiabilitiesInRespectOfTeva_170"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RepaymentOfLiabilitiesInRespectOfTeva" xlink:label="loc_mdwd_RepaymentOfLiabilitiesInRespectOfTeva_171"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet" xlink:label="loc_mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet_172"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet" xlink:label="loc_mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet_173"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet" xlink:label="loc_mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet_174"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet" xlink:label="loc_mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet_175"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet" xlink:label="loc_mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet_176"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ReplenishmentAmount" xlink:label="loc_mdwd_ReplenishmentAmount_177"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ReplenishmentAmount" xlink:label="loc_mdwd_ReplenishmentAmount_178"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ReplenishmentAmount" xlink:label="loc_mdwd_ReplenishmentAmount_179"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ResearchAndDevelopmentExpenseGross" xlink:label="loc_mdwd_ResearchAndDevelopmentExpenseGross_180"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ResearchAndDevelopmentExpenseGross" xlink:label="loc_mdwd_ResearchAndDevelopmentExpenseGross_181"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ResearchAndDevelopmentExpenseGross" xlink:label="loc_mdwd_ResearchAndDevelopmentExpenseGross_182"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RestrictedSharesUnitsMember" xlink:label="loc_mdwd_RestrictedSharesUnitsMember_183"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RestrictedSharesUnitsMember" xlink:label="loc_mdwd_RestrictedSharesUnitsMember_184"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RestrictedSharesUnitsMember" xlink:label="loc_mdwd_RestrictedSharesUnitsMember_185"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RevaluationOfLeaseLiabilities" xlink:label="loc_mdwd_RevaluationOfLeaseLiabilities_186"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RevaluationOfLeaseLiabilities" xlink:label="loc_mdwd_RevaluationOfLeaseLiabilities_187"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RevaluationOfLeaseLiabilities" xlink:label="loc_mdwd_RevaluationOfLeaseLiabilities_188"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfGrants" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_189"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfGrants" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_190"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfGrants" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_191"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfTeva" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfTeva_192"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfTeva" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfTeva_193"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfTeva" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfTeva_194"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RevaluationOfWarrantsAccountedAtFairValue" xlink:label="loc_mdwd_RevaluationOfWarrantsAccountedAtFairValue_195"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RevaluationOfWarrantsAccountedAtFairValue" xlink:label="loc_mdwd_RevaluationOfWarrantsAccountedAtFairValue_196"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RevaluationOfWarrantsAccountedAtFairValue" xlink:label="loc_mdwd_RevaluationOfWarrantsAccountedAtFairValue_197"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_SaleOfStocksAxis" xlink:label="loc_mdwd_SaleOfStocksAxis_198"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_SaleOfStocksAxis" xlink:label="loc_mdwd_SaleOfStocksAxis_199"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_SaleOfStocksDomain" xlink:label="loc_mdwd_SaleOfStocksDomain_200"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_SaleOfStocksDomain" xlink:label="loc_mdwd_SaleOfStocksDomain_201"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare" xlink:label="loc_mdwd_ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare_202"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare" xlink:label="loc_mdwd_ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare_203"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare" xlink:label="loc_mdwd_ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare_204"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_SharesIssuedPriceInInitialPublicOffering" xlink:label="loc_mdwd_SharesIssuedPriceInInitialPublicOffering_205"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_SharesIssuedPriceInInitialPublicOffering" xlink:label="loc_mdwd_SharesIssuedPriceInInitialPublicOffering_206"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_StockOptionsMember" xlink:label="loc_mdwd_StockOptionsMember_207"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_StockOptionValue" xlink:label="loc_mdwd_StockOptionValue_208"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_StockOptionValue" xlink:label="loc_mdwd_StockOptionValue_209"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_StockOptionValue" xlink:label="loc_mdwd_StockOptionValue_210"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_SubsequentsEventMember" xlink:label="loc_mdwd_SubsequentsEventMember_211"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_SubsequentsEventMember" xlink:label="loc_mdwd_SubsequentsEventMember_212"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_SupplementalFunding" xlink:label="loc_mdwd_SupplementalFunding_213"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_SupplementalFunding" xlink:label="loc_mdwd_SupplementalFunding_214"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_TevaMember" xlink:label="loc_mdwd_TevaMember_215"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_UnderwritingDiscounts" xlink:label="loc_mdwd_UnderwritingDiscounts_216"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_UnderwritingDiscounts" xlink:label="loc_mdwd_UnderwritingDiscounts_217"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_USDepartmentOfDefenseMember" xlink:label="loc_mdwd_USDepartmentOfDefenseMember_218"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_USDepartmentOfDefenseMember" xlink:label="loc_mdwd_USDepartmentOfDefenseMember_219"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_USDepartmentOfDefenseMember" xlink:label="loc_mdwd_USDepartmentOfDefenseMember_220"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_USFoodAndDrugAdministrationMember" xlink:label="loc_mdwd_USFoodAndDrugAdministrationMember_221"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_USFoodAndDrugAdministrationMember" xlink:label="loc_mdwd_USFoodAndDrugAdministrationMember_222"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_USFoodAndDrugAdministrationMember" xlink:label="loc_mdwd_USFoodAndDrugAdministrationMember_223"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_VericelMember" xlink:label="loc_mdwd_VericelMember_224"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForFinanceIncomeCost" xlink:label="loc_ifrs-full_AdjustmentsForFinanceIncomeCost_225"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForFinanceIncomeCost" xlink:label="loc_ifrs-full_AdjustmentsForFinanceIncomeCost_226"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_227"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_228"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_229"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_230"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_231"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_232"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_233"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_234"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_235"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_236"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_237"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" xlink:label="loc_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_238"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" xlink:label="loc_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_239"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" xlink:label="loc_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_240"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" xlink:label="loc_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_241"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" xlink:label="loc_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_242"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" xlink:label="loc_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_243"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" xlink:label="loc_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_244"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_245"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_246"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_247"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_248"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_249"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_250"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_251"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_252"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_253"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_254"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_255"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_256"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_257"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_258"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_259"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_260"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_261"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_262"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_263"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_264"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_dei_AmendmentDescription_265"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_266"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_267"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_268"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_269"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_270"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_271"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_272"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_273"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_274"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_275"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_276"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_277"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_278"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_279"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_280"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_281"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_282"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_283"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_284"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_285"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_286"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_287"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_288"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_289"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_290"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_291"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_292"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_293"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities_294"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_295"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_296"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_297"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_298"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_299"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_300"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_301"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_302"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_303"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_304"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_305"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets_306"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets_307"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="loc_ifrs-full_BasicEarningsLossPerShare_308"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="loc_ifrs-full_BasicEarningsLossPerShare_309"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_310"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_311"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_312"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_313"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" xlink:label="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_314"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" xlink:label="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_315"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" xlink:label="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_316"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_317"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_318"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_319"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_320"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_321"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_322"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_323"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_324"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_325"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_326"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_327"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_328"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_329"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_330"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_331"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_332"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_333"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_334"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CostOfMerchandiseSold" xlink:label="loc_ifrs-full_CostOfMerchandiseSold_335"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CostOfMerchandiseSold" xlink:label="loc_ifrs-full_CostOfMerchandiseSold_336"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_337"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_338"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CounterpartiesMember" xlink:label="loc_ifrs-full_CounterpartiesMember_339"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_340"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_341"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="loc_ifrs-full_CurrentAssetsAbstract_342"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_343"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_344"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_345"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract_346"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables_347"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="loc_ifrs-full_DepreciationRightofuseAssets_348"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_349"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_350"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_351"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_352"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_353"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_354"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_355"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_356"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_357"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_358"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_359"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_360"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_361"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_362"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_363"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForReclassificationOfFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForReclassificationOfFinancialInstrumentsExplanatory_364"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_365"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_366"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_367"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_368"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_369"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements" xlink:label="loc_ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements_370"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_371"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_372"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_373"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_374"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_375"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfContingentLiabilitiesAbstract" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_376"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfDepositaryReceiptsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDepositaryReceiptsAbstract_377"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfDepositaryReceiptsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDepositaryReceiptsAbstract_378"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_379"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_380"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfExpensesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfExpensesExplanatory_381"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfExpensesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfExpensesExplanatory_382"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_383"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_384"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_385"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_386"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_387"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_388"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_389"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_390"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_391"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:label="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_392"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:label="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_393"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_394"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_395"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_396"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_397"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_398"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_399"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_400"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="loc_ifrs-full_EntitysTotalForAssociatesMember_401"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_402"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityAbstract" xlink:label="loc_ifrs-full_EquityAbstract_403"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityAbstract" xlink:label="loc_ifrs-full_EquityAbstract_404"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities_405"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities_406"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ExpenseByNatureAbstract" xlink:label="loc_ifrs-full_ExpenseByNatureAbstract_407"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_408"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_409"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome_410"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-full_GrossProfit_411"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-full_GrossProfit_412"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="loc_ifrs-full_IncomeStatementAbstract_413"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_414"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_415"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings_416"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_417"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_418"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_419"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_420"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_421"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_422"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_423"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_424"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_425"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_426"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InvestmentProperty" xlink:label="loc_ifrs-full_InvestmentProperty_427"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InvestmentProperty" xlink:label="loc_ifrs-full_InvestmentProperty_428"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InvestmentPropertyMember" xlink:label="loc_ifrs-full_InvestmentPropertyMember_429"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_430"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_431"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_432"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember_433"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_434"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_435"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_436"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_437"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_438"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LicenceFeeIncome" xlink:label="loc_ifrs-full_LicenceFeeIncome_439"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_440"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_441"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentAssets_442"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentAssets_443"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract_444"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract_445"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentGovernmentGrants" xlink:label="loc_ifrs-full_NoncurrentGovernmentGrants_446"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentGovernmentGrants" xlink:label="loc_ifrs-full_NoncurrentGovernmentGrants_447"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-full_NoncurrentLiabilities_448"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-full_NoncurrentLiabilities_449"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesAbstract_450"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:label="loc_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_451"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentWarrantLiability" xlink:label="loc_ifrs-full_NoncurrentWarrantLiability_452"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentWarrantLiability" xlink:label="loc_ifrs-full_NoncurrentWarrantLiability_453"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_454"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_455"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_456"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_457"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesAuthorised" xlink:label="loc_ifrs-full_NumberOfSharesAuthorised_458"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesAuthorised" xlink:label="loc_ifrs-full_NumberOfSharesAuthorised_459"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_460"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_461"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OperatingExpense" xlink:label="loc_ifrs-full_OperatingExpense_462"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OperatingExpense" xlink:label="loc_ifrs-full_OperatingExpense_463"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_464"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherComprehensiveIncomeAbstract" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeAbstract_465"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherComprehensiveIncomeAbstract" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeAbstract_466"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherCurrentPayables" xlink:label="loc_ifrs-full_OtherCurrentPayables_467"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherCurrentReceivables" xlink:label="loc_ifrs-full_OtherCurrentReceivables_468"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherExpenseByFunction" xlink:label="loc_ifrs-full_OtherExpenseByFunction_469"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherNoncurrentLiabilities" xlink:label="loc_ifrs-full_OtherNoncurrentLiabilities_470"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherNoncurrentLiabilities" xlink:label="loc_ifrs-full_OtherNoncurrentLiabilities_471"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherNoncurrentReceivables" xlink:label="loc_ifrs-full_OtherNoncurrentReceivables_472"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherNoncurrentReceivables" xlink:label="loc_ifrs-full_OtherNoncurrentReceivables_473"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_474"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_475"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromExerciseOfOptions" xlink:label="loc_ifrs-full_ProceedsFromExerciseOfOptions_476"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromExerciseOfOptions" xlink:label="loc_ifrs-full_ProceedsFromExerciseOfOptions_477"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromExerciseOfWarrants" xlink:label="loc_ifrs-full_ProceedsFromExerciseOfWarrants_478"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromExerciseOfWarrants" xlink:label="loc_ifrs-full_ProceedsFromExerciseOfWarrants_479"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares_480"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_481"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_482"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_483"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_484"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_485"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_486"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_487"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_488"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_489"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate_490"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_491"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_492"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RentalExpense" xlink:label="loc_ifrs-full_RentalExpense_493"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RentDeferredIncomeClassifiedAsNoncurrent" xlink:label="loc_ifrs-full_RentDeferredIncomeClassifiedAsNoncurrent_494"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_495"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_496"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads" xlink:label="loc_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads_497"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" xlink:label="loc_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember_498"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RestrictedCashAndCashEquivalents" xlink:label="loc_ifrs-full_RestrictedCashAndCashEquivalents_499"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_500"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_501"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-full_RetainedEarningsMember_502"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_503"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_504"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RevenueFromRenderingOfServices" xlink:label="loc_ifrs-full_RevenueFromRenderingOfServices_505"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_506"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_507"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RightofuseAssetsIncreaseDecreaseInRevaluationSurplus" xlink:label="loc_ifrs-full_RightofuseAssetsIncreaseDecreaseInRevaluationSurplus_508"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RightofuseAssetsIncreaseDecreaseInRevaluationSurplus" xlink:label="loc_ifrs-full_RightofuseAssetsIncreaseDecreaseInRevaluationSurplus_509"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SalesAndMarketingExpense" xlink:label="loc_ifrs-full_SalesAndMarketingExpense_510"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_511"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ServicesExpense" xlink:label="loc_ifrs-full_ServicesExpense_512"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ServicesExpense" xlink:label="loc_ifrs-full_ServicesExpense_513"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_514"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SharePremium" xlink:label="loc_ifrs-full_SharePremium_515"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SharePremiumMember" xlink:label="loc_ifrs-full_SharePremiumMember_516"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents" xlink:label="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_517"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents" xlink:label="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_518"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_519"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract_520"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_521"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_522"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="loc_ifrs-full_StatementOfFinancialPositionAbstract_523"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TerminationBenefitsExpense" xlink:label="loc_ifrs-full_TerminationBenefitsExpense_524"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TerminationBenefitsExpense" xlink:label="loc_ifrs-full_TerminationBenefitsExpense_525"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_526"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_527"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_528"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TypesOfInvestmentPropertyAxis" xlink:label="loc_ifrs-full_TypesOfInvestmentPropertyAxis_529"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_530"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares_531"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares_532"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AdjustmentsToReconcileNetLossToNetCashUsedInContinuingOperatingActivitiesAbstract" xlink:label="loc_mdwd_AdjustmentsToReconcileNetLossToNetCashUsedInContinuingOperatingActivitiesAbstract_533"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AdjustmentsToReconcileNetLossToNetCashUsedInContinuingOperatingActivitiesAbstract" xlink:label="loc_mdwd_AdjustmentsToReconcileNetLossToNetCashUsedInContinuingOperatingActivitiesAbstract_534"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AdjustmentsToReconcileNetLossToNetCashUsedInContinuingOperatingActivitiesAbstract" xlink:label="loc_mdwd_AdjustmentsToReconcileNetLossToNetCashUsedInContinuingOperatingActivitiesAbstract_535"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ChangesInAssetAndLiabilityItemsAbstract" xlink:label="loc_mdwd_ChangesInAssetAndLiabilityItemsAbstract_536"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ChangesInAssetAndLiabilityItemsAbstract" xlink:label="loc_mdwd_ChangesInAssetAndLiabilityItemsAbstract_537"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_DisclosureOfGeneralInformationAbstract" xlink:label="loc_mdwd_DisclosureOfGeneralInformationAbstract_538"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_DisclosureOfSignificantAccountingPoliciesAbstract" xlink:label="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_539"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_DisclosureOfSignificantAccountingPoliciesAbstract" xlink:label="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_540"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_DocumentAndEntityInformationAbstract" xlink:label="loc_mdwd_DocumentAndEntityInformationAbstract_541"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_NonCashTransactionsAbstract" xlink:label="loc_mdwd_NonCashTransactionsAbstract_542"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_NonCashTransactionsAbstract" xlink:label="loc_mdwd_NonCashTransactionsAbstract_543"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_StatementsLineItems" xlink:label="loc_mdwd_StatementsLineItems_544"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_StatementsTableTable" xlink:label="loc_mdwd_StatementsTableTable_545"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srt_ChiefExecutiveOfficerMember_546"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_547"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_548"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_549"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_550"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_551"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/commentaryGuidance" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShare_0" xml:lang="en-US">The reported value should be tagged twice, with both this element and the element &#8216;Basic earnings (loss) per share&#8217; when: (a) basic and diluted earnings per share are equal; and (b) an entity presents one line item to accomplish the dual presentation requirement of paragraph 67 of IAS 33.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShare_1" xml:lang="en-US">Diluted earnings (loss) per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShare_2" xml:lang="en-US">Diluted net profit (loss) per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShare_3" xml:lang="en-US">Total diluted earnings (loss) per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShare_4" xml:lang="en-US">Basic and diluted net profit (loss) per share - USD</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/commentaryGuidance" xlink:label="lab_mdwd_BasicAndDilutedNetProfitLossPerShare_0" xml:lang="en-US">The reported value should be tagged twice, with both this element and the element &#8216;Basic earnings (loss) per share&#8217; when: (a) basic and diluted earnings per share are equal; and (b) an entity presents one line item to accomplish the dual presentation requirement of paragraph 67 of IAS 33.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_BasicAndDilutedNetProfitLossPerShare_1" xml:lang="en-US">The amount of net income (loss) from per each basic and diluted share of common stock or unit when the per share amount is the same for both basic and diluted shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_BasicAndDilutedNetProfitLossPerShare_2" xml:lang="en-US">Basic And Diluted Net Profit (Loss) Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_BasicAndDilutedNetProfitLossPerShare_3" xml:lang="en-US">Total Basic and diluted net loss per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_mdwd_BasicAndDilutedNetProfitLossPerShare_4" xml:lang="en-US">Total diluted earnings (loss) per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_BasicAndDilutedNetProfitLossPerShare_5" xml:lang="en-US">Basic and diluted net profit (loss) per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AdditionalProceedsFromFunding_0" xml:lang="en-US">Additional funding amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AdditionalProceedsFromFunding_1" xml:lang="en-US">Additional Proceeds From Funding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_AdditionalProceedsFromFunding_2" xml:lang="en-US">Additional funding amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_0" xml:lang="en-US">Changes in asset and liability items, total.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_1" xml:lang="en-US">Adjustments For Changes In Increase Decrease In Asset And Liability Items</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_2" xml:lang="en-US">Changes in asset and liability items, total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_3" xml:lang="en-US">Changes in asset and liability items, total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_0" xml:lang="en-US">Adjustment for increase in other payables and deferred revenues.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_1" xml:lang="en-US">Adjustments For Increase Decrease In Other Payables And Deferred Revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_2" xml:lang="en-US">Increase (decrease) in other payables and deferred revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_3" xml:lang="en-US">Decrease in other payables and deferred revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss_0" xml:lang="en-US">Adjustment for issuance expenses of warrants through profit and loss.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss_1" xml:lang="en-US">Adjustments For Issuance Expenses Of Warrants Through Profit And Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss_2" xml:lang="en-US">Issuance expenses of warrants through profit and loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AdjustmentsMember_0" xml:lang="en-US">Adjustments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AreaOfLand_0" xml:lang="en-US">The area of land used for business by the entity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AreaOfLand_1" xml:lang="en-US">Area Of Land</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_AreaOfLand_2" xml:lang="en-US">Area of land</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_AuthorizedShareCapital_0" xml:lang="en-US">Authorized share capital.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AuthorizedShareCapital_1" xml:lang="en-US">Authorized Share Capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_AuthorizedShareCapital_2" xml:lang="en-US">Authorized: 20,000,000 shares as of June 30, 2023, 12,857,143 as of December 31, 2022; and 7,142,858 as of June 30, 2022; Issued and Outstanding: 7,252,234 as of June 30, 2023; 7,240,020 as of December 31, 2022 and 4,734,774 as of June 30, 2022</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_mdwd_AuthorizedShareCapital_3" xml:lang="en-US">Total issued capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_AuthorizedShareCapital_4" xml:lang="en-US">Authorized share capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_BardaMember_0" xml:lang="en-US">BARDA [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_BardaMember_1" xml:lang="en-US">Barda [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_BardaMember_2" xml:lang="en-US">BARDA</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_BasicAndDilutedEarningsLossPerShare_0" xml:lang="en-US">The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_BasicAndDilutedEarningsLossPerShare_1" xml:lang="en-US">Basic And Diluted Earnings (Loss) Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_BasicAndDilutedEarningsLossPerShare_2" xml:lang="en-US">Total Basic and diluted net loss per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_mdwd_BasicAndDilutedEarningsLossPerShare_3" xml:lang="en-US">Total Basic and diluted net profit (loss) per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_0" xml:lang="en-US">BARDA [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_BiopharmaxGroupLtdMember_0" xml:lang="en-US">Biopharmax Group Ltd [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_BiopharmaxGroupLtdMember_1" xml:lang="en-US">Biopharmax Group Ltd [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_BiopharmaxGroupLtdMember_2" xml:lang="en-US">Biopharmax Group Ltd. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_BoardMembersAndOfficersMember_0" xml:lang="en-US">This member stands for board members and officers.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_BoardMembersAndOfficersMember_1" xml:lang="en-US">Board Members And Officers [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_BoardMembersAndOfficersMember_2" xml:lang="en-US">Board members and officers [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_CertainEntitiesAffiliatedWithCbiMember_0" xml:lang="en-US">This member stands for certain entities affiliated with CBI.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_CertainEntitiesAffiliatedWithCbiMember_1" xml:lang="en-US">Certain Entities Affiliated With Cbi [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_CertainEntitiesAffiliatedWithCbiMember_2" xml:lang="en-US">Certain entities affiliated with CBI [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ChiefExecutiveOfficersMember_0" xml:lang="en-US">CEO [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ContractAmountForResearchDevelopmentAndManufacturing_0" xml:lang="en-US">Represents the amount of contract for research, development and manufacturing.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ContractAmountForResearchDevelopmentAndManufacturing_1" xml:lang="en-US">Contract Amount For Research Development And Manufacturing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_ContractAmountForResearchDevelopmentAndManufacturing_2" xml:lang="en-US">Contract amount for research, development and manufacturing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ContractTerm_0" xml:lang="en-US">Contract term in years.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ContractTerm_1" xml:lang="en-US">Contract term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ContractWithCustomers_0" xml:lang="en-US">Represents the amount of contract with customers.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ContractWithCustomers_1" xml:lang="en-US">Contract With Customers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_ContractWithCustomers_2" xml:lang="en-US">Contracts with customers</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_CostOfLicenseAgreements_0" xml:lang="en-US">Represents the amount of cost of license agreements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_CostOfLicenseAgreements_1" xml:lang="en-US">Cost Of License Agreements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_CostOfLicenseAgreements_2" xml:lang="en-US">Cost of revenues from license agreements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_CumulativeEffectAdjustmentOnAccumulatedDeficitAsResultOfAdoptingIfrsFifteen_0" xml:lang="en-US">Cumulative effect adjustment on accumulated deficit as a result of adopting IFRS 15.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_CumulativeEffectAdjustmentOnAccumulatedDeficitAsResultOfAdoptingIfrsFifteen_1" xml:lang="en-US">Cumulative Effect Adjustment On Accumulated Deficit As Result Of Adopting Ifrs Fifteen</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DescriptionOfAccountingPolicyForShorttermBankDepositsExplanatory_0" xml:lang="en-US">The description of the entity's accounting policy for short-term bank deposits.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DescriptionOfAccountingPolicyForShorttermBankDepositsExplanatory_1" xml:lang="en-US">Description Of Accounting Policy For Shortterm Bank Deposits Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DescriptionOfAccountingPolicyForShorttermBankDepositsExplanatory_2" xml:lang="en-US">Short-term bank deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DescriptionOfOtherAccountingPoliciesBasisOfPreparationOfInterimConsolidatedFinancialStatementsExplanatory_0" xml:lang="en-US">The description of accounting policies basis of preparation of the interim consolidated financial statements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DescriptionOfOtherAccountingPoliciesBasisOfPreparationOfInterimConsolidatedFinancialStatementsExplanatory_1" xml:lang="en-US">Description Of Other Accounting Policies Basis Of Preparation Of Interim Consolidated Financial Statements Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_DescriptionOfOtherAccountingPoliciesBasisOfPreparationOfInterimConsolidatedFinancialStatementsExplanatory_2" xml:lang="en-US">Basis of preparation of the interim consolidated financial statements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DescriptionOfOtherAccountingPoliciesChangesInSignificantAccountingPoliciesExplanatory_0" xml:lang="en-US">The description of accounting policies changes in significant accounting policies.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DescriptionOfOtherAccountingPoliciesChangesInSignificantAccountingPoliciesExplanatory_1" xml:lang="en-US">Description Of Other Accounting Policies Changes In Significant Accounting Policies Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfFinancialPositionExplanatory_0" xml:lang="en-US">The disclosure of detailed information about condensed interim consolidated statement of financial position.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfFinancialPositionExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Condensed Interim Consolidated Statement Of Financial Position Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfProfitOrLossExplanatory_0" xml:lang="en-US">The disclosure of detailed information about condensed interim consolidated statement of profit or loss.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfProfitOrLossExplanatory_1" xml:lang="en-US">Disclosure Of Detailed Information About Condensed Interim Consolidated Statement Of Profit Or Loss Explanatory</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_EmployeesAndOfficersMember_0" xml:lang="en-US">Employees and Officers [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_EmployeesAndOfficersMember_1" xml:lang="en-US">Employees And Officers [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_EmployeesAndOfficersMember_2" xml:lang="en-US">Employees and officers [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_Equity1_0" xml:lang="en-US">The amount of residual interest in the assets of the entity after deducting all its liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_mdwd_Equity1_1" xml:lang="en-US">Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_Equity1_2" xml:lang="en-US">Equity1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_EquityIncentivePlanMember_0" xml:lang="en-US">2014 Equity Incentive Plan (the "2014 Plan") [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_EquityIncentivePlanMember_1" xml:lang="en-US">Equity Incentive Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_EquityIncentivePlanMember_2" xml:lang="en-US">2014 Equity Incentive Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_EventsAfterReportingPeriodMember_0" xml:lang="en-US">Represents the member information related to event after reporting date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_EventsAfterReportingPeriodMember_1" xml:lang="en-US">Events After Reporting Period [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_EventsAfterReportingPeriodMember_2" xml:lang="en-US">Events after reporting period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ExerciseOfRsuOption_0" xml:lang="en-US">it represents exercie of RSU option.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ExerciseOfRsuOption_1" xml:lang="en-US">Exercise Of Rsu Option</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_ExerciseOfRsuOption_2" xml:lang="en-US">Issuance of shares due to RSUs exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_ExerciseOfRsuOption_3" xml:lang="en-US">Exercise of RSU&#8217;s</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ExtensionPeriodForOptionsExercised_0" xml:lang="en-US">Extension period for options exercised.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ExtensionPeriodForOptionsExercised_1" xml:lang="en-US">Extension Period For Options Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_ExtensionPeriodForOptionsExercised_2" xml:lang="en-US">Extension period for options exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_FinanceIncomeExpenseNet_0" xml:lang="en-US">Represents the amount of financing income (expenses), net.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_FinanceIncomeExpenseNet_1" xml:lang="en-US">Finance Income Expense Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_mdwd_FinanceIncomeExpenseNet_2" xml:lang="en-US">Financing income (expenses), net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_IncreaseInAuthorizedShareCapital_0" xml:lang="en-US">It represents Increase In authorized share capital.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_IncreaseInAuthorizedShareCapital_1" xml:lang="en-US">Increase In Authorized Share Capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_IncreaseInAuthorizedShareCapital_2" xml:lang="en-US">Increase Iin authorized share capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_IncreaseInPricePerShareOfSharesIssued_0" xml:lang="en-US">Represents the per share or per unit amount of equity securities issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_IncreaseInPricePerShareOfSharesIssued_1" xml:lang="en-US">Increase In Price Per Share Of Shares Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_IncreaseInPricePerShareOfSharesIssued_2" xml:lang="en-US">Increase in price per common shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_IncreaseInRentAsPercentageInEveryThreeYear_0" xml:lang="en-US">Increase In Rent As Percentage In Every Three Year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_IncreaseInRentAsPercentageInEveryThreeYear_1" xml:lang="en-US">Increase In Rent As Percentage In Every Three Year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_IncreaseInRentAsPercentageInEveryThreeYear_2" xml:lang="en-US">Increase in rent as percentage in every three years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_IncreaseInSharesIssued_0" xml:lang="en-US">Increase In Shares Issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_IncreaseInSharesIssued_1" xml:lang="en-US">Increase In Shares Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_IncreaseInSharesIssued_2" xml:lang="en-US">Increase In shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_IncrementalInterestRatesOfLeaseLiability_0" xml:lang="en-US">Incremental interest rates of lease liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_IncrementalInterestRatesOfLeaseLiability_1" xml:lang="en-US">Incremental interest rates of lease liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_IssueOfEquityShares_0" xml:lang="en-US">The increase in equity through the issue of equity instruments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_IssueOfEquityShares_1" xml:lang="en-US">Issue Of Equity Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_LeaseExpenses_0" xml:lang="en-US">Lease expenses for the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_LeaseExpenses_1" xml:lang="en-US">Lease expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_MedicalTechnologyEnterpriseConsortiumMember_0" xml:lang="en-US">This member stands for Medical Technology Enterprise Consortium.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_MedicalTechnologyEnterpriseConsortiumMember_1" xml:lang="en-US">Medical Technology Enterprise Consortium [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_MedicalTechnologyEnterpriseConsortiumMember_2" xml:lang="en-US">MTEC</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_NetProceedsFromIssueOfOrdinaryShares_0" xml:lang="en-US">The net cash inflow from the issuing of ordinary shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_NetProceedsFromIssueOfOrdinaryShares_1" xml:lang="en-US">Net Proceeds From Issue Of Ordinary Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_NexoBridMember_0" xml:lang="en-US">NexoBrid [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_NoncurrentLeaseLiability_0" xml:lang="en-US">Noncurrent lease liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_NoncurrentLeaseLiability_1" xml:lang="en-US">Noncurrent Lease Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_NoncurrentLeaseLiability_2" xml:lang="en-US">Lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_NumberOfOrdinarySharesIssuable_0" xml:lang="en-US">Represents the number of ordinary shares issuable on exercising the options granted.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_NumberOfOrdinarySharesIssuable_1" xml:lang="en-US">Number Of Ordinary Shares Issuable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_NumberOfOrdinarySharesIssuable_2" xml:lang="en-US">Number of ordinary shares issuable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_NumberOfPatients_0" xml:lang="en-US">Number of patients.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_NumberOfPatients_1" xml:lang="en-US">Number Of Patients</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_NumberOfPatients_2" xml:lang="en-US">Number of patients</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_NumberOfRestrictedShareUnits_0" xml:lang="en-US">Represents number of restricted share units.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_NumberOfRestrictedShareUnits_1" xml:lang="en-US">Number Of Restricted Share Units</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_NumberOfRestrictedShareUnits_2" xml:lang="en-US">Number of restricted share units</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_NumberOfShareAvailableForIssuance_0" xml:lang="en-US">Number of share available for issuance.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_NumberOfShareAvailableForIssuance_1" xml:lang="en-US">Number Of Share Available For Issuance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_NumberOfShareAvailableForIssuance_2" xml:lang="en-US">Number of share available for issuance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_NumberOfSharesUsedInCalculatingBasicAndDilutedProfitLossPerShare_0" xml:lang="en-US">Represents the number of shares used in calculating basic and diluted profit (loss) per share.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_NumberOfSharesUsedInCalculatingBasicAndDilutedProfitLossPerShare_1" xml:lang="en-US">Number Of Shares Used In Calculating Basic And Diluted Profit (Loss) Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_NumberOfSharesUsedInCalculatingBasicAndDilutedProfitLossPerShare_2" xml:lang="en-US">Number of shares used in calculating basic and diluted net loss per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ParticipationsByBardaAndIia_0" xml:lang="en-US">Participations by BARDA and IIA</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ParticipationsByBardaAndIia_1" xml:lang="en-US">Participations by BARDA and IIA</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_PolyHealLtdMember_0" xml:lang="en-US">PolyHeal Ltd. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_PolyHealLtdMember_1" xml:lang="en-US">Poly Heal Ltd [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ProceedsFromAdditionalFunding_0" xml:lang="en-US">Additional funding amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ProceedsFromAdditionalFunding_1" xml:lang="en-US">Proceeds From Additional Funding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ProceedsFromAdditionalProcurement_0" xml:lang="en-US">Additional procurement amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ProceedsFromAdditionalProcurement_1" xml:lang="en-US">Proceeds From Additional Procurement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ProceedsFromGrants_0" xml:lang="en-US">Proceeds from grants during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ProceedsFromGrants_1" xml:lang="en-US">Proceeds From Grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_ProceedsFromGrants_2" xml:lang="en-US">Repayments of IIA grant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ProceedsFromIssuingAdditionalShares_0" xml:lang="en-US">The cash inflow from issuing additional shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ProceedsFromIssuingAdditionalShares_1" xml:lang="en-US">Proceeds From Issuing Additional Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_ProceedsFromIssuingAdditionalShares_2" xml:lang="en-US">Net proceeds from the issue of additional shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ProceedsFromProcurement_0" xml:lang="en-US">Procurement amount.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ProceedsFromProcurement_1" xml:lang="en-US">Proceeds From Procurement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ProceedsFromRepaymentOfIssuingShares_0" xml:lang="en-US">Represents the amount of proceeds from repayment of Issuing shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ProceedsFromRepaymentOfIssuingShares_1" xml:lang="en-US">Proceeds From Repayment Of Issuing Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_ProceedsFromRepaymentOfIssuingShares_2" xml:lang="en-US">Proceeds from issuance of shares, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_ProceedsFromRepaymentOfIssuingShares_3" xml:lang="en-US">Proceeds from issuance of shares, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_PublicOfferingMember_0" xml:lang="en-US">First sale of stock by a private company to the public.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_PublicOfferingMember_1" xml:lang="en-US">Public Offering [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_PublicOfferingMember_2" xml:lang="en-US">Public offering [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RepaymentFromGrants_0" xml:lang="en-US">Repayment from grants during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_mdwd_RepaymentFromGrants_1" xml:lang="en-US">Repayment of IIA grants, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RepaymentFromGrants_2" xml:lang="en-US">Repayment From Grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_RepaymentFromGrants_3" xml:lang="en-US">Repayments of IIA grant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RepaymentOfLiabilitiesInRespectOfTeva_0" xml:lang="en-US">Represent the amount of Repayment of liabilities in respect of TEVA.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_mdwd_RepaymentOfLiabilitiesInRespectOfTeva_1" xml:lang="en-US">Repayment of liabilities in respect of TEVA</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RepaymentOfLiabilitiesInRespectOfTeva_2" xml:lang="en-US">Repayment Of Liabilities In Respect Of Teva</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet_0" xml:lang="en-US">Proceeds from (Repayment of) issuance of shares and warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet_1" xml:lang="en-US">Proceeds from (Repayment of) issuance of shares and warrants, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet_2" xml:lang="en-US">Repayment Of Proceeds From Issuance Of Shares And Warrants Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet_3" xml:lang="en-US">Proceeds from issuance of shares, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet_4" xml:lang="en-US">Proceeds from (Repayment of) issuance of shares and warrants, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ReplenishmentAmount_0" xml:lang="en-US">The amount of replenishment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ReplenishmentAmount_1" xml:lang="en-US">Replenishment Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_ReplenishmentAmount_2" xml:lang="en-US">Replenishment amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ResearchAndDevelopmentExpenseGross_0" xml:lang="en-US">Research and development, gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ResearchAndDevelopmentExpenseGross_1" xml:lang="en-US">Research And Development Expense Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_ResearchAndDevelopmentExpenseGross_2" xml:lang="en-US">Research and development, gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RestrictedSharesUnitsMember_0" xml:lang="en-US">Restricted Shares Unit [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RestrictedSharesUnitsMember_1" xml:lang="en-US">Restricted Shares Units [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_RestrictedSharesUnitsMember_2" xml:lang="en-US">Restricted Shares Units [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RevaluationOfLeaseLiabilities_0" xml:lang="en-US">Revaluation of lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_mdwd_RevaluationOfLeaseLiabilities_1" xml:lang="en-US">Revaluation of lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RevaluationOfLeaseLiabilities_2" xml:lang="en-US">Revaluation Of Lease Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_0" xml:lang="en-US">Revaluation of liabilities in respect of IIA grants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_1" xml:lang="en-US">Revaluation of liabilities in respect of IIA grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_2" xml:lang="en-US">Revaluation Of Liabilities In Respect Of Grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RevaluationOfLiabilitiesInRespectOfTeva_0" xml:lang="en-US">Represent the amount of Revaluation of liabilities in respect of TEVA.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_mdwd_RevaluationOfLiabilitiesInRespectOfTeva_1" xml:lang="en-US">Revaluation of liabilities in respect of TEVA</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RevaluationOfLiabilitiesInRespectOfTeva_2" xml:lang="en-US">Revaluation Of Liabilities In Respect Of Teva</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_RevaluationOfWarrantsAccountedAtFairValue_0" xml:lang="en-US">Represent the amount of Revaluation of warrants accounted at fair value.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_mdwd_RevaluationOfWarrantsAccountedAtFairValue_1" xml:lang="en-US">Revaluation of warrants accounted at fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_RevaluationOfWarrantsAccountedAtFairValue_2" xml:lang="en-US">Revaluation Of Warrants Accounted At Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_SaleOfStocksAxis_0" xml:lang="en-US">Information by type of sale of the entity's stock.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_SaleOfStocksAxis_1" xml:lang="en-US">Sale Of Stocks [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_SaleOfStocksDomain_0" xml:lang="en-US">Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_SaleOfStocksDomain_1" xml:lang="en-US">Sale Of Stocks [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare_0" xml:lang="en-US">Represents the amount of exercise price per share.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare_1" xml:lang="en-US">Share Options In Share Based Payment Arrangement Exercise Price Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare_2" xml:lang="en-US">Exercise price per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_SharesIssuedPriceInInitialPublicOffering_0" xml:lang="en-US">Shares issued price in initial public offering.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_SharesIssuedPriceInInitialPublicOffering_1" xml:lang="en-US">Shares issued price in initial public offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_StockOptionsMember_0" xml:lang="en-US">Stock Options [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_StockOptionValue_0" xml:lang="en-US">It represents value of stock option.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_StockOptionValue_1" xml:lang="en-US">Stock Option Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_StockOptionValue_2" xml:lang="en-US">Total estimated value of stock option</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_SubsequentsEventMember_0" xml:lang="en-US">Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_SubsequentsEventMember_1" xml:lang="en-US">Subsequents Event [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_SupplementalFunding_0" xml:lang="en-US">Supplemental Funding.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_SupplementalFunding_1" xml:lang="en-US">Supplemental Funding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_TevaMember_0" xml:lang="en-US">Teva [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_UnderwritingDiscounts_0" xml:lang="en-US">Underwriting discounts.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_UnderwritingDiscounts_1" xml:lang="en-US">Underwriting Discounts</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_USDepartmentOfDefenseMember_0" xml:lang="en-US">U S Department Of Defense [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_USDepartmentOfDefenseMember_1" xml:lang="en-US">U S Department Of Defense [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_USDepartmentOfDefenseMember_2" xml:lang="en-US">U.S. Department of Defense (DoD) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_USFoodAndDrugAdministrationMember_0" xml:lang="en-US">U.S. Food and Drug Administration.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_USFoodAndDrugAdministrationMember_1" xml:lang="en-US">U S Food And Drug Administration [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_USFoodAndDrugAdministrationMember_2" xml:lang="en-US">U.S. Food and Drug Administration (FDA) [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_mdwd_VericelMember_0" xml:lang="en-US">Vericel [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_AdjustmentsForFinanceIncomeCost_0" xml:lang="en-US">Net financing income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForFinanceIncomeCost_1" xml:lang="en-US">Adjustments for finance income (cost)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_FinanceCosts_0" xml:lang="en-US">Financial expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinanceCosts_1" xml:lang="en-US">Finance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_0" xml:lang="en-US">Un-realized foreign currency loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_1" xml:lang="en-US">Foreign exchange gain (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_0" xml:lang="en-US">Taxes on income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_1" xml:lang="en-US">Tax expense (income)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_2" xml:lang="en-US">Taxes on income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_0" xml:lang="en-US">Repayment of leases liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_1" xml:lang="en-US">Payments of lease liabilities, classified as financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_0" xml:lang="en-US">Purchase of property and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_1" xml:lang="en-US">Purchase of property, plant and equipment, classified as investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_0" xml:lang="en-US">Foreign currency translation adjustments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:label="lab_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_1" xml:lang="en-US">Other comprehensive loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_2" xml:lang="en-US">Other comprehensive income (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_3" xml:lang="en-US">Reclassification adjustments on change in value of foreign currency basis spreads, net of tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_4" xml:lang="en-US">Foreign currency translation adjustments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_5" xml:lang="en-US">Total other comprehensive income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_6" xml:lang="en-US">Other comprehensive income (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ShareIssueRelatedCost_0" xml:lang="en-US">Issuance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ShareIssueRelatedCost_1" xml:lang="en-US">Share issue related cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ShareIssueRelatedCost_2" xml:lang="en-US">Commissions and other offering expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_0" xml:lang="en-US">Net cash flows from (used in) investing activities, continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_1" xml:lang="en-US">Cash flows from (used in) investing activities, continuing operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_2" xml:lang="en-US">Net cash provided by (used in) continuing investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_3" xml:lang="en-US">Net cash used in investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalents_0" xml:lang="en-US">Balance of cash and cash equivalents at the end of the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalents_1" xml:lang="en-US">Balance of cash and cash equivalents at the beginning of the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashAndCashEquivalents_2" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_Equity_0" xml:lang="en-US">Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_Equity_1" xml:lang="en-US">Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Equity_2" xml:lang="en-US">Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Equity_3" xml:lang="en-US">Total equity (deficit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_Equity_4" xml:lang="en-US">Shareholders' equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel" xlink:label="lab_ifrs-full_ProfitLoss_0" xml:lang="en-US">Profit (loss) for the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLoss_1" xml:lang="en-US">Loss for the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfitLoss_2" xml:lang="en-US">Net income (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ProfitLoss_3" xml:lang="en-US">Net profit (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfitLoss_4" xml:lang="en-US">Net Profit (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AmendmentDescription_0" xml:lang="en-US">Amendment Description</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AmendmentFlag_0" xml:lang="en-US">Amendment Flag</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CoverAbstract_0" xml:lang="en-US">Cover [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CurrentFiscalYearEndDate_0" xml:lang="en-US">Current Fiscal Year End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalPeriodFocus_0" xml:lang="en-US">Document Fiscal Period Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalYearFocus_0" xml:lang="en-US">Document Fiscal Year Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentPeriodEndDate_0" xml:lang="en-US">Document Period End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentType_0" xml:lang="en-US">Document Type</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressAddressLine1_0" xml:lang="en-US">Entity Address, Address Line One</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressCityOrTown_0" xml:lang="en-US">Entity Address, City or Town</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressCountry_0" xml:lang="en-US">Entity Address, Country</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressPostalZipCode_0" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCentralIndexKey_0" xml:lang="en-US">Entity Central Index Key</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityDomain_0" xml:lang="en-US">Entity [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityFileNumber_0" xml:lang="en-US">Entity File Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityRegistrantName_0" xml:lang="en-US">Entity Registrant Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_LegalEntityAxis_0" xml:lang="en-US">Legal Entity [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares_0" xml:lang="en-US">Weighted average number of ordinary shares used in calculating diluted earnings per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares_1" xml:lang="en-US">Number of shares used in calculating diluted net loss per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_0" xml:lang="en-US">Decrease (increase) in inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_1" xml:lang="en-US">(Increase) decrease in inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_2" xml:lang="en-US">Increase in inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_0" xml:lang="en-US">Decrease (increase) in other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_1" xml:lang="en-US">Decrease in other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_2" xml:lang="en-US">Decrease (increase) in other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_0" xml:lang="en-US">Decrease (increase) in trade receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_1" xml:lang="en-US">Decrease (increase) in trade receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_2" xml:lang="en-US">(Increase) decrease in trade receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_0" xml:lang="en-US">Depreciation and amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities_0" xml:lang="en-US">Increase of deferred revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_0" xml:lang="en-US">Adjustments for increase (decrease) in employee benefit liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_1" xml:lang="en-US">Increase (decrease) in severance pay liability, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_2" xml:lang="en-US">Increase (decrease) in severance pay liability, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_0" xml:lang="en-US">Increase (decrease) in trade payables and accrued expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_1" xml:lang="en-US">Increase (decrease) in trade payables and accrued expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLoss_0" xml:lang="en-US">Adjustments to reconcile profit (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLoss_1" xml:lang="en-US">Adjustments to profit and loss items, total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLoss_2" xml:lang="en-US">Adjustments to profit and loss items, total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_0" xml:lang="en-US">Adjustments to profit and loss items:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForSharebasedPayments_0" xml:lang="en-US">Adjustments for share-based payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustmentsForSharebasedPayments_1" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Assets_0" xml:lang="en-US">Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Assets_1" xml:lang="en-US">Total assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BasicEarningsLossPerShare_0" xml:lang="en-US">Basic earnings (loss) per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BasicEarningsLossPerShare_1" xml:lang="en-US">Basic net profit (loss) per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BorrowingsByNameAxis_0" xml:lang="en-US">Borrowings by name [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BorrowingsByNameMember_0" xml:lang="en-US">Borrowings by name [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BottomOfRangeMember_0" xml:lang="en-US">Bottom of range [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_BottomOfRangeMember_1" xml:lang="en-US">Minimum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_0" xml:lang="en-US">Cash flows from (used in) decrease (increase) in short-term deposits and investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_1" xml:lang="en-US">Investment in short term bank deposits, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_2" xml:lang="en-US">(Increase) decrease in short term bank deposits, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_0" xml:lang="en-US">Cash flows from (used in) financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_1" xml:lang="en-US">Net cash provided by (used in) financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_0" xml:lang="en-US">Cash Flows from Financing Activities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_0" xml:lang="en-US">Cash Flows from Investing Activities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_0" xml:lang="en-US">Cash flows from (used in) operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_1" xml:lang="en-US">Cash used in operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_2" xml:lang="en-US">Net cash (used in) operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_0" xml:lang="en-US">Cash Flows from Operating Activities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xml:lang="en-US">Cash flows from operating activities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CategoriesOfRelatedPartiesAxis_0" xml:lang="en-US">Categories of related parties [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfShareCapitalAxis_0" xml:lang="en-US">Classes of share capital [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfShareCapitalMember_0" xml:lang="en-US">Share capital [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComponentsOfEquityAxis_0" xml:lang="en-US">Components of equity [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ComponentsOfEquityAxis_1" xml:lang="en-US">Components of equity [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComprehensiveIncome_0" xml:lang="en-US">Comprehensive income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ComprehensiveIncome_1" xml:lang="en-US">Total comprehensive loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ComprehensiveIncome_2" xml:lang="en-US">Total comprehensive profit (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ComprehensiveIncome_3" xml:lang="en-US">Total comprehensive income (loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CostOfMerchandiseSold_0" xml:lang="en-US">Cost of merchandise sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CostOfMerchandiseSold_1" xml:lang="en-US">Cost of revenues from sale of products</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CostOfSales_0" xml:lang="en-US">Cost of revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CostOfSales_1" xml:lang="en-US">Total cost of revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CounterpartiesMember_0" xml:lang="en-US">Counterparties [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentAssets_0" xml:lang="en-US">Current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CurrentAssets_1" xml:lang="en-US">Total current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentAssetsAbstract_0" xml:lang="en-US">CURRENT ASSETS:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentLeaseLiabilities_0" xml:lang="en-US">Current maturities of non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentLiabilities_0" xml:lang="en-US">Current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CurrentLiabilities_1" xml:lang="en-US">Total current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentLiabilitiesAbstract_0" xml:lang="en-US">CURRENT LIABILITIES:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentTradeReceivables_0" xml:lang="en-US">Trade receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DepreciationRightofuseAssets_0" xml:lang="en-US">Depreciation expenses right-of-use asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_0" xml:lang="en-US">Discontinued operation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_0" xml:lang="en-US">Loss per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_0" xml:lang="en-US">Short-term employee benefits and severance pay liability, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_0" xml:lang="en-US">Financial instruments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_0" xml:lang="en-US">Functional currency, reporting currency and foreign currency</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_0" xml:lang="en-US">Participation by governments support</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_0" xml:lang="en-US">Impairment of non-financial assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_0" xml:lang="en-US">Description of accounting policy for intangible assets other than goodwill [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_1" xml:lang="en-US">Intangible assets, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_0" xml:lang="en-US">Leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_0" xml:lang="en-US">Description of accounting policy for measuring inventories [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_1" xml:lang="en-US">Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_0" xml:lang="en-US">Description of accounting policy for property, plant and equipment [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_1" xml:lang="en-US">Property, plant and equipment, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_0" xml:lang="en-US">Provisions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForReclassificationOfFinancialInstrumentsExplanatory_0" xml:lang="en-US">Reclassification</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_0" xml:lang="en-US">Revenue recognition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_0" xml:lang="en-US">Research and development expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_0" xml:lang="en-US">Description of accounting policy for share-based payment transactions [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_1" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_0" xml:lang="en-US">Cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements_0" xml:lang="en-US">Basis of presentation of financial statements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_0" xml:lang="en-US">Description of vesting requirements for share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_1" xml:lang="en-US">Vesting period of share options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0" xml:lang="en-US">Disclosure of classes of share capital [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalTable_0" xml:lang="en-US">Disclosure of classes of share capital [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_0" xml:lang="en-US">CONTINGENT LIABILITIES AND COMMITMENTS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_0" xml:lang="en-US">Disclosure of contingent liabilities [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDepositaryReceiptsAbstract_0" xml:lang="en-US">Disclosure of depositary receipts [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDepositaryReceiptsAbstract_1" xml:lang="en-US">Loss per share data:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_0" xml:lang="en-US">Disclosure of events after reporting period [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_1" xml:lang="en-US">Subsequent events</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfExpensesExplanatory_0" xml:lang="en-US">Disclosure of expenses [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DisclosureOfExpensesExplanatory_1" xml:lang="en-US">OTHER EXPENSES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_0" xml:lang="en-US">GENERAL</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_1" xml:lang="en-US">General</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_0" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [text block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_1" xml:lang="en-US">SUBSEQUENT EVENTS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_0" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_0" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_0" xml:lang="en-US">EQUITY</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_1" xml:lang="en-US">Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0" xml:lang="en-US">Disclosure of associates [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_0" xml:lang="en-US">Disclosure of associates [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_0" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_1" xml:lang="en-US">Significant Accounting Policies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EarningsPerShareAbstract_0" xml:lang="en-US">Earnings per share [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_EarningsPerShareAbstract_1" xml:lang="en-US">Loss per share data:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_0" xml:lang="en-US">Exchange rate differences on cash and cash equivalent balances</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EntitysTotalForAssociatesMember_0" xml:lang="en-US">Entity's total for associates [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EntitysTotalForRelatedPartiesMember_0" xml:lang="en-US">Entity's total for related parties [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityAbstract_0" xml:lang="en-US">SHAREHOLDERS' EQUITY:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_EquityAbstract_1" xml:lang="en-US">Shareholders' equity:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityAndLiabilities_0" xml:lang="en-US">Equity and liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_EquityAndLiabilities_1" xml:lang="en-US">Total liabilities and equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExpenseByNatureAbstract_0" xml:lang="en-US">Expenses by nature [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_0" xml:lang="en-US">Expense from share-based payment transactions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_1" xml:lang="en-US">Expenses recognized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinanceIncome_0" xml:lang="en-US">Financial income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GrossProfit_0" xml:lang="en-US">Gross profit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_GrossProfit_1" xml:lang="en-US">Gross profit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncomeStatementAbstract_0" xml:lang="en-US">Profit or loss [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0" xml:lang="en-US">Increase (decrease) in cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_1" xml:lang="en-US">Increase (decrease) in cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings_0" xml:lang="en-US">Increase of accumulated deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_0" xml:lang="en-US">Increase (decrease) through exercise of options, equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_1" xml:lang="en-US">Exercise of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_0" xml:lang="en-US">Increase (decrease) through exercise of warrants, equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_1" xml:lang="en-US">Exercise of pre-funded warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_0" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_0" xml:lang="en-US">Intangible assets, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InterestExpenseOnLeaseLiabilities_0" xml:lang="en-US">Finance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_0" xml:lang="en-US">Interest received, classified as investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_1" xml:lang="en-US">Interest received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Inventories_0" xml:lang="en-US">Inventories</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InvestmentProperty_0" xml:lang="en-US">Investment property</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_InvestmentProperty_1" xml:lang="en-US">Investment amount in property</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InvestmentPropertyMember_0" xml:lang="en-US">Investment property [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IssuedCapital_0" xml:lang="en-US">Issued capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IssuedCapital_1" xml:lang="en-US">Ordinary shares of NIS 0.01 par value: Authorized: 20,000,000 shares as of June 30, 2023, 12,857,143 as of December 31, 2022; and 7,142,858 as of June 30, 2022; Issued and Outstanding: 7,252,234 as of June 30, 2023; 7,240,020 as of December 31, 2022 and 4,734,774 as of June 30, 2022</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IssuedCapital_2" xml:lang="en-US">Authorized share capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IssuedCapitalMember_0" xml:lang="en-US">Share capital [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IssueOfEquity_0" xml:lang="en-US">Issue of equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IssueOfEquity_1" xml:lang="en-US">Issuance of ordinary shares, net of issuance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LeaseLiabilities_0" xml:lang="en-US">Lease liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Liabilities_0" xml:lang="en-US">Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Liabilities_1" xml:lang="en-US">Total liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LicenceFeeIncome_0" xml:lang="en-US">Revenues from license agreements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_0" xml:lang="en-US">Non-adjusting events after reporting period [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NonadjustingEventsMember_0" xml:lang="en-US">Non-adjusting events after reporting period [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentAssets_0" xml:lang="en-US">Non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_NoncurrentAssets_1" xml:lang="en-US">Total non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentAssetsAbstract_0" xml:lang="en-US">LONG-TERM ASSETS:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NoncurrentAssetsAbstract_1" xml:lang="en-US">LONG?TERM ASSETS:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentGovernmentGrants_0" xml:lang="en-US">Liability in respect of IIA grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NoncurrentGovernmentGrants_1" xml:lang="en-US">Liabilities in respect of IIA grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentLiabilities_0" xml:lang="en-US">Non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_NoncurrentLiabilities_1" xml:lang="en-US">Total non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentLiabilitiesAbstract_0" xml:lang="en-US">LONG-TERM LIABILITIES:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_0" xml:lang="en-US">Severance pay liability, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentWarrantLiability_0" xml:lang="en-US">Non-current warrant liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NoncurrentWarrantLiability_1" xml:lang="en-US">Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_0" xml:lang="en-US">Number of other equity instruments granted in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_1" xml:lang="en-US">Number of restricted share units granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_0" xml:lang="en-US">Number of share options granted in share-based payment arrangement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_1" xml:lang="en-US">Number of options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfSharesAuthorised_0" xml:lang="en-US">Number of shares authorised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfSharesAuthorised_1" xml:lang="en-US">Number of shares authorised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfSharesIssued_0" xml:lang="en-US">Number of shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfSharesOutstanding_0" xml:lang="en-US">Ordinary shares, Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OperatingExpense_0" xml:lang="en-US">Operating expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_OperatingExpense_1" xml:lang="en-US">Total operating expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherComprehensiveIncome_0" xml:lang="en-US">Other comprehensive loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeAbstract_0" xml:lang="en-US">Other comprehensive income (loss):</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeAbstract_1" xml:lang="en-US">Other comprehensive income:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherCurrentPayables_0" xml:lang="en-US">Other payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherCurrentReceivables_0" xml:lang="en-US">Other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherExpenseByFunction_0" xml:lang="en-US">Other expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherNoncurrentLiabilities_0" xml:lang="en-US">Contingent consideration for purchase of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_OtherNoncurrentLiabilities_1" xml:lang="en-US">Liabilities in respect of TEVA</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherNoncurrentReceivables_0" xml:lang="en-US">Other non-current receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherNoncurrentReceivables_1" xml:lang="en-US">Other receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ParValuePerShare_0" xml:lang="en-US">Par value per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ParValuePerShare_1" xml:lang="en-US">Ordinary shares, par value (per share)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromExerciseOfOptions_0" xml:lang="en-US">Proceeds from exercise of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProceedsFromExerciseOfOptions_1" xml:lang="en-US">Proceeds from exercise of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromExerciseOfWarrants_0" xml:lang="en-US">Proceeds from exercise of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProceedsFromExerciseOfWarrants_1" xml:lang="en-US">Proceeds from exercise of pre-funded warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromIssueOfOrdinaryShares_0" xml:lang="en-US">Gross proceeds from initial public offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares_0" xml:lang="en-US">Proceeds from issuing shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares_1" xml:lang="en-US">Proceeds from issuance of shares, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares_2" xml:lang="en-US">Proceeds from (Repayment of) issuance of shares and warrants, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossBeforeTax_0" xml:lang="en-US">Profit (loss) before tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfitLossBeforeTax_1" xml:lang="en-US">Loss before taxes on income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ProfitLossBeforeTax_2" xml:lang="en-US">Profit (loss) before taxes on income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities_0" xml:lang="en-US">Profit (loss) from operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities_1" xml:lang="en-US">Operating loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment_0" xml:lang="en-US">Property, plant and equipment, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestInAssociate_0" xml:lang="en-US">Ownership percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RangeAxis_0" xml:lang="en-US">Range [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RangesMember_0" xml:lang="en-US">Ranges [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RentalExpense_0" xml:lang="en-US">Rental expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RentDeferredIncomeClassifiedAsNoncurrent_0" xml:lang="en-US">Deferred revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ResearchAndDevelopmentExpense_0" xml:lang="en-US">Research and development, net of participations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ResearchAndDevelopmentExpense_1" xml:lang="en-US">Research and development</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads_0" xml:lang="en-US">Foreign currency translation adjustments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember_0" xml:lang="en-US">Foreign currency translation reserve [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RestrictedCashAndCashEquivalents_0" xml:lang="en-US">Restricted deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RetainedEarnings_0" xml:lang="en-US">Accumulated deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RetainedEarnings_1" xml:lang="en-US">Accumulated deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RetainedEarningsMember_0" xml:lang="en-US">Accumulated deficit [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Revenue_0" xml:lang="en-US">Revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Revenue_1" xml:lang="en-US">Total revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RevenueFromRenderingOfServices_0" xml:lang="en-US">Revenues from development services</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RevenueFromSaleOfGoods_0" xml:lang="en-US">Revenues from sale of products</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RightofuseAssets_0" xml:lang="en-US">Right of-use assets, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RightofuseAssetsIncreaseDecreaseInRevaluationSurplus_0" xml:lang="en-US">Right-of-use assets, increase (decrease) in revaluation surplus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_RightofuseAssetsIncreaseDecreaseInRevaluationSurplus_1" xml:lang="en-US">ROU asset, net recognized with corresponding lease liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SalesAndMarketingExpense_0" xml:lang="en-US">Selling and marketing</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SellingGeneralAndAdministrativeExpense_0" xml:lang="en-US">General and administrative</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ServicesExpense_0" xml:lang="en-US">Services expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ServicesExpense_1" xml:lang="en-US">Cost of revenues from development services</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SharebasedPaymentArrangementsMember_0" xml:lang="en-US">Share-based payment arrangements [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SharePremium_0" xml:lang="en-US">Share premium</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SharePremiumMember_0" xml:lang="en-US">Share premium [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_0" xml:lang="en-US">Short-term bank deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_1" xml:lang="en-US">Short?term bank deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SignificantInvestmentsInAssociatesAxis_0" xml:lang="en-US">Associates [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfCashFlowsAbstract_0" xml:lang="en-US">Statement of cash flows [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfChangesInEquityLineItems_0" xml:lang="en-US">Statement of changes in equity [line items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfChangesInEquityTable_0" xml:lang="en-US">Statement of changes in equity [table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfFinancialPositionAbstract_0" xml:lang="en-US">Statement of financial position [abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TerminationBenefitsExpense_0" xml:lang="en-US">Termination benefits expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TerminationBenefitsExpense_1" xml:lang="en-US">Termination expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TopOfRangeMember_0" xml:lang="en-US">Top of range [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_TopOfRangeMember_1" xml:lang="en-US">Maximum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_0" xml:lang="en-US">Trade payables and accrued expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TypesOfInvestmentPropertyAxis_0" xml:lang="en-US">Types of investment property [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_0" xml:lang="en-US">Types of share-based payment arrangements [axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageShares_0" xml:lang="en-US">Weighted average number of ordinary shares used in calculating basic earnings per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WeightedAverageShares_1" xml:lang="en-US">Number of shares used in calculating basic net loss per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_AdjustmentsToReconcileNetLossToNetCashUsedInContinuingOperatingActivitiesAbstract_0" xml:lang="en-US">Adjustments To Reconcile Net Loss To Net Cash Used In Continuing Operating Activities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_AdjustmentsToReconcileNetLossToNetCashUsedInContinuingOperatingActivitiesAbstract_1" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in continuing operating activities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_AdjustmentsToReconcileNetLossToNetCashUsedInContinuingOperatingActivitiesAbstract_2" xml:lang="en-US">Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_ChangesInAssetAndLiabilityItemsAbstract_0" xml:lang="en-US">Changes In Asset And Liability Items [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_mdwd_ChangesInAssetAndLiabilityItemsAbstract_1" xml:lang="en-US">Changes in asset and liability items:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfGeneralInformationAbstract_0" xml:lang="en-US">Disclosure Of General Information [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xml:lang="en-US">Disclosure of significant accounting policies [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_1" xml:lang="en-US">Significant Accounting Policies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_DocumentAndEntityInformationAbstract_0" xml:lang="en-US">Document And Entity Information [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_NonCashTransactionsAbstract_0" xml:lang="en-US">Non Cash Transactions [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_mdwd_NonCashTransactionsAbstract_1" xml:lang="en-US">Supplement disclosure of Non-cash transactions:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_StatementsLineItems_0" xml:lang="en-US">Statements [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_mdwd_StatementsTableTable_0" xml:lang="en-US">Statements Table [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ChiefExecutiveOfficerMember_0" xml:lang="en-US">CEO [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MaximumMember_0" xml:lang="en-US">Maximum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MinimumMember_0" xml:lang="en-US">Minimum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RangeAxis_0" xml:lang="en-US">Statistical Measurement [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RangeMember_0" xml:lang="en-US">Statistical Measurement [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_0" xml:lang="en-US">Title of Individual [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShare_1" xlink:to="lab_ifrs-full_DilutedEarningsLossPerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShare_2" xlink:to="lab_ifrs-full_DilutedEarningsLossPerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShare_3" xlink:to="lab_ifrs-full_DilutedEarningsLossPerShare_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShare_4" xlink:to="lab_ifrs-full_DilutedEarningsLossPerShare_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShare_5" xlink:to="lab_ifrs-full_DilutedEarningsLossPerShare_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BasicAndDilutedNetProfitLossPerShare_6" xlink:to="lab_mdwd_BasicAndDilutedNetProfitLossPerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BasicAndDilutedNetProfitLossPerShare_7" xlink:to="lab_mdwd_BasicAndDilutedNetProfitLossPerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BasicAndDilutedNetProfitLossPerShare_8" xlink:to="lab_mdwd_BasicAndDilutedNetProfitLossPerShare_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BasicAndDilutedNetProfitLossPerShare_9" xlink:to="lab_mdwd_BasicAndDilutedNetProfitLossPerShare_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BasicAndDilutedNetProfitLossPerShare_10" xlink:to="lab_mdwd_BasicAndDilutedNetProfitLossPerShare_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BasicAndDilutedNetProfitLossPerShare_11" xlink:to="lab_mdwd_BasicAndDilutedNetProfitLossPerShare_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdditionalProceedsFromFunding_12" xlink:to="lab_mdwd_AdditionalProceedsFromFunding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdditionalProceedsFromFunding_13" xlink:to="lab_mdwd_AdditionalProceedsFromFunding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdditionalProceedsFromFunding_14" xlink:to="lab_mdwd_AdditionalProceedsFromFunding_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_15" xlink:to="lab_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_16" xlink:to="lab_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_17" xlink:to="lab_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_18" xlink:to="lab_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_19" xlink:to="lab_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_20" xlink:to="lab_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_21" xlink:to="lab_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_22" xlink:to="lab_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss_23" xlink:to="lab_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss_24" xlink:to="lab_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss_25" xlink:to="lab_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsMember_26" xlink:to="lab_mdwd_AdjustmentsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AreaOfLand_27" xlink:to="lab_mdwd_AreaOfLand_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AreaOfLand_28" xlink:to="lab_mdwd_AreaOfLand_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AreaOfLand_29" xlink:to="lab_mdwd_AreaOfLand_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AuthorizedShareCapital_30" xlink:to="lab_mdwd_AuthorizedShareCapital_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AuthorizedShareCapital_31" xlink:to="lab_mdwd_AuthorizedShareCapital_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AuthorizedShareCapital_32" xlink:to="lab_mdwd_AuthorizedShareCapital_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AuthorizedShareCapital_33" xlink:to="lab_mdwd_AuthorizedShareCapital_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AuthorizedShareCapital_34" xlink:to="lab_mdwd_AuthorizedShareCapital_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BardaMember_35" xlink:to="lab_mdwd_BardaMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BardaMember_36" xlink:to="lab_mdwd_BardaMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BardaMember_37" xlink:to="lab_mdwd_BardaMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BasicAndDilutedEarningsLossPerShare_38" xlink:to="lab_mdwd_BasicAndDilutedEarningsLossPerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BasicAndDilutedEarningsLossPerShare_39" xlink:to="lab_mdwd_BasicAndDilutedEarningsLossPerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BasicAndDilutedEarningsLossPerShare_40" xlink:to="lab_mdwd_BasicAndDilutedEarningsLossPerShare_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BasicAndDilutedEarningsLossPerShare_41" xlink:to="lab_mdwd_BasicAndDilutedEarningsLossPerShare_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_42" xlink:to="lab_mdwd_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BiopharmaxGroupLtdMember_43" xlink:to="lab_mdwd_BiopharmaxGroupLtdMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BiopharmaxGroupLtdMember_44" xlink:to="lab_mdwd_BiopharmaxGroupLtdMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BiopharmaxGroupLtdMember_45" xlink:to="lab_mdwd_BiopharmaxGroupLtdMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BoardMembersAndOfficersMember_46" xlink:to="lab_mdwd_BoardMembersAndOfficersMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BoardMembersAndOfficersMember_47" xlink:to="lab_mdwd_BoardMembersAndOfficersMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_BoardMembersAndOfficersMember_48" xlink:to="lab_mdwd_BoardMembersAndOfficersMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CertainEntitiesAffiliatedWithCbiMember_49" xlink:to="lab_mdwd_CertainEntitiesAffiliatedWithCbiMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CertainEntitiesAffiliatedWithCbiMember_50" xlink:to="lab_mdwd_CertainEntitiesAffiliatedWithCbiMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CertainEntitiesAffiliatedWithCbiMember_51" xlink:to="lab_mdwd_CertainEntitiesAffiliatedWithCbiMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ChiefExecutiveOfficersMember_52" xlink:to="lab_mdwd_ChiefExecutiveOfficersMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ContractAmountForResearchDevelopmentAndManufacturing_53" xlink:to="lab_mdwd_ContractAmountForResearchDevelopmentAndManufacturing_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ContractAmountForResearchDevelopmentAndManufacturing_54" xlink:to="lab_mdwd_ContractAmountForResearchDevelopmentAndManufacturing_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ContractAmountForResearchDevelopmentAndManufacturing_55" xlink:to="lab_mdwd_ContractAmountForResearchDevelopmentAndManufacturing_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ContractTerm_56" xlink:to="lab_mdwd_ContractTerm_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ContractTerm_57" xlink:to="lab_mdwd_ContractTerm_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ContractWithCustomers_58" xlink:to="lab_mdwd_ContractWithCustomers_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ContractWithCustomers_59" xlink:to="lab_mdwd_ContractWithCustomers_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ContractWithCustomers_60" xlink:to="lab_mdwd_ContractWithCustomers_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CostOfLicenseAgreements_61" xlink:to="lab_mdwd_CostOfLicenseAgreements_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CostOfLicenseAgreements_62" xlink:to="lab_mdwd_CostOfLicenseAgreements_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CostOfLicenseAgreements_63" xlink:to="lab_mdwd_CostOfLicenseAgreements_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CumulativeEffectAdjustmentOnAccumulatedDeficitAsResultOfAdoptingIfrsFifteen_64" xlink:to="lab_mdwd_CumulativeEffectAdjustmentOnAccumulatedDeficitAsResultOfAdoptingIfrsFifteen_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_CumulativeEffectAdjustmentOnAccumulatedDeficitAsResultOfAdoptingIfrsFifteen_65" xlink:to="lab_mdwd_CumulativeEffectAdjustmentOnAccumulatedDeficitAsResultOfAdoptingIfrsFifteen_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DescriptionOfAccountingPolicyForShorttermBankDepositsExplanatory_66" xlink:to="lab_mdwd_DescriptionOfAccountingPolicyForShorttermBankDepositsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DescriptionOfAccountingPolicyForShorttermBankDepositsExplanatory_67" xlink:to="lab_mdwd_DescriptionOfAccountingPolicyForShorttermBankDepositsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DescriptionOfAccountingPolicyForShorttermBankDepositsExplanatory_68" xlink:to="lab_mdwd_DescriptionOfAccountingPolicyForShorttermBankDepositsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DescriptionOfOtherAccountingPoliciesBasisOfPreparationOfInterimConsolidatedFinancialStatementsExplanatory_69" xlink:to="lab_mdwd_DescriptionOfOtherAccountingPoliciesBasisOfPreparationOfInterimConsolidatedFinancialStatementsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DescriptionOfOtherAccountingPoliciesBasisOfPreparationOfInterimConsolidatedFinancialStatementsExplanatory_70" xlink:to="lab_mdwd_DescriptionOfOtherAccountingPoliciesBasisOfPreparationOfInterimConsolidatedFinancialStatementsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DescriptionOfOtherAccountingPoliciesBasisOfPreparationOfInterimConsolidatedFinancialStatementsExplanatory_71" xlink:to="lab_mdwd_DescriptionOfOtherAccountingPoliciesBasisOfPreparationOfInterimConsolidatedFinancialStatementsExplanatory_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DescriptionOfOtherAccountingPoliciesChangesInSignificantAccountingPoliciesExplanatory_72" xlink:to="lab_mdwd_DescriptionOfOtherAccountingPoliciesChangesInSignificantAccountingPoliciesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DescriptionOfOtherAccountingPoliciesChangesInSignificantAccountingPoliciesExplanatory_73" xlink:to="lab_mdwd_DescriptionOfOtherAccountingPoliciesChangesInSignificantAccountingPoliciesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfFinancialPositionExplanatory_74" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfFinancialPositionExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfFinancialPositionExplanatory_75" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfFinancialPositionExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfProfitOrLossExplanatory_76" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfProfitOrLossExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfProfitOrLossExplanatory_77" xlink:to="lab_mdwd_DisclosureOfDetailedInformationAboutCondensedInterimConsolidatedStatementOfProfitOrLossExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_EmployeesAndOfficersMember_78" xlink:to="lab_mdwd_EmployeesAndOfficersMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_EmployeesAndOfficersMember_79" xlink:to="lab_mdwd_EmployeesAndOfficersMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_EmployeesAndOfficersMember_80" xlink:to="lab_mdwd_EmployeesAndOfficersMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_Equity1_81" xlink:to="lab_mdwd_Equity1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_Equity1_82" xlink:to="lab_mdwd_Equity1_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_Equity1_83" xlink:to="lab_mdwd_Equity1_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_EquityIncentivePlanMember_84" xlink:to="lab_mdwd_EquityIncentivePlanMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_EquityIncentivePlanMember_85" xlink:to="lab_mdwd_EquityIncentivePlanMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_EquityIncentivePlanMember_86" xlink:to="lab_mdwd_EquityIncentivePlanMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_EventsAfterReportingPeriodMember_87" xlink:to="lab_mdwd_EventsAfterReportingPeriodMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_EventsAfterReportingPeriodMember_88" xlink:to="lab_mdwd_EventsAfterReportingPeriodMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_EventsAfterReportingPeriodMember_89" xlink:to="lab_mdwd_EventsAfterReportingPeriodMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ExerciseOfRsuOption_90" xlink:to="lab_mdwd_ExerciseOfRsuOption_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ExerciseOfRsuOption_91" xlink:to="lab_mdwd_ExerciseOfRsuOption_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ExerciseOfRsuOption_92" xlink:to="lab_mdwd_ExerciseOfRsuOption_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ExerciseOfRsuOption_93" xlink:to="lab_mdwd_ExerciseOfRsuOption_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ExtensionPeriodForOptionsExercised_94" xlink:to="lab_mdwd_ExtensionPeriodForOptionsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ExtensionPeriodForOptionsExercised_95" xlink:to="lab_mdwd_ExtensionPeriodForOptionsExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ExtensionPeriodForOptionsExercised_96" xlink:to="lab_mdwd_ExtensionPeriodForOptionsExercised_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FinanceIncomeExpenseNet_97" xlink:to="lab_mdwd_FinanceIncomeExpenseNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FinanceIncomeExpenseNet_98" xlink:to="lab_mdwd_FinanceIncomeExpenseNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_FinanceIncomeExpenseNet_99" xlink:to="lab_mdwd_FinanceIncomeExpenseNet_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncreaseInAuthorizedShareCapital_100" xlink:to="lab_mdwd_IncreaseInAuthorizedShareCapital_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncreaseInAuthorizedShareCapital_101" xlink:to="lab_mdwd_IncreaseInAuthorizedShareCapital_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncreaseInAuthorizedShareCapital_102" xlink:to="lab_mdwd_IncreaseInAuthorizedShareCapital_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncreaseInPricePerShareOfSharesIssued_103" xlink:to="lab_mdwd_IncreaseInPricePerShareOfSharesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncreaseInPricePerShareOfSharesIssued_104" xlink:to="lab_mdwd_IncreaseInPricePerShareOfSharesIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncreaseInPricePerShareOfSharesIssued_105" xlink:to="lab_mdwd_IncreaseInPricePerShareOfSharesIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncreaseInRentAsPercentageInEveryThreeYear_106" xlink:to="lab_mdwd_IncreaseInRentAsPercentageInEveryThreeYear_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncreaseInRentAsPercentageInEveryThreeYear_107" xlink:to="lab_mdwd_IncreaseInRentAsPercentageInEveryThreeYear_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncreaseInRentAsPercentageInEveryThreeYear_108" xlink:to="lab_mdwd_IncreaseInRentAsPercentageInEveryThreeYear_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncreaseInSharesIssued_109" xlink:to="lab_mdwd_IncreaseInSharesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncreaseInSharesIssued_110" xlink:to="lab_mdwd_IncreaseInSharesIssued_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncreaseInSharesIssued_111" xlink:to="lab_mdwd_IncreaseInSharesIssued_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncrementalInterestRatesOfLeaseLiability_112" xlink:to="lab_mdwd_IncrementalInterestRatesOfLeaseLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IncrementalInterestRatesOfLeaseLiability_113" xlink:to="lab_mdwd_IncrementalInterestRatesOfLeaseLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IssueOfEquityShares_114" xlink:to="lab_mdwd_IssueOfEquityShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_IssueOfEquityShares_115" xlink:to="lab_mdwd_IssueOfEquityShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LeaseExpenses_116" xlink:to="lab_mdwd_LeaseExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_LeaseExpenses_117" xlink:to="lab_mdwd_LeaseExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_MedicalTechnologyEnterpriseConsortiumMember_118" xlink:to="lab_mdwd_MedicalTechnologyEnterpriseConsortiumMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_MedicalTechnologyEnterpriseConsortiumMember_119" xlink:to="lab_mdwd_MedicalTechnologyEnterpriseConsortiumMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_MedicalTechnologyEnterpriseConsortiumMember_120" xlink:to="lab_mdwd_MedicalTechnologyEnterpriseConsortiumMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NetProceedsFromIssueOfOrdinaryShares_121" xlink:to="lab_mdwd_NetProceedsFromIssueOfOrdinaryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NetProceedsFromIssueOfOrdinaryShares_122" xlink:to="lab_mdwd_NetProceedsFromIssueOfOrdinaryShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NexoBridMember_123" xlink:to="lab_mdwd_NexoBridMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NoncurrentLeaseLiability_124" xlink:to="lab_mdwd_NoncurrentLeaseLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NoncurrentLeaseLiability_125" xlink:to="lab_mdwd_NoncurrentLeaseLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NoncurrentLeaseLiability_126" xlink:to="lab_mdwd_NoncurrentLeaseLiability_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfOrdinarySharesIssuable_127" xlink:to="lab_mdwd_NumberOfOrdinarySharesIssuable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfOrdinarySharesIssuable_128" xlink:to="lab_mdwd_NumberOfOrdinarySharesIssuable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfOrdinarySharesIssuable_129" xlink:to="lab_mdwd_NumberOfOrdinarySharesIssuable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfPatients_130" xlink:to="lab_mdwd_NumberOfPatients_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfPatients_131" xlink:to="lab_mdwd_NumberOfPatients_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfPatients_132" xlink:to="lab_mdwd_NumberOfPatients_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfRestrictedShareUnits_133" xlink:to="lab_mdwd_NumberOfRestrictedShareUnits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfRestrictedShareUnits_134" xlink:to="lab_mdwd_NumberOfRestrictedShareUnits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfRestrictedShareUnits_135" xlink:to="lab_mdwd_NumberOfRestrictedShareUnits_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfShareAvailableForIssuance_136" xlink:to="lab_mdwd_NumberOfShareAvailableForIssuance_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfShareAvailableForIssuance_137" xlink:to="lab_mdwd_NumberOfShareAvailableForIssuance_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfShareAvailableForIssuance_138" xlink:to="lab_mdwd_NumberOfShareAvailableForIssuance_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfSharesUsedInCalculatingBasicAndDilutedProfitLossPerShare_139" xlink:to="lab_mdwd_NumberOfSharesUsedInCalculatingBasicAndDilutedProfitLossPerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfSharesUsedInCalculatingBasicAndDilutedProfitLossPerShare_140" xlink:to="lab_mdwd_NumberOfSharesUsedInCalculatingBasicAndDilutedProfitLossPerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NumberOfSharesUsedInCalculatingBasicAndDilutedProfitLossPerShare_141" xlink:to="lab_mdwd_NumberOfSharesUsedInCalculatingBasicAndDilutedProfitLossPerShare_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ParticipationsByBardaAndIia_142" xlink:to="lab_mdwd_ParticipationsByBardaAndIia_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ParticipationsByBardaAndIia_143" xlink:to="lab_mdwd_ParticipationsByBardaAndIia_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PolyHealLtdMember_144" xlink:to="lab_mdwd_PolyHealLtdMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PolyHealLtdMember_145" xlink:to="lab_mdwd_PolyHealLtdMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromAdditionalFunding_146" xlink:to="lab_mdwd_ProceedsFromAdditionalFunding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromAdditionalFunding_147" xlink:to="lab_mdwd_ProceedsFromAdditionalFunding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromAdditionalProcurement_148" xlink:to="lab_mdwd_ProceedsFromAdditionalProcurement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromAdditionalProcurement_149" xlink:to="lab_mdwd_ProceedsFromAdditionalProcurement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromGrants_150" xlink:to="lab_mdwd_ProceedsFromGrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromGrants_151" xlink:to="lab_mdwd_ProceedsFromGrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromGrants_152" xlink:to="lab_mdwd_ProceedsFromGrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromIssuingAdditionalShares_153" xlink:to="lab_mdwd_ProceedsFromIssuingAdditionalShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromIssuingAdditionalShares_154" xlink:to="lab_mdwd_ProceedsFromIssuingAdditionalShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromIssuingAdditionalShares_155" xlink:to="lab_mdwd_ProceedsFromIssuingAdditionalShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromProcurement_156" xlink:to="lab_mdwd_ProceedsFromProcurement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromProcurement_157" xlink:to="lab_mdwd_ProceedsFromProcurement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromRepaymentOfIssuingShares_158" xlink:to="lab_mdwd_ProceedsFromRepaymentOfIssuingShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromRepaymentOfIssuingShares_159" xlink:to="lab_mdwd_ProceedsFromRepaymentOfIssuingShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromRepaymentOfIssuingShares_160" xlink:to="lab_mdwd_ProceedsFromRepaymentOfIssuingShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ProceedsFromRepaymentOfIssuingShares_161" xlink:to="lab_mdwd_ProceedsFromRepaymentOfIssuingShares_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PublicOfferingMember_162" xlink:to="lab_mdwd_PublicOfferingMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PublicOfferingMember_163" xlink:to="lab_mdwd_PublicOfferingMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_PublicOfferingMember_164" xlink:to="lab_mdwd_PublicOfferingMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RepaymentFromGrants_165" xlink:to="lab_mdwd_RepaymentFromGrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RepaymentFromGrants_166" xlink:to="lab_mdwd_RepaymentFromGrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RepaymentFromGrants_167" xlink:to="lab_mdwd_RepaymentFromGrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RepaymentFromGrants_168" xlink:to="lab_mdwd_RepaymentFromGrants_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RepaymentOfLiabilitiesInRespectOfTeva_169" xlink:to="lab_mdwd_RepaymentOfLiabilitiesInRespectOfTeva_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RepaymentOfLiabilitiesInRespectOfTeva_170" xlink:to="lab_mdwd_RepaymentOfLiabilitiesInRespectOfTeva_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RepaymentOfLiabilitiesInRespectOfTeva_171" xlink:to="lab_mdwd_RepaymentOfLiabilitiesInRespectOfTeva_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet_172" xlink:to="lab_mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet_173" xlink:to="lab_mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet_174" xlink:to="lab_mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet_175" xlink:to="lab_mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet_176" xlink:to="lab_mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ReplenishmentAmount_177" xlink:to="lab_mdwd_ReplenishmentAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ReplenishmentAmount_178" xlink:to="lab_mdwd_ReplenishmentAmount_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ReplenishmentAmount_179" xlink:to="lab_mdwd_ReplenishmentAmount_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ResearchAndDevelopmentExpenseGross_180" xlink:to="lab_mdwd_ResearchAndDevelopmentExpenseGross_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ResearchAndDevelopmentExpenseGross_181" xlink:to="lab_mdwd_ResearchAndDevelopmentExpenseGross_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ResearchAndDevelopmentExpenseGross_182" xlink:to="lab_mdwd_ResearchAndDevelopmentExpenseGross_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RestrictedSharesUnitsMember_183" xlink:to="lab_mdwd_RestrictedSharesUnitsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RestrictedSharesUnitsMember_184" xlink:to="lab_mdwd_RestrictedSharesUnitsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RestrictedSharesUnitsMember_185" xlink:to="lab_mdwd_RestrictedSharesUnitsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfLeaseLiabilities_186" xlink:to="lab_mdwd_RevaluationOfLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfLeaseLiabilities_187" xlink:to="lab_mdwd_RevaluationOfLeaseLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfLeaseLiabilities_188" xlink:to="lab_mdwd_RevaluationOfLeaseLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_189" xlink:to="lab_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_190" xlink:to="lab_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_191" xlink:to="lab_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfLiabilitiesInRespectOfTeva_192" xlink:to="lab_mdwd_RevaluationOfLiabilitiesInRespectOfTeva_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfLiabilitiesInRespectOfTeva_193" xlink:to="lab_mdwd_RevaluationOfLiabilitiesInRespectOfTeva_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfLiabilitiesInRespectOfTeva_194" xlink:to="lab_mdwd_RevaluationOfLiabilitiesInRespectOfTeva_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfWarrantsAccountedAtFairValue_195" xlink:to="lab_mdwd_RevaluationOfWarrantsAccountedAtFairValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfWarrantsAccountedAtFairValue_196" xlink:to="lab_mdwd_RevaluationOfWarrantsAccountedAtFairValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_RevaluationOfWarrantsAccountedAtFairValue_197" xlink:to="lab_mdwd_RevaluationOfWarrantsAccountedAtFairValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SaleOfStocksAxis_198" xlink:to="lab_mdwd_SaleOfStocksAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SaleOfStocksAxis_199" xlink:to="lab_mdwd_SaleOfStocksAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SaleOfStocksDomain_200" xlink:to="lab_mdwd_SaleOfStocksDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SaleOfStocksDomain_201" xlink:to="lab_mdwd_SaleOfStocksDomain_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare_202" xlink:to="lab_mdwd_ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare_203" xlink:to="lab_mdwd_ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare_204" xlink:to="lab_mdwd_ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SharesIssuedPriceInInitialPublicOffering_205" xlink:to="lab_mdwd_SharesIssuedPriceInInitialPublicOffering_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SharesIssuedPriceInInitialPublicOffering_206" xlink:to="lab_mdwd_SharesIssuedPriceInInitialPublicOffering_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_StockOptionsMember_207" xlink:to="lab_mdwd_StockOptionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_StockOptionValue_208" xlink:to="lab_mdwd_StockOptionValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_StockOptionValue_209" xlink:to="lab_mdwd_StockOptionValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_StockOptionValue_210" xlink:to="lab_mdwd_StockOptionValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SubsequentsEventMember_211" xlink:to="lab_mdwd_SubsequentsEventMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SubsequentsEventMember_212" xlink:to="lab_mdwd_SubsequentsEventMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SupplementalFunding_213" xlink:to="lab_mdwd_SupplementalFunding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_SupplementalFunding_214" xlink:to="lab_mdwd_SupplementalFunding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_TevaMember_215" xlink:to="lab_mdwd_TevaMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_UnderwritingDiscounts_216" xlink:to="lab_mdwd_UnderwritingDiscounts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_UnderwritingDiscounts_217" xlink:to="lab_mdwd_UnderwritingDiscounts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_USDepartmentOfDefenseMember_218" xlink:to="lab_mdwd_USDepartmentOfDefenseMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_USDepartmentOfDefenseMember_219" xlink:to="lab_mdwd_USDepartmentOfDefenseMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_USDepartmentOfDefenseMember_220" xlink:to="lab_mdwd_USDepartmentOfDefenseMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_USFoodAndDrugAdministrationMember_221" xlink:to="lab_mdwd_USFoodAndDrugAdministrationMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_USFoodAndDrugAdministrationMember_222" xlink:to="lab_mdwd_USFoodAndDrugAdministrationMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_USFoodAndDrugAdministrationMember_223" xlink:to="lab_mdwd_USFoodAndDrugAdministrationMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_VericelMember_224" xlink:to="lab_mdwd_VericelMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForFinanceIncomeCost_225" xlink:to="lab_ifrs-full_AdjustmentsForFinanceIncomeCost_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForFinanceIncomeCost_226" xlink:to="lab_ifrs-full_AdjustmentsForFinanceIncomeCost_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceCosts_227" xlink:to="lab_ifrs-full_FinanceCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceCosts_228" xlink:to="lab_ifrs-full_FinanceCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_229" xlink:to="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_230" xlink:to="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_231" xlink:to="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_232" xlink:to="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_233" xlink:to="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_234" xlink:to="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_235" xlink:to="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_236" xlink:to="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_237" xlink:to="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_238" xlink:to="lab_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_239" xlink:to="lab_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_240" xlink:to="lab_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_241" xlink:to="lab_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_242" xlink:to="lab_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_243" xlink:to="lab_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_5"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_244" xlink:to="lab_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_6"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareIssueRelatedCost_245" xlink:to="lab_ifrs-full_ShareIssueRelatedCost_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareIssueRelatedCost_246" xlink:to="lab_ifrs-full_ShareIssueRelatedCost_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareIssueRelatedCost_247" xlink:to="lab_ifrs-full_ShareIssueRelatedCost_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_248" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_249" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_250" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_251" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalents_252" xlink:to="lab_ifrs-full_CashAndCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalents_253" xlink:to="lab_ifrs-full_CashAndCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalents_254" xlink:to="lab_ifrs-full_CashAndCashEquivalents_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_255" xlink:to="lab_ifrs-full_Equity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_256" xlink:to="lab_ifrs-full_Equity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_257" xlink:to="lab_ifrs-full_Equity_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_258" xlink:to="lab_ifrs-full_Equity_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity_259" xlink:to="lab_ifrs-full_Equity_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss_260" xlink:to="lab_ifrs-full_ProfitLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss_261" xlink:to="lab_ifrs-full_ProfitLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss_262" xlink:to="lab_ifrs-full_ProfitLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss_263" xlink:to="lab_ifrs-full_ProfitLoss_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss_264" xlink:to="lab_ifrs-full_ProfitLoss_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentDescription_265" xlink:to="lab_dei_AmendmentDescription_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_266" xlink:to="lab_dei_AmendmentFlag_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract_267" xlink:to="lab_dei_CoverAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate_268" xlink:to="lab_dei_CurrentFiscalYearEndDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus_269" xlink:to="lab_dei_DocumentFiscalPeriodFocus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus_270" xlink:to="lab_dei_DocumentFiscalYearFocus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_271" xlink:to="lab_dei_DocumentPeriodEndDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_272" xlink:to="lab_dei_DocumentType_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1_273" xlink:to="lab_dei_EntityAddressAddressLine1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown_274" xlink:to="lab_dei_EntityAddressCityOrTown_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry_275" xlink:to="lab_dei_EntityAddressCountry_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode_276" xlink:to="lab_dei_EntityAddressPostalZipCode_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_277" xlink:to="lab_dei_EntityCentralIndexKey_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain_278" xlink:to="lab_dei_EntityDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber_279" xlink:to="lab_dei_EntityFileNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_280" xlink:to="lab_dei_EntityRegistrantName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis_281" xlink:to="lab_dei_LegalEntityAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares_282" xlink:to="lab_ifrs-full_AdjustedWeightedAverageShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares_283" xlink:to="lab_ifrs-full_AdjustedWeightedAverageShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_284" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_285" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_286" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_287" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_288" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_289" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_290" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_291" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_292" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_293" xlink:to="lab_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities_294" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeOtherThanContractLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_295" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_296" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_297" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_298" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_299" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_300" xlink:to="lab_ifrs-full_AdjustmentsForReconcileProfitLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_301" xlink:to="lab_ifrs-full_AdjustmentsForReconcileProfitLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_302" xlink:to="lab_ifrs-full_AdjustmentsForReconcileProfitLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_303" xlink:to="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForSharebasedPayments_304" xlink:to="lab_ifrs-full_AdjustmentsForSharebasedPayments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForSharebasedPayments_305" xlink:to="lab_ifrs-full_AdjustmentsForSharebasedPayments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Assets_306" xlink:to="lab_ifrs-full_Assets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Assets_307" xlink:to="lab_ifrs-full_Assets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicEarningsLossPerShare_308" xlink:to="lab_ifrs-full_BasicEarningsLossPerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicEarningsLossPerShare_309" xlink:to="lab_ifrs-full_BasicEarningsLossPerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_310" xlink:to="lab_ifrs-full_BorrowingsByNameAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsByNameMember_311" xlink:to="lab_ifrs-full_BorrowingsByNameMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BottomOfRangeMember_312" xlink:to="lab_ifrs-full_BottomOfRangeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BottomOfRangeMember_313" xlink:to="lab_ifrs-full_BottomOfRangeMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_314" xlink:to="lab_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_315" xlink:to="lab_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_316" xlink:to="lab_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_317" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_318" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_319" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_320" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_321" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_322" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_323" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_324" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_325" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_326" xlink:to="lab_ifrs-full_CategoriesOfRelatedPartiesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_327" xlink:to="lab_ifrs-full_ClassesOfShareCapitalAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_328" xlink:to="lab_ifrs-full_ClassesOfShareCapitalMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_329" xlink:to="lab_ifrs-full_ComponentsOfEquityAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_330" xlink:to="lab_ifrs-full_ComponentsOfEquityAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncome_331" xlink:to="lab_ifrs-full_ComprehensiveIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncome_332" xlink:to="lab_ifrs-full_ComprehensiveIncome_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncome_333" xlink:to="lab_ifrs-full_ComprehensiveIncome_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncome_334" xlink:to="lab_ifrs-full_ComprehensiveIncome_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfMerchandiseSold_335" xlink:to="lab_ifrs-full_CostOfMerchandiseSold_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfMerchandiseSold_336" xlink:to="lab_ifrs-full_CostOfMerchandiseSold_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfSales_337" xlink:to="lab_ifrs-full_CostOfSales_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfSales_338" xlink:to="lab_ifrs-full_CostOfSales_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CounterpartiesMember_339" xlink:to="lab_ifrs-full_CounterpartiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssets_340" xlink:to="lab_ifrs-full_CurrentAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssets_341" xlink:to="lab_ifrs-full_CurrentAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_342" xlink:to="lab_ifrs-full_CurrentAssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLeaseLiabilities_343" xlink:to="lab_ifrs-full_CurrentLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilities_344" xlink:to="lab_ifrs-full_CurrentLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilities_345" xlink:to="lab_ifrs-full_CurrentLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_346" xlink:to="lab_ifrs-full_CurrentLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTradeReceivables_347" xlink:to="lab_ifrs-full_CurrentTradeReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationRightofuseAssets_348" xlink:to="lab_ifrs-full_DepreciationRightofuseAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_349" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_350" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_351" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_352" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_353" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_354" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_355" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_356" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_357" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_358" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_359" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_360" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_361" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_362" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_363" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForReclassificationOfFinancialInstrumentsExplanatory_364" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForReclassificationOfFinancialInstrumentsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_365" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_366" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_367" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_368" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_369" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements_370" xlink:to="lab_ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_371" xlink:to="lab_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_372" xlink:to="lab_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_373" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_374" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_375" xlink:to="lab_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_376" xlink:to="lab_ifrs-full_DisclosureOfContingentLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDepositaryReceiptsAbstract_377" xlink:to="lab_ifrs-full_DisclosureOfDepositaryReceiptsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDepositaryReceiptsAbstract_378" xlink:to="lab_ifrs-full_DisclosureOfDepositaryReceiptsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_379" xlink:to="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_380" xlink:to="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfExpensesExplanatory_381" xlink:to="lab_ifrs-full_DisclosureOfExpensesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfExpensesExplanatory_382" xlink:to="lab_ifrs-full_DisclosureOfExpensesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_383" xlink:to="lab_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_384" xlink:to="lab_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_385" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_386" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_387" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_388" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_389" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_390" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_391" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_392" xlink:to="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_393" xlink:to="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_394" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_395" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_396" xlink:to="lab_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_397" xlink:to="lab_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_398" xlink:to="lab_ifrs-full_EarningsPerShareAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_399" xlink:to="lab_ifrs-full_EarningsPerShareAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_400" xlink:to="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EntitysTotalForAssociatesMember_401" xlink:to="lab_ifrs-full_EntitysTotalForAssociatesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_402" xlink:to="lab_ifrs-full_EntitysTotalForRelatedPartiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAbstract_403" xlink:to="lab_ifrs-full_EquityAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAbstract_404" xlink:to="lab_ifrs-full_EquityAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAndLiabilities_405" xlink:to="lab_ifrs-full_EquityAndLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAndLiabilities_406" xlink:to="lab_ifrs-full_EquityAndLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseByNatureAbstract_407" xlink:to="lab_ifrs-full_ExpenseByNatureAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_408" xlink:to="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_409" xlink:to="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceIncome_410" xlink:to="lab_ifrs-full_FinanceIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossProfit_411" xlink:to="lab_ifrs-full_GrossProfit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossProfit_412" xlink:to="lab_ifrs-full_GrossProfit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeStatementAbstract_413" xlink:to="lab_ifrs-full_IncomeStatementAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_414" xlink:to="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_415" xlink:to="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings_416" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughAppropriationOfRetainedEarnings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_417" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_418" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_419" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_420" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_421" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_422" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_423" xlink:to="lab_ifrs-full_InterestExpenseOnLeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_424" xlink:to="lab_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_425" xlink:to="lab_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Inventories_426" xlink:to="lab_ifrs-full_Inventories_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InvestmentProperty_427" xlink:to="lab_ifrs-full_InvestmentProperty_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InvestmentProperty_428" xlink:to="lab_ifrs-full_InvestmentProperty_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InvestmentPropertyMember_429" xlink:to="lab_ifrs-full_InvestmentPropertyMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapital_430" xlink:to="lab_ifrs-full_IssuedCapital_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapital_431" xlink:to="lab_ifrs-full_IssuedCapital_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapital_432" xlink:to="lab_ifrs-full_IssuedCapital_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapitalMember_433" xlink:to="lab_ifrs-full_IssuedCapitalMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssueOfEquity_434" xlink:to="lab_ifrs-full_IssueOfEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssueOfEquity_435" xlink:to="lab_ifrs-full_IssueOfEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilities_436" xlink:to="lab_ifrs-full_LeaseLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Liabilities_437" xlink:to="lab_ifrs-full_Liabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Liabilities_438" xlink:to="lab_ifrs-full_Liabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LicenceFeeIncome_439" xlink:to="lab_ifrs-full_LicenceFeeIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_440" xlink:to="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NonadjustingEventsMember_441" xlink:to="lab_ifrs-full_NonadjustingEventsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssets_442" xlink:to="lab_ifrs-full_NoncurrentAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssets_443" xlink:to="lab_ifrs-full_NoncurrentAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_444" xlink:to="lab_ifrs-full_NoncurrentAssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_445" xlink:to="lab_ifrs-full_NoncurrentAssetsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentGovernmentGrants_446" xlink:to="lab_ifrs-full_NoncurrentGovernmentGrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentGovernmentGrants_447" xlink:to="lab_ifrs-full_NoncurrentGovernmentGrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilities_448" xlink:to="lab_ifrs-full_NoncurrentLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilities_449" xlink:to="lab_ifrs-full_NoncurrentLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_450" xlink:to="lab_ifrs-full_NoncurrentLiabilitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_451" xlink:to="lab_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentWarrantLiability_452" xlink:to="lab_ifrs-full_NoncurrentWarrantLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentWarrantLiability_453" xlink:to="lab_ifrs-full_NoncurrentWarrantLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_454" xlink:to="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_455" xlink:to="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_456" xlink:to="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_457" xlink:to="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesAuthorised_458" xlink:to="lab_ifrs-full_NumberOfSharesAuthorised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesAuthorised_459" xlink:to="lab_ifrs-full_NumberOfSharesAuthorised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesIssued_460" xlink:to="lab_ifrs-full_NumberOfSharesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesOutstanding_461" xlink:to="lab_ifrs-full_NumberOfSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OperatingExpense_462" xlink:to="lab_ifrs-full_OperatingExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OperatingExpense_463" xlink:to="lab_ifrs-full_OperatingExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncome_464" xlink:to="lab_ifrs-full_OtherComprehensiveIncome_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_465" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_466" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCurrentPayables_467" xlink:to="lab_ifrs-full_OtherCurrentPayables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCurrentReceivables_468" xlink:to="lab_ifrs-full_OtherCurrentReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherExpenseByFunction_469" xlink:to="lab_ifrs-full_OtherExpenseByFunction_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherNoncurrentLiabilities_470" xlink:to="lab_ifrs-full_OtherNoncurrentLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherNoncurrentLiabilities_471" xlink:to="lab_ifrs-full_OtherNoncurrentLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherNoncurrentReceivables_472" xlink:to="lab_ifrs-full_OtherNoncurrentReceivables_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherNoncurrentReceivables_473" xlink:to="lab_ifrs-full_OtherNoncurrentReceivables_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ParValuePerShare_474" xlink:to="lab_ifrs-full_ParValuePerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ParValuePerShare_475" xlink:to="lab_ifrs-full_ParValuePerShare_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromExerciseOfOptions_476" xlink:to="lab_ifrs-full_ProceedsFromExerciseOfOptions_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromExerciseOfOptions_477" xlink:to="lab_ifrs-full_ProceedsFromExerciseOfOptions_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromExerciseOfWarrants_478" xlink:to="lab_ifrs-full_ProceedsFromExerciseOfWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromExerciseOfWarrants_479" xlink:to="lab_ifrs-full_ProceedsFromExerciseOfWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssueOfOrdinaryShares_480" xlink:to="lab_ifrs-full_ProceedsFromIssueOfOrdinaryShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingShares_481" xlink:to="lab_ifrs-full_ProceedsFromIssuingShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingShares_482" xlink:to="lab_ifrs-full_ProceedsFromIssuingShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingShares_483" xlink:to="lab_ifrs-full_ProceedsFromIssuingShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_484" xlink:to="lab_ifrs-full_ProfitLossBeforeTax_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_485" xlink:to="lab_ifrs-full_ProfitLossBeforeTax_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_486" xlink:to="lab_ifrs-full_ProfitLossBeforeTax_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_487" xlink:to="lab_ifrs-full_ProfitLossFromOperatingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_488" xlink:to="lab_ifrs-full_ProfitLossFromOperatingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipment_489" xlink:to="lab_ifrs-full_PropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate_490" xlink:to="lab_ifrs-full_ProportionOfOwnershipInterestInAssociate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangeAxis_491" xlink:to="lab_ifrs-full_RangeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangesMember_492" xlink:to="lab_ifrs-full_RangesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RentalExpense_493" xlink:to="lab_ifrs-full_RentalExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RentDeferredIncomeClassifiedAsNoncurrent_494" xlink:to="lab_ifrs-full_RentDeferredIncomeClassifiedAsNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ResearchAndDevelopmentExpense_495" xlink:to="lab_ifrs-full_ResearchAndDevelopmentExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ResearchAndDevelopmentExpense_496" xlink:to="lab_ifrs-full_ResearchAndDevelopmentExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads_497" xlink:to="lab_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember_498" xlink:to="lab_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RestrictedCashAndCashEquivalents_499" xlink:to="lab_ifrs-full_RestrictedCashAndCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarnings_500" xlink:to="lab_ifrs-full_RetainedEarnings_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarnings_501" xlink:to="lab_ifrs-full_RetainedEarnings_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarningsMember_502" xlink:to="lab_ifrs-full_RetainedEarningsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Revenue_503" xlink:to="lab_ifrs-full_Revenue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Revenue_504" xlink:to="lab_ifrs-full_Revenue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueFromRenderingOfServices_505" xlink:to="lab_ifrs-full_RevenueFromRenderingOfServices_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueFromSaleOfGoods_506" xlink:to="lab_ifrs-full_RevenueFromSaleOfGoods_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssets_507" xlink:to="lab_ifrs-full_RightofuseAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssetsIncreaseDecreaseInRevaluationSurplus_508" xlink:to="lab_ifrs-full_RightofuseAssetsIncreaseDecreaseInRevaluationSurplus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssetsIncreaseDecreaseInRevaluationSurplus_509" xlink:to="lab_ifrs-full_RightofuseAssetsIncreaseDecreaseInRevaluationSurplus_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SalesAndMarketingExpense_510" xlink:to="lab_ifrs-full_SalesAndMarketingExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_511" xlink:to="lab_ifrs-full_SellingGeneralAndAdministrativeExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ServicesExpense_512" xlink:to="lab_ifrs-full_ServicesExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ServicesExpense_513" xlink:to="lab_ifrs-full_ServicesExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_514" xlink:to="lab_ifrs-full_SharebasedPaymentArrangementsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SharePremium_515" xlink:to="lab_ifrs-full_SharePremium_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SharePremiumMember_516" xlink:to="lab_ifrs-full_SharePremiumMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_517" xlink:to="lab_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_518" xlink:to="lab_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_519" xlink:to="lab_ifrs-full_SignificantInvestmentsInAssociatesAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_520" xlink:to="lab_ifrs-full_StatementOfCashFlowsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_521" xlink:to="lab_ifrs-full_StatementOfChangesInEquityLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_522" xlink:to="lab_ifrs-full_StatementOfChangesInEquityTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_523" xlink:to="lab_ifrs-full_StatementOfFinancialPositionAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TerminationBenefitsExpense_524" xlink:to="lab_ifrs-full_TerminationBenefitsExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TerminationBenefitsExpense_525" xlink:to="lab_ifrs-full_TerminationBenefitsExpense_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TopOfRangeMember_526" xlink:to="lab_ifrs-full_TopOfRangeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TopOfRangeMember_527" xlink:to="lab_ifrs-full_TopOfRangeMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_528" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfInvestmentPropertyAxis_529" xlink:to="lab_ifrs-full_TypesOfInvestmentPropertyAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_530" xlink:to="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageShares_531" xlink:to="lab_ifrs-full_WeightedAverageShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageShares_532" xlink:to="lab_ifrs-full_WeightedAverageShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsToReconcileNetLossToNetCashUsedInContinuingOperatingActivitiesAbstract_533" xlink:to="lab_mdwd_AdjustmentsToReconcileNetLossToNetCashUsedInContinuingOperatingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsToReconcileNetLossToNetCashUsedInContinuingOperatingActivitiesAbstract_534" xlink:to="lab_mdwd_AdjustmentsToReconcileNetLossToNetCashUsedInContinuingOperatingActivitiesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_AdjustmentsToReconcileNetLossToNetCashUsedInContinuingOperatingActivitiesAbstract_535" xlink:to="lab_mdwd_AdjustmentsToReconcileNetLossToNetCashUsedInContinuingOperatingActivitiesAbstract_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ChangesInAssetAndLiabilityItemsAbstract_536" xlink:to="lab_mdwd_ChangesInAssetAndLiabilityItemsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_ChangesInAssetAndLiabilityItemsAbstract_537" xlink:to="lab_mdwd_ChangesInAssetAndLiabilityItemsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfGeneralInformationAbstract_538" xlink:to="lab_mdwd_DisclosureOfGeneralInformationAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_539" xlink:to="lab_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_540" xlink:to="lab_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_DocumentAndEntityInformationAbstract_541" xlink:to="lab_mdwd_DocumentAndEntityInformationAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NonCashTransactionsAbstract_542" xlink:to="lab_mdwd_NonCashTransactionsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_NonCashTransactionsAbstract_543" xlink:to="lab_mdwd_NonCashTransactionsAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_StatementsLineItems_544" xlink:to="lab_mdwd_StatementsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mdwd_StatementsTableTable_545" xlink:to="lab_mdwd_StatementsTableTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ChiefExecutiveOfficerMember_546" xlink:to="lab_srt_ChiefExecutiveOfficerMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember_547" xlink:to="lab_srt_MaximumMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember_548" xlink:to="lab_srt_MinimumMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis_549" xlink:to="lab_srt_RangeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember_550" xlink:to="lab_srt_RangeMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_551" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_0"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>mdwd-20230630_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20230630.xsd#DocumentAndEntityInformation" roleURI="http://mediwound.com/role/DocumentAndEntityInformation"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20230630.xsd#CondensedInterimConsolidatedBalanceSheets" roleURI="http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20230630.xsd#CondensedInterimConsolidatedBalanceSheetsParenthetical" roleURI="http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheetsParenthetical"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20230630.xsd#CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss" roleURI="http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20230630.xsd#CondensedInterimConsolidatedStatementsOfChangesInShareholdersEquity" roleURI="http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfChangesInShareholdersEquity"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20230630.xsd#CondensedInterimConsolidatedStatementsOfCashFlows" roleURI="http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20230630.xsd#General" roleURI="http://mediwound.com/role/General"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20230630.xsd#SignificantAccountingPolicies" roleURI="http://mediwound.com/role/SignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20230630.xsd#Equity" roleURI="http://mediwound.com/role/Equity"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20230630.xsd#SignificantAccountingPoliciesPolicies" roleURI="http://mediwound.com/role/SignificantAccountingPoliciesPolicies"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20230630.xsd#EquityDetails" roleURI="http://mediwound.com/role/EquityDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20230630.xsd#GENERALTextual" roleURI="http://mediwound.com/role/GENERALTextual"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20230630.xsd#SubsequentEventsNarrativeDetails" roleURI="http://mediwound.com/role/SubsequentEventsNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="mdwd-20230630.xsd#SubsequentEvents" roleURI="http://mediwound.com/role/SubsequentEvents"/>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_dei_AmendmentDescription_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_14"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityRegistrantName_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityCentralIndexKey_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_DocumentType_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_DocumentPeriodEndDate_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_AmendmentFlag_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_AmendmentDescription_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_CurrentFiscalYearEndDate_7" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_DocumentFiscalPeriodFocus_8" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_DocumentFiscalYearFocus_9" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityFileNumber_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityAddressAddressLine1_11" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityAddressCityOrTown_12" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityAddressPostalZipCode_13" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityAddressCountry_14" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="loc_ifrs-full_StatementOfFinancialPositionAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="loc_ifrs-full_CurrentAssetsAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RestrictedCashAndCashEquivalents" xlink:label="loc_ifrs-full_RestrictedCashAndCashEquivalents_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents" xlink:label="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherCurrentReceivables" xlink:label="loc_ifrs-full_OtherCurrentReceivables_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherNoncurrentReceivables" xlink:label="loc_ifrs-full_OtherNoncurrentReceivables_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentAssets_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherCurrentPayables" xlink:label="loc_ifrs-full_OtherCurrentPayables_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesAbstract_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RentDeferredIncomeClassifiedAsNoncurrent" xlink:label="loc_ifrs-full_RentDeferredIncomeClassifiedAsNoncurrent_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentWarrantLiability" xlink:label="loc_ifrs-full_NoncurrentWarrantLiability_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentGovernmentGrants" xlink:label="loc_ifrs-full_NoncurrentGovernmentGrants_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherNoncurrentLiabilities" xlink:label="loc_ifrs-full_OtherNoncurrentLiabilities_24"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_NoncurrentLeaseLiability" xlink:label="loc_mdwd_NoncurrentLeaseLiability_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:label="loc_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-full_NoncurrentLiabilities_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-full_Liabilities_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityAbstract" xlink:label="loc_ifrs-full_EquityAbstract_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SharePremium" xlink:label="loc_ifrs-full_SharePremium_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads" xlink:label="loc_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-full_RetainedEarnings_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities_36"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_0" xlink:to="loc_ifrs-full_CurrentAssetsAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_CashAndCashEquivalents_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_RestrictedCashAndCashEquivalents_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_CurrentTradeReceivables_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_Inventories_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_OtherCurrentReceivables_6" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_1" xlink:to="loc_ifrs-full_CurrentAssets_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_0" xlink:to="loc_ifrs-full_NoncurrentAssetsAbstract_9" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_9" xlink:to="loc_ifrs-full_OtherNoncurrentReceivables_9" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_9" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_10" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_9" xlink:to="loc_ifrs-full_RightofuseAssets_11" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_9" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_12" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_9" xlink:to="loc_ifrs-full_NoncurrentAssets_13" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_0" xlink:to="loc_ifrs-full_Assets_15" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_0" xlink:to="loc_ifrs-full_CurrentLiabilitiesAbstract_16" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_16" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_16" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_16" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_17" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_16" xlink:to="loc_ifrs-full_OtherCurrentPayables_18" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_16" xlink:to="loc_ifrs-full_CurrentLiabilities_19" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_0" xlink:to="loc_ifrs-full_NoncurrentLiabilitiesAbstract_21" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_21" xlink:to="loc_ifrs-full_RentDeferredIncomeClassifiedAsNoncurrent_21" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_21" xlink:to="loc_ifrs-full_NoncurrentWarrantLiability_22" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_21" xlink:to="loc_ifrs-full_NoncurrentGovernmentGrants_23" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_21" xlink:to="loc_ifrs-full_OtherNoncurrentLiabilities_24" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_21" xlink:to="loc_mdwd_NoncurrentLeaseLiability_25" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_21" xlink:to="loc_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_26" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_21" xlink:to="loc_ifrs-full_NoncurrentLiabilities_27" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_0" xlink:to="loc_ifrs-full_Liabilities_29" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_0" xlink:to="loc_ifrs-full_EquityAbstract_30" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_30" xlink:to="loc_ifrs-full_IssuedCapital_30" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_30" xlink:to="loc_ifrs-full_SharePremium_31" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_30" xlink:to="loc_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads_32" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_30" xlink:to="loc_ifrs-full_RetainedEarnings_33" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_30" xlink:to="loc_ifrs-full_Equity_34" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_0" xlink:to="loc_ifrs-full_EquityAndLiabilities_36" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheetsParenthetical">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="loc_ifrs-full_StatementOfFinancialPositionAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesAuthorised" xlink:label="loc_ifrs-full_NumberOfSharesAuthorised_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_0" xlink:to="loc_ifrs-full_ParValuePerShare_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_0" xlink:to="loc_ifrs-full_NumberOfSharesAuthorised_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_0" xlink:to="loc_ifrs-full_NumberOfSharesIssued_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_0" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_4" order="30" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="loc_ifrs-full_IncomeStatementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RevenueFromRenderingOfServices" xlink:label="loc_ifrs-full_RevenueFromRenderingOfServices_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_LicenceFeeIncome" xlink:label="loc_ifrs-full_LicenceFeeIncome_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-full_Revenue_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CostOfMerchandiseSold" xlink:label="loc_ifrs-full_CostOfMerchandiseSold_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ServicesExpense" xlink:label="loc_ifrs-full_ServicesExpense_6"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_CostOfLicenseAgreements" xlink:label="loc_mdwd_CostOfLicenseAgreements_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-full_GrossProfit_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SalesAndMarketingExpense" xlink:label="loc_ifrs-full_SalesAndMarketingExpense_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherExpenseByFunction" xlink:label="loc_ifrs-full_OtherExpenseByFunction_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OperatingExpense" xlink:label="loc_ifrs-full_OperatingExpense_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_17"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_FinanceIncomeExpenseNet" xlink:label="loc_mdwd_FinanceIncomeExpenseNet_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherComprehensiveIncomeAbstract" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeAbstract_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" xlink:label="loc_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfDepositaryReceiptsAbstract" xlink:label="loc_ifrs-full_DisclosureOfDepositaryReceiptsAbstract_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="loc_ifrs-full_BasicEarningsLossPerShare_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_28"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoods_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_RevenueFromRenderingOfServices_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_LicenceFeeIncome_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_Revenue_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_CostOfMerchandiseSold_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ServicesExpense_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_mdwd_CostOfLicenseAgreements_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_CostOfSales_8" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_GrossProfit_9" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_SalesAndMarketingExpense_11" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_12" order="110" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_OtherExpenseByFunction_13" order="120" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_OperatingExpense_14" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_15" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_FinanceIncome_16" order="150" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_FinanceCosts_17" order="160" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_mdwd_FinanceIncomeExpenseNet_18" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_19" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_20" order="190" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ProfitLoss_21" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeAbstract_22" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_22" xlink:to="loc_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_22" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_ComprehensiveIncome_24" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfDepositaryReceiptsAbstract_25" order="230" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDepositaryReceiptsAbstract_25" xlink:to="loc_ifrs-full_BasicEarningsLossPerShare_25" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDepositaryReceiptsAbstract_25" xlink:to="loc_ifrs-full_DilutedEarningsLossPerShare_26" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDepositaryReceiptsAbstract_25" xlink:to="loc_ifrs-full_WeightedAverageShares_27" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDepositaryReceiptsAbstract_25" xlink:to="loc_ifrs-full_AdjustedWeightedAverageShares_28" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfChangesInShareholdersEquity">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="loc_ifrs-full_StatementOfChangesInEquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SharePremiumMember" xlink:label="loc_ifrs-full_SharePremiumMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember" xlink:label="loc_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-full_RetainedEarningsMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-full_EquityMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax" xlink:label="loc_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-full_IssueOfEquity_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_16"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityAbstract_0" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_IssuedCapitalMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_SharePremiumMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_RetainedEarningsMember_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_1" xlink:to="loc_ifrs-full_EquityMember_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_1" xlink:to="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ifrs-full_Equity_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ifrs-full_ProfitLoss_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ifrs-full_ComprehensiveIncome_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ifrs-full_ShareIssueRelatedCost_11" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ifrs-full_IssueOfEquity_12" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_13" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity_14" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_15" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_7" xlink:to="loc_ifrs-full_Equity_16" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AdjustmentsToReconcileNetLossToNetCashUsedInContinuingOperatingActivitiesAbstract" xlink:label="loc_mdwd_AdjustmentsToReconcileNetLossToNetCashUsedInContinuingOperatingActivitiesAbstract_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_3"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RevaluationOfWarrantsAccountedAtFairValue" xlink:label="loc_mdwd_RevaluationOfWarrantsAccountedAtFairValue_4"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss" xlink:label="loc_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss_5"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfGrants" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_6"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RevaluationOfLiabilitiesInRespectOfTeva" xlink:label="loc_mdwd_RevaluationOfLiabilitiesInRespectOfTeva_7"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RevaluationOfLeaseLiabilities" xlink:label="loc_mdwd_RevaluationOfLeaseLiabilities_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForFinanceIncomeCost" xlink:label="loc_ifrs-full_AdjustmentsForFinanceIncomeCost_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_12"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ChangesInAssetAndLiabilityItemsAbstract" xlink:label="loc_mdwd_ChangesInAssetAndLiabilityItemsAbstract_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_18"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue" xlink:label="loc_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_19"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems" xlink:label="loc_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" xlink:label="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromExerciseOfOptions" xlink:label="loc_ifrs-full_ProceedsFromExerciseOfOptions_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromExerciseOfWarrants" xlink:label="loc_ifrs-full_ProceedsFromExerciseOfWarrants_31"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet" xlink:label="loc_mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet_32"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RepaymentFromGrants" xlink:label="loc_mdwd_RepaymentFromGrants_33"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RepaymentOfLiabilitiesInRespectOfTeva" xlink:label="loc_mdwd_RepaymentOfLiabilitiesInRespectOfTeva_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_40"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_NonCashTransactionsAbstract" xlink:label="loc_mdwd_NonCashTransactionsAbstract_41"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RightofuseAssetsIncreaseDecreaseInRevaluationSurplus" xlink:label="loc_ifrs-full_RightofuseAssetsIncreaseDecreaseInRevaluationSurplus_41"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xlink:to="loc_ifrs-full_ProfitLoss_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xlink:to="loc_mdwd_AdjustmentsToReconcileNetLossToNetCashUsedInContinuingOperatingActivitiesAbstract_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_AdjustmentsToReconcileNetLossToNetCashUsedInContinuingOperatingActivitiesAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_2" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_mdwd_RevaluationOfWarrantsAccountedAtFairValue_4" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss_5" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_mdwd_RevaluationOfLiabilitiesInRespectOfGrants_6" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_mdwd_RevaluationOfLiabilitiesInRespectOfTeva_7" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_mdwd_RevaluationOfLeaseLiabilities_8" order="60" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_9" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForFinanceIncomeCost_10" order="80" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_11" order="90" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_2" xlink:to="loc_ifrs-full_AdjustmentsForReconcileProfitLoss_12" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_1" xlink:to="loc_mdwd_ChangesInAssetAndLiabilityItemsAbstract_15" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_ChangesInAssetAndLiabilityItemsAbstract_15" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_15" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_ChangesInAssetAndLiabilityItemsAbstract_15" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_16" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_ChangesInAssetAndLiabilityItemsAbstract_15" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables_17" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_ChangesInAssetAndLiabilityItemsAbstract_15" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_18" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_ChangesInAssetAndLiabilityItemsAbstract_15" xlink:to="loc_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue_19" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_ChangesInAssetAndLiabilityItemsAbstract_15" xlink:to="loc_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems_20" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_ChangesInAssetAndLiabilityItemsAbstract_15" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_21" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_24" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_24" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_24" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_24" xlink:to="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_25" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_24" xlink:to="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_26" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_24" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_27" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_29" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_29" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_29" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_29" xlink:to="loc_ifrs-full_ProceedsFromExerciseOfOptions_30" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_29" xlink:to="loc_ifrs-full_ProceedsFromExerciseOfWarrants_31" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_29" xlink:to="loc_mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet_32" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_29" xlink:to="loc_mdwd_RepaymentFromGrants_33" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_29" xlink:to="loc_mdwd_RepaymentOfLiabilitiesInRespectOfTeva_34" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_29" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_35" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_37" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_38" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_CashAndCashEquivalents_39" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_ifrs-full_CashAndCashEquivalents_40" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_0" xlink:to="loc_mdwd_NonCashTransactionsAbstract_41" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_NonCashTransactionsAbstract_41" xlink:to="loc_ifrs-full_RightofuseAssetsIncreaseDecreaseInRevaluationSurplus_41" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/General">
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_DisclosureOfGeneralInformationAbstract" xlink:label="loc_mdwd_DisclosureOfGeneralInformationAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfGeneralInformationAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/SignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_DisclosureOfSignificantAccountingPoliciesAbstract" xlink:label="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/Equity">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityAbstract" xlink:label="loc_ifrs-full_EquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:label="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/SignificantAccountingPoliciesPolicies">
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_DisclosureOfSignificantAccountingPoliciesAbstract" xlink:label="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements" xlink:label="loc_ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_DescriptionOfOtherAccountingPoliciesBasisOfPreparationOfInterimConsolidatedFinancialStatementsExplanatory" xlink:label="loc_mdwd_DescriptionOfOtherAccountingPoliciesBasisOfPreparationOfInterimConsolidatedFinancialStatementsExplanatory_2"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_DescriptionOfOtherAccountingPoliciesChangesInSignificantAccountingPoliciesExplanatory" xlink:label="loc_mdwd_DescriptionOfOtherAccountingPoliciesChangesInSignificantAccountingPoliciesExplanatory_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_5"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_DescriptionOfAccountingPolicyForShorttermBankDepositsExplanatory" xlink:label="loc_mdwd_DescriptionOfAccountingPolicyForShorttermBankDepositsExplanatory_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForReclassificationOfFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForReclassificationOfFinancialInstrumentsExplanatory_21"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_mdwd_DescriptionOfOtherAccountingPoliciesBasisOfPreparationOfInterimConsolidatedFinancialStatementsExplanatory_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_mdwd_DescriptionOfOtherAccountingPoliciesChangesInSignificantAccountingPoliciesExplanatory_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_mdwd_DescriptionOfAccountingPolicyForShorttermBankDepositsExplanatory_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_7" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_8" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_9" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_10" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_11" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_12" order="110" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_13" order="120" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_14" order="130" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_15" order="140" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_16" order="150" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_17" order="160" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_18" order="170" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory_19" order="180" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_20" order="190" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract_0" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForReclassificationOfFinancialInstrumentsExplanatory_21" order="200" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/EquityDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityAbstract" xlink:label="loc_ifrs-full_EquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-full_SharebasedPaymentArrangementsMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_EquityIncentivePlanMember" xlink:label="loc_mdwd_EquityIncentivePlanMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_4"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_EmployeesAndOfficersMember" xlink:label="loc_mdwd_EmployeesAndOfficersMember_4"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_BoardMembersAndOfficersMember" xlink:label="loc_mdwd_BoardMembersAndOfficersMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-full_ClassesOfShareCapitalMember_8"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_RestrictedSharesUnitsMember" xlink:label="loc_mdwd_RestrictedSharesUnitsMember_8"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_SaleOfStocksAxis" xlink:label="loc_mdwd_SaleOfStocksAxis_11"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_SaleOfStocksDomain" xlink:label="loc_mdwd_SaleOfStocksDomain_11"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_PublicOfferingMember" xlink:label="loc_mdwd_PublicOfferingMember_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-full_RangesMember_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-full_ShareIssueRelatedCost_22"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare" xlink:label="loc_mdwd_ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_24"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_StockOptionValue" xlink:label="loc_mdwd_StockOptionValue_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_26"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AuthorizedShareCapital" xlink:label="loc_mdwd_AuthorizedShareCapital_27"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_IncreaseInAuthorizedShareCapital" xlink:label="loc_mdwd_IncreaseInAuthorizedShareCapital_28"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_IncreaseInSharesIssued" xlink:label="loc_mdwd_IncreaseInSharesIssued_29"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_IncreaseInPricePerShareOfSharesIssued" xlink:label="loc_mdwd_IncreaseInPricePerShareOfSharesIssued_30"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_NumberOfShareAvailableForIssuance" xlink:label="loc_mdwd_NumberOfShareAvailableForIssuance_31"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ExtensionPeriodForOptionsExercised" xlink:label="loc_mdwd_ExtensionPeriodForOptionsExercised_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_33"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_1" xlink:to="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SharebasedPaymentArrangementsMember_1" xlink:to="loc_mdwd_EquityIncentivePlanMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_4" xlink:to="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_4" xlink:to="loc_mdwd_EmployeesAndOfficersMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EntitysTotalForRelatedPartiesMember_4" xlink:to="loc_mdwd_BoardMembersAndOfficersMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_8" xlink:to="loc_ifrs-full_ClassesOfShareCapitalMember_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalMember_8" xlink:to="loc_mdwd_RestrictedSharesUnitsMember_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_mdwd_SaleOfStocksAxis_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_SaleOfStocksAxis_11" xlink:to="loc_mdwd_SaleOfStocksDomain_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_SaleOfStocksDomain_11" xlink:to="loc_mdwd_PublicOfferingMember_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_RangeAxis_14" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_14" xlink:to="loc_ifrs-full_RangesMember_14" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_14" xlink:to="loc_ifrs-full_BottomOfRangeMember_14" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesMember_14" xlink:to="loc_ifrs-full_TopOfRangeMember_15" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_1" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_18" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_18" xlink:to="loc_ifrs-full_NumberOfSharesIssued_18" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_18" xlink:to="loc_ifrs-full_ParValuePerShare_19" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_18" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_20" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_18" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_21" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_18" xlink:to="loc_ifrs-full_ShareIssueRelatedCost_22" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_18" xlink:to="loc_mdwd_ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare_23" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_18" xlink:to="loc_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_24" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_18" xlink:to="loc_mdwd_StockOptionValue_25" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_18" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_26" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_18" xlink:to="loc_mdwd_AuthorizedShareCapital_27" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_18" xlink:to="loc_mdwd_IncreaseInAuthorizedShareCapital_28" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_18" xlink:to="loc_mdwd_IncreaseInSharesIssued_29" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_18" xlink:to="loc_mdwd_IncreaseInPricePerShareOfSharesIssued_30" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_18" xlink:to="loc_mdwd_NumberOfShareAvailableForIssuance_31" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_18" xlink:to="loc_mdwd_ExtensionPeriodForOptionsExercised_32" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_18" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_33" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/GENERALTextual">
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_DisclosureOfGeneralInformationAbstract" xlink:label="loc_mdwd_DisclosureOfGeneralInformationAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_USFoodAndDrugAdministrationMember" xlink:label="loc_mdwd_USFoodAndDrugAdministrationMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_USDepartmentOfDefenseMember" xlink:label="loc_mdwd_USDepartmentOfDefenseMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-full_BorrowingsByNameMember_5"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_BardaMember" xlink:label="loc_mdwd_BardaMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_8"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ContractAmountForResearchDevelopmentAndManufacturing" xlink:label="loc_mdwd_ContractAmountForResearchDevelopmentAndManufacturing_8"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AdditionalProceedsFromFunding" xlink:label="loc_mdwd_AdditionalProceedsFromFunding_9"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ReplenishmentAmount" xlink:label="loc_mdwd_ReplenishmentAmount_10"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_NumberOfPatients" xlink:label="loc_mdwd_NumberOfPatients_11"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_ContractWithCustomers" xlink:label="loc_mdwd_ContractWithCustomers_12"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mdwd_DisclosureOfGeneralInformationAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1" xlink:to="loc_dei_LegalEntityAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1" xlink:to="loc_dei_EntityDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_1" xlink:to="loc_mdwd_USFoodAndDrugAdministrationMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_1" xlink:to="loc_mdwd_USDepartmentOfDefenseMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_5" xlink:to="loc_ifrs-full_BorrowingsByNameMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameMember_5" xlink:to="loc_mdwd_BardaMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable_1" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_8" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_8" xlink:to="loc_mdwd_ContractAmountForResearchDevelopmentAndManufacturing_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_8" xlink:to="loc_mdwd_AdditionalProceedsFromFunding_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_8" xlink:to="loc_mdwd_ReplenishmentAmount_10" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_8" xlink:to="loc_mdwd_NumberOfPatients_11" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems_8" xlink:to="loc_mdwd_ContractWithCustomers_12" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/SubsequentEventsNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NonadjustingEventsMember" xlink:label="loc_ifrs-full_NonadjustingEventsMember_1"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_SubsequentsEventMember" xlink:label="loc_mdwd_SubsequentsEventMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TypesOfInvestmentPropertyAxis" xlink:label="loc_ifrs-full_TypesOfInvestmentPropertyAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InvestmentPropertyMember" xlink:label="loc_ifrs-full_InvestmentPropertyMember_4"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_BiopharmaxGroupLtdMember" xlink:label="loc_mdwd_BiopharmaxGroupLtdMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InvestmentProperty" xlink:label="loc_ifrs-full_InvestmentProperty_7"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_AreaOfLand" xlink:label="loc_mdwd_AreaOfLand_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RentalExpense" xlink:label="loc_ifrs-full_RentalExpense_9"/>
    <loc xlink:type="locator" xlink:href="mdwd-20230630.xsd#mdwd_IncreaseInRentAsPercentageInEveryThreeYear" xlink:label="loc_mdwd_IncreaseInRentAsPercentageInEveryThreeYear_10"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_1" xlink:to="loc_ifrs-full_NonadjustingEventsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsMember_1" xlink:to="loc_mdwd_SubsequentsEventMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_TypesOfInvestmentPropertyAxis_4" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfInvestmentPropertyAxis_4" xlink:to="loc_ifrs-full_InvestmentPropertyMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_InvestmentPropertyMember_4" xlink:to="loc_mdwd_BiopharmaxGroupLtdMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_1" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_7" xlink:to="loc_ifrs-full_InvestmentProperty_7" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_7" xlink:to="loc_mdwd_AreaOfLand_8" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_7" xlink:to="loc_ifrs-full_RentalExpense_9" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_7" xlink:to="loc_mdwd_IncreaseInRentAsPercentageInEveryThreeYear_10" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://mediwound.com/role/SubsequentEvents">
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_0" xlink:to="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image00001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image00001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" !4 .,# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#ZHHHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *YGXB^+;;P5X6N=7ND\UU(C@A!P99#]U<]AU)/H#73
M5X'^UK(XT?PY$"=C7,K$>I"#'\S6M""G4463-\L6SR?5OBUXVU*^>X_MV>T!
M.5AM0(XT'H!C)_'->A>!_CY<6OA_4(O%4?VS4;>+=9RHNTW#=-CXX!'7=Z9[
M]?*_AEX<@\6>.--T:\EDBMK@N9&BP&PJ%L#/TK!U:V%EJU]:*Q9;>XDA#'J0
MK$ _I7K2HTI>Y8Y5.2]ZYU^J?%GQMJ-Z]P=>N+4,<K#:@1QH/0#'/XYKV#X#
M?%:_\1:DWA[Q+(DUZ8S):W04*9-OWD8#C..0?8UXQ>>$[:#X3Z?XJ$\IO+G4
M6M&B.-@0!L>^<K^M:_P)T*]N_'6D:JA,-G:W _>$?ZPD$%5_ \FHJ4Z<Z;LM
M@4Y1DKL^Q:***\<[ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "O /VMO\ D&^&?^N\W_H*U[_7@'[6W_(-\,_]=YO_ $%:
MZ,+_ !49U?@9YI^S[_R5K1?]V;_T6U<;XF_Y&;6/^OV?_P!&-79?L^_\E:T7
M_=F_]%M7&^)O^1FUC_K]G_\ 1C5ZJ_BOT7ZG-]@]D\-Z!'XA^!&A6UQ(4MX]
M7DED"]6 +C:/3.>M=%HFHV.C^)?#^EVZ*KRW,<<<,? C7/4_YYK \-ZP=%_9
M[TZXCC\R5]2ECC!Z DOR?RKE/A]<2W7Q)T&>XD:2:2_C+,W4G-51H.<)R>RN
M<6)K\M6$%Y&]\0O&GB6Q\<ZY:V>N7T%M#=,D<:2851QP*WM+\5Z])\%]:U.3
M5[QM0BU!(X[@O\ZJ2F0#Z<G\ZX'XH?\ )1/$/_7XW]*Z/1_^2!:__P!A./\
MG'71.E#V5-\JWCT..%6?M:BYGM(Q]'\=^*I=7L(Y/$&H,CW$:LIDX(+ $5Z)
M^TSKVM:+)X<30M2O+)K@S!Q;2%3(1LQG'7J?SKQ;0_\ D.:;_P!?47_H8KV'
M]ILXUWP,1_S]/_Z'%6&.IPC6IV2ZG7EDY2ISYG?8ZKX'^,WUGX;2W6M73RWF
ME-)'=RRMEV51O#-_P$X_"O'/ 7COQ/K7Q3T8W6L:A_9]_J!86QE/E&,D_*!Z
M#I^%1^/KB\\ >*/'/AZQC;[)KZ(\ 4X"J[;N/SD2MF70AX9^+?PUTE5 EM[.
M'S?>4M(S'_OHFN)0BN:5OBV^X]-MNR['L_BSXI^$O"VHFPU34\WB_P"LA@C:
M4Q_[V.!].M;^E^)]%U3P^=;L=1MY-*56=[C=M5 .N[/0CT-?-_P=MO$]]=>)
M'T?_ (1UM0-R?MHU>-GF/)SC_9SG/O6?J.D7VB_#?QI'9ZQI-_:27ML;F'2Y
M'=+=M[9!R  OW1P3T%9/#0ORIZZ%>T>YZIXS^,/AK4_"FOVGAS6I8=62V8VT
MFQHB[#^XQ'6L&PURYN_AYX#N]6\;W^CW=Q<S!G\MYFO<2X",5Z8&!SZUI>(K
M3PQ_PS>DEO'9;!81M"X"[_M/&>>N_=G/X]J\WUG_ ))I\*?^OZX_]'+5TX1:
MM%=?T8I2?7L>EZ5KNL:/^T9>Z%J.IW4^E7\3/:P2R$I'N4.-H[8*NM<GX@^(
M^K6_QU_=:E=)X?MM1CL9+=7/DD8V.2.F<EC^%;W[1B2>'_%WA#QA:IN>VE\I
MP.-VT[U!^H+BN'M_#4NH? /7/$;K_ILFK?;P^.=BG8<?B[G\*=.,&E-]5;YB
MDW=I>IZ1\1M<U>_^-OACPQHNI7=I;*J2WB6\A4."2[;L?["?K74:M\9?!&F:
MHUC/J_F2(VQW@A:2-#_O 8/X9KQGP?<ZEXMO_B!XPCC?[9!HYA@V\E':,*<>
M^U&_.NZ^!5GX9E^#-PU]%8N&,_\ :#2A21R<;B>0-NW'Z5G4IQC%<W2RT[LJ
M,FWIU/2-9\>^&M'T.RUB]U./^S;UMEO/$K2*YP3_  @^AJUXI\6Z-X6TF'4M
M<NS;6<SB-)/+9\L06 P 3T!KY"D-P?@RN_>;%-?/D%NW[DEL?I^.:]>_:7U&
MSG^&.@Q0W,4DDT\<L:HP)9!"V6^G(_.D\-%2C'NV'M'9L].U7XD>%=)U+[#J
M6JI;7'V87>)(V \LC(.<8R1VZU'X-^)?A?QA?O9:+?E[M5+B*6-HV=1U*YZ_
MSKR&6QMM1_:)\-07T,<\']FP2&.094E8&(R/8@&K_B*UBL/VG]%_LZ&.!I;3
M>1&H4,YBE&2!ZX'Y4O80M;K:X^=_B>C^(/BQX.T#6CI6HZJ!=(VR7RXF=83Z
M,0,#W]*X[X*^)-0USXE>-8I]5N+[38G+6BM+OC5#*V"GMC%9'[,4&EW%KXF;
M58[:76?M/[_[0 7$>.>O;=OS^&:3]GA;)/B9XY72MG]GJ2+?9]WR_.;&/;'2
MJ=.,(SBMU82DVTSZ$HHHKA-@HHHH *Y7QYX$T;QQ#9Q:Z+DK:,SQ>1+Y?+
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MJ*GGE:UQV6YS?@GP7HW@O3[BST.&1(;B3S)?-D,A8X ZGM@=*Y;4_@AX+O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140249310809568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MediWound Ltd.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001593984<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">6-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">42 Hayarkon Street<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Yavne<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">8122745<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140249301314464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Unaudited Condensed Interim Consolidated Statements of Financial Position - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssetsAbstract', window );"><strong>CURRENT ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 19,166<span></span>
</td>
<td class="nump">$ 33,895<span></span>
</td>
<td class="nump">$ 7,729<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RestrictedCashAndCashEquivalents', window );">Restricted deposits</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents', window );">Short-term bank deposits</a></td>
<td class="nump">31,956<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,509<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Trade receivables</a></td>
<td class="nump">3,228<span></span>
</td>
<td class="nump">9,332<span></span>
</td>
<td class="nump">3,759<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventories</a></td>
<td class="nump">3,113<span></span>
</td>
<td class="nump">1,963<span></span>
</td>
<td class="nump">1,991<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentReceivables', window );">Other receivables</a></td>
<td class="nump">590<span></span>
</td>
<td class="nump">650<span></span>
</td>
<td class="nump">653<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Total current assets</a></td>
<td class="nump">58,053<span></span>
</td>
<td class="nump">45,840<span></span>
</td>
<td class="nump">16,809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>LONG-TERM ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentReceivables', window );">Other receivables</a></td>
<td class="nump">277<span></span>
</td>
<td class="nump">364<span></span>
</td>
<td class="nump">230<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment, net</a></td>
<td class="nump">4,705<span></span>
</td>
<td class="nump">2,366<span></span>
</td>
<td class="nump">2,439<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right of-use assets, net</a></td>
<td class="nump">1,133<span></span>
</td>
<td class="nump">1,215<span></span>
</td>
<td class="nump">1,364<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">198<span></span>
</td>
<td class="nump">231<span></span>
</td>
<td class="nump">264<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Total non-current assets</a></td>
<td class="nump">6,313<span></span>
</td>
<td class="nump">4,176<span></span>
</td>
<td class="nump">4,297<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">64,366<span></span>
</td>
<td class="nump">50,016<span></span>
</td>
<td class="nump">21,106<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>CURRENT LIABILITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Current maturities of non-current liabilities</a></td>
<td class="nump">1,961<span></span>
</td>
<td class="nump">2,242<span></span>
</td>
<td class="nump">2,479<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers', window );">Trade payables and accrued expenses</a></td>
<td class="nump">3,531<span></span>
</td>
<td class="nump">5,656<span></span>
</td>
<td class="nump">4,877<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentPayables', window );">Other payables</a></td>
<td class="nump">2,817<span></span>
</td>
<td class="nump">4,159<span></span>
</td>
<td class="nump">3,060<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Total current liabilities</a></td>
<td class="nump">8,309<span></span>
</td>
<td class="nump">12,057<span></span>
</td>
<td class="nump">10,416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilitiesAbstract', window );"><strong>LONG-TERM LIABILITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RentDeferredIncomeClassifiedAsNoncurrent', window );">Deferred revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentWarrantLiability', window );">Warrants</a></td>
<td class="nump">9,683<span></span>
</td>
<td class="nump">15,606<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentGovernmentGrants', window );">Liabilities in respect of IIA grants</a></td>
<td class="nump">7,806<span></span>
</td>
<td class="nump">7,445<span></span>
</td>
<td class="nump">8,131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentLiabilities', window );">Liabilities in respect of TEVA</a></td>
<td class="nump">2,529<span></span>
</td>
<td class="nump">2,788<span></span>
</td>
<td class="nump">3,361<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_NoncurrentLeaseLiability', window );">Lease liabilities</a></td>
<td class="nump">677<span></span>
</td>
<td class="nump">846<span></span>
</td>
<td class="nump">1,053<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan', window );">Severance pay liability, net</a></td>
<td class="nump">433<span></span>
</td>
<td class="nump">360<span></span>
</td>
<td class="nump">319<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Total non-current liabilities</a></td>
<td class="nump">21,128<span></span>
</td>
<td class="nump">27,045<span></span>
</td>
<td class="nump">12,925<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Total liabilities</a></td>
<td class="nump">29,437<span></span>
</td>
<td class="nump">39,102<span></span>
</td>
<td class="nump">23,341<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>Shareholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Ordinary shares of NIS 0.01 par value: Authorized: 20,000,000 shares as of June 30, 2023, 12,857,143 as of December 31, 2022; and 7,142,858 as of June 30, 2022; Issued and Outstanding: 7,252,234 as of June 30, 2023; 7,240,020 as of December 31, 2022 and 4,734,774 as of June 30, 2022</a></td>
<td class="nump">184<span></span>
</td>
<td class="nump">143<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharePremium', window );">Share premium</a></td>
<td class="nump">205,642<span></span>
</td>
<td class="nump">178,882<span></span>
</td>
<td class="nump">154,119<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads', window );">Foreign currency translation adjustments</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RetainedEarnings', window );">Accumulated deficit</a></td>
<td class="num">(170,883)<span></span>
</td>
<td class="num">(168,106)<span></span>
</td>
<td class="num">(156,450)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity (deficit)</a></td>
<td class="nump">34,929<span></span>
</td>
<td class="nump">10,914<span></span>
</td>
<td class="num">(2,235)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total liabilities and equity</a></td>
<td class="nump">$ 64,366<span></span>
</td>
<td class="nump">$ 50,016<span></span>
</td>
<td class="nump">$ 21,106<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 28<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2022-03-24<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.
Effective 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2022-03-24<br> -Paragraph 118<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Inventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2022-03-24<br> -Paragraph 36<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_36_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 54<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Inventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 28<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_28_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentGovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current government grants recognised on the statement of financial position as deferred income. [Refer: Government [member]; Government grants]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentGovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current net defined benefit liability. [Refer: Net defined benefit liability]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current warrant liabilities. [Refer: Warrant liability]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current payables that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current other receivables. [Refer: Other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Non-current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current other receivables. [Refer: Other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2022-03-24<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 54<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RentDeferredIncomeClassifiedAsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of rent deferred income classified as non-current. [Refer: Rent deferred income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RentDeferredIncomeClassifiedAsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the accumulated change in the value of foreign currency basis spreads of financial instruments when excluding them from the designation of these financial instruments as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 9<br> -IssueDate 2022-03-24<br> -Paragraph 6.5.16<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=9&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_6.5.16&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash and cash equivalents whose use or withdrawal is restricted. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the entity's cumulative undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph IG6<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2022-03-24<br> -Paragraph 53<br> -Subparagraph j<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SharePremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount received or receivable from the issuance of the entity's shares in excess of nominal value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SharePremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A classification of cash equivalents representing short-term deposits. [Refer: Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 70<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_NoncurrentLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncurrent lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_NoncurrentLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140249310767808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Unaudited Condensed Interim Consolidated Statements of Financial Position (Parenthetical) - &#8362; / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_StatementOfFinancialPositionAbstract', window );"><strong>Statement of financial position [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Ordinary shares, par value (per share)</a></td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesAuthorised', window );">Number of shares authorised</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">12,857,143<span></span>
</td>
<td class="nump">7,142,858<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued</a></td>
<td class="nump">7,252,234<span></span>
</td>
<td class="nump">7,240,020<span></span>
</td>
<td class="nump">4,734,774<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Ordinary shares, Outstanding</a></td>
<td class="nump">7,252,234<span></span>
</td>
<td class="nump">7,240,020<span></span>
</td>
<td class="nump">4,734,774<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesAuthorised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 79<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_79_a_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesAuthorised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_79_a_iv&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140249310396000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Unaudited Condensed Interim Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="3">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeStatementAbstract', window );"><strong>Profit or loss [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Revenues from sale of products</a></td>
<td class="nump">$ 1,206<span></span>
</td>
<td class="nump">$ 1,669<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 2,358<span></span>
</td>
<td class="nump">$ 2,771<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 5,347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromRenderingOfServices', window );">Revenues from development services</a></td>
<td class="nump">3,534<span></span>
</td>
<td class="nump">2,777<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,149<span></span>
</td>
<td class="nump">5,866<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12,943<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LicenceFeeIncome', window );">Revenues from license agreements</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">222<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">65<span></span>
</td>
<td class="nump">438<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8,206<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenues</a></td>
<td class="nump">4,773<span></span>
</td>
<td class="nump">4,668<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8,572<span></span>
</td>
<td class="nump">9,075<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">26,496<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfMerchandiseSold', window );">Cost of revenues from sale of products</a></td>
<td class="nump">628<span></span>
</td>
<td class="nump">1,148<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,436<span></span>
</td>
<td class="nump">1,539<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,184<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ServicesExpense', window );">Cost of revenues from development services</a></td>
<td class="nump">3,005<span></span>
</td>
<td class="nump">2,391<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,170<span></span>
</td>
<td class="nump">4,932<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,829<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_CostOfLicenseAgreements', window );">Cost of revenues from license agreements</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">318<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Total cost of revenues</a></td>
<td class="nump">3,636<span></span>
</td>
<td class="nump">3,555<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,609<span></span>
</td>
<td class="nump">6,502<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13,331<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="nump">1,137<span></span>
</td>
<td class="nump">1,113<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,963<span></span>
</td>
<td class="nump">2,573<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13,165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">2,024<span></span>
</td>
<td class="nump">2,191<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,126<span></span>
</td>
<td class="nump">4,599<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10,181<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SalesAndMarketingExpense', window );">Selling and marketing</a></td>
<td class="nump">1,332<span></span>
</td>
<td class="nump">935<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,438<span></span>
</td>
<td class="nump">1,854<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,725<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">1,788<span></span>
</td>
<td class="nump">1,352<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,770<span></span>
</td>
<td class="nump">2,769<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,920<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherExpenseByFunction', window );">Other expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">309<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="nump">309<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">684<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OperatingExpense', window );">Total operating expenses</a></td>
<td class="nump">5,144<span></span>
</td>
<td class="nump">4,787<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10,334<span></span>
</td>
<td class="nump">9,531<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">21,510<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating loss</a></td>
<td class="num">(4,007)<span></span>
</td>
<td class="num">(3,674)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(8,371)<span></span>
</td>
<td class="num">(6,958)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(8,345)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Financial income</a></td>
<td class="nump">5,828<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,480<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">461<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Financial expenses</a></td>
<td class="num">(893)<span></span>
</td>
<td class="num">(687)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,869)<span></span>
</td>
<td class="num">(988)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(11,637)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_FinanceIncomeExpenseNet', window );">Financing income (expenses), net</a></td>
<td class="nump">4,935<span></span>
</td>
<td class="num">(676)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,611<span></span>
</td>
<td class="num">(977)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(11,176)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Profit (loss) before taxes on income</a></td>
<td class="nump">928<span></span>
</td>
<td class="num">(4,350)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,760)<span></span>
</td>
<td class="num">(7,935)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(19,521)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Taxes on income</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(78)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net profit (loss)</a></td>
<td class="nump">916<span></span>
</td>
<td class="num">(4,354)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,777)<span></span>
</td>
<td class="num">(7,943)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(19,599)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeAbstract', window );"><strong>Other comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(9)<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive profit (loss)</a></td>
<td class="nump">$ 916<span></span>
</td>
<td class="num">$ (4,337)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (2,786)<span></span>
</td>
<td class="num">$ (7,921)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (19,585)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDepositaryReceiptsAbstract', window );"><strong>Loss per share data:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Basic net profit (loss) per share</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="num">$ (0.92)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (0.32)<span></span>
</td>
<td class="num">$ (1.79)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (3.93)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShare', window );">Diluted net profit (loss) per share</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="num">$ (0.92)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (0.32)<span></span>
</td>
<td class="num">$ (1.79)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (3.93)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Number of shares used in calculating basic net loss per share</a></td>
<td class="nump">9,209<span></span>
</td>
<td class="nump">4,734<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">8,803<span></span>
</td>
<td class="nump">4,440<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">4,987<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustedWeightedAverageShares', window );">Number of shares used in calculating diluted net loss per share</a></td>
<td class="nump">9,209<span></span>
</td>
<td class="nump">4,734<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8,803<span></span>
</td>
<td class="nump">4,440<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,987<span></span>
</td>
</tr>
<tr><td colspan="8"></td></tr>
<tr><td colspan="8"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Restated to reflect 1:7 reverse ratio of shares</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustedWeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2022-03-24<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustedWeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2022-03-24<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2022-03-24<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 81A<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfMerchandiseSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of merchandise that was sold during the period and recognised as an expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfMerchandiseSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2022-03-24<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2022-03-24<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDepositaryReceiptsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDepositaryReceiptsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of costs associated with financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 82<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2022-03-24<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 23<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B13<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 82<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LicenceFeeIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income arising from licence fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LicenceFeeIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of all operating expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherExpenseByFunction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses that the entity does not separately disclose in the same statement or note when the entity uses the 'function of expense' form for its analysis of expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2022-03-24<br> -Paragraph 35<br> -Subparagraph b<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_35_b_vii&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherExpenseByFunction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2022-03-24<br> -Paragraph 39L<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2022-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2023-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2022-03-24<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2022-03-24<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2022-03-24<br> -Paragraph IE33<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of reclassification adjustments related to change in value of foreign currency basis spreads, net of tax. Reclassification adjustments are amounts reclassified to profit (loss) in the current period that were recognised in other comprehensive income in the current or previous periods. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 92<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_92&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenditure directly attributable to research or development activities, recognised in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2022-03-24<br> -Paragraph 126<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 28<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 23<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 32<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2022-03-24<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 82<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromRenderingOfServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from the rendering of services. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromRenderingOfServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromSaleOfGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from the sale of goods. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromSaleOfGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SalesAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to the marketing and selling of goods or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SalesAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to selling, general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ServicesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ServicesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2022-03-24<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_CostOfLicenseAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of cost of license agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_CostOfLicenseAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_FinanceIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of financing income (expenses), net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_FinanceIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140249299966704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Unaudited Condensed Interim Consolidated Statements of Changes in Shareholders' Equity (Deficit) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2"><div>Share capital [Member]</div></th>
<th class="th" colspan="2"><div>Share premium [Member]</div></th>
<th class="th"><div>Foreign currency translation reserve [Member]</div></th>
<th class="th"><div>Accumulated deficit [Member]</div></th>
<th class="th" colspan="2"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">$ 75<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 143,869<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (19)<span></span>
</td>
<td class="num">$ (148,507)<span></span>
</td>
<td class="num">$ (4,582)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Profit (loss) for the period</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="num">(7,943)<span></span>
</td>
<td class="num">(7,943)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">22<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">22<span></span>
</td>
<td class="num">(7,943)<span></span>
</td>
<td class="num">(7,921)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Issuance of ordinary shares, net of issuance expenses</a></td>
<td class="nump">18<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,653<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,671<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Exercise of options</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based compensation</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">597<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">597<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Jun. 30, 2022</a></td>
<td class="nump">93<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">154,119<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3<span></span>
</td>
<td class="num">(156,450)<span></span>
</td>
<td class="num">(2,235)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">75<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">143,869<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(19)<span></span>
</td>
<td class="num">(148,507)<span></span>
</td>
<td class="num">(4,582)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Profit (loss) for the period</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="num">(19,599)<span></span>
</td>
<td class="num">(19,599)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14<span></span>
</td>
<td class="num">(19,599)<span></span>
</td>
<td class="num">(19,585)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Issuance of ordinary shares, net of issuance expenses</a></td>
<td class="nump">40<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17,389<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">17,429<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Exercise of options</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity', window );">Exercise of pre-funded warrants</a></td>
<td class="nump">28<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">15,678<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">15,706<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based compensation</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,946<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,946<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Dec. 31, 2022</a></td>
<td class="nump">143<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">178,882<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(168,106)<span></span>
</td>
<td class="nump">10,914<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Mar. 31, 2022</a></td>
<td class="nump">93<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">153,962<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(152,096)<span></span>
</td>
<td class="nump">1,945<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Profit (loss) for the period</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,354)<span></span>
</td>
<td class="num">(4,354)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17<span></span>
</td>
<td class="num">(4,354)<span></span>
</td>
<td class="num">(4,337)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Issuance expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(95)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(95)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Exercise of options</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based compensation</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">252<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">252<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Jun. 30, 2022</a></td>
<td class="nump">93<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">154,119<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3<span></span>
</td>
<td class="num">(156,450)<span></span>
</td>
<td class="num">(2,235)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Dec. 31, 2022</a></td>
<td class="nump">143<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">178,882<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(168,106)<span></span>
</td>
<td class="nump">10,914<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Profit (loss) for the period</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,777)<span></span>
</td>
<td class="num">(2,777)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(9)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(2,777)<span></span>
</td>
<td class="num">(2,786)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Issuance of ordinary shares, net of issuance expenses</a></td>
<td class="nump">40<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">25,429<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">25,469<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Exercise of options</a></td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based compensation</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,331<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,331<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Jun. 30, 2023</a></td>
<td class="nump">184<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">205,642<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(170,883)<span></span>
</td>
<td class="nump">34,929<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Mar. 31, 2023</a></td>
<td class="nump">183<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">204,930<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(171,799)<span></span>
</td>
<td class="nump">33,300<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Profit (loss) for the period</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="nump">916<span></span>
</td>
<td class="nump">916<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="nump">916<span></span>
</td>
<td class="nump">916<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Issuance expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Exercise of options</a></td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based compensation</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">712<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">712<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Jun. 30, 2023</a></td>
<td class="nump">$ 184<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 205,642<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (14)<span></span>
</td>
<td class="num">$ (170,883)<span></span>
</td>
<td class="nump">$ 34,929<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="9"></td></tr>
<tr><td colspan="9"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Represents less than $ 1.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 81A<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2022-03-24<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssueOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in equity through the issue of equity instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssueOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2022-03-24<br> -Paragraph 39L<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2022-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2023-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2022-03-24<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of reclassification adjustments related to change in value of foreign currency basis spreads, net of tax. Reclassification adjustments are amounts reclassified to profit (loss) in the current period that were recognised in other comprehensive income in the current or previous periods. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 92<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_92&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareIssueRelatedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cost related to the issuance of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareIssueRelatedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140249299410800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Unaudited Condensed Interim Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 916<span></span>
</td>
<td class="num">$ (4,354)<span></span>
</td>
<td class="num">$ (2,777)<span></span>
</td>
<td class="num">$ (7,943)<span></span>
</td>
<td class="num">$ (19,599)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract', window );"><strong>Adjustments to profit and loss items:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense', window );">Depreciation and amortization</a></td>
<td class="nump">315<span></span>
</td>
<td class="nump">329<span></span>
</td>
<td class="nump">618<span></span>
</td>
<td class="nump">650<span></span>
</td>
<td class="nump">1,272<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Share-based compensation</a></td>
<td class="nump">712<span></span>
</td>
<td class="nump">252<span></span>
</td>
<td class="nump">1,331<span></span>
</td>
<td class="nump">597<span></span>
</td>
<td class="nump">1,946<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RevaluationOfWarrantsAccountedAtFairValue', window );">Revaluation of warrants accounted at fair value</a></td>
<td class="num">(4,990)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,923)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,977<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss', window );">Issuance expenses of warrants through profit and loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,911<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RevaluationOfLiabilitiesInRespectOfGrants', window );">Revaluation of liabilities in respect of IIA grants</a></td>
<td class="nump">233<span></span>
</td>
<td class="nump">248<span></span>
</td>
<td class="nump">492<span></span>
</td>
<td class="nump">482<span></span>
</td>
<td class="num">(132)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RevaluationOfLiabilitiesInRespectOfTeva', window );">Revaluation of liabilities in respect of TEVA</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">135<span></span>
</td>
<td class="nump">241<span></span>
</td>
<td class="nump">272<span></span>
</td>
<td class="nump">533<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RevaluationOfLeaseLiabilities', window );">Revaluation of lease liabilities</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(138)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="num">(152)<span></span>
</td>
<td class="num">(109)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities', window );">Increase (decrease) in severance pay liability, net</a></td>
<td class="num">(10)<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="nump">109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForFinanceIncomeCost', window );">Net financing income</a></td>
<td class="num">(759)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(1,005)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(74)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss', window );">Un-realized foreign currency loss</a></td>
<td class="nump">120<span></span>
</td>
<td class="nump">283<span></span>
</td>
<td class="nump">466<span></span>
</td>
<td class="nump">528<span></span>
</td>
<td class="nump">525<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForReconcileProfitLoss', window );">Adjustments to profit and loss items, total</a></td>
<td class="num">(4,269)<span></span>
</td>
<td class="nump">1,133<span></span>
</td>
<td class="num">(3,735)<span></span>
</td>
<td class="nump">2,421<span></span>
</td>
<td class="nump">14,958<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ChangesInAssetAndLiabilityItemsAbstract', window );"><strong>Changes in asset and liability items:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable', window );">Decrease (increase) in trade receivables</a></td>
<td class="num">(707)<span></span>
</td>
<td class="num">(1,445)<span></span>
</td>
<td class="nump">6,115<span></span>
</td>
<td class="num">(2,024)<span></span>
</td>
<td class="num">(7,582)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories', window );">Increase in inventories</a></td>
<td class="num">(579)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
<td class="num">(1,162)<span></span>
</td>
<td class="num">(747)<span></span>
</td>
<td class="num">(721)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables', window );">Decrease in other receivables</a></td>
<td class="nump">435<span></span>
</td>
<td class="nump">205<span></span>
</td>
<td class="nump">122<span></span>
</td>
<td class="nump">330<span></span>
</td>
<td class="nump">364<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable', window );">Increase (decrease) in trade payables and accrued expenses</a></td>
<td class="nump">312<span></span>
</td>
<td class="num">(272)<span></span>
</td>
<td class="num">(1,636)<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">414<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue', window );">Increase (decrease) in other payables and deferred revenues</a></td>
<td class="num">(1,359)<span></span>
</td>
<td class="num">(484)<span></span>
</td>
<td class="num">(1,526)<span></span>
</td>
<td class="num">(1,367)<span></span>
</td>
<td class="nump">281<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems', window );">Changes in asset and liability items, total</a></td>
<td class="num">(1,898)<span></span>
</td>
<td class="num">(2,033)<span></span>
</td>
<td class="nump">1,913<span></span>
</td>
<td class="num">(3,797)<span></span>
</td>
<td class="num">(7,244)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Net cash (used in) operating activities</a></td>
<td class="num">(5,251)<span></span>
</td>
<td class="num">(5,254)<span></span>
</td>
<td class="num">(4,599)<span></span>
</td>
<td class="num">(9,319)<span></span>
</td>
<td class="num">(11,885)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows from Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Purchase of property and equipment</a></td>
<td class="num">(1,065)<span></span>
</td>
<td class="num">(138)<span></span>
</td>
<td class="num">(2,570)<span></span>
</td>
<td class="num">(298)<span></span>
</td>
<td class="num">(555)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestReceivedClassifiedAsInvestingActivities', window );">Interest received</a></td>
<td class="nump">577<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">879<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments', window );">Investment in short term bank deposits, net</a></td>
<td class="num">(25,590)<span></span>
</td>
<td class="num">(2,499)<span></span>
</td>
<td class="num">(31,830)<span></span>
</td>
<td class="num">(2,499)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations', window );">Net cash used in investing activities</a></td>
<td class="num">(26,078)<span></span>
</td>
<td class="num">(2,637)<span></span>
</td>
<td class="num">(33,521)<span></span>
</td>
<td class="num">(2,797)<span></span>
</td>
<td class="num">(481)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows from Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Repayment of leases liabilities</a></td>
<td class="num">(157)<span></span>
</td>
<td class="num">(172)<span></span>
</td>
<td class="num">(334)<span></span>
</td>
<td class="num">(350)<span></span>
</td>
<td class="num">(701)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromExerciseOfOptions', window );">Proceeds from exercise of options</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromExerciseOfWarrants', window );">Proceeds from exercise of pre-funded warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet', window );">Proceeds from (Repayment of) issuance of shares and warrants, net</a></td>
<td class="num">(248)<span></span>
</td>
<td class="num">(556)<span></span>
</td>
<td class="nump">24,909<span></span>
</td>
<td class="nump">9,861<span></span>
</td>
<td class="nump">38,380<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RepaymentFromGrants', window );">Repayment of IIA grants, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(310)<span></span>
</td>
<td class="num">(162)<span></span>
</td>
<td class="num">(258)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_RepaymentOfLiabilitiesInRespectOfTeva', window );">Repayment of liabilities in respect of TEVA</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(417)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,667)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="num">(405)<span></span>
</td>
<td class="num">(728)<span></span>
</td>
<td class="nump">23,848<span></span>
</td>
<td class="nump">9,349<span></span>
</td>
<td class="nump">35,764<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents', window );">Exchange rate differences on cash and cash equivalent balances</a></td>
<td class="num">(120)<span></span>
</td>
<td class="num">(303)<span></span>
</td>
<td class="num">(457)<span></span>
</td>
<td class="num">(550)<span></span>
</td>
<td class="num">(549)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">Increase (decrease) in cash and cash equivalents</a></td>
<td class="num">(31,854)<span></span>
</td>
<td class="num">(8,922)<span></span>
</td>
<td class="num">(14,729)<span></span>
</td>
<td class="num">(3,317)<span></span>
</td>
<td class="nump">22,849<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Balance of cash and cash equivalents at the beginning of the period</a></td>
<td class="nump">51,020<span></span>
</td>
<td class="nump">16,651<span></span>
</td>
<td class="nump">33,895<span></span>
</td>
<td class="nump">11,046<span></span>
</td>
<td class="nump">11,046<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Balance of cash and cash equivalents at the end of the period</a></td>
<td class="nump">19,166<span></span>
</td>
<td class="nump">7,729<span></span>
</td>
<td class="nump">19,166<span></span>
</td>
<td class="nump">7,729<span></span>
</td>
<td class="nump">33,895<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_NonCashTransactionsAbstract', window );"><strong>Supplement disclosure of Non-cash transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssetsIncreaseDecreaseInRevaluationSurplus', window );">ROU asset, net recognized with corresponding lease liability</a></td>
<td class="nump">$ 102<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="nump">$ 154<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="nump">$ 117<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in other operating receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in trade accounts receivable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForFinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for net finance income or cost to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Finance income (cost); Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForFinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in employee benefit liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForReconcileProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForReconcileProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForReconcileProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow (outflow) due to a decrease (increase) in short-term deposits and investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 16<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) the entity's investing activities, related to continuing operations. [Refer: Continuing operations [member]; Cash flows from (used in) investing activities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2022-03-24<br> -Paragraph 33<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_33_c&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 28<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2022-03-24<br> -Paragraph 52<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 35<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestReceivedClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from interest received, classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 31<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestReceivedClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 17<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the exercise of share purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2022-03-24<br> -Paragraph 39L<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2022-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2022-03-24<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2022-03-24<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2022-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2023-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2022-03-24<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 16<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssetsIncreaseDecreaseInRevaluationSurplus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the revaluation surplus that relates to right-of-use assets. [Refer: Revaluation surplus; Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2022-03-24<br> -Paragraph 57<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_57&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssetsIncreaseDecreaseInRevaluationSurplus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Changes in asset and liability items, total.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment for increase in other payables and deferred revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment for issuance expenses of warrants through profit and loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_ChangesInAssetAndLiabilityItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_ChangesInAssetAndLiabilityItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_NonCashTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_NonCashTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_RepaymentFromGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repayment from grants during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_RepaymentFromGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_RepaymentOfLiabilitiesInRespectOfTeva">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of Repayment of liabilities in respect of TEVA.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_RepaymentOfLiabilitiesInRespectOfTeva</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from (Repayment of) issuance of shares and warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_RevaluationOfLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revaluation of lease liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_RevaluationOfLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_RevaluationOfLiabilitiesInRespectOfGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revaluation of liabilities in respect of IIA grants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_RevaluationOfLiabilitiesInRespectOfGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_RevaluationOfLiabilitiesInRespectOfTeva">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of Revaluation of liabilities in respect of TEVA.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_RevaluationOfLiabilitiesInRespectOfTeva</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_RevaluationOfWarrantsAccountedAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of Revaluation of warrants accounted at fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_RevaluationOfWarrantsAccountedAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140249307081632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfGeneralInformationAbstract', window );"><strong>Disclosure Of General Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory', window );">General</a></td>
<td class="text">
    <div>
      <div>
        <div>
          <div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:56.7pt;vertical-align:top;font-weight:bold">Note 1:</td>
                  <td style="width:auto;vertical-align:top">
                    <div style="font-weight:bold">General</div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:57.3pt">&#160;</td>
                  <td style="width:27.75pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold">a.</td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="font-weight:bold">Description of the Company and its operations:</div>
                    <div style="font-weight:bold">&#160;</div>
                    <div style="font-weight:bold">
                      <div style="line-height:1.25;font-weight:normal">MediWound Ltd. Was incorporated in Israel. The Company which is located in Yavne, Israel (The "Company" or "MediWound"), is biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, bio-therapeutic, non-surgical solutions for tissue repair and regeneration. The Company&#8217;s strategy leverages its breakthrough enzymatic technology platform into diversified portfolio of biotherapeutics across multiple indications to pioneer solutions for unmet medical needs.<span style="font-size:12pt;color:rgb(61, 61, 100)">&#160;</span> The Company&#8217;s current portfolio is focused on next-generation protein-based therapies for burn care, wound care and tissue repair.<br/><span style="font-weight:normal">&#160;</span></div>
                      <div style="line-height:1.25;font-weight:normal">The Company's first innovative biopharmaceutical product, NexoBrid, has received in December 2022, an approval from the U.S. Food and Drug Administration (&#8220;FDA&#8221;) and marketing approval in each of India, Switzerland and Japan. In addition it has a marketing authorization from the European Medicines Agency (&#8220;EMA&#8221;) and regulatory agencies in other international markets for removal of dead or damaged tissue, known as eschar, in adults with deep partial and full thickness thermal burns.<br/><span style="font-weight:normal">&#160;</span></div>
                      <div style="line-height:1.25;font-weight:normal">The Company commercialize NexoBrid globally through multiple sales channels.</div>
                    </div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:102.45pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top">&#8226;</td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div>The Company sell NexoBrid to burn centers in the European Union, United Kingdom and Israel, primarily through its commercial organizations.</div>
                  </td>
                </tr>

            </table>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:102.45pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top">&#8226;</td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div>The Company have established local distribution channels in multiple international markets, focusing on Asia Pacific, EMEA, CEE and LATAM, which local distributors are also responsible for obtaining local marketing authorization within the relevant territories.</div>
                  </td>
                </tr>

            </table>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:102.5pt">&#160;</td>
                  <td style="width:18pt;vertical-align:top">&#8226;</td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div>In the United States, the Company entered into exclusive license and supply agreements with Vericel Corporation (&#8220;Vericel&#8221;) to commercialize NexoBrid in North America upon FDA approval.</div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="line-height:1.25">
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:57.3pt">&#160;</td>
                    <td style="width:27.75pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;</td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div style="font-weight:bold">
                        <div style="line-height:1.25;font-weight:normal">
                          <div style="line-height:1.25">The Company&#8217;s second investigational next-generation enzymatic therapy product, EscharEx, a topical biological drug being developed for debridement of chronic and other hard-to-heal wounds, is currently under discussions with the FDA regarding the pivotal Phase 3 study design.</div>
                          <div style="line-height:1.25">&#160;</div>
                          <div style="line-height:1.25;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);margin-bottom:10pt">The third clinical-stage innovative product candidate, MW005, is a topical applied biological drug candidate for the treatment of non-melanoma skin cancers. A U.S. phase 1/2 study of MW005 for the treatment of low-risk basal cell carcinoma (BCC) was initiated in July 2021, and an investigator-initiated phase II trial of MW005 in non-melanoma skin cancer is being conducted in parallel in Israel. In December 2022, the Company announced final positive results from the study. Based on the positive results, The Company plan to continue enrolling patients in its Phase 1/2 study.</div>
                        </div>
                      </div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div></div>
        <div>
          <div>
            <div style="margin-top:0px">
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                  <tr>
                    <td style="width:57.3pt">&#160;</td>
                    <td style="width:27.75pt;vertical-align:top;font-weight:bold"><span style="font-family:Times New Roman,Times,serif">b.</span></td>
                    <td style="width:auto;vertical-align:top;text-align:justify">
                      <div><span style="font-family:Times New Roman,Times,serif">The Company's securities are listed for trading on NASDAQ since March 2014.</span></div>
                    </td>
                  </tr>

              </table>
            </div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:57.3pt">&#160;</td>
                  <td style="width:27.75pt;vertical-align:top;font-weight:bold"><span style="font-family:Times New Roman,Times,serif">c.</span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-family:Times New Roman,Times,serif">The Company has three wholly owned subsidiaries: MediWound Germany GmbH, acting as Europe (&#8220;EU&#8221;) marketing authorization holder and EU sales and marketing arm, and MediWound UK Limited and MediWound US, Inc. which are currently inactive companies.</span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:57.3pt">&#160;</td>
                  <td style="width:27.75pt;vertical-align:top;font-weight:bold"><span style="font-family:Times New Roman,Times,serif">d.</span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-family:Times New Roman,Times,serif">The Company awarded two contracts with the U.S. Biomedical Advanced Research and Development Authority ("BARDA") valued at up to $209,000 for the advancement of the development, manufacturing and emergency readiness for NexoBrid deployment as well as the procurement of NexoBrid as a medical countermeasure as part of BARDA preparedness for mass casualty events.</span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
            <div style="text-align:justify;margin-left:85.05pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On May 9, 2023 BARDA has awarded an additional $10,000 to the Company. The supplemental funding will support $7,000 R&amp;D activities and $3,000 replenishment of expired product previously procured for emergency preparedness, the pediatric indication sBLA submission to the U.S. Food and Drug Administration (FDA), and enrollment of an additional 50 patients in the ongoing expanded access treatment protocol (NEXT).</span></span></div>
            <div style="line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:57.3pt">&#160;</td>
                  <td style="width:27.75pt;vertical-align:top;color:#000000;font-weight:bold"><span style="font-family:Times New Roman,Times,serif">e.</span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div style="color:#000000"><span style="font-family:Times New Roman,Times,serif">Our Partner, Vericel Corporation Inc. (&#8220;<span style="font-weight:bold">Vericel</span>&#8221;) has received the first lot of NexoBrid&#174; finished product from the company for the U.S. commercial market in June 2023, which currently is warehoused at Vericel&#8217;s third-party logistics distributor. Although this NexoBrid finished product batch has met all required release criteria for distribution in the U.S., Vericel is unable to release this product into the commercial channel at this time due to a deviation associated with a third-party testing lab used during the manufacturing process. A detailed risk assessment prepared by the Company and Vericel has concluded that the deviation presents no incremental risk to the finished product&#8217;s quality and safety, and the company actively engaged with Vericel and the U.S. Food and Drug Administration (FDA) to address this matter. Future manufacturing of NexoBrid drug product for the U.S. market will not be impacted because the at-issue test will be conducted directly by the Company. As the FDA has not yet authorized the commercial release of the finished product affected by the deviation, the company is currently preparing for a production campaign scheduled to begin in September 2023.</span></div>
                  </td>
                </tr>

            </table>
            <div style="text-align:justify;margin-left:63.85pt;line-height:1.25">&#160;</div>
            <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                <tr>
                  <td style="width:57.3pt">&#160;</td>
                  <td style="width:27.75pt;vertical-align:top;font-weight:bold"><span style="font-family:Times New Roman,Times,serif">f.</span></td>
                  <td style="width:auto;vertical-align:top;text-align:justify">
                    <div><span style="font-family:Times New Roman,Times,serif">In 2022 the Company engaged with the U.S. Department of Defense (DoD), through the Medical Technology Enterprise Consortium (MTEC), for a $1,800 contract for the development of NexoBrid as a non-surgical solution for field-care burn treatment for the U.S. Army. This contract was amended in April 2023 to extend the total value, up to a total amount of $2,700.</span></div>
                  </td>
                </tr>

            </table>
            <div style="line-height:1.25">&#160;</div>
          </div>
        </div>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for general information about financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 51<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_51&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfGeneralInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfGeneralInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140249310792464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract', window );"><strong>Disclosure of significant accounting policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory', window );">Significant Accounting Policies</a></td>
<td class="text">
                <div>
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span>Note 2:</span></span></span></span></span></span></td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <div style="font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span>S</span></span></span></span><strong><span style="line-height:110%">ignificant Accounting Policies</span></strong></span></span></div>
                          </td>
                        </tr>
                        <tr>
                          <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold">&#160;</td>
                          <td style="width:auto;vertical-align:top;text-align:justify">&#160;</td>
                        </tr>
                        <tr>
                          <td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold">&#160;</td>
                          <td style="width:auto;vertical-align:top;text-align:justify">
                            <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">The following accounting policies have been applied consistently in the financial statements for all periods presented unless otherwise stated.</span></p>
                          </td>
                        </tr>

                    </table>
                    <div style="line-height:1.25">&#160;</div>

                      <div>
                        <div>
                          <table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt">

                              <tr style="vertical-align:top">
                                <td style="width:57pt">&#160;</td>
                                <td style="vertical-align:top;width:27pt">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">a.</span></span></span></span></span></div>
                                </td>
                                <td style="vertical-align:top;width:auto">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Basis of presentation of financial statements:</span></span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:57pt">&#160;</td>
                                <td style="vertical-align:top;width:27pt">&#160;</td>
                                <td style="vertical-align:top;width:auto">&#160;</td>
                              </tr>
                              <tr>
                                <td style="width:57pt">&#160;</td>
                                <td style="vertical-align:top;width:27pt">&#160;</td>
                                <td style="vertical-align:top;width:auto">
                                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">These financial statements have been prepared in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board ("IASB").</span></p>
                                </td>
                              </tr>

                          </table>
                        </div>
                      </div>

                    <div style="line-height:1.25">&#160;</div>

                      <div>
                        <div>
                          <table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt">

                              <tr style="vertical-align:top">
                                <td style="width:57pt">&#160;</td>
                                <td style="vertical-align:top;width:27pt">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">b.</span></span></span></span></span></div>
                                </td>
                                <td style="vertical-align:top;width:auto">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Basis of preparation of the interim consolidated financial statements:</span></span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:57pt">&#160;</td>
                                <td style="vertical-align:top;width:27pt">&#160;</td>
                                <td style="vertical-align:top;width:auto">&#160;</td>
                              </tr>
                              <tr>
                                <td style="width:57pt">&#160;</td>
                                <td style="vertical-align:top;width:27pt">&#160;</td>
                                <td style="vertical-align:top;width:auto">
                                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">The interim condensed consolidated financial statements for the six and three months ended June 30, 2023&#160;have been prepared in accordance with IAS 34 "Interim Financial Reporting".</span></p>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:57pt">&#160;</td>
                                <td style="vertical-align:top;width:27pt">&#160;</td>
                                <td style="vertical-align:top;width:auto">&#160;</td>
                              </tr>
                              <tr>
                                <td style="width:57pt">&#160;</td>
                                <td style="vertical-align:top;width:27pt">&#160;</td>
                                <td style="vertical-align:top;width:auto">
                                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">The interim condensed consolidated financial statements do not include all the information and disclosures required in the annual financial statements, and should be read in conjunction with the Company's annual financial statements as of December 31, 2022 that were included in the Annual Report on Form 20-F filed on March 16, 2023.</span></p>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:57pt">&#160;</td>
                                <td style="vertical-align:top;width:27pt">&#160;</td>
                                <td style="vertical-align:top;width:auto">&#160;</td>
                              </tr>
                              <tr>
                                <td style="width:57pt">&#160;</td>
                                <td style="vertical-align:top;width:27pt">&#160;</td>
                                <td style="vertical-align:top;width:auto">
                                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">The accounting policies adopted in the preparation of the interim condensed consolidated financial statements are consistent with those followed in the preparation of the Company&#8217;s annual consolidated financial statements for the year ended December 31, 2022 that were included in the Annual Report on Form 20-F filed on March 16, 2023.&#160;</span></p>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:57pt">&#160;</td>
                                <td style="vertical-align:top;width:27pt">&#160;</td>
                                <td style="vertical-align:top;width:auto">&#160;</td>
                              </tr>

                          </table>
                        </div>
                      </div>

                  </div>
                </div>
              <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant accounting policies applied by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfSignificantAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140249310763360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>SHAREHOLDERS' EQUITY:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory', window );">Equity</a></td>
<td class="text">
                            <div style="margin-top:0pt;margin-bottom:0pt">
                              <div style="margin-top:0pt;margin-bottom:0pt">
                                <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;margin-top:0pt;margin-bottom:0pt">

                                    <tr style="vertical-align:top;margin-top:0pt;margin-bottom:0pt">
                                      <td style="text-align:right;vertical-align:top;width:56.7pt;margin-top:0pt;margin-bottom:0pt">
                                        <div style="text-align:left;line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold;margin-top:0pt;margin-bottom:0pt">Note 3:</span></div>
                                      </td>
                                      <td style="text-align:left;vertical-align:top;width:auto;margin-top:0pt;margin-bottom:0pt">
                                        <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold;margin-top:0pt;margin-bottom:0pt">Equity</span></div>
                                      </td>
                                    </tr>

                                </table>
                              </div>
                              <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
                              <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">

                                  <tr style="margin-top:0pt;margin-bottom:0pt">
                                    <td style="width:56.7pt;margin-top:0pt;margin-bottom:0pt">&#160;</td>
                                    <td style="width:18pt;vertical-align:top;font-weight:bold;margin-top:0pt;margin-bottom:0pt">1.</td>
                                    <td style="width:auto;vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt">
                                      <div style="margin-top:0pt;margin-bottom:0pt">On February 7, 2023, the Company completed a public offering of 1,964,286 new ordinary shares which were issued in consideration to offering price of $14.0 per share. The gross proceeds were $27,500, before deducting commissions and other offering expenses in the amount of $2,031.</div>
                                    </td>
                                  </tr>

                              </table>
                              <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
                              <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">

                                  <tr style="margin-top:0pt;margin-bottom:0pt">
                                    <td style="width:56.7pt;margin-top:0pt;margin-bottom:0pt">&#160;</td>
                                    <td style="width:18pt;vertical-align:top;font-weight:bold;margin-top:0pt;margin-bottom:0pt">2.</td>
                                    <td style="width:auto;vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt">
                                      <div style="margin-top:0pt;margin-bottom:0pt">On February 15, 2023, the Company granted to its employees and officers 130,600 share options for an exercise price of $13.32 per share and 9,100 RSUs. The share options vest over a period of 4 years. The total value was estimated at $1,129.</div>
                                    </td>
                                  </tr>

                              </table>
                              <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
                              <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">

                                  <tr style="margin-top:0pt;margin-bottom:0pt">
                                    <td style="width:56.7pt;margin-top:0pt;margin-bottom:0pt">&#160;</td>
                                    <td style="width:18pt;vertical-align:top;font-weight:bold;margin-top:0pt;margin-bottom:0pt">3.</td>
                                    <td style="width:auto;vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt">
                                      <div style="margin-top:0pt;margin-bottom:0pt">On April 3, 2023, the Company granted to its board members and officers 160,400 share options for an exercise price of $11.89 and $11.91 per share. The grants to the directors and CEO were subject to the approval of the shareholders&#8217; meeting held on May, 2023. The share options vest over a period of 1-4 years and the total value was estimated at $884.</div>
                                    </td>
                                  </tr>

                              </table>
                              <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
                              <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">

                                  <tr style="margin-top:0pt;margin-bottom:0pt">
                                    <td style="width:56.7pt;margin-top:0pt;margin-bottom:0pt">&#160;</td>
                                    <td style="width:18pt;vertical-align:top;font-weight:bold;margin-top:0pt;margin-bottom:0pt">4.</td>
                                    <td style="width:auto;vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt">
                                      <div style="margin-bottom:10pt;margin-top:0pt">On May 31, 2023 the Shareholders of the Company approved an amendment to Article 6 of the Company&#8217;s Amended and Restated Articles of Association, which increased the Company&#8217;s authorized share capital from 900,000 NIS consisting of 12,857,143 ordinary shares par value NIS 0.07 to NIS 1,400,000, consisting of 20,000,000 ordinary shares, par value NIS 0.07 per share.</div>
                                    </td>
                                  </tr>

                              </table>
                              <div style="clear:both;margin-top:0pt;margin-bottom:0pt">
                                <div style="margin-top:0pt;margin-bottom:0pt">
                                  <div style="margin-top:0pt;margin-bottom:0pt"></div>
                                </div>
                              </div>
                              <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">

                                  <tr style="margin-top:0pt;margin-bottom:0pt">
                                    <td style="width:56.7pt;margin-top:0pt;margin-bottom:0pt">&#160;</td>
                                    <td style="width:18pt;vertical-align:top;font-weight:bold;margin-top:0pt;margin-bottom:0pt">5.</td>
                                    <td style="width:auto;vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt">
                                      <div style="margin-top:0pt;margin-bottom:0pt">On May 31, 2023 the Shareholders of the Company approved the increase by 1,000,000 in the number of ordinary shares available for issuance under the Company&#8217;s 2014 Equity Incentive Plan.</div>
                                    </td>
                                  </tr>

                              </table>
                              <div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt">&#160;</div>
                              <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">

                                  <tr style="margin-top:0pt;margin-bottom:0pt">
                                    <td style="width:56.7pt;margin-top:0pt;margin-bottom:0pt">&#160;</td>
                                    <td style="width:18pt;vertical-align:top;font-weight:bold;margin-top:0pt;margin-bottom:0pt">6.</td>
                                    <td style="width:auto;vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt">
                                      <div style="margin-top:0pt;margin-bottom:0pt">On May 31, 2023 the Shareholders of the Company approved the extension to the exercise period of options which were granted to the company&#8217;s directors on April 23, 2020 for an additional five years, until April 23, 2030. According to this extension, an expense of $146 was recognized.<p style="margin:0pt">&#160;</p>
                                      </div>
                                    </td>
                                  </tr>

                              </table>
                            </div>
                          <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share capital, reserves and other equity interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140249307701840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent events<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract', window );"><strong>Disclosure of non-adjusting events after reporting period [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory', window );">Subsequent events</a></td>
<td class="text">
                        <div style="margin-top:0pt;margin-bottom:0pt">
                          <table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt">

                              <tr style="margin-top:0pt;margin-bottom:0pt">
                                <td style="margin-top:0pt;margin-bottom:0pt">
                                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold;margin-top:0pt;margin-bottom:0pt">Note&#160;4:</span></span></span></span></span></span></span></p>
                                </td>
                                <td colspan="3" rowspan="1" style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;margin-top:0pt;margin-bottom:0pt">
                                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><strong style="margin-top:0pt;margin-bottom:0pt"><span style="line-height:110%;margin-top:0pt;margin-bottom:0pt">Subsequent events</span></strong></span></span></span></span></span></span></p>
                                </td>
                              </tr>
                              <tr style="margin-top:0pt;margin-bottom:0pt">
                                <td style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;margin-top:0pt;margin-bottom:0pt;width:56pt">&#160;</td>
                                <td style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:18pt">&#160;</td>
                                <td style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:auto">&#160;</td>
                              </tr>
                              <tr style="margin-top:0pt;margin-bottom:0pt">
                                <td style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;margin-top:0pt;margin-bottom:0pt;width:56pt">&#160;</td>
                                <td style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:18pt">
                                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><strong style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">1.</span></strong></span></span></span></span></p>
                                </td>
                                <td style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:auto">
                                  <div style="margin-top:0pt;margin-bottom:0pt">
                                    <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">On July 17, 2023 the company signed a turnkey scale-up agreement with Biopharmax Group Ltd. This strategic agreement is designed to bolster the company&#8217;s manufacturing infrastructure to support our long-term growth trajectory. &#160;The objective of this agreement is to establish, commission, and validate a cutting-edge, sterile, and GMP-compliant manufacturing facility. The venture aims to increase our production capacity significantly, projected to expand to six times the current capacity, aligning with our strategic plan to meet the escalating global demand for NexoBrid.</span></span></span></span></p>
                                  </div>
                                </td>
                              </tr>
                              <tr style="margin-top:0pt;margin-bottom:0pt">
                                <td colspan="1" style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;margin-top:0pt;margin-bottom:0pt;width:56pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">&#160;</span></span></span></span></td>
                                <td colspan="1" style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:18pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">&#160;</span></span></span></span></td>
                                <td colspan="1" style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:auto"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">&#160;</span></span></span></span></td>
                              </tr>
                              <tr style="margin-top:0pt;margin-bottom:0pt">
                                <td colspan="1" style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;margin-top:0pt;margin-bottom:0pt;width:56pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">&#160;</span></span></span></span></td>
                                <td colspan="1" style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:18pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">&#160;</span></span></span></span></td>
                                <td colspan="1" style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:auto"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">The new facility, equipped with fully operational clean rooms, will be exclusively designed for NexoBrid production. It will comply with stringent regulations from the GMP, FDA, EMA, Israeli Ministry of Health, and relevant Israeli regulatory bodies. An estimated $12,000&#160;will be invested in the project, set for completion by mid-2024, with full-scale manufacturing expected to commence in 2025.</span></span>
                                  <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
                                  <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">The Scale-up Agreement encompasses various standard provisions, including those related to reporting, compliance, guarantees, representations, liability, insurance, confidentiality, and ownership.</span></span></span></span></p>
                                </td>
                              </tr>
                              <tr style="margin-top:0pt;margin-bottom:0pt">
                                <td colspan="1" style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;margin-top:0pt;margin-bottom:0pt;width:56pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">&#160;</span></span></span></span></td>
                                <td colspan="1" style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:18pt"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">&#160;</span></span></span></span></td>
                                <td colspan="1" style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:auto"><span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">&#160;</span></span></span></span></td>
                              </tr>
                              <tr style="margin-top:0pt;margin-bottom:0pt">
                                <td colspan="1" style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;margin-top:0pt;margin-bottom:0pt;width:56pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">&#160;</span></span></span></span></span></span></td>
                                <td colspan="1" style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:18pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong style="margin-top:0pt;margin-bottom:0pt">2.</strong></span></span></td>
                                <td colspan="1" style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:auto">
                                  <p style="margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Alongside entering the Scale-up Agreement, the company has also secured a new lease agreement with the current property owner. This agreement allows the company to continue the utilization of our existing facilities and the planned manufacturing site. This property, located in Yavne, Israel, serves as the base for the company&#8217;s administrative headquarters, research and development laboratories, and manufacturing plant. The duration of the lease extends until 2035, with an option for a further three-year extension until 2038. In parallel the existing sub lease agreement with Clal Life Science L.P. and the company was terminated.</span></span></p>
                                  <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
                                  <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt"><span style="margin-top:0pt;margin-bottom:0pt">The property, measuring approximately 32,500 square feet, will encompass the new manufacturing facility. As per the Lease Agreement, the annual rent is set at approximately $625. This rent is indexed to the Israeli Consumer Price Index and will see a staged increase of 6% every three years.</span></span></span></span></span></span></p>
                                </td>
                              </tr>

                          </table>
                        </div>
                      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for events after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 10<br> -IssueDate 2022-03-24<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=10&amp;code=ifrs-tx-2022-en-r&amp;doctype=Standard&amp;dita_xref=IAS10_g17-22_IAS10_g17-22_TI<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140249310513216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract', window );"><strong>Disclosure of significant accounting policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements', window );">Basis of presentation of financial statements</a></td>
<td class="text">
                      <div>
                        <div>
                          <table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt">

                              <tr style="vertical-align:top">
                                <td style="width:57pt">&#160;</td>
                                <td style="vertical-align:top;width:27pt">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">a.</span></span></span></span></span></div>
                                </td>
                                <td style="vertical-align:top;width:auto">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Basis of presentation of financial statements:</span></span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:57pt">&#160;</td>
                                <td style="vertical-align:top;width:27pt">&#160;</td>
                                <td style="vertical-align:top;width:auto">&#160;</td>
                              </tr>
                              <tr>
                                <td style="width:57pt">&#160;</td>
                                <td style="vertical-align:top;width:27pt">&#160;</td>
                                <td style="vertical-align:top;width:auto">
                                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">These financial statements have been prepared in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board ("IASB").</span></p>
                                </td>
                              </tr>

                          </table>
                        </div>
                      </div>
                    <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_DescriptionOfOtherAccountingPoliciesBasisOfPreparationOfInterimConsolidatedFinancialStatementsExplanatory', window );">Basis of preparation of the interim consolidated financial statements</a></td>
<td class="text">
                      <div>
                        <div>
                          <table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt">

                              <tr style="vertical-align:top">
                                <td style="width:57pt">&#160;</td>
                                <td style="vertical-align:top;width:27pt">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="font-weight:bold">b.</span></span></span></span></span></div>
                                </td>
                                <td style="vertical-align:top;width:auto">
                                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Basis of preparation of the interim consolidated financial statements:</span></span></span></span></span></div>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:57pt">&#160;</td>
                                <td style="vertical-align:top;width:27pt">&#160;</td>
                                <td style="vertical-align:top;width:auto">&#160;</td>
                              </tr>
                              <tr>
                                <td style="width:57pt">&#160;</td>
                                <td style="vertical-align:top;width:27pt">&#160;</td>
                                <td style="vertical-align:top;width:auto">
                                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">The interim condensed consolidated financial statements for the six and three months ended June 30, 2023&#160;have been prepared in accordance with IAS 34 "Interim Financial Reporting".</span></p>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:57pt">&#160;</td>
                                <td style="vertical-align:top;width:27pt">&#160;</td>
                                <td style="vertical-align:top;width:auto">&#160;</td>
                              </tr>
                              <tr>
                                <td style="width:57pt">&#160;</td>
                                <td style="vertical-align:top;width:27pt">&#160;</td>
                                <td style="vertical-align:top;width:auto">
                                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">The interim condensed consolidated financial statements do not include all the information and disclosures required in the annual financial statements, and should be read in conjunction with the Company's annual financial statements as of December 31, 2022 that were included in the Annual Report on Form 20-F filed on March 16, 2023.</span></p>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:57pt">&#160;</td>
                                <td style="vertical-align:top;width:27pt">&#160;</td>
                                <td style="vertical-align:top;width:auto">&#160;</td>
                              </tr>
                              <tr>
                                <td style="width:57pt">&#160;</td>
                                <td style="vertical-align:top;width:27pt">&#160;</td>
                                <td style="vertical-align:top;width:auto">
                                  <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">The accounting policies adopted in the preparation of the interim condensed consolidated financial statements are consistent with those followed in the preparation of the Company&#8217;s annual consolidated financial statements for the year ended December 31, 2022 that were included in the Annual Report on Form 20-F filed on March 16, 2023.&#160;</span></p>
                                </td>
                              </tr>
                              <tr>
                                <td style="width:57pt">&#160;</td>
                                <td style="vertical-align:top;width:27pt">&#160;</td>
                                <td style="vertical-align:top;width:auto">&#160;</td>
                              </tr>

                          </table>
                        </div>
                      </div>
                    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of accounting policies relevant to an understanding of financial statements, which the entity does not separately disclose.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2023-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 117<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DescriptionOfOtherAccountingPoliciesBasisOfPreparationOfInterimConsolidatedFinancialStatementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of accounting policies basis of preparation of the interim consolidated financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DescriptionOfOtherAccountingPoliciesBasisOfPreparationOfInterimConsolidatedFinancialStatementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_DisclosureOfSignificantAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_DisclosureOfSignificantAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140249310604192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General (Narrative) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>May 09, 2023 </div>
<div>USD ($) </div>
<div>Patient</div>
</th>
<th class="th">
<div>Apr. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mdwd_BardaMember', window );">BARDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems', window );"><strong>Disclosure of associates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ContractAmountForResearchDevelopmentAndManufacturing', window );">Contract amount for research, development and manufacturing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 209,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AdditionalProceedsFromFunding', window );">Additional funding amount</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mdwd_USFoodAndDrugAdministrationMember', window );">U.S. Food and Drug Administration (FDA) [Member] | BARDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems', window );"><strong>Disclosure of associates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ContractAmountForResearchDevelopmentAndManufacturing', window );">Contract amount for research, development and manufacturing</a></td>
<td class="nump">7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ReplenishmentAmount', window );">Replenishment amount</a></td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_NumberOfPatients', window );">Number of patients | Patient</a></td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mdwd_USDepartmentOfDefenseMember', window );">U.S. Department of Defense (DoD) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems', window );"><strong>Disclosure of associates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ContractWithCustomers', window );">Contracts with customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_AdditionalProceedsFromFunding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional funding amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_AdditionalProceedsFromFunding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_ContractAmountForResearchDevelopmentAndManufacturing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of contract for research, development and manufacturing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_ContractAmountForResearchDevelopmentAndManufacturing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_ContractWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of contract with customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_ContractWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_NumberOfPatients">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of patients.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_NumberOfPatients</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_ReplenishmentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of replenishment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_ReplenishmentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=mdwd_BardaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=mdwd_BardaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mdwd_USFoodAndDrugAdministrationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mdwd_USFoodAndDrugAdministrationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mdwd_USDepartmentOfDefenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mdwd_USDepartmentOfDefenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140249299825504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Narrative) (Details)<br> &#8362; / shares in Units, $ / shares in Units, &#8362; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 03, 2023 </div>
<div>USD ($) </div>
<div>Share </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Feb. 07, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>May 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 15, 2023 </div>
<div>USD ($) </div>
<div>Share </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>May 31, 2023 </div>
<div>ILS (&#8362;) </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>&#8362; / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,252,234<span></span>
</td>
<td class="nump">12,857,143<span></span>
</td>
<td class="nump">7,240,020<span></span>
</td>
<td class="nump">4,734,774<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Ordinary shares, par value (per share) | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="nump">&#8362; 0.07<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
<td class="nump">&#8362; 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Commissions and other offering expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AuthorizedShareCapital', window );">Authorized share capital | &#8362;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_IncreaseInAuthorizedShareCapital', window );">Increase Iin authorized share capital | &#8362;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_IncreaseInSharesIssued', window );">Increase In shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_IncreaseInPricePerShareOfSharesIssued', window );">Increase in price per common shares issued | &#8362; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 0.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ExtensionPeriodForOptionsExercised', window );">Extension period for options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Expenses recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_SaleOfStocksAxis=mdwd_PublicOfferingMember', window );">Public offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,964,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Ordinary shares, par value (per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Proceeds from issuance of shares, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Commissions and other offering expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_EmployeesAndOfficersMember', window );">Employees and officers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of options granted | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare', window );">Exercise price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Vesting period of share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_StockOptionValue', window );">Total estimated value of stock option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_EmployeesAndOfficersMember', window );">Employees and officers [Member] | Restricted Shares Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Number of restricted share units granted | Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_BoardMembersAndOfficersMember', window );">Board members and officers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of options granted | Share</a></td>
<td class="nump">160,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement', window );">Vesting period of share options</a></td>
<td class="text">1-4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_StockOptionValue', window );">Total estimated value of stock option</a></td>
<td class="nump">$ 884<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_BoardMembersAndOfficersMember', window );">Board members and officers [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare', window );">Exercise price per share | $ / shares</a></td>
<td class="nump">$ 11.89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_BoardMembersAndOfficersMember', window );">Board members and officers [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare', window );">Exercise price per share | $ / shares</a></td>
<td class="nump">$ 11.91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mdwd_EquityIncentivePlanMember', window );">2014 Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_NumberOfShareAvailableForIssuance', window );">Number of share available for issuance | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the vesting requirements for a type of share-based payment arrangement that existed at any time during the period. An entity with substantially similar types of share-based payment arrangements may aggregate this information. [Refer: Share-based payment arrangements [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2022-03-24<br> -Paragraph 45<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_45_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from share-based payment transactions in which the goods or services received did not qualify for recognition as assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2022-03-24<br> -Paragraph 51<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_51_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2022-03-24<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2022-03-24<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2022-03-24<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2022-03-24<br> -Paragraph 17<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareIssueRelatedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cost related to the issuance of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareIssueRelatedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_AuthorizedShareCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Authorized share capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_AuthorizedShareCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_ExtensionPeriodForOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Extension period for options exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_ExtensionPeriodForOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_IncreaseInAuthorizedShareCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents Increase In authorized share capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_IncreaseInAuthorizedShareCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_IncreaseInPricePerShareOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_IncreaseInPricePerShareOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_IncreaseInSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase In Shares Issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_IncreaseInSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_NumberOfShareAvailableForIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share available for issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_NumberOfShareAvailableForIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of exercise price per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_StockOptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents value of stock option.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_StockOptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_SaleOfStocksAxis=mdwd_PublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_SaleOfStocksAxis=mdwd_PublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_EmployeesAndOfficersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_EmployeesAndOfficersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=mdwd_RestrictedSharesUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=mdwd_RestrictedSharesUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_BoardMembersAndOfficersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mdwd_BoardMembersAndOfficersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mdwd_EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mdwd_EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140249300149376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent events (Narrative) (Details) - Subsequents Event [Member] - Biopharmax Group Ltd. [Member]<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jul. 17, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentProperty', window );">Investment amount in property</a></td>
<td class="nump">$ 12,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_AreaOfLand', window );">Area of land | ft&#178;</a></td>
<td class="nump">32,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RentalExpense', window );">Rental expense</a></td>
<td class="nump">$ 625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mdwd_IncreaseInRentAsPercentageInEveryThreeYear', window );">Increase in rent as percentage in every three years</a></td>
<td class="nump">6.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property (land or a building - or part of a building - or both) held (by the owner or by the lessee as a right-of-use asset) to earn rentals or for capital appreciation or both, rather than for: (a) use in the production or supply of goods or services or for administrative purposes; or (b) sale in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 40<br> -IssueDate 2022-03-24<br> -Paragraph 76<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=40&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_76&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 40<br> -IssueDate 2022-03-24<br> -Paragraph 79<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=40&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_79_d&amp;doctype=Standard<br> -URIDate 2022-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 54<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_54_b&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RentalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognised on rental activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2022-03-24<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2022-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2022-03-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RentalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_AreaOfLand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The area of land used for business by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_AreaOfLand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mdwd_IncreaseInRentAsPercentageInEveryThreeYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase In Rent As Percentage In Every Three Year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdwd_IncreaseInRentAsPercentageInEveryThreeYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mdwd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=mdwd_SubsequentsEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=mdwd_SubsequentsEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfInvestmentPropertyAxis=mdwd_BiopharmaxGroupLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfInvestmentPropertyAxis=mdwd_BiopharmaxGroupLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>zk2330152_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mdwd="http://mediwound.com/20230630"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="mdwd-20230630.xsd" xlink:type="simple"/>
    <context id="C_20230630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="C_20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_20230331_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_20230331_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_20230331_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_20230331_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="C_20230401to20230630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_20230630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="C_20230630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="C_20230630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="C_20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_20220331_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_20220331_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_20220331_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_20220401to20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_20220630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_20220630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_20220630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_20230101to20230630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20230630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="C_20220331_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20230717_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentsEventMember_ifrsfullTypesOfInvestmentPropertyAxis_mdwdBiopharmaxGroupLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">mdwd:SubsequentsEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInvestmentPropertyAxis">mdwd:BiopharmaxGroupLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-17</instant>
        </period>
    </context>
    <context id="C_20230716to20230717_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentsEventMember_ifrsfullTypesOfInvestmentPropertyAxis_mdwdBiopharmaxGroupLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">mdwd:SubsequentsEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInvestmentPropertyAxis">mdwd:BiopharmaxGroupLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-16</startDate>
            <endDate>2023-07-17</endDate>
        </period>
    </context>
    <context id="C_20230207_mdwdSaleOfStocksAxis_mdwdPublicOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="mdwd:SaleOfStocksAxis">mdwd:PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-07</instant>
        </period>
    </context>
    <context id="C_20230201to20230207_mdwdSaleOfStocksAxis_mdwdPublicOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="mdwd:SaleOfStocksAxis">mdwd:PublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-07</endDate>
        </period>
    </context>
    <context id="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndOfficersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesAndOfficersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-15</endDate>
        </period>
    </context>
    <context id="C_20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndOfficersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesAndOfficersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-15</instant>
        </period>
    </context>
    <context id="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndOfficersMember_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:EmployeesAndOfficersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mdwd:RestrictedSharesUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-15</endDate>
        </period>
    </context>
    <context id="C_20230401to20230403_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdBoardMembersAndOfficersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:BoardMembersAndOfficersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-04-03</endDate>
        </period>
    </context>
    <context id="C_20230403_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdBoardMembersAndOfficersMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:BoardMembersAndOfficersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-03</instant>
        </period>
    </context>
    <context id="C_20230403_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdBoardMembersAndOfficersMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mdwd:BoardMembersAndOfficersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-03</instant>
        </period>
    </context>
    <context id="C_20230531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
        </entity>
        <period>
            <instant>2023-05-31</instant>
        </period>
    </context>
    <context id="C_20230531_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mdwd:EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-31</instant>
        </period>
    </context>
    <context id="C_20230501to20230531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20221231_deiLegalEntityAxis_mdwdUSDepartmentOfDefenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdwd:USDepartmentOfDefenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20230401to20230430_deiLegalEntityAxis_mdwdUSDepartmentOfDefenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdwd:USDepartmentOfDefenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="C_20230101to20230630_ifrsfullBorrowingsByNameAxis_mdwdBardaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mdwd:BardaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_20230501to20230509_deiLegalEntityAxis_mdwdUSFoodAndDrugAdministrationMember_ifrsfullBorrowingsByNameAxis_mdwdBardaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mdwd:USFoodAndDrugAdministrationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mdwd:BardaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-09</endDate>
        </period>
    </context>
    <context id="C_20230501to20230509_ifrsfullBorrowingsByNameAxis_mdwdBardaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001593984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mdwd:BardaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-09</endDate>
        </period>
    </context>
    <unit id="NIS">
        <measure>iso4217:ILS</measure>
    </unit>
    <unit id="NIS_Per_Share">
        <divide>
            <unitNumerator>
                <measure>iso4217:ILS</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Patient">
        <measure>mdwd:Patient</measure>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="SQFT">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="Share">
        <measure>mdwd:Share</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="USD_Per_Share">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="C_20230101to20230630"
      id="Fdei_EntityCentralIndexKey20210716162222544">0001593984</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalPeriodFocus
      contextRef="C_20230101to20230630"
      id="Fdei_DocumentFiscalPeriodFocus20210716162636197">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="C_20230101to20230630"
      id="Fdei_DocumentFiscalYearFocus20210716162643159">2023</dei:DocumentFiscalYearFocus>
    <dei:AmendmentFlag
      contextRef="C_20230101to20230630"
      id="Fdei_AmendmentFlag20210716162658228">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_20230101to20230630"
      id="Fdei_CurrentFiscalYearEndDate20210716171522618">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentPeriodEndDate
      contextRef="C_20230101to20230630"
      id="Fdei_DocumentPeriodEndDate20210721135646372">2023-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentType
      contextRef="C_20230101to20230630"
      id="Fxbrl_20230813182125172">6-K</dei:DocumentType>
    <dei:EntityFileNumber
      contextRef="C_20230101to20230630"
      id="Fxbrl_20230813182132611">001-36349</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="C_20230101to20230630"
      id="Fxbrl_20230813182138942">MediWound Ltd.</dei:EntityRegistrantName>
    <dei:EntityAddressAddressLine1
      contextRef="C_20230101to20230630"
      id="Fxbrl_20230813182145764">42 Hayarkon Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="C_20230101to20230630"
      id="Fxbrl_20230813182151711">Yavne</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode
      contextRef="C_20230101to20230630"
      id="Fxbrl_20230813182157924">8122745</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry
      contextRef="C_20230101to20230630"
      id="Fxbrl_20230813182208620">IL</dei:EntityAddressCountry>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      id="Fxbrl_20220804205853790"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20220101to20220630"
      id="Fxbrl_20220804205858797"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      id="Fxbrl_20230807111545632"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20220401to20220630"
      id="Fxbrl_20230807111557608"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230807164406322_xbrl_20220804205858797"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      id="Fxbrl_20230807164406322_xbrl_20220804200911308_xbrl_20220726011223576"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      id="Fxbrl_20230811011212291"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromExerciseOfOptions
      contextRef="C_20220101to20221231"
      id="Fxbrl_20230807114925679_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_419"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromExerciseOfOptions
      contextRef="C_20220401to20220630"
      id="Fxbrl_20230807114925679_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_415"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromExerciseOfOptions
      contextRef="C_20230401to20230630"
      id="Fxbrl_20230807114925679_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_411"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromExerciseOfOptions
      contextRef="C_20220101to20220630"
      id="Fxbrl_20230807114925679_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_47"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromExerciseOfOptions
      contextRef="C_20230101to20230630"
      id="Fxbrl_20230807114925679_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_43"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20210716112257610_43"
      unitRef="USD">19166000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20210716112257610_47"
      unitRef="USD">7729000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210716112257610_411"
      unitRef="USD">33895000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:RestrictedCashAndCashEquivalents
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20210716112257610_53"
      unitRef="USD">0</ifrs-full:RestrictedCashAndCashEquivalents>
    <ifrs-full:RestrictedCashAndCashEquivalents
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20210716112257610_57"
      unitRef="USD">168000</ifrs-full:RestrictedCashAndCashEquivalents>
    <ifrs-full:RestrictedCashAndCashEquivalents
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210716112257610_511"
      unitRef="USD">0</ifrs-full:RestrictedCashAndCashEquivalents>
    <ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20210726110844571"
      unitRef="USD">31956000</ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20210726110919054"
      unitRef="USD">2509000</ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210716112257610_611"
      unitRef="USD">0</ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents>
    <ifrs-full:CurrentTradeReceivables
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20210716112257610_73"
      unitRef="USD">3228000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20210716112257610_77"
      unitRef="USD">3759000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210716112257610_711"
      unitRef="USD">9332000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:Inventories
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20210716112257610_83"
      unitRef="USD">3113000</ifrs-full:Inventories>
    <ifrs-full:Inventories
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20210716112257610_87"
      unitRef="USD">1991000</ifrs-full:Inventories>
    <ifrs-full:Inventories
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210716112257610_811"
      unitRef="USD">1963000</ifrs-full:Inventories>
    <ifrs-full:OtherCurrentReceivables
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20210716112257610_93"
      unitRef="USD">590000</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:OtherCurrentReceivables
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20210716112257610_97"
      unitRef="USD">653000</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:OtherCurrentReceivables
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210716112257610_911"
      unitRef="USD">650000</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:CurrentAssets
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20210805153502250_xbrl_20210716112257610_93"
      unitRef="USD">58053000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20210805153502250_xbrl_20210716112257610_97"
      unitRef="USD">16809000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210805153502250_xbrl_20210716112257610_911"
      unitRef="USD">45840000</ifrs-full:CurrentAssets>
    <ifrs-full:OtherNoncurrentReceivables
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20220725183617324"
      unitRef="USD">277000</ifrs-full:OtherNoncurrentReceivables>
    <ifrs-full:OtherNoncurrentReceivables
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20220725183653486"
      unitRef="USD">230000</ifrs-full:OtherNoncurrentReceivables>
    <ifrs-full:OtherNoncurrentReceivables
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220725183637886"
      unitRef="USD">364000</ifrs-full:OtherNoncurrentReceivables>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20210716112257610_133"
      unitRef="USD">4705000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20210716112257610_137"
      unitRef="USD">2439000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210716112257610_1311"
      unitRef="USD">2366000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:RightofuseAssets
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20210716112257610_143"
      unitRef="USD">1133000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20210716112257610_147"
      unitRef="USD">1364000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210716112257610_1411"
      unitRef="USD">1215000</ifrs-full:RightofuseAssets>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20210716112257610_153"
      unitRef="USD">198000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20210716112257610_157"
      unitRef="USD">264000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210716112257610_1511"
      unitRef="USD">231000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:NoncurrentAssets
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20210726102408924"
      unitRef="USD">6313000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20210716112257610_173"
      unitRef="USD">4297000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210716112257610_177"
      unitRef="USD">4176000</ifrs-full:NoncurrentAssets>
    <ifrs-full:Assets
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20210805153535386_xbrl_20210716112257610_93"
      unitRef="USD">64366000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20210805153535386_xbrl_20210716112257610_97"
      unitRef="USD">21106000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210805153535386_xbrl_20210716112257610_911"
      unitRef="USD">50016000</ifrs-full:Assets>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20210716112257610_213"
      unitRef="USD">1961000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20210716112257610_217"
      unitRef="USD">2479000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210716112257610_2111"
      unitRef="USD">2242000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20210716112257610_223"
      unitRef="USD">3531000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20210716112257610_227"
      unitRef="USD">4877000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210716112257610_2211"
      unitRef="USD">5656000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:OtherCurrentPayables
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20210716112257610_233"
      unitRef="USD">2817000</ifrs-full:OtherCurrentPayables>
    <ifrs-full:OtherCurrentPayables
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20210716112257610_237"
      unitRef="USD">3060000</ifrs-full:OtherCurrentPayables>
    <ifrs-full:OtherCurrentPayables
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210716112257610_2311"
      unitRef="USD">4159000</ifrs-full:OtherCurrentPayables>
    <ifrs-full:CurrentLiabilities
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20210726102959251_xbrl_20210716112257610_233"
      unitRef="USD">8309000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20210726102959251_xbrl_20210716112257610_237"
      unitRef="USD">10416000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210726102959251_xbrl_20210716112257610_2311"
      unitRef="USD">12057000</ifrs-full:CurrentLiabilities>
    <ifrs-full:RentDeferredIncomeClassifiedAsNoncurrent
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20220725185154212"
      unitRef="USD">0</ifrs-full:RentDeferredIncomeClassifiedAsNoncurrent>
    <ifrs-full:RentDeferredIncomeClassifiedAsNoncurrent
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20220725191008115"
      unitRef="USD">61000</ifrs-full:RentDeferredIncomeClassifiedAsNoncurrent>
    <ifrs-full:RentDeferredIncomeClassifiedAsNoncurrent
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220725191032194"
      unitRef="USD">0</ifrs-full:RentDeferredIncomeClassifiedAsNoncurrent>
    <ifrs-full:NoncurrentWarrantLiability
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20230807104610196_xbrl_20220725185154212"
      unitRef="USD">9683000</ifrs-full:NoncurrentWarrantLiability>
    <ifrs-full:NoncurrentWarrantLiability
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20230807104610196_xbrl_20220725191008115"
      unitRef="USD">0</ifrs-full:NoncurrentWarrantLiability>
    <ifrs-full:NoncurrentWarrantLiability
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20230807104610196_xbrl_20220725191032194"
      unitRef="USD">15606000</ifrs-full:NoncurrentWarrantLiability>
    <ifrs-full:NoncurrentGovernmentGrants
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20210716112257610_283"
      unitRef="USD">7806000</ifrs-full:NoncurrentGovernmentGrants>
    <ifrs-full:NoncurrentGovernmentGrants
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20210716112257610_287"
      unitRef="USD">8131000</ifrs-full:NoncurrentGovernmentGrants>
    <ifrs-full:NoncurrentGovernmentGrants
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210716112257610_2811"
      unitRef="USD">7445000</ifrs-full:NoncurrentGovernmentGrants>
    <ifrs-full:OtherNoncurrentLiabilities
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20210716112257610_293"
      unitRef="USD">2529000</ifrs-full:OtherNoncurrentLiabilities>
    <ifrs-full:OtherNoncurrentLiabilities
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20210716112257610_297"
      unitRef="USD">3361000</ifrs-full:OtherNoncurrentLiabilities>
    <ifrs-full:OtherNoncurrentLiabilities
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210716112257610_2911"
      unitRef="USD">2788000</ifrs-full:OtherNoncurrentLiabilities>
    <mdwd:NoncurrentLeaseLiability
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20210716112257610_313"
      unitRef="USD">677000</mdwd:NoncurrentLeaseLiability>
    <mdwd:NoncurrentLeaseLiability
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20210716112257610_317"
      unitRef="USD">1053000</mdwd:NoncurrentLeaseLiability>
    <mdwd:NoncurrentLeaseLiability
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210716112257610_3111"
      unitRef="USD">846000</mdwd:NoncurrentLeaseLiability>
    <ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20210716112257610_323"
      unitRef="USD">433000</ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan>
    <ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20210716112257610_327"
      unitRef="USD">319000</ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan>
    <ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210716112257610_3211"
      unitRef="USD">360000</ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan>
    <ifrs-full:NoncurrentLiabilities
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20210726102530177_xbrl_20210716112257610_323"
      unitRef="USD">21128000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20210726102530177_xbrl_20210716112257610_327"
      unitRef="USD">12925000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210726102530177_xbrl_20210716112257610_3211"
      unitRef="USD">27045000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:Liabilities
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20220725183852478"
      unitRef="USD">29437000</ifrs-full:Liabilities>
    <ifrs-full:Liabilities
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20220725225336460"
      unitRef="USD">23341000</ifrs-full:Liabilities>
    <ifrs-full:Liabilities
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220725204127469"
      unitRef="USD">39102000</ifrs-full:Liabilities>
    <ifrs-full:ParValuePerShare
      contextRef="C_20220630"
      decimals="2"
      id="Fxbrl_20230811120745142"
      unitRef="NIS_Per_Share">0.01</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="C_20221231"
      decimals="2"
      id="Fxbrl_20230811120707313"
      unitRef="NIS_Per_Share">0.01</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="C_20230630"
      decimals="2"
      id="Fxbrl_20230811103934280"
      unitRef="NIS_Per_Share">0.01</ifrs-full:ParValuePerShare>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="C_20230630"
      decimals="INF"
      id="Fxbrl_20210805153830052"
      unitRef="Shares">20000000</ifrs-full:NumberOfSharesAuthorised>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="C_20221231"
      decimals="INF"
      id="Fxbrl_20230807104410495"
      unitRef="Shares">12857143</ifrs-full:NumberOfSharesAuthorised>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="C_20220630"
      decimals="INF"
      id="Fxbrl_20230807104419939"
      unitRef="Shares">7142858</ifrs-full:NumberOfSharesAuthorised>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="C_20230630"
      decimals="INF"
      id="Fxbrl_20210726103615822"
      unitRef="Shares">7252234</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:NumberOfSharesIssued
      contextRef="C_20230630"
      decimals="INF"
      id="Fxbrl_20210726103539748"
      unitRef="Shares">7252234</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="C_20221231"
      decimals="INF"
      id="Fxbrl_20210726103713177"
      unitRef="Shares">7240020</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:NumberOfSharesIssued
      contextRef="C_20221231"
      decimals="INF"
      id="Fxbrl_20210726103707094"
      unitRef="Shares">7240020</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="C_20220630"
      decimals="INF"
      id="Fxbrl_20210716120925440"
      unitRef="Shares">4734774</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:NumberOfSharesIssued
      contextRef="C_20220630"
      decimals="INF"
      id="Fxbrl_20210716120922887"
      unitRef="Shares">4734774</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:IssuedCapital
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20210726102554936_xbrl_20210716112257610_323"
      unitRef="USD">184000</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20210726102554936_xbrl_20210716112257610_327"
      unitRef="USD">93000</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210726102554936_xbrl_20210716112257610_3211"
      unitRef="USD">143000</ifrs-full:IssuedCapital>
    <ifrs-full:SharePremium
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20210716112257610_383"
      unitRef="USD">205642000</ifrs-full:SharePremium>
    <ifrs-full:SharePremium
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20210716112257610_387"
      unitRef="USD">154119000</ifrs-full:SharePremium>
    <ifrs-full:SharePremium
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210716112257610_3811"
      unitRef="USD">178882000</ifrs-full:SharePremium>
    <ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreads
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20230807104154280"
      unitRef="USD">-14000</ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreads>
    <ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreads
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20210716112257610_397"
      unitRef="USD">3000</ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreads>
    <ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreads
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210716112257610_3911"
      unitRef="USD">-5000</ifrs-full:ReserveOfChangeInValueOfForeignCurrencyBasisSpreads>
    <ifrs-full:RetainedEarnings
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20210716112257610_403"
      unitRef="USD">-170883000</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20210716112257610_407"
      unitRef="USD">-156450000</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210716112257610_4011"
      unitRef="USD">-168106000</ifrs-full:RetainedEarnings>
    <ifrs-full:Equity
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20220725190156165"
      unitRef="USD">34929000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20230807104207402"
      unitRef="USD">-2235000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220725204146028"
      unitRef="USD">10914000</ifrs-full:Equity>
    <ifrs-full:EquityAndLiabilities
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20210805153704172_xbrl_20210716112257610_93"
      unitRef="USD">64366000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20210805153704172_xbrl_20210716112257610_97"
      unitRef="USD">21106000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210805153704172_xbrl_20210716112257610_911"
      unitRef="USD">50016000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20210716123322526_33"
      unitRef="USD">2358000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20210716123322526_37"
      unitRef="USD">2771000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20210716123322526_311"
      unitRef="USD">1206000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20210716123322526_315"
      unitRef="USD">1669000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20210716123322526_319"
      unitRef="USD">5347000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromRenderingOfServices
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20210716124154186_xbrl_20210716123322526_33"
      unitRef="USD">6149000</ifrs-full:RevenueFromRenderingOfServices>
    <ifrs-full:RevenueFromRenderingOfServices
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20210716124154186_xbrl_20210716123322526_37"
      unitRef="USD">5866000</ifrs-full:RevenueFromRenderingOfServices>
    <ifrs-full:RevenueFromRenderingOfServices
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20210716124154186_xbrl_20210716123322526_311"
      unitRef="USD">3534000</ifrs-full:RevenueFromRenderingOfServices>
    <ifrs-full:RevenueFromRenderingOfServices
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20210716124154186_xbrl_20210716123322526_315"
      unitRef="USD">2777000</ifrs-full:RevenueFromRenderingOfServices>
    <ifrs-full:RevenueFromRenderingOfServices
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20210716124154186_xbrl_20210716123322526_319"
      unitRef="USD">12943000</ifrs-full:RevenueFromRenderingOfServices>
    <ifrs-full:LicenceFeeIncome
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20210716124304306_xbrl_20210716123322526_33"
      unitRef="USD">65000</ifrs-full:LicenceFeeIncome>
    <ifrs-full:LicenceFeeIncome
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20210716124304306_xbrl_20210716123322526_37"
      unitRef="USD">438000</ifrs-full:LicenceFeeIncome>
    <ifrs-full:LicenceFeeIncome
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20210716124304306_xbrl_20210716123322526_311"
      unitRef="USD">33000</ifrs-full:LicenceFeeIncome>
    <ifrs-full:LicenceFeeIncome
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20210716124304306_xbrl_20210716123322526_315"
      unitRef="USD">222000</ifrs-full:LicenceFeeIncome>
    <ifrs-full:LicenceFeeIncome
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20210716124304306_xbrl_20210716123322526_319"
      unitRef="USD">8206000</ifrs-full:LicenceFeeIncome>
    <ifrs-full:Revenue
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20210716124308513_xbrl_20210716123322526_33"
      unitRef="USD">8572000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20210716124308513_xbrl_20210716123322526_37"
      unitRef="USD">9075000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20210716124308513_xbrl_20210716123322526_311"
      unitRef="USD">4773000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20210716124308513_xbrl_20210716123322526_315"
      unitRef="USD">4668000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20210716124308513_xbrl_20210716123322526_319"
      unitRef="USD">26496000</ifrs-full:Revenue>
    <ifrs-full:CostOfMerchandiseSold
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20220725183352579"
      unitRef="USD">1436000</ifrs-full:CostOfMerchandiseSold>
    <ifrs-full:CostOfMerchandiseSold
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20220725183414122"
      unitRef="USD">1539000</ifrs-full:CostOfMerchandiseSold>
    <ifrs-full:CostOfMerchandiseSold
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20220725183435472"
      unitRef="USD">628000</ifrs-full:CostOfMerchandiseSold>
    <ifrs-full:CostOfMerchandiseSold
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20220725183445820"
      unitRef="USD">1148000</ifrs-full:CostOfMerchandiseSold>
    <ifrs-full:CostOfMerchandiseSold
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220725183512382"
      unitRef="USD">3184000</ifrs-full:CostOfMerchandiseSold>
    <ifrs-full:ServicesExpense
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20220725183528211"
      unitRef="USD">5170000</ifrs-full:ServicesExpense>
    <ifrs-full:ServicesExpense
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20220725183633645"
      unitRef="USD">4932000</ifrs-full:ServicesExpense>
    <ifrs-full:ServicesExpense
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20220725183628926"
      unitRef="USD">3005000</ifrs-full:ServicesExpense>
    <ifrs-full:ServicesExpense
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20220725183620249"
      unitRef="USD">2391000</ifrs-full:ServicesExpense>
    <ifrs-full:ServicesExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220725183548595"
      unitRef="USD">9829000</ifrs-full:ServicesExpense>
    <mdwd:CostOfLicenseAgreements
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20220725183706414"
      unitRef="USD">3000</mdwd:CostOfLicenseAgreements>
    <mdwd:CostOfLicenseAgreements
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20220725183709901"
      unitRef="USD">31000</mdwd:CostOfLicenseAgreements>
    <mdwd:CostOfLicenseAgreements
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20220725183716764"
      unitRef="USD">3000</mdwd:CostOfLicenseAgreements>
    <mdwd:CostOfLicenseAgreements
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20220725183719713"
      unitRef="USD">16000</mdwd:CostOfLicenseAgreements>
    <mdwd:CostOfLicenseAgreements
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220725183554874"
      unitRef="USD">318000</mdwd:CostOfLicenseAgreements>
    <ifrs-full:CostOfSales
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20210716124310657_xbrl_20210716123322526_33"
      unitRef="USD">6609000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20210716124310657_xbrl_20210716123322526_37"
      unitRef="USD">6502000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20210716124310657_xbrl_20210716123322526_311"
      unitRef="USD">3636000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20210716124310657_xbrl_20210716123322526_315"
      unitRef="USD">3555000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20210716124310657_xbrl_20210716123322526_319"
      unitRef="USD">13331000</ifrs-full:CostOfSales>
    <ifrs-full:GrossProfit
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20210716124313801_xbrl_20210716123322526_33"
      unitRef="USD">1963000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20210716124313801_xbrl_20210716123322526_37"
      unitRef="USD">2573000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20210716124313801_xbrl_20210716123322526_311"
      unitRef="USD">1137000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20210716124313801_xbrl_20210716123322526_315"
      unitRef="USD">1113000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20210716124313801_xbrl_20210716123322526_319"
      unitRef="USD">13165000</ifrs-full:GrossProfit>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20210726102137309_xbrl_20210716124313801_xbrl_20210716123322526_33"
      unitRef="USD">4126000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20210726102137309_xbrl_20210716124313801_xbrl_20210716123322526_37"
      unitRef="USD">4599000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20210726102137309_xbrl_20210716124313801_xbrl_20210716123322526_311"
      unitRef="USD">2024000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20210726102137309_xbrl_20210716124313801_xbrl_20210716123322526_315"
      unitRef="USD">2191000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20210726102137309_xbrl_20210716124313801_xbrl_20210716123322526_319"
      unitRef="USD">10181000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20210716124325241_xbrl_20210716123322526_33"
      unitRef="USD">2438000</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20210716124325241_xbrl_20210716123322526_37"
      unitRef="USD">1854000</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20210716124325241_xbrl_20210716123322526_311"
      unitRef="USD">1332000</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20210716124325241_xbrl_20210716123322526_315"
      unitRef="USD">935000</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20210716124325241_xbrl_20210716123322526_319"
      unitRef="USD">3725000</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20210716124327322_xbrl_20210716123322526_33"
      unitRef="USD">3770000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20210716124327322_xbrl_20210716123322526_37"
      unitRef="USD">2769000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20210716124327322_xbrl_20210716123322526_311"
      unitRef="USD">1788000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20210716124327322_xbrl_20210716123322526_315"
      unitRef="USD">1352000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20210716124327322_xbrl_20210716123322526_319"
      unitRef="USD">6920000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:OtherExpenseByFunction
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20220804191525677_xbrl_20210716124327322_xbrl_20210716123322526_33"
      unitRef="USD">0</ifrs-full:OtherExpenseByFunction>
    <ifrs-full:OtherExpenseByFunction
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20220804191525677_xbrl_20210716124327322_xbrl_20210716123322526_37"
      unitRef="USD">309000</ifrs-full:OtherExpenseByFunction>
    <ifrs-full:OtherExpenseByFunction
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20220804191525677_xbrl_20210716124327322_xbrl_20210716123322526_311"
      unitRef="USD">0</ifrs-full:OtherExpenseByFunction>
    <ifrs-full:OtherExpenseByFunction
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20220804191525677_xbrl_20210716124327322_xbrl_20210716123322526_315"
      unitRef="USD">309000</ifrs-full:OtherExpenseByFunction>
    <ifrs-full:OtherExpenseByFunction
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220804191525677_xbrl_20210716124327322_xbrl_20210716123322526_319"
      unitRef="USD">684000</ifrs-full:OtherExpenseByFunction>
    <ifrs-full:OperatingExpense
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20210716124333082_xbrl_20210716123322526_33"
      unitRef="USD">10334000</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20210716124333082_xbrl_20210716123322526_37"
      unitRef="USD">9531000</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20210716124333082_xbrl_20210716123322526_311"
      unitRef="USD">5144000</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20210716124333082_xbrl_20210716123322526_315"
      unitRef="USD">4787000</ifrs-full:OperatingExpense>
    <ifrs-full:OperatingExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20210716124333082_xbrl_20210716123322526_319"
      unitRef="USD">21510000</ifrs-full:OperatingExpense>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20210805160008519_xbrl_20210716124333082_xbrl_20210716123322526_33"
      unitRef="USD">-8371000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20210805160008519_xbrl_20210716124333082_xbrl_20210716123322526_37"
      unitRef="USD">-6958000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20210805160008519_xbrl_20210716124333082_xbrl_20210716123322526_311"
      unitRef="USD">-4007000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20210805160008519_xbrl_20210716124333082_xbrl_20210716123322526_315"
      unitRef="USD">-3674000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20210805160008519_xbrl_20210716124333082_xbrl_20210716123322526_319"
      unitRef="USD">-8345000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:FinanceIncome
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20210716124337921_xbrl_20210716123322526_33"
      unitRef="USD">7480000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20210716124337921_xbrl_20210716123322526_37"
      unitRef="USD">11000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20210716124337921_xbrl_20210716123322526_311"
      unitRef="USD">5828000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20210716124337921_xbrl_20210716123322526_315"
      unitRef="USD">11000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20210716124337921_xbrl_20210716123322526_319"
      unitRef="USD">461000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceCosts
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20210716124340706_xbrl_20210716123322526_33"
      unitRef="USD">1869000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20210716124340706_xbrl_20210716123322526_37"
      unitRef="USD">988000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20210716124340706_xbrl_20210716123322526_311"
      unitRef="USD">893000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20210716124340706_xbrl_20210716123322526_315"
      unitRef="USD">687000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20210716124340706_xbrl_20210716123322526_319"
      unitRef="USD">11637000</ifrs-full:FinanceCosts>
    <mdwd:FinanceIncomeExpenseNet
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20220725190414450"
      unitRef="USD">5611000</mdwd:FinanceIncomeExpenseNet>
    <mdwd:FinanceIncomeExpenseNet
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20220725190434660"
      unitRef="USD">-977000</mdwd:FinanceIncomeExpenseNet>
    <mdwd:FinanceIncomeExpenseNet
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20220725190505672"
      unitRef="USD">4935000</mdwd:FinanceIncomeExpenseNet>
    <mdwd:FinanceIncomeExpenseNet
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20220725190517131"
      unitRef="USD">-676000</mdwd:FinanceIncomeExpenseNet>
    <mdwd:FinanceIncomeExpenseNet
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220725190532031"
      unitRef="USD">-11176000</mdwd:FinanceIncomeExpenseNet>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20210726103206944_xbrl_20210716124337921_xbrl_20210716123322526_33"
      unitRef="USD">-2760000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20210726103206944_xbrl_20210716124337921_xbrl_20210716123322526_37"
      unitRef="USD">-7935000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20210726103206944_xbrl_20210716124337921_xbrl_20210716123322526_311"
      unitRef="USD">928000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20210726103206944_xbrl_20210716124337921_xbrl_20210716123322526_315"
      unitRef="USD">-4350000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20210726103206944_xbrl_20210716124337921_xbrl_20210716123322526_319"
      unitRef="USD">-19521000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20220725222501270_xbrl_20210726103209193_xbrl_20210716124337921_xbrl_20210716123322526_315"
      unitRef="USD">17000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20220725222501270_xbrl_20210726103337085"
      unitRef="USD">8000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20220725222501270_xbrl_20210726103209193_xbrl_20210716124337921_xbrl_20210716123322526_319"
      unitRef="USD">12000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20220725222501270_xbrl_20210726103354908"
      unitRef="USD">4000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220725222501270_xbrl_20210726103409366"
      unitRef="USD">78000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ProfitLoss
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20210726103237527_xbrl_20210716124337921_xbrl_20210716123322526_33"
      unitRef="USD">-2777000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20210726103237527_xbrl_20210716124337921_xbrl_20210716123322526_37"
      unitRef="USD">-7943000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20210726103237527_xbrl_20210716124337921_xbrl_20210716123322526_311"
      unitRef="USD">916000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20210726103237527_xbrl_20210716124337921_xbrl_20210716123322526_315"
      unitRef="USD">-4354000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20210726103237527_xbrl_20210716124337921_xbrl_20210716123322526_319"
      unitRef="USD">-19599000</ifrs-full:ProfitLoss>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20230807100443673"
      unitRef="USD">9000</ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20210716124351857_xbrl_20210716123322526_37"
      unitRef="USD">-22000</ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20210726104832566"
      unitRef="USD">0</ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20220804191745488"
      unitRef="USD">-17000</ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20210716124351857_xbrl_20210716123322526_319"
      unitRef="USD">-14000</ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20210726103241224_xbrl_20210716124337921_xbrl_20210716123322526_33"
      unitRef="USD">-2786000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20210726103241224_xbrl_20210716124337921_xbrl_20210716123322526_37"
      unitRef="USD">-7921000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20210726103241224_xbrl_20210716124337921_xbrl_20210716123322526_311"
      unitRef="USD">916000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20210726103241224_xbrl_20210716124337921_xbrl_20210716123322526_315"
      unitRef="USD">-4337000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20210726103241224_xbrl_20210716124337921_xbrl_20210716123322526_319"
      unitRef="USD">-19585000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="C_20230101to20230630"
      decimals="2"
      id="Fxbrl_20230807164026424"
      unitRef="USD_Per_Share">-0.32</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="C_20230101to20230630"
      decimals="2"
      id="Fxbrl_20210726103243244_xbrl_20210716124337921_xbrl_20210716123322526_33"
      unitRef="USD_Per_Share">-0.32</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="C_20220101to20220630"
      decimals="2"
      id="Fxbrl_s_20230811005753136"
      unitRef="USD_Per_Share">-1.79</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="C_20220101to20220630"
      decimals="2"
      id="Fxbrl_20230811005753137"
      unitRef="USD_Per_Share">-1.79</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="C_20230401to20230630"
      decimals="2"
      id="Fxbrl_20230807164112851"
      unitRef="USD_Per_Share">0.1</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="C_20230401to20230630"
      decimals="2"
      id="Fxbrl_20210726103243244_xbrl_20210716124337921_xbrl_20210716123322526_311"
      unitRef="USD_Per_Share">0.1</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="C_20220401to20220630"
      decimals="2"
      id="Fxbrl_s_20230811005838682"
      unitRef="USD_Per_Share">-0.92</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="C_20220401to20220630"
      decimals="2"
      id="Fxbrl_20230811005838682"
      unitRef="USD_Per_Share">-0.92</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="C_20220101to20221231"
      decimals="2"
      id="Fxbrl_20230807164157083"
      unitRef="USD_Per_Share">-3.93</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="C_20220101to20221231"
      decimals="2"
      id="Fxbrl_20210726103243244_xbrl_20210716124337921_xbrl_20210716123322526_319"
      unitRef="USD_Per_Share">-3.93</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="C_20230101to20230630"
      decimals="INF"
      id="Fxbrl_20230807164243675"
      unitRef="Shares">8803</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="C_20230101to20230630"
      decimals="INF"
      id="Fxbrl_20220725175133735"
      unitRef="Shares">8803</ifrs-full:WeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="C_20220101to20220630"
      decimals="INF"
      id="Fxbrl_s_20230811104343177"
      unitRef="Shares">4440</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="C_20220101to20220630"
      decimals="INF"
      id="Fxbrl_20230811104343178"
      unitRef="Shares">4440</ifrs-full:WeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="C_20230401to20230630"
      decimals="INF"
      id="Fxbrl_20230807164300115"
      unitRef="Shares">9209</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="C_20230401to20230630"
      decimals="INF"
      id="Fxbrl_20220725175207243"
      unitRef="Shares">9209</ifrs-full:WeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="C_20220401to20220630"
      decimals="INF"
      id="Fxbrl_s_20230811005902765"
      unitRef="Shares">4734</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="C_20220401to20220630"
      decimals="INF"
      id="Fxbrl_20230811005902765"
      unitRef="Shares">4734</ifrs-full:WeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="Fxbrl_20230807164316251"
      unitRef="Shares">4987</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="C_20220101to20221231"
      decimals="INF"
      id="Fxbrl_20220725175224909"
      unitRef="Shares">4987</ifrs-full:WeightedAverageShares>
    <ifrs-full:Equity
      contextRef="C_20230331_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220804194401541_xbrl_20210805162349215_xbrl_20210726103916501_xbrl_20210726103844427_xbrl_20210716145820874_xbrl_20210716144837125_23"
      unitRef="USD">183000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20230331_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804194401541_xbrl_20210805162349215_xbrl_20210726103916501_xbrl_20210726103844427_xbrl_20210716145820874_xbrl_20210716144837125_27"
      unitRef="USD">204930000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20230331_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220804194401541_xbrl_20210805162349215_xbrl_20210726103916501_xbrl_20210726103844427_xbrl_20210716145820874_xbrl_20210716144837125_211"
      unitRef="USD">-14000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20230331_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804194401541_xbrl_20210805162349215_xbrl_20210726103916501_xbrl_20210726103844427_xbrl_20210716145820874_xbrl_20210716144837125_215"
      unitRef="USD">-171799000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20230331"
      decimals="-3"
      id="Fxbrl_20220804194401541_xbrl_20210805162349215_xbrl_20210726103916501_xbrl_20210726103844427_xbrl_20210716145820874_xbrl_20210716144837125_219"
      unitRef="USD">33300000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220804194419581_xbrl_20220726010534919"
      unitRef="USD">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804194419581_xbrl_20220726010540999"
      unitRef="USD">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220804194419581_xbrl_20220726010546988"
      unitRef="USD">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804194419581_xbrl_20210805162426882_xbrl_20210726103505618_xbrl_20210716150154169_xbrl_20210716145835728_xbrl_20210716144837125_415"
      unitRef="USD">916000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20220804194419581_xbrl_20210805162426882_xbrl_20210726103505618_xbrl_20210716150154169_xbrl_20210716145835728_xbrl_20210716144837125_419"
      unitRef="USD">916000</ifrs-full:ProfitLoss>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax
      contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220804194437283_xbrl_20220726010951571"
      unitRef="USD">0</ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax
      contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804194437283_xbrl_20220726011000691"
      unitRef="USD">0</ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax
      contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220804194437283_xbrl_20210805162907744_xbrl_20210726103505630_xbrl_20210716150923612_xbrl_20210716145820903_xbrl_20210716144837125_511"
      unitRef="USD">-0</ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax
      contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804194437283_xbrl_20220726011003910"
      unitRef="USD">0</ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20220804194437283_xbrl_20210805162907744_xbrl_20210726103505630_xbrl_20210716150923612_xbrl_20210716145820903_xbrl_20210716144837125_519"
      unitRef="USD">-0</ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220804194513119_xbrl_20220726010613077"
      unitRef="USD">0</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804194513119_xbrl_20220726010619109"
      unitRef="USD">0</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220804194513119_xbrl_20210805162633992_xbrl_20210726103820235_xbrl_20210716144837125_611"
      unitRef="USD">0</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804194513119_xbrl_20210805162633992_xbrl_20210726103820235_xbrl_20210716144837125_615"
      unitRef="USD">916000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20220804194513119_xbrl_20210805162633992_xbrl_20210726103820235_xbrl_20210716144837125_619"
      unitRef="USD">916000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220804204701105_xbrl_20220804195959675_xbrl_20220726010731719"
      unitRef="USD">0</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804204701105_xbrl_20220804195959675_xbrl_20210805162426893_xbrl_20210726103505658_xbrl_20210716151223357_xbrl_20210716145820919_xbrl_20210716144837125_87"
      unitRef="USD">0</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220804204701105_xbrl_20220804195959675_xbrl_20220726010737773"
      unitRef="USD">0</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804204701105_xbrl_20220804195959675_xbrl_20220726010742299"
      unitRef="USD">0</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20220804204701105_xbrl_20220804195959675_xbrl_20210805162426893_xbrl_20210726103505658_xbrl_20210716151223357_xbrl_20210716145820919_xbrl_20210716144837125_819"
      unitRef="USD">0</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220804203216763"
      unitRef="USD">1000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804195919524"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220804194601328_xbrl_20220726011042902"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804194601328_xbrl_20220726011052629"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20220804203226556"
      unitRef="USD">1000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220804195959675_xbrl_20220726010731719"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804195959675_xbrl_20210805162426893_xbrl_20210726103505658_xbrl_20210716151223357_xbrl_20210716145820919_xbrl_20210716144837125_87"
      unitRef="USD">712000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220804195959675_xbrl_20220726010737773"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20230401to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804195959675_xbrl_20220726010742299"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20220804195959675_xbrl_20210805162426893_xbrl_20210726103505658_xbrl_20210716151223357_xbrl_20210716145820919_xbrl_20210716144837125_819"
      unitRef="USD">712000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:Equity
      contextRef="C_20230630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220804200040800_xbrl_20220725181900025_xbrl_20210805162426907_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_23"
      unitRef="USD">184000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20230630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804200040800_xbrl_20220725181900025_xbrl_20210805162426907_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_27"
      unitRef="USD">205642000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20230630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20230807103014560"
      unitRef="USD">-14000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20230630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804200040800_xbrl_20220725181900025_xbrl_20210805162426907_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_215"
      unitRef="USD">-170883000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20220804200040800_xbrl_20220725181900025_xbrl_20210805162426907_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_219"
      unitRef="USD">34929000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20220331_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20230807110720967"
      unitRef="USD">93000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20220331_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804200204394_xbrl_20220725173724728_xbrl_20210805162715251_xbrl_20210726103844427_xbrl_20210716145820874_xbrl_20210716144837125_27"
      unitRef="USD">153962000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20220331_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220804200204394_xbrl_20220725173724728_xbrl_20210805162715251_xbrl_20210726103844427_xbrl_20210716145820874_xbrl_20210716144837125_211"
      unitRef="USD">-14000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20220331_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804200204394_xbrl_20220725173724728_xbrl_20210805162715251_xbrl_20210726103844427_xbrl_20210716145820874_xbrl_20210716144837125_215"
      unitRef="USD">-152096000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20220331"
      decimals="-3"
      id="Fxbrl_20220804200204394_xbrl_20220725173724728_xbrl_20210805162715251_xbrl_20210726103844427_xbrl_20210716145820874_xbrl_20210716144837125_219"
      unitRef="USD">1945000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220804200219505_xbrl_20220726010751147"
      unitRef="USD">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804200219505_xbrl_20220726010757650"
      unitRef="USD">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220804200219505_xbrl_20220726010801530"
      unitRef="USD">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804200219505_xbrl_20220725173739413_xbrl_20210805162742179_xbrl_20210726103844444_xbrl_20210716145835728_xbrl_20210716144837125_415"
      unitRef="USD">-4354000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20220804200219505_xbrl_20220725173739413_xbrl_20210805162742179_xbrl_20210726103844444_xbrl_20210716145835728_xbrl_20210716144837125_419"
      unitRef="USD">-4354000</ifrs-full:ProfitLoss>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax
      contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220804200242228_xbrl_20220726010807761"
      unitRef="USD">0</ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax
      contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804200242228_xbrl_20220726010813554"
      unitRef="USD">0</ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax
      contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220804200242228_xbrl_20220725173759919_xbrl_20210805162715279_xbrl_20210726103844451_xbrl_20210716145820903_xbrl_20210716144837125_511"
      unitRef="USD">-17000</ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax
      contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804200242228_xbrl_20220726010823921"
      unitRef="USD">0</ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20220804200242228_xbrl_20220725173759919_xbrl_20210805162715279_xbrl_20210726103844451_xbrl_20210716145820903_xbrl_20210716144837125_519"
      unitRef="USD">-17000</ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220804200303307_xbrl_20220726011206594"
      unitRef="USD">0</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804200303307_xbrl_20220726011214615"
      unitRef="USD">0</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220804200303307_xbrl_20220725182607499_xbrl_20210805162907757_xbrl_20210726103505639_xbrl_20210716151159324_xbrl_20210716145845544_xbrl_20210716144837125_611"
      unitRef="USD">17000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804200303307_xbrl_20220725182607499_xbrl_20210805162907757_xbrl_20210726103505639_xbrl_20210716151159324_xbrl_20210716145845544_xbrl_20210716144837125_615"
      unitRef="USD">-4354000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20220804200303307_xbrl_20220725182607499_xbrl_20210805162907757_xbrl_20210726103505639_xbrl_20210716151159324_xbrl_20210716145845544_xbrl_20210716144837125_619"
      unitRef="USD">-4337000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20230807105953383_xbrl_20220804204701105_xbrl_20220804195959675_xbrl_20220726010731719"
      unitRef="USD">0</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20230807111456280"
      unitRef="USD">95000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20230807105953383_xbrl_20220804204701105_xbrl_20220804195959675_xbrl_20220726010737773"
      unitRef="USD">0</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230807105953383_xbrl_20220804204701105_xbrl_20220804195959675_xbrl_20220726010742299"
      unitRef="USD">0</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20230807111504799"
      unitRef="USD">95000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804200732492_xbrl_20220726010845363"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220804200732492_xbrl_20220726010853214"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804200732492_xbrl_20220726010857927"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220804200757567_xbrl_20220726010905573"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804200757567_xbrl_20220725173937130_xbrl_20210805162715292_xbrl_20210726103844475_xbrl_20210716145820919_xbrl_20210716144837125_87"
      unitRef="USD">252000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220804200757567_xbrl_20220726010911443"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20220401to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804200757567_xbrl_20220726010921099"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20220804200757567_xbrl_20220725173937130_xbrl_20210805162715292_xbrl_20210726103844475_xbrl_20210716145820919_xbrl_20210716144837125_819"
      unitRef="USD">252000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:Equity
      contextRef="C_20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220804200811104_xbrl_20220725173957369_xbrl_20210805162715305_xbrl_20210726103905588_xbrl_20210726103844427_xbrl_20210716145820874_xbrl_20210716144837125_23"
      unitRef="USD">93000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20220630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804200811104_xbrl_20220725173957369_xbrl_20210805162715305_xbrl_20210726103905588_xbrl_20210726103844427_xbrl_20210716145820874_xbrl_20210716144837125_27"
      unitRef="USD">154119000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20220630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220804200811104_xbrl_20220725173957369_xbrl_20210805162715305_xbrl_20210726103905588_xbrl_20210726103844427_xbrl_20210716145820874_xbrl_20210716144837125_211"
      unitRef="USD">3000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20220630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804200811104_xbrl_20220725173957369_xbrl_20210805162715305_xbrl_20210726103905588_xbrl_20210726103844427_xbrl_20210716145820874_xbrl_20210716144837125_215"
      unitRef="USD">-156450000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20230807103054329"
      unitRef="USD">-2235000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220804200911213_xbrl_20220725181317026_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_23"
      unitRef="USD">143000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804200911213_xbrl_20220725181317026_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_27"
      unitRef="USD">178882000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220804200911213_xbrl_20220725181317026_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_211"
      unitRef="USD">-5000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804200911213_xbrl_20220725181317026_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_215"
      unitRef="USD">-168106000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220804200911213_xbrl_20220725181317026_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_219"
      unitRef="USD">10914000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220804200911130_xbrl_20220726010936179"
      unitRef="USD">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804200911130_xbrl_20220726010943050"
      unitRef="USD">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220804200911130_xbrl_20220726010946073"
      unitRef="USD">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804200911130_xbrl_20210805162907731_xbrl_20210726103505618_xbrl_20210716150154169_xbrl_20210716145835728_xbrl_20210716144837125_415"
      unitRef="USD">-2777000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20220804200911130_xbrl_20210805162907731_xbrl_20210726103505618_xbrl_20210716150154169_xbrl_20210716145835728_xbrl_20210716144837125_419"
      unitRef="USD">-2777000</ifrs-full:ProfitLoss>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax
      contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220804200911142_xbrl_20220726010951571"
      unitRef="USD">0</ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax
      contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804200911142_xbrl_20220726011000691"
      unitRef="USD">0</ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax
      contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20230807112358119"
      unitRef="USD">9000</ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax
      contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804200911142_xbrl_20220726011003910"
      unitRef="USD">0</ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20230807140236151"
      unitRef="USD">9000</ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220804200911154_xbrl_20220726011011047"
      unitRef="USD">0</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804200911154_xbrl_20220726011017500"
      unitRef="USD">0</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20230807112347815"
      unitRef="USD">-9000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804200911154_xbrl_20210805162907757_xbrl_20210726103505639_xbrl_20210716151159324_xbrl_20210716145845544_xbrl_20210716144837125_615"
      unitRef="USD">-2777000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20220804200911154_xbrl_20210805162907757_xbrl_20210726103505639_xbrl_20210716151159324_xbrl_20210716145845544_xbrl_20210716144837125_619"
      unitRef="USD">-2786000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IssueOfEquity
      contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220804201533828_xbrl_20220725182104960"
      unitRef="USD">40000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804201533828_xbrl_20220725182054265_xbrl_20220725181931129_xbrl_20210805162633992_xbrl_20210726103820235_xbrl_20210716144837125_615"
      unitRef="USD">25429000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220804201533828_xbrl_20220726011028297"
      unitRef="USD">0</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804201533828_xbrl_20220726011031293"
      unitRef="USD">0</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20220804201533828_xbrl_20220725182054265_xbrl_20220725181931129_xbrl_20210805162633992_xbrl_20210726103820235_xbrl_20210716144837125_619"
      unitRef="USD">25469000</ifrs-full:IssueOfEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220804205734843"
      unitRef="USD">1000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804205739952"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220804200911171_xbrl_20220726011042902"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804200911171_xbrl_20220726011052629"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20220804205747127"
      unitRef="USD">1000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220804200911179_xbrl_20220726011059298"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804200911179_xbrl_20210805162907776_xbrl_20210726103505658_xbrl_20210716151223357_xbrl_20210716145820919_xbrl_20210716144837125_87"
      unitRef="USD">1331000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220804200911179_xbrl_20220726011110899"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20230101to20230630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804200911179_xbrl_20220726011114078"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20220804200911179_xbrl_20210805162907776_xbrl_20210726103505658_xbrl_20210716151223357_xbrl_20210716145820919_xbrl_20210716144837125_819"
      unitRef="USD">1331000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:Equity
      contextRef="C_20230630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220804200911197_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_23"
      unitRef="USD">184000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20230630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804200911197_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_27"
      unitRef="USD">205642000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20230630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20230807112331639"
      unitRef="USD">-14000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20230630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804200911197_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_215"
      unitRef="USD">-170883000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20220804200911197_xbrl_20220725193210582"
      unitRef="USD">34929000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220804200911447_xbrl_20220725182314592_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_23"
      unitRef="USD">75000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804200911447_xbrl_20220725182314592_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_27"
      unitRef="USD">143869000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220804200911447_xbrl_20220725182314592_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_211"
      unitRef="USD">-19000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804200911447_xbrl_20220725182314592_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_215"
      unitRef="USD">-148507000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20230807140310911"
      unitRef="USD">-4582000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220804200911250_xbrl_20220726011122465"
      unitRef="USD">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804200911250_xbrl_20220726011132381"
      unitRef="USD">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220804200911250_xbrl_20220726011135513"
      unitRef="USD">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804200911250_xbrl_20220725182637766_xbrl_20210805162907731_xbrl_20210726103505618_xbrl_20210716150154169_xbrl_20210716145835728_xbrl_20210716144837125_415"
      unitRef="USD">-7943000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20220804200911250_xbrl_20220725182637766_xbrl_20210805162907731_xbrl_20210726103505618_xbrl_20210716150154169_xbrl_20210716145835728_xbrl_20210716144837125_419"
      unitRef="USD">-7943000</ifrs-full:ProfitLoss>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax
      contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220804200911268_xbrl_20220726011149344"
      unitRef="USD">0</ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax
      contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804200911268_xbrl_20220726011155262"
      unitRef="USD">0</ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax
      contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220804200911268_xbrl_20220725182708825_xbrl_20210805162907744_xbrl_20210726103505630_xbrl_20210716150923612_xbrl_20210716145820903_xbrl_20210716144837125_511"
      unitRef="USD">-22000</ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax
      contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804200911268_xbrl_20220726011159642"
      unitRef="USD">0</ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20220804200911268_xbrl_20220725182708825_xbrl_20210805162907744_xbrl_20210726103505630_xbrl_20210716150923612_xbrl_20210716145820903_xbrl_20210716144837125_519"
      unitRef="USD">-22000</ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220804200911287_xbrl_20220726011206594"
      unitRef="USD">0</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804200911287_xbrl_20220726011214615"
      unitRef="USD">0</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220804200911287_xbrl_20220725182607499_xbrl_20210805162907757_xbrl_20210726103505639_xbrl_20210716151159324_xbrl_20210716145845544_xbrl_20210716144837125_611"
      unitRef="USD">22000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804200911287_xbrl_20220725182607499_xbrl_20210805162907757_xbrl_20210726103505639_xbrl_20210716151159324_xbrl_20210716145845544_xbrl_20210716144837125_615"
      unitRef="USD">-7943000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20220804200911287_xbrl_20220725182607499_xbrl_20210805162907757_xbrl_20210726103505639_xbrl_20210716151159324_xbrl_20210716145845544_xbrl_20210716144837125_619"
      unitRef="USD">-7921000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IssueOfEquity
      contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20230807105825648_xbrl_20220804201533828_xbrl_20220725182104960"
      unitRef="USD">18000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20230807105825648_xbrl_20220804201533828_xbrl_20220725182054265_xbrl_20220725181931129_xbrl_20210805162633992_xbrl_20210726103820235_xbrl_20210716144837125_615"
      unitRef="USD">9653000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20230807105825648_xbrl_20220804201533828_xbrl_20220726011028297"
      unitRef="USD">0</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230807105825648_xbrl_20220804201533828_xbrl_20220726011031293"
      unitRef="USD">0</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20230807105825648_xbrl_20220804201533828_xbrl_20220725182054265_xbrl_20220725181931129_xbrl_20210805162633992_xbrl_20210726103820235_xbrl_20210716144837125_619"
      unitRef="USD">9671000</ifrs-full:IssueOfEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804200911308_xbrl_20220726011223576"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220804200911308_xbrl_20220726011230580"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804200911308_xbrl_20220726011233993"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220804200911319_xbrl_20220726011240408"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804200911319_xbrl_20220725182444873_xbrl_20210805162907776_xbrl_20210726103505658_xbrl_20210716151223357_xbrl_20210716145820919_xbrl_20210716144837125_87"
      unitRef="USD">597000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220804200911319_xbrl_20220726011246769"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804200911319_xbrl_20220726011250232"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20220804200911319_xbrl_20220725182444873_xbrl_20210805162907776_xbrl_20210726103505658_xbrl_20210716151223357_xbrl_20210716145820919_xbrl_20210716144837125_819"
      unitRef="USD">597000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:Equity
      contextRef="C_20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220804200911338_xbrl_20220725182308741_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_23"
      unitRef="USD">93000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20220630_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804200911338_xbrl_20220725182308741_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_27"
      unitRef="USD">154119000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20220630_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220804200911338_xbrl_20220725182308741_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_211"
      unitRef="USD">3000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20220630_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804200911338_xbrl_20220725182308741_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_215"
      unitRef="USD">-156450000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20230807141756506"
      unitRef="USD">-2235000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220804201102031_xbrl_20220725182311049_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_23"
      unitRef="USD">75000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804201102031_xbrl_20220725182311049_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_27"
      unitRef="USD">143869000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220804201102031_xbrl_20220725182311049_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_211"
      unitRef="USD">-19000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804201102031_xbrl_20220725182311049_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_215"
      unitRef="USD">-148507000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20230807112948167"
      unitRef="USD">-4582000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220804200911374_xbrl_20220726011257799"
      unitRef="USD">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804200911374_xbrl_20220726011307287"
      unitRef="USD">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220804200911374_xbrl_20220726011310153"
      unitRef="USD">0</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804200911374_xbrl_20220725182640742_xbrl_20210805162907731_xbrl_20210726103505618_xbrl_20210716150154169_xbrl_20210716145835728_xbrl_20210716144837125_415"
      unitRef="USD">-19599000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220804200911374_xbrl_20220725182640742_xbrl_20210805162907731_xbrl_20210726103505618_xbrl_20210716150154169_xbrl_20210716145835728_xbrl_20210716144837125_419"
      unitRef="USD">-19599000</ifrs-full:ProfitLoss>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220804200911392_xbrl_20220726011317028"
      unitRef="USD">0</ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804200911392_xbrl_20220726011322488"
      unitRef="USD">0</ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220804200911392_xbrl_20220725182713730_xbrl_20210805162907744_xbrl_20210726103505630_xbrl_20210716150923612_xbrl_20210716145820903_xbrl_20210716144837125_511"
      unitRef="USD">-14000</ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804200911392_xbrl_20220726011325504"
      unitRef="USD">0</ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax>
    <ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220804200911392_xbrl_20220725182713730_xbrl_20210805162907744_xbrl_20210726103505630_xbrl_20210716150923612_xbrl_20210716145820903_xbrl_20210716144837125_519"
      unitRef="USD">-14000</ifrs-full:ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220804200911408_xbrl_20220726011333568"
      unitRef="USD">0</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220804200911408_xbrl_20220725182613379_xbrl_20210805162907757_xbrl_20210726103505639_xbrl_20210716151159324_xbrl_20210716145845544_xbrl_20210716144837125_611"
      unitRef="USD">14000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804200911408_xbrl_20220725182613379_xbrl_20210805162907757_xbrl_20210726103505639_xbrl_20210716151159324_xbrl_20210716145845544_xbrl_20210716144837125_615"
      unitRef="USD">-19599000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220804200911408_xbrl_20220725182613379_xbrl_20210805162907757_xbrl_20210726103505639_xbrl_20210716151159324_xbrl_20210716145845544_xbrl_20210716144837125_619"
      unitRef="USD">-19585000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20230807164406322_xbrl_20220804200911308_xbrl_20220726011230580"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230807164406322_xbrl_20220804200911308_xbrl_20220726011233993"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IssueOfEquity
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20230807105833497_xbrl_20220804201533828_xbrl_20220725182104960"
      unitRef="USD">40000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20230807105833497_xbrl_20220804201533828_xbrl_20220725182054265_xbrl_20220725181931129_xbrl_20210805162633992_xbrl_20210726103820235_xbrl_20210716144837125_615"
      unitRef="USD">17389000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20230807105833497_xbrl_20220804201533828_xbrl_20220726011028297"
      unitRef="USD">0</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230807105833497_xbrl_20220804201533828_xbrl_20220726011031293"
      unitRef="USD">0</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230807105833497_xbrl_20220804201533828_xbrl_20220725182054265_xbrl_20220725181931129_xbrl_20210805162633992_xbrl_20210726103820235_xbrl_20210716144837125_619"
      unitRef="USD">17429000</ifrs-full:IssueOfEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20230807110509789_xbrl_20230807105833497_xbrl_20220804201533828_xbrl_20220725182104960"
      unitRef="USD">28000</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20230807110509789_xbrl_20230807105833497_xbrl_20220804201533828_xbrl_20220725182054265_xbrl_20220725181931129_xbrl_20210805162633992_xbrl_20210726103820235_xbrl_20210716144837125_615"
      unitRef="USD">15678000</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20230807110509789_xbrl_20230807105833497_xbrl_20220804201533828_xbrl_20220726011028297"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20230807110509789_xbrl_20230807105833497_xbrl_20220804201533828_xbrl_20220726011031293"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230807110509789_xbrl_20230807105833497_xbrl_20220804201533828_xbrl_20220725182054265_xbrl_20220725181931129_xbrl_20210805162633992_xbrl_20210726103820235_xbrl_20210716144837125_619"
      unitRef="USD">15706000</ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220804200911433_xbrl_20220726011400608"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804200911433_xbrl_20220725182440873_xbrl_20210805162907776_xbrl_20210726103505658_xbrl_20210716151223357_xbrl_20210716145820919_xbrl_20210716144837125_87"
      unitRef="USD">1946000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220804200911433_xbrl_20220726011406088"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20220101to20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804200911433_xbrl_20220726011408975"
      unitRef="USD">0</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220804200911433_xbrl_20220725182440873_xbrl_20210805162907776_xbrl_20210726103505658_xbrl_20210716151223357_xbrl_20210716145820919_xbrl_20210716144837125_819"
      unitRef="USD">1946000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:Equity
      contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember"
      decimals="-3"
      id="Fxbrl_20220804200950679_xbrl_20220725182314592_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_23"
      unitRef="USD">143000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullSharePremiumMember"
      decimals="-3"
      id="Fxbrl_20220804200950679_xbrl_20220725182314592_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_27"
      unitRef="USD">178882000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember"
      decimals="-3"
      id="Fxbrl_20220804200950679_xbrl_20220725182314592_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_211"
      unitRef="USD">-5000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20221231_ifrsfullComponentsOfEquityAxis_ifrsfullRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220804200950679_xbrl_20220725182314592_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_215"
      unitRef="USD">-168106000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20220804200950679_xbrl_20220725182314592_xbrl_20210805162907789_xbrl_20210726103525064_xbrl_20210726103505597_xbrl_20210716150121962_xbrl_20210716145820874_xbrl_20210716144837125_219"
      unitRef="USD">10914000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20210716153321700_xbrl_20210716153257620_xbrl_20210716153212506_43"
      unitRef="USD">-2777000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20210726131029374"
      unitRef="USD">-7943000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20210726105355449"
      unitRef="USD">916000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20210726095130879"
      unitRef="USD">-4354000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20210726112027429"
      unitRef="USD">-19599000</ifrs-full:ProfitLoss>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20210716153328165_xbrl_20210716153257620_xbrl_20210716153212506_43"
      unitRef="USD">618000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20210716153328165_xbrl_20210716153257620_xbrl_20210716153212506_47"
      unitRef="USD">650000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20210716153328165_xbrl_20210716153257620_xbrl_20210716153212506_411"
      unitRef="USD">315000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20210716153328165_xbrl_20210716153257620_xbrl_20210716153212506_415"
      unitRef="USD">329000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20210716153328165_xbrl_20210716153257620_xbrl_20210716153212506_419"
      unitRef="USD">1272000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_43"
      unitRef="USD">1331000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_47"
      unitRef="USD">597000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_411"
      unitRef="USD">712000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_415"
      unitRef="USD">252000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_419"
      unitRef="USD">1946000</ifrs-full:AdjustmentsForSharebasedPayments>
    <mdwd:RevaluationOfWarrantsAccountedAtFairValue
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20230807102241950_xbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_43"
      unitRef="USD">5923000</mdwd:RevaluationOfWarrantsAccountedAtFairValue>
    <mdwd:RevaluationOfWarrantsAccountedAtFairValue
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20230807102241950_xbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_47"
      unitRef="USD">0</mdwd:RevaluationOfWarrantsAccountedAtFairValue>
    <mdwd:RevaluationOfWarrantsAccountedAtFairValue
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20230807102241950_xbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_411"
      unitRef="USD">4990000</mdwd:RevaluationOfWarrantsAccountedAtFairValue>
    <mdwd:RevaluationOfWarrantsAccountedAtFairValue
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20230807102241950_xbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_415"
      unitRef="USD">0</mdwd:RevaluationOfWarrantsAccountedAtFairValue>
    <mdwd:RevaluationOfWarrantsAccountedAtFairValue
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230807102241950_xbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_419"
      unitRef="USD">-8977000</mdwd:RevaluationOfWarrantsAccountedAtFairValue>
    <mdwd:AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20230807102243878_xbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_43"
      unitRef="USD">0</mdwd:AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss>
    <mdwd:AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20230807102243878_xbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_47"
      unitRef="USD">0</mdwd:AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss>
    <mdwd:AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20230807102243878_xbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_411"
      unitRef="USD">0</mdwd:AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss>
    <mdwd:AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20230807102243878_xbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_415"
      unitRef="USD">0</mdwd:AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss>
    <mdwd:AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230807102243878_xbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_419"
      unitRef="USD">1911000</mdwd:AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss>
    <mdwd:RevaluationOfLiabilitiesInRespectOfGrants
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20210716153332948_xbrl_20210716153257620_xbrl_20210716153212506_43"
      unitRef="USD">-492000</mdwd:RevaluationOfLiabilitiesInRespectOfGrants>
    <mdwd:RevaluationOfLiabilitiesInRespectOfGrants
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20210716153332948_xbrl_20210716153257620_xbrl_20210716153212506_47"
      unitRef="USD">-482000</mdwd:RevaluationOfLiabilitiesInRespectOfGrants>
    <mdwd:RevaluationOfLiabilitiesInRespectOfGrants
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20210716153332948_xbrl_20210716153257620_xbrl_20210716153212506_411"
      unitRef="USD">-233000</mdwd:RevaluationOfLiabilitiesInRespectOfGrants>
    <mdwd:RevaluationOfLiabilitiesInRespectOfGrants
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20210716153332948_xbrl_20210716153257620_xbrl_20210716153212506_415"
      unitRef="USD">-248000</mdwd:RevaluationOfLiabilitiesInRespectOfGrants>
    <mdwd:RevaluationOfLiabilitiesInRespectOfGrants
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230807105852423"
      unitRef="USD">132000</mdwd:RevaluationOfLiabilitiesInRespectOfGrants>
    <mdwd:RevaluationOfLiabilitiesInRespectOfTeva
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20230807102257423_xbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_43"
      unitRef="USD">-241000</mdwd:RevaluationOfLiabilitiesInRespectOfTeva>
    <mdwd:RevaluationOfLiabilitiesInRespectOfTeva
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20230807102257423_xbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_47"
      unitRef="USD">-272000</mdwd:RevaluationOfLiabilitiesInRespectOfTeva>
    <mdwd:RevaluationOfLiabilitiesInRespectOfTeva
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20230807102257423_xbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_411"
      unitRef="USD">-119000</mdwd:RevaluationOfLiabilitiesInRespectOfTeva>
    <mdwd:RevaluationOfLiabilitiesInRespectOfTeva
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20230807102257423_xbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_415"
      unitRef="USD">-135000</mdwd:RevaluationOfLiabilitiesInRespectOfTeva>
    <mdwd:RevaluationOfLiabilitiesInRespectOfTeva
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230807102257423_xbrl_20210716153330243_xbrl_20210716153257620_xbrl_20210716153212506_419"
      unitRef="USD">-533000</mdwd:RevaluationOfLiabilitiesInRespectOfTeva>
    <mdwd:RevaluationOfLeaseLiabilities
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20220725190439309"
      unitRef="USD">22000</mdwd:RevaluationOfLeaseLiabilities>
    <mdwd:RevaluationOfLeaseLiabilities
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20230807105705827"
      unitRef="USD">152000</mdwd:RevaluationOfLeaseLiabilities>
    <mdwd:RevaluationOfLeaseLiabilities
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20220725190507709"
      unitRef="USD">9000</mdwd:RevaluationOfLeaseLiabilities>
    <mdwd:RevaluationOfLeaseLiabilities
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20230807105841079"
      unitRef="USD">138000</mdwd:RevaluationOfLeaseLiabilities>
    <mdwd:RevaluationOfLeaseLiabilities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230807105859758"
      unitRef="USD">109000</mdwd:RevaluationOfLeaseLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20210726100109446"
      unitRef="USD">67000</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20220725190609462"
      unitRef="USD">55000</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20230807105719939"
      unitRef="USD">-10000</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20210716153343060_xbrl_20210716153257620_xbrl_20210716153212506_415"
      unitRef="USD">35000</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20210716153343060_xbrl_20210716153257620_xbrl_20210716153212506_419"
      unitRef="USD">109000</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <ifrs-full:AdjustmentsForFinanceIncomeCost
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20210716153345828_xbrl_20210716153257620_xbrl_20210716153212506_43"
      unitRef="USD">1005000</ifrs-full:AdjustmentsForFinanceIncomeCost>
    <ifrs-full:AdjustmentsForFinanceIncomeCost
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20210716153345828_xbrl_20210716153257620_xbrl_20210716153212506_47"
      unitRef="USD">11000</ifrs-full:AdjustmentsForFinanceIncomeCost>
    <ifrs-full:AdjustmentsForFinanceIncomeCost
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20220725190634806"
      unitRef="USD">759000</ifrs-full:AdjustmentsForFinanceIncomeCost>
    <ifrs-full:AdjustmentsForFinanceIncomeCost
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20230807105832831"
      unitRef="USD">11000</ifrs-full:AdjustmentsForFinanceIncomeCost>
    <ifrs-full:AdjustmentsForFinanceIncomeCost
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20210716153345828_xbrl_20210716153257620_xbrl_20210716153212506_419"
      unitRef="USD">74000</ifrs-full:AdjustmentsForFinanceIncomeCost>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20210726112501750"
      unitRef="USD">-466000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20220725191200728"
      unitRef="USD">-528000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20210716153347948_xbrl_20210716153257620_xbrl_20210716153212506_411"
      unitRef="USD">-120000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20210726112629145"
      unitRef="USD">-283000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20210716153347948_xbrl_20210716153257620_xbrl_20210716153212506_419"
      unitRef="USD">-525000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:AdjustmentsForReconcileProfitLoss
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20230807105623029"
      unitRef="USD">-3735000</ifrs-full:AdjustmentsForReconcileProfitLoss>
    <ifrs-full:AdjustmentsForReconcileProfitLoss
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20210716153350142_xbrl_20210716153257620_xbrl_20210716153212506_47"
      unitRef="USD">2421000</ifrs-full:AdjustmentsForReconcileProfitLoss>
    <ifrs-full:AdjustmentsForReconcileProfitLoss
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20230807105731252"
      unitRef="USD">-4269000</ifrs-full:AdjustmentsForReconcileProfitLoss>
    <ifrs-full:AdjustmentsForReconcileProfitLoss
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20210716153350142_xbrl_20210716153257620_xbrl_20210716153212506_415"
      unitRef="USD">1133000</ifrs-full:AdjustmentsForReconcileProfitLoss>
    <ifrs-full:AdjustmentsForReconcileProfitLoss
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20210716153350142_xbrl_20210716153257620_xbrl_20210716153212506_419"
      unitRef="USD">14958000</ifrs-full:AdjustmentsForReconcileProfitLoss>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20220725191253189"
      unitRef="USD">6115000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20230807105652603"
      unitRef="USD">-2024000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20220725191311342"
      unitRef="USD">-707000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20230807105825740"
      unitRef="USD">-1445000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230807105917686"
      unitRef="USD">-7582000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20220725191327749"
      unitRef="USD">-1162000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20230807105645859"
      unitRef="USD">-747000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20220725191340709"
      unitRef="USD">-579000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20230807105819372"
      unitRef="USD">-37000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230807110024376"
      unitRef="USD">-721000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20210716153356166_xbrl_20210716153257620_xbrl_20210716153212506_43"
      unitRef="USD">122000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20210726113603315"
      unitRef="USD">330000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20210716153356166_xbrl_20210716153257620_xbrl_20210716153212506_411"
      unitRef="USD">435000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20210726113612210"
      unitRef="USD">205000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20210726113620306"
      unitRef="USD">364000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20230807105634171"
      unitRef="USD">-1636000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20210726113947029"
      unitRef="USD">11000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20220725191412516"
      unitRef="USD">312000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20230807105809964"
      unitRef="USD">-272000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20210726113922821"
      unitRef="USD">414000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <mdwd:AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20210726114139269"
      unitRef="USD">-1526000</mdwd:AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue>
    <mdwd:AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20220725191435632"
      unitRef="USD">-1367000</mdwd:AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue>
    <mdwd:AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20210726114147954"
      unitRef="USD">-1359000</mdwd:AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue>
    <mdwd:AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20220725192637042"
      unitRef="USD">-484000</mdwd:AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue>
    <mdwd:AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220725192651617"
      unitRef="USD">281000</mdwd:AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue>
    <mdwd:AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20220725192742457"
      unitRef="USD">1913000</mdwd:AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems>
    <mdwd:AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20230807111039091"
      unitRef="USD">-3797000</mdwd:AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems>
    <mdwd:AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20220725192758962"
      unitRef="USD">-1898000</mdwd:AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems>
    <mdwd:AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20230807105801631"
      unitRef="USD">-2033000</mdwd:AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems>
    <mdwd:AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230807110108148"
      unitRef="USD">-7244000</mdwd:AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20210716153413812_xbrl_20210716153257620_xbrl_20210716153212506_43"
      unitRef="USD">-4599000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20210726115928284"
      unitRef="USD">-9319000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20210716153413812_xbrl_20210716153257620_xbrl_20210716153212506_411"
      unitRef="USD">-5251000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20210726115939736"
      unitRef="USD">-5254000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20210726115948143"
      unitRef="USD">-11885000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20210716153257620_xbrl_20210716153212506_43"
      unitRef="USD">2570000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20210716153257620_xbrl_20210716153212506_47"
      unitRef="USD">298000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20210716153257620_xbrl_20210716153212506_411"
      unitRef="USD">1065000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20210716153257620_xbrl_20210716153212506_415"
      unitRef="USD">138000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20210716153257620_xbrl_20210716153212506_419"
      unitRef="USD">555000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:InterestReceivedClassifiedAsInvestingActivities
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20210716153417028_xbrl_20210716153257620_xbrl_20210716153212506_43"
      unitRef="USD">879000</ifrs-full:InterestReceivedClassifiedAsInvestingActivities>
    <ifrs-full:InterestReceivedClassifiedAsInvestingActivities
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20210716153417028_xbrl_20210716153257620_xbrl_20210716153212506_47"
      unitRef="USD">0</ifrs-full:InterestReceivedClassifiedAsInvestingActivities>
    <ifrs-full:InterestReceivedClassifiedAsInvestingActivities
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20210726120225212"
      unitRef="USD">577000</ifrs-full:InterestReceivedClassifiedAsInvestingActivities>
    <ifrs-full:InterestReceivedClassifiedAsInvestingActivities
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20210716153417028_xbrl_20210716153257620_xbrl_20210716153212506_415"
      unitRef="USD">0</ifrs-full:InterestReceivedClassifiedAsInvestingActivities>
    <ifrs-full:InterestReceivedClassifiedAsInvestingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20210716153417028_xbrl_20210716153257620_xbrl_20210716153212506_419"
      unitRef="USD">74000</ifrs-full:InterestReceivedClassifiedAsInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20220725193000184"
      unitRef="USD">-31830000</ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments>
    <ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20230807120316315"
      unitRef="USD">-2499000</ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments>
    <ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20210716153419069_xbrl_20210716153257620_xbrl_20210716153212506_411"
      unitRef="USD">-25590000</ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments>
    <ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20220725193146197"
      unitRef="USD">-2499000</ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments>
    <ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20210716153419069_xbrl_20210716153257620_xbrl_20210716153212506_419"
      unitRef="USD">0</ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments>
    <ifrs-full:CashFlowsFromUsedInInvestingActivitiesContinuingOperations
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20220725193158809"
      unitRef="USD">-33521000</ifrs-full:CashFlowsFromUsedInInvestingActivitiesContinuingOperations>
    <ifrs-full:CashFlowsFromUsedInInvestingActivitiesContinuingOperations
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20230807120326674"
      unitRef="USD">-2797000</ifrs-full:CashFlowsFromUsedInInvestingActivitiesContinuingOperations>
    <ifrs-full:CashFlowsFromUsedInInvestingActivitiesContinuingOperations
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20210726121036886"
      unitRef="USD">-26078000</ifrs-full:CashFlowsFromUsedInInvestingActivitiesContinuingOperations>
    <ifrs-full:CashFlowsFromUsedInInvestingActivitiesContinuingOperations
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20220725193224511"
      unitRef="USD">-2637000</ifrs-full:CashFlowsFromUsedInInvestingActivitiesContinuingOperations>
    <ifrs-full:CashFlowsFromUsedInInvestingActivitiesContinuingOperations
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230807120336153"
      unitRef="USD">-481000</ifrs-full:CashFlowsFromUsedInInvestingActivitiesContinuingOperations>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_43"
      unitRef="USD">334000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_47"
      unitRef="USD">350000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_411"
      unitRef="USD">157000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_415"
      unitRef="USD">172000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_419"
      unitRef="USD">701000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromExerciseOfWarrants
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20230807114928344_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_43"
      unitRef="USD">0</ifrs-full:ProceedsFromExerciseOfWarrants>
    <ifrs-full:ProceedsFromExerciseOfWarrants
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20230807114928344_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_47"
      unitRef="USD">0</ifrs-full:ProceedsFromExerciseOfWarrants>
    <ifrs-full:ProceedsFromExerciseOfWarrants
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20230807114928344_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_411"
      unitRef="USD">0</ifrs-full:ProceedsFromExerciseOfWarrants>
    <ifrs-full:ProceedsFromExerciseOfWarrants
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20230807114928344_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_415"
      unitRef="USD">0</ifrs-full:ProceedsFromExerciseOfWarrants>
    <ifrs-full:ProceedsFromExerciseOfWarrants
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230807114928344_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_419"
      unitRef="USD">10000</ifrs-full:ProceedsFromExerciseOfWarrants>
    <mdwd:RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20230811014007588"
      unitRef="USD">-24909000</mdwd:RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet>
    <mdwd:RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20230811014016505"
      unitRef="USD">-9861000</mdwd:RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet>
    <mdwd:RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20230811014019140"
      unitRef="USD">248000</mdwd:RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet>
    <mdwd:RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20230811014022090"
      unitRef="USD">556000</mdwd:RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet>
    <mdwd:RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230811014025058"
      unitRef="USD">-38380000</mdwd:RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet>
    <mdwd:RepaymentFromGrants
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20210805171548721_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_43"
      unitRef="USD">310000</mdwd:RepaymentFromGrants>
    <mdwd:RepaymentFromGrants
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20210805171548721_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_47"
      unitRef="USD">162000</mdwd:RepaymentFromGrants>
    <mdwd:RepaymentFromGrants
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20210805171548721_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_411"
      unitRef="USD">0</mdwd:RepaymentFromGrants>
    <mdwd:RepaymentFromGrants
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20210805171548721_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_415"
      unitRef="USD">0</mdwd:RepaymentFromGrants>
    <mdwd:RepaymentFromGrants
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20210805171548721_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_419"
      unitRef="USD">258000</mdwd:RepaymentFromGrants>
    <mdwd:RepaymentOfLiabilitiesInRespectOfTeva
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20230807114936719_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_43"
      unitRef="USD">417000</mdwd:RepaymentOfLiabilitiesInRespectOfTeva>
    <mdwd:RepaymentOfLiabilitiesInRespectOfTeva
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20230807114936719_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_47"
      unitRef="USD">0</mdwd:RepaymentOfLiabilitiesInRespectOfTeva>
    <mdwd:RepaymentOfLiabilitiesInRespectOfTeva
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20230807114936719_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_411"
      unitRef="USD">0</mdwd:RepaymentOfLiabilitiesInRespectOfTeva>
    <mdwd:RepaymentOfLiabilitiesInRespectOfTeva
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20230807114936719_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_415"
      unitRef="USD">0</mdwd:RepaymentOfLiabilitiesInRespectOfTeva>
    <mdwd:RepaymentOfLiabilitiesInRespectOfTeva
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230807114936719_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_419"
      unitRef="USD">1667000</mdwd:RepaymentOfLiabilitiesInRespectOfTeva>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20210716153439236_xbrl_20210716153257620_xbrl_20210716153212506_43"
      unitRef="USD">23848000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20210716153439236_xbrl_20210716153257620_xbrl_20210716153212506_47"
      unitRef="USD">9349000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20210716153439236_xbrl_20210716153257620_xbrl_20210716153212506_411"
      unitRef="USD">-405000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20210726121603510"
      unitRef="USD">-728000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20210716153439236_xbrl_20210716153257620_xbrl_20210716153212506_419"
      unitRef="USD">35764000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20220725195249758"
      unitRef="USD">-457000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20230807120520323"
      unitRef="USD">-550000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20220725195317273"
      unitRef="USD">-120000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20230807120526776"
      unitRef="USD">-303000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20230807120533068"
      unitRef="USD">-549000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20210726122051717"
      unitRef="USD">-14729000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20220725195333303"
      unitRef="USD">-3317000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20210726122144986"
      unitRef="USD">-31854000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20220725195344490"
      unitRef="USD">-8922000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20220725195510182"
      unitRef="USD">22849000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210716153449900_xbrl_20210716153257620_xbrl_20210716153212506_43"
      unitRef="USD">33895000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20210716153449900_xbrl_20210716153257620_xbrl_20210716153212506_47"
      unitRef="USD">11046000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20230331"
      decimals="-3"
      id="Fxbrl_20210716153449900_xbrl_20210716153257620_xbrl_20210716153212506_411"
      unitRef="USD">51020000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20220331"
      decimals="-3"
      id="Fxbrl_20230530171912645"
      unitRef="USD">16651000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20210716153449900_xbrl_20210716153257620_xbrl_20210716153212506_419"
      unitRef="USD">11046000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20210716153452373_xbrl_20210716153257620_xbrl_20210716153212506_43"
      unitRef="USD">19166000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20210716153452373_xbrl_20210716153257620_xbrl_20210716153212506_47"
      unitRef="USD">7729000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20230630"
      decimals="-3"
      id="Fxbrl_20210716153452373_xbrl_20210716153257620_xbrl_20210716153212506_411"
      unitRef="USD">19166000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20210716153452373_xbrl_20210716153257620_xbrl_20210716153212506_415"
      unitRef="USD">7729000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="C_20221231"
      decimals="-3"
      id="Fxbrl_20210716153452373_xbrl_20210716153257620_xbrl_20210716153212506_419"
      unitRef="USD">33895000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:RightofuseAssetsIncreaseDecreaseInRevaluationSurplus
      contextRef="C_20230101to20230630"
      decimals="-3"
      id="Fxbrl_20210805171624139_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_43"
      unitRef="USD">154000</ifrs-full:RightofuseAssetsIncreaseDecreaseInRevaluationSurplus>
    <ifrs-full:RightofuseAssetsIncreaseDecreaseInRevaluationSurplus
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20210805171624139_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_47"
      unitRef="USD">43000</ifrs-full:RightofuseAssetsIncreaseDecreaseInRevaluationSurplus>
    <ifrs-full:RightofuseAssetsIncreaseDecreaseInRevaluationSurplus
      contextRef="C_20230401to20230630"
      decimals="-3"
      id="Fxbrl_20210805171624139_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_411"
      unitRef="USD">102000</ifrs-full:RightofuseAssetsIncreaseDecreaseInRevaluationSurplus>
    <ifrs-full:RightofuseAssetsIncreaseDecreaseInRevaluationSurplus
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20210805171624139_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_415"
      unitRef="USD">43000</ifrs-full:RightofuseAssetsIncreaseDecreaseInRevaluationSurplus>
    <ifrs-full:RightofuseAssetsIncreaseDecreaseInRevaluationSurplus
      contextRef="C_20220101to20221231"
      decimals="-3"
      id="Fxbrl_20210805171624139_xbrl_20210716153431240_xbrl_20210716153257620_xbrl_20210716153212506_419"
      unitRef="USD">117000</ifrs-full:RightofuseAssetsIncreaseDecreaseInRevaluationSurplus>
    <ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory
      contextRef="C_20230101to20230630"
      id="Fxbrl_20220725183253877">
    &lt;div&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:56.7pt;vertical-align:top;font-weight:bold"&gt;Note 1:&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top"&gt;
                    &lt;div style="font-weight:bold"&gt;General&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:57.3pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:27.75pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;a.&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div style="font-weight:bold"&gt;Description of the Company and its operations:&lt;/div&gt;
                    &lt;div style="font-weight:bold"&gt;&#160;&lt;/div&gt;
                    &lt;div style="font-weight:bold"&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;MediWound Ltd. Was incorporated in Israel. The Company which is located in Yavne, Israel (The "Company" or "MediWound"), is biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, bio-therapeutic, non-surgical solutions for tissue repair and regeneration. The Company&#x2019;s strategy leverages its breakthrough enzymatic technology platform into diversified portfolio of biotherapeutics across multiple indications to pioneer solutions for unmet medical needs.&lt;span style="font-size:12pt;color:rgb(61, 61, 100)"&gt;&#160;&lt;/span&gt; The Company&#x2019;s current portfolio is focused on next-generation protein-based therapies for burn care, wound care and tissue repair.&lt;br/&gt;&lt;span style="font-weight:normal"&gt;&#160;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;The Company's first innovative biopharmaceutical product, NexoBrid, has received in December 2022, an approval from the U.S. Food and Drug Administration (&#x201c;FDA&#x201d;) and marketing approval in each of India, Switzerland and Japan. In addition it has a marketing authorization from the European Medicines Agency (&#x201c;EMA&#x201d;) and regulatory agencies in other international markets for removal of dead or damaged tissue, known as eschar, in adults with deep partial and full thickness thermal burns.&lt;br/&gt;&lt;span style="font-weight:normal"&gt;&#160;&lt;/span&gt;&lt;/div&gt;
                      &lt;div style="line-height:1.25;font-weight:normal"&gt;The Company commercialize NexoBrid globally through multiple sales channels.&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:102.45pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&#x2022;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;The Company sell NexoBrid to burn centers in the European Union, United Kingdom and Israel, primarily through its commercial organizations.&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:102.45pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&#x2022;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;The Company have established local distribution channels in multiple international markets, focusing on Asia Pacific, EMEA, CEE and LATAM, which local distributors are also responsible for obtaining local marketing authorization within the relevant territories.&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:102.5pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:18pt;vertical-align:top"&gt;&#x2022;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;In the United States, the Company entered into exclusive license and supply agreements with Vericel Corporation (&#x201c;Vericel&#x201d;) to commercialize NexoBrid in North America upon FDA approval.&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:57.3pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:27.75pt;vertical-align:top;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                      &lt;div style="font-weight:bold"&gt;
                        &lt;div style="line-height:1.25;font-weight:normal"&gt;
                          &lt;div style="line-height:1.25"&gt;The Company&#x2019;s second investigational next-generation enzymatic therapy product, EscharEx, a topical biological drug being developed for debridement of chronic and other hard-to-heal wounds, is currently under discussions with the FDA regarding the pivotal Phase 3 study design.&lt;/div&gt;
                          &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                          &lt;div style="line-height:1.25;font-family:Times New Roman, Times, serif;color:rgb(0, 0, 0);margin-bottom:10pt"&gt;The third clinical-stage innovative product candidate, MW005, is a topical applied biological drug candidate for the treatment of non-melanoma skin cancers. A U.S. phase 1/2 study of MW005 for the treatment of low-risk basal cell carcinoma (BCC) was initiated in July 2021, and an investigator-initiated phase II trial of MW005 in non-melanoma skin cancer is being conducted in parallel in Israel. In December 2022, the Company announced final positive results from the study. Based on the positive results, The Company plan to continue enrolling patients in its Phase 1/2 study.&lt;/div&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
        &lt;div&gt;&lt;/div&gt;
        &lt;div&gt;
          &lt;div&gt;
            &lt;div style="margin-top:0px"&gt;
              &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                  &lt;tr&gt;
                    &lt;td style="width:57.3pt"&gt;&#160;&lt;/td&gt;
                    &lt;td style="width:27.75pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                      &lt;div&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company's securities are listed for trading on NASDAQ since March 2014.&lt;/span&gt;&lt;/div&gt;
                    &lt;/td&gt;
                  &lt;/tr&gt;

              &lt;/table&gt;
            &lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:57.3pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:27.75pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;c.&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company has three wholly owned subsidiaries: MediWound Germany GmbH, acting as Europe (&#x201c;EU&#x201d;) marketing authorization holder and EU sales and marketing arm, and MediWound UK Limited and MediWound US, Inc. which are currently inactive companies.&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:57.3pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:27.75pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;d.&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company awarded two contracts with the U.S. Biomedical Advanced Research and Development Authority ("BARDA") valued at up to $209,000 for the advancement of the development, manufacturing and emergency readiness for NexoBrid deployment as well as the procurement of NexoBrid as a medical countermeasure as part of BARDA preparedness for mass casualty events.&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;div style="text-align:justify;margin-left:85.05pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;On May 9, 2023 BARDA has awarded an additional $10,000 to the Company. The supplemental funding will support $7,000 R&amp;amp;D activities and $3,000 replenishment of expired product previously procured for emergency preparedness, the pediatric indication sBLA submission to the U.S. Food and Drug Administration (FDA), and enrollment of an additional 50 patients in the ongoing expanded access treatment protocol (NEXT).&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:57.3pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:27.75pt;vertical-align:top;color:#000000;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;e.&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div style="color:#000000"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Our Partner, Vericel Corporation Inc. (&#x201c;&lt;span style="font-weight:bold"&gt;Vericel&lt;/span&gt;&#x201d;) has received the first lot of NexoBrid&#xae; finished product from the company for the U.S. commercial market in June 2023, which currently is warehoused at Vericel&#x2019;s third-party logistics distributor. Although this NexoBrid finished product batch has met all required release criteria for distribution in the U.S., Vericel is unable to release this product into the commercial channel at this time due to a deviation associated with a third-party testing lab used during the manufacturing process. A detailed risk assessment prepared by the Company and Vericel has concluded that the deviation presents no incremental risk to the finished product&#x2019;s quality and safety, and the company actively engaged with Vericel and the U.S. Food and Drug Administration (FDA) to address this matter. Future manufacturing of NexoBrid drug product for the U.S. market will not be impacted because the at-issue test will be conducted directly by the Company. As the FDA has not yet authorized the commercial release of the finished product affected by the deviation, the company is currently preparing for a production campaign scheduled to begin in September 2023.&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="text-align:justify;margin-left:63.85pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
            &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                &lt;tr&gt;
                  &lt;td style="width:57.3pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:27.75pt;vertical-align:top;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;f.&lt;/span&gt;&lt;/td&gt;
                  &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                    &lt;div&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In 2022 the Company engaged with the U.S. Department of Defense (DoD), through the Medical Technology Enterprise Consortium (MTEC), for a $1,800 contract for the development of NexoBrid as a non-surgical solution for field-care burn treatment for the U.S. Army. This contract was amended in April 2023 to extend the total value, up to a total amount of $2,700.&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
            &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory>
    <mdwd:ContractAmountForResearchDevelopmentAndManufacturing
      contextRef="C_20230101to20230630_ifrsfullBorrowingsByNameAxis_mdwdBardaMember"
      decimals="-3"
      id="Fxbrl_20230811093412429"
      unitRef="USD">209000000</mdwd:ContractAmountForResearchDevelopmentAndManufacturing>
    <mdwd:AdditionalProceedsFromFunding
      contextRef="C_20230501to20230509_ifrsfullBorrowingsByNameAxis_mdwdBardaMember"
      decimals="-3"
      id="Fxbrl_20230811094644882"
      unitRef="USD">10000000</mdwd:AdditionalProceedsFromFunding>
    <mdwd:ContractAmountForResearchDevelopmentAndManufacturing
      contextRef="C_20230501to20230509_deiLegalEntityAxis_mdwdUSFoodAndDrugAdministrationMember_ifrsfullBorrowingsByNameAxis_mdwdBardaMember"
      decimals="-3"
      id="Fxbrl_20230811094030718"
      unitRef="USD">7000000</mdwd:ContractAmountForResearchDevelopmentAndManufacturing>
    <mdwd:ReplenishmentAmount
      contextRef="C_20230501to20230509_deiLegalEntityAxis_mdwdUSFoodAndDrugAdministrationMember_ifrsfullBorrowingsByNameAxis_mdwdBardaMember"
      decimals="-3"
      id="Fxbrl_20230811094911752"
      unitRef="USD">3000000</mdwd:ReplenishmentAmount>
    <mdwd:NumberOfPatients
      contextRef="C_20230501to20230509_deiLegalEntityAxis_mdwdUSFoodAndDrugAdministrationMember_ifrsfullBorrowingsByNameAxis_mdwdBardaMember"
      decimals="INF"
      id="Fxbrl_20230811094900063"
      unitRef="Patient">50</mdwd:NumberOfPatients>
    <mdwd:ContractWithCustomers
      contextRef="C_20220101to20221231_deiLegalEntityAxis_mdwdUSDepartmentOfDefenseMember"
      decimals="-3"
      id="Fxbrl_20230807130321124"
      unitRef="USD">1800000</mdwd:ContractWithCustomers>
    <mdwd:ContractWithCustomers
      contextRef="C_20230401to20230430_deiLegalEntityAxis_mdwdUSDepartmentOfDefenseMember"
      decimals="-3"
      id="Fxbrl_20230807130333507"
      unitRef="USD">2700000</mdwd:ContractWithCustomers>
    <ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory
      contextRef="C_20230101to20230630"
      id="Fxbrl_20220725172057415">
                &lt;div&gt;
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Note 2:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;div style="font-weight:bold"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;S&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;strong&gt;&lt;span style="line-height:110%"&gt;ignificant Accounting Policies&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;&#160;&lt;/td&gt;
                        &lt;/tr&gt;
                        &lt;tr&gt;
                          &lt;td style="width:56.7pt;vertical-align:top;align:right;font-weight:bold"&gt;&#160;&lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top;text-align:justify"&gt;
                            &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;The following accounting policies have been applied consistently in the financial statements for all periods presented unless otherwise stated.&lt;/span&gt;&lt;/p&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

                      &lt;div&gt;
                        &lt;div&gt;
                          &lt;table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt"&gt;

                              &lt;tr style="vertical-align:top"&gt;
                                &lt;td style="width:57pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:27pt"&gt;
                                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-weight:bold"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="vertical-align:top;width:auto"&gt;
                                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Basis of presentation of financial statements:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:57pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:27pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:auto"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:57pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:27pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:auto"&gt;
                                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;These financial statements have been prepared in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board ("IASB").&lt;/span&gt;&lt;/p&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;

                          &lt;/table&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;

                    &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;

                      &lt;div&gt;
                        &lt;div&gt;
                          &lt;table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt"&gt;

                              &lt;tr style="vertical-align:top"&gt;
                                &lt;td style="width:57pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:27pt"&gt;
                                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-weight:bold"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="vertical-align:top;width:auto"&gt;
                                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Basis of preparation of the interim consolidated financial statements:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:57pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:27pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:auto"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:57pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:27pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:auto"&gt;
                                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;The interim condensed consolidated financial statements for the six and three months ended June 30, 2023&#160;have been prepared in accordance with IAS 34 "Interim Financial Reporting".&lt;/span&gt;&lt;/p&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:57pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:27pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:auto"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:57pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:27pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:auto"&gt;
                                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;The interim condensed consolidated financial statements do not include all the information and disclosures required in the annual financial statements, and should be read in conjunction with the Company's annual financial statements as of December 31, 2022 that were included in the Annual Report on Form 20-F filed on March 16, 2023.&lt;/span&gt;&lt;/p&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:57pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:27pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:auto"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:57pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:27pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:auto"&gt;
                                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;The accounting policies adopted in the preparation of the interim condensed consolidated financial statements are consistent with those followed in the preparation of the Company&#x2019;s annual consolidated financial statements for the year ended December 31, 2022 that were included in the Annual Report on Form 20-F filed on March 16, 2023.&#160;&lt;/span&gt;&lt;/p&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:57pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:27pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:auto"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;

                          &lt;/table&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;

                  &lt;/div&gt;
                &lt;/div&gt;
              </ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory>
    <ifrs-full:DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements
      contextRef="C_20230101to20230630"
      id="Fxbrl_20210805180246968">
                      &lt;div&gt;
                        &lt;div&gt;
                          &lt;table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt"&gt;

                              &lt;tr style="vertical-align:top"&gt;
                                &lt;td style="width:57pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:27pt"&gt;
                                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-weight:bold"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="vertical-align:top;width:auto"&gt;
                                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Basis of presentation of financial statements:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:57pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:27pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:auto"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:57pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:27pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:auto"&gt;
                                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;These financial statements have been prepared in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board ("IASB").&lt;/span&gt;&lt;/p&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;

                          &lt;/table&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    </ifrs-full:DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements>
    <mdwd:DescriptionOfOtherAccountingPoliciesBasisOfPreparationOfInterimConsolidatedFinancialStatementsExplanatory
      contextRef="C_20230101to20230630"
      id="Fxbrl_20210805180300927">
                      &lt;div&gt;
                        &lt;div&gt;
                          &lt;table cellpadding="0" cellspacing="0" style="width:100%;font-family:'Times New Roman', Times, serif;font-size:10pt"&gt;

                              &lt;tr style="vertical-align:top"&gt;
                                &lt;td style="width:57pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:27pt"&gt;
                                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="font-weight:bold"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                                &lt;td style="vertical-align:top;width:auto"&gt;
                                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;Basis of preparation of the interim consolidated financial statements:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:57pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:27pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:auto"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:57pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:27pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:auto"&gt;
                                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;The interim condensed consolidated financial statements for the six and three months ended June 30, 2023&#160;have been prepared in accordance with IAS 34 "Interim Financial Reporting".&lt;/span&gt;&lt;/p&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:57pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:27pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:auto"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:57pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:27pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:auto"&gt;
                                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;The interim condensed consolidated financial statements do not include all the information and disclosures required in the annual financial statements, and should be read in conjunction with the Company's annual financial statements as of December 31, 2022 that were included in the Annual Report on Form 20-F filed on March 16, 2023.&lt;/span&gt;&lt;/p&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:57pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:27pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:auto"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:57pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:27pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:auto"&gt;
                                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:justify"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;The accounting policies adopted in the preparation of the interim condensed consolidated financial statements are consistent with those followed in the preparation of the Company&#x2019;s annual consolidated financial statements for the year ended December 31, 2022 that were included in the Annual Report on Form 20-F filed on March 16, 2023.&#160;&lt;/span&gt;&lt;/p&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr&gt;
                                &lt;td style="width:57pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:27pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;width:auto"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;

                          &lt;/table&gt;
                        &lt;/div&gt;
                      &lt;/div&gt;
                    </mdwd:DescriptionOfOtherAccountingPoliciesBasisOfPreparationOfInterimConsolidatedFinancialStatementsExplanatory>
    <ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory
      contextRef="C_20230101to20230630"
      id="Fxbrl_20230811021241930">
                            &lt;div style="margin-top:0pt;margin-bottom:0pt"&gt;
                              &lt;div style="margin-top:0pt;margin-bottom:0pt"&gt;
                                &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;margin-top:0pt;margin-bottom:0pt"&gt;

                                    &lt;tr style="vertical-align:top;margin-top:0pt;margin-bottom:0pt"&gt;
                                      &lt;td style="text-align:right;vertical-align:top;width:56.7pt;margin-top:0pt;margin-bottom:0pt"&gt;
                                        &lt;div style="text-align:left;line-height:1.25;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold;margin-top:0pt;margin-bottom:0pt"&gt;Note 3:&lt;/span&gt;&lt;/div&gt;
                                      &lt;/td&gt;
                                      &lt;td style="text-align:left;vertical-align:top;width:auto;margin-top:0pt;margin-bottom:0pt"&gt;
                                        &lt;div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold;margin-top:0pt;margin-bottom:0pt"&gt;Equity&lt;/span&gt;&lt;/div&gt;
                                      &lt;/td&gt;
                                    &lt;/tr&gt;

                                &lt;/table&gt;
                              &lt;/div&gt;
                              &lt;div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
                              &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;

                                  &lt;tr style="margin-top:0pt;margin-bottom:0pt"&gt;
                                    &lt;td style="width:56.7pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/td&gt;
                                    &lt;td style="width:18pt;vertical-align:top;font-weight:bold;margin-top:0pt;margin-bottom:0pt"&gt;1.&lt;/td&gt;
                                    &lt;td style="width:auto;vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;
                                      &lt;div style="margin-top:0pt;margin-bottom:0pt"&gt;On February 7, 2023, the Company completed a public offering of 1,964,286 new ordinary shares which were issued in consideration to offering price of $14.0 per share. The gross proceeds were $27,500, before deducting commissions and other offering expenses in the amount of $2,031.&lt;/div&gt;
                                    &lt;/td&gt;
                                  &lt;/tr&gt;

                              &lt;/table&gt;
                              &lt;div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
                              &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;

                                  &lt;tr style="margin-top:0pt;margin-bottom:0pt"&gt;
                                    &lt;td style="width:56.7pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/td&gt;
                                    &lt;td style="width:18pt;vertical-align:top;font-weight:bold;margin-top:0pt;margin-bottom:0pt"&gt;2.&lt;/td&gt;
                                    &lt;td style="width:auto;vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;
                                      &lt;div style="margin-top:0pt;margin-bottom:0pt"&gt;On February 15, 2023, the Company granted to its employees and officers 130,600 share options for an exercise price of $13.32 per share and 9,100 RSUs. The share options vest over a period of 4 years. The total value was estimated at $1,129.&lt;/div&gt;
                                    &lt;/td&gt;
                                  &lt;/tr&gt;

                              &lt;/table&gt;
                              &lt;div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
                              &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;

                                  &lt;tr style="margin-top:0pt;margin-bottom:0pt"&gt;
                                    &lt;td style="width:56.7pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/td&gt;
                                    &lt;td style="width:18pt;vertical-align:top;font-weight:bold;margin-top:0pt;margin-bottom:0pt"&gt;3.&lt;/td&gt;
                                    &lt;td style="width:auto;vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;
                                      &lt;div style="margin-top:0pt;margin-bottom:0pt"&gt;On April 3, 2023, the Company granted to its board members and officers 160,400 share options for an exercise price of $11.89 and $11.91 per share. The grants to the directors and CEO were subject to the approval of the shareholders&#x2019; meeting held on May, 2023. The share options vest over a period of 1-4 years and the total value was estimated at $884.&lt;/div&gt;
                                    &lt;/td&gt;
                                  &lt;/tr&gt;

                              &lt;/table&gt;
                              &lt;div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
                              &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;

                                  &lt;tr style="margin-top:0pt;margin-bottom:0pt"&gt;
                                    &lt;td style="width:56.7pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/td&gt;
                                    &lt;td style="width:18pt;vertical-align:top;font-weight:bold;margin-top:0pt;margin-bottom:0pt"&gt;4.&lt;/td&gt;
                                    &lt;td style="width:auto;vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;
                                      &lt;div style="margin-bottom:10pt;margin-top:0pt"&gt;On May 31, 2023 the Shareholders of the Company approved an amendment to Article 6 of the Company&#x2019;s Amended and Restated Articles of Association, which increased the Company&#x2019;s authorized share capital from 900,000 NIS consisting of 12,857,143 ordinary shares par value NIS 0.07 to NIS 1,400,000, consisting of 20,000,000 ordinary shares, par value NIS 0.07 per share.&lt;/div&gt;
                                    &lt;/td&gt;
                                  &lt;/tr&gt;

                              &lt;/table&gt;
                              &lt;div style="clear:both;margin-top:0pt;margin-bottom:0pt"&gt;
                                &lt;div style="margin-top:0pt;margin-bottom:0pt"&gt;
                                  &lt;div style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;/div&gt;
                                &lt;/div&gt;
                              &lt;/div&gt;
                              &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;

                                  &lt;tr style="margin-top:0pt;margin-bottom:0pt"&gt;
                                    &lt;td style="width:56.7pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/td&gt;
                                    &lt;td style="width:18pt;vertical-align:top;font-weight:bold;margin-top:0pt;margin-bottom:0pt"&gt;5.&lt;/td&gt;
                                    &lt;td style="width:auto;vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;
                                      &lt;div style="margin-top:0pt;margin-bottom:0pt"&gt;On May 31, 2023 the Shareholders of the Company approved the increase by 1,000,000 in the number of ordinary shares available for issuance under the Company&#x2019;s 2014 Equity Incentive Plan.&lt;/div&gt;
                                    &lt;/td&gt;
                                  &lt;/tr&gt;

                              &lt;/table&gt;
                              &lt;div style="line-height:1.25;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
                              &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;

                                  &lt;tr style="margin-top:0pt;margin-bottom:0pt"&gt;
                                    &lt;td style="width:56.7pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/td&gt;
                                    &lt;td style="width:18pt;vertical-align:top;font-weight:bold;margin-top:0pt;margin-bottom:0pt"&gt;6.&lt;/td&gt;
                                    &lt;td style="width:auto;vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;
                                      &lt;div style="margin-top:0pt;margin-bottom:0pt"&gt;On May 31, 2023 the Shareholders of the Company approved the extension to the exercise period of options which were granted to the company&#x2019;s directors on April 23, 2020 for an additional five years, until April 23, 2030. According to this extension, an expense of $146 was recognized.&lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
                                      &lt;/div&gt;
                                    &lt;/td&gt;
                                  &lt;/tr&gt;

                              &lt;/table&gt;
                            &lt;/div&gt;
                          </ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory>
    <ifrs-full:NumberOfSharesIssued
      contextRef="C_20230207_mdwdSaleOfStocksAxis_mdwdPublicOfferingMember"
      decimals="INF"
      id="Fxbrl_20230807123402491"
      unitRef="Shares">1964286</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:ParValuePerShare
      contextRef="C_20230207_mdwdSaleOfStocksAxis_mdwdPublicOfferingMember"
      decimals="2"
      id="Fxbrl_20230807123447913"
      unitRef="USD_Per_Share">14</ifrs-full:ParValuePerShare>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="C_20230201to20230207_mdwdSaleOfStocksAxis_mdwdPublicOfferingMember"
      decimals="-3"
      id="Fxbrl_20230807124926726"
      unitRef="USD">27500000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="C_20230201to20230207_mdwdSaleOfStocksAxis_mdwdPublicOfferingMember"
      decimals="-3"
      id="Fxbrl_20230811100933146"
      unitRef="USD">2031000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndOfficersMember"
      decimals="INF"
      id="Fxbrl_20230807125153248"
      unitRef="Share">130600</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <mdwd:ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare
      contextRef="C_20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndOfficersMember"
      decimals="3"
      id="Fxbrl_20230807125845831"
      unitRef="USD_Per_Share">13.32</mdwd:ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndOfficersMember_ifrsfullClassesOfShareCapitalAxis_mdwdRestrictedSharesUnitsMember"
      decimals="INF"
      id="Fxbrl_20230807125926325"
      unitRef="Share">9100</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement
      contextRef="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndOfficersMember"
      id="Fxbrl_20230811101057353">4 years</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <mdwd:StockOptionValue
      contextRef="C_20230201to20230215_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdEmployeesAndOfficersMember"
      decimals="-3"
      id="Fxbrl_20230807131315417"
      unitRef="USD">1129000</mdwd:StockOptionValue>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="C_20230401to20230403_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdBoardMembersAndOfficersMember"
      decimals="INF"
      id="Fxbrl_20230807132607028"
      unitRef="Share">160400</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <mdwd:ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare
      contextRef="C_20230403_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdBoardMembersAndOfficersMember_ifrsfullRangeAxis_ifrsfullBottomOfRangeMember"
      decimals="3"
      id="Fxbrl_20230807132643606"
      unitRef="USD_Per_Share">11.89</mdwd:ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare>
    <mdwd:ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare
      contextRef="C_20230403_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdBoardMembersAndOfficersMember_ifrsfullRangeAxis_ifrsfullTopOfRangeMember"
      decimals="3"
      id="Fxbrl_20230807132651045"
      unitRef="USD_Per_Share">11.91</mdwd:ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare>
    <ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement
      contextRef="C_20230401to20230403_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdBoardMembersAndOfficersMember"
      id="Fxbrl_20230807132809388">1-4 years</ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement>
    <mdwd:StockOptionValue
      contextRef="C_20230401to20230403_ifrsfullCategoriesOfRelatedPartiesAxis_mdwdBoardMembersAndOfficersMember"
      decimals="-3"
      id="Fxbrl_20230807132832899"
      unitRef="USD">884000</mdwd:StockOptionValue>
    <mdwd:AuthorizedShareCapital
      contextRef="C_20230531"
      decimals="-3"
      id="Fxbrl_20230811101339577"
      unitRef="NIS">900000000</mdwd:AuthorizedShareCapital>
    <ifrs-full:NumberOfSharesIssued
      contextRef="C_20230531"
      decimals="INF"
      id="Fxbrl_20230807133505406"
      unitRef="Shares">12857143</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:ParValuePerShare
      contextRef="C_20230531"
      decimals="2"
      id="Fxbrl_20230811101400427"
      unitRef="NIS_Per_Share">0.07</ifrs-full:ParValuePerShare>
    <mdwd:IncreaseInAuthorizedShareCapital
      contextRef="C_20230531"
      decimals="-3"
      id="Fxbrl_20230807135404503"
      unitRef="NIS">1400000000</mdwd:IncreaseInAuthorizedShareCapital>
    <mdwd:IncreaseInSharesIssued
      contextRef="C_20230531"
      decimals="INF"
      id="Fxbrl_20230811101349394"
      unitRef="Shares">20000000</mdwd:IncreaseInSharesIssued>
    <mdwd:IncreaseInPricePerShareOfSharesIssued
      contextRef="C_20230531"
      decimals="2"
      id="Fxbrl_20230811101357361"
      unitRef="NIS_Per_Share">0.07</mdwd:IncreaseInPricePerShareOfSharesIssued>
    <mdwd:NumberOfShareAvailableForIssuance
      contextRef="C_20230531_ifrsfullTypesOfSharebasedPaymentArrangementsAxis_mdwdEquityIncentivePlanMember"
      decimals="INF"
      id="Fxbrl_20230807140002045"
      unitRef="Shares">1000000</mdwd:NumberOfShareAvailableForIssuance>
    <mdwd:ExtensionPeriodForOptionsExercised
      contextRef="C_20230501to20230531"
      id="Fxbrl_20230811100607158">P5Y</mdwd:ExtensionPeriodForOptionsExercised>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="C_20230501to20230531"
      decimals="-3"
      id="Fxbrl_20230811100623146"
      unitRef="USD">146000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory
      contextRef="C_20230101to20230630"
      id="Fxbrl_20230807111535655">
                        &lt;div style="margin-top:0pt;margin-bottom:0pt"&gt;
                          &lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;width:100%;text-align:left;color:rgb(0, 0, 0);margin-top:0pt;margin-bottom:0pt"&gt;

                              &lt;tr style="margin-top:0pt;margin-bottom:0pt"&gt;
                                &lt;td style="margin-top:0pt;margin-bottom:0pt"&gt;
                                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-weight:bold;margin-top:0pt;margin-bottom:0pt"&gt;Note&#160;4:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                                &lt;/td&gt;
                                &lt;td colspan="3" rowspan="1" style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;margin-top:0pt;margin-bottom:0pt"&gt;
                                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="line-height:110%;margin-top:0pt;margin-bottom:0pt"&gt;Subsequent events&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr style="margin-top:0pt;margin-bottom:0pt"&gt;
                                &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;margin-top:0pt;margin-bottom:0pt;width:56pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:18pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:auto"&gt;&#160;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr style="margin-top:0pt;margin-bottom:0pt"&gt;
                                &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;margin-top:0pt;margin-bottom:0pt;width:56pt"&gt;&#160;&lt;/td&gt;
                                &lt;td style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:18pt"&gt;
                                  &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;1.&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                                &lt;/td&gt;
                                &lt;td style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:auto"&gt;
                                  &lt;div style="margin-top:0pt;margin-bottom:0pt"&gt;
                                    &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;On July 17, 2023 the company signed a turnkey scale-up agreement with Biopharmax Group Ltd. This strategic agreement is designed to bolster the company&#x2019;s manufacturing infrastructure to support our long-term growth trajectory. &#160;The objective of this agreement is to establish, commission, and validate a cutting-edge, sterile, and GMP-compliant manufacturing facility. The venture aims to increase our production capacity significantly, projected to expand to six times the current capacity, aligning with our strategic plan to meet the escalating global demand for NexoBrid.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                                  &lt;/div&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr style="margin-top:0pt;margin-bottom:0pt"&gt;
                                &lt;td colspan="1" style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;margin-top:0pt;margin-bottom:0pt;width:56pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:18pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:auto"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr style="margin-top:0pt;margin-bottom:0pt"&gt;
                                &lt;td colspan="1" style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;margin-top:0pt;margin-bottom:0pt;width:56pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:18pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:auto"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;The new facility, equipped with fully operational clean rooms, will be exclusively designed for NexoBrid production. It will comply with stringent regulations from the GMP, FDA, EMA, Israeli Ministry of Health, and relevant Israeli regulatory bodies. An estimated $12,000&#160;will be invested in the project, set for completion by mid-2024, with full-scale manufacturing expected to commence in 2025.&lt;/span&gt;&lt;/span&gt;
                                  &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&#160;&lt;/p&gt;
                                  &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;The Scale-up Agreement encompasses various standard provisions, including those related to reporting, compliance, guarantees, representations, liability, insurance, confidentiality, and ownership.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr style="margin-top:0pt;margin-bottom:0pt"&gt;
                                &lt;td colspan="1" style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;margin-top:0pt;margin-bottom:0pt;width:56pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:18pt"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:auto"&gt;&lt;span style="font-size:10pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                              &lt;/tr&gt;
                              &lt;tr style="margin-top:0pt;margin-bottom:0pt"&gt;
                                &lt;td colspan="1" style="vertical-align:top;font-family:Times New Roman, Times, serif;font-weight:bold;margin-top:0pt;margin-bottom:0pt;width:56pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:18pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;strong style="margin-top:0pt;margin-bottom:0pt"&gt;2.&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                                &lt;td colspan="1" style="vertical-align:top;text-align:justify;margin-top:0pt;margin-bottom:0pt;width:auto"&gt;
                                  &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Alongside entering the Scale-up Agreement, the company has also secured a new lease agreement with the current property owner. This agreement allows the company to continue the utilization of our existing facilities and the planned manufacturing site. This property, located in Yavne, Israel, serves as the base for the company&#x2019;s administrative headquarters, research and development laboratories, and manufacturing plant. The duration of the lease extends until 2035, with an option for a further three-year extension until 2038. In parallel the existing sub lease agreement with Clal Life Science L.P. and the company was terminated.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                                  &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
                                  &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="margin-top:0pt;margin-bottom:0pt"&gt;The property, measuring approximately 32,500 square feet, will encompass the new manufacturing facility. As per the Lease Agreement, the annual rent is set at approximately $625. This rent is indexed to the Israeli Consumer Price Index and will see a staged increase of 6% every three years.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
                                &lt;/td&gt;
                              &lt;/tr&gt;

                          &lt;/table&gt;
                        &lt;/div&gt;
                      </ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory>
    <ifrs-full:InvestmentProperty
      contextRef="C_20230717_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentsEventMember_ifrsfullTypesOfInvestmentPropertyAxis_mdwdBiopharmaxGroupLtdMember"
      decimals="-3"
      id="Fxbrl_20230807144738138"
      unitRef="USD">12000000</ifrs-full:InvestmentProperty>
    <mdwd:AreaOfLand
      contextRef="C_20230716to20230717_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentsEventMember_ifrsfullTypesOfInvestmentPropertyAxis_mdwdBiopharmaxGroupLtdMember"
      decimals="0"
      id="Fxbrl_20230807144807112"
      unitRef="SQFT">32500</mdwd:AreaOfLand>
    <ifrs-full:RentalExpense
      contextRef="C_20230716to20230717_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentsEventMember_ifrsfullTypesOfInvestmentPropertyAxis_mdwdBiopharmaxGroupLtdMember"
      decimals="-3"
      id="Fxbrl_20230807144900801"
      unitRef="USD">625000</ifrs-full:RentalExpense>
    <mdwd:IncreaseInRentAsPercentageInEveryThreeYear
      contextRef="C_20230716to20230717_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentsEventMember_ifrsfullTypesOfInvestmentPropertyAxis_mdwdBiopharmaxGroupLtdMember"
      decimals="2"
      id="Fxbrl_20230807144911817"
      unitRef="Pure">0.06</mdwd:IncreaseInRentAsPercentageInEveryThreeYear>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fxbrl_20230811005753137"
          xlink:label="Fxbrl_20230811005753137"
          xlink:type="locator"/>
        <link:footnote id="FN20230811133219545" xlink:label="FN20230811133219545" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Restated to reflect 1:7 reverse ratio of shares</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230811005753137"
          xlink:to="FN20230811133219545"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230811005838682"
          xlink:label="Fxbrl_20230811005838682"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230811005838682"
          xlink:to="FN20230811133219545"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230811005902765"
          xlink:label="Fxbrl_20230811005902765"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230811005902765"
          xlink:to="FN20230811133219545"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230811104343178"
          xlink:label="Fxbrl_20230811104343178"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230811104343178"
          xlink:to="FN20230811133219545"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220804205853790"
          xlink:label="Fxbrl_20220804205853790"
          xlink:type="locator"/>
        <link:footnote id="FN20230811141517863" xlink:label="FN20230811141517863" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents less than $ 1.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220804205853790"
          xlink:to="FN20230811141517863"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220804205858797"
          xlink:label="Fxbrl_20220804205858797"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220804205858797"
          xlink:to="FN20230811141517863"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230807111545632"
          xlink:label="Fxbrl_20230807111545632"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230807111545632"
          xlink:to="FN20230811141517863"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230807111557608"
          xlink:label="Fxbrl_20230807111557608"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230807111557608"
          xlink:to="FN20230811141517863"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230807164406322_xbrl_20220804205858797"
          xlink:label="Fxbrl_20230807164406322_xbrl_20220804205858797"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230807164406322_xbrl_20220804205858797"
          xlink:to="FN20230811141517863"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230807164406322_xbrl_20220804200911308_xbrl_20220726011223576"
          xlink:label="Fxbrl_20230807164406322_xbrl_20220804200911308_xbrl_20220726011223576"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230807164406322_xbrl_20220804200911308_xbrl_20220726011223576"
          xlink:to="FN20230811141517863"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20230811011212291"
          xlink:label="Fxbrl_20230811011212291"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20230811011212291"
          xlink:to="FN20230811141517863"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>25
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M([3B]ZS)Y4WU]!OO" 7:7UKE=?L_>NJPW@BE32VKHC-6(RBR<ON7?>LF8L\
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MT5ZN.5.U4P/4_?NJDB\?](\\=K\"FOX/4$L#!!0    ( %&!#U>S#=DEWP(
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MCGAW0783;UVD5?O7>.Y8<V:L#U5=9%UAT8(LR8__XQ^=$&<%*!LI0+L"5"I
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M6U$4'Z%)K4W8E0F5/5_F/G9N9R^7<V5BIHS:K(T* !1Q7;>-"@&4ZS/:1D4
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M/)T>"&1WT--4U+B_I+Y&.WV2OY3Q%B3*K&BGC#B&+P&%+];37P 9HZZ^"$,
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M(E"];]M&KP+$,3U<!A",8D\O!,/KS$4 S.H@K)$8I%]BG#/0,0%5.J.X)O\
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M4Y+H766C[[E1SK1;K6VCXDYRJ7S#YL_@\OZ4F(A;992"C=A.NF>C;^-1=U>
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MUDC]Z0JXIXB,"EX(?M<2/6*E3=!BY;C*N:$,?F;W=X\K]@&X!6%M38SKER#
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M9K@S&>Z<<SM[" $Z=U@"]%AH_7LSJY+H:NW1" 3RI^G%U-2IM1Z,K>T.00K
M3[190M$.KSMYJ7&M\?<\I>PC A,IK<> ./])<3.3N+5HI?+QTW8&*),B361
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MS;*.1<@*M9-&@\7UE,U'5XNS(!\%?I>X=7MC")ZLC/D<)G=BRH;!(%18^,#
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M' %3'>3S#:7BI:$2-"?UB^]02P,$%     @ 48$/5P* "KK\"@  ]HL  !D
M  !X;"]W;W)K<VAE971S+W-H965T,3,N>&ULO=U;<YM(&@;@O]*EF9I*JK(6
M)YT\MJIB<VK8S+KBR>S%U%Y@U+*H<-  LIVI_?$+" LU0BWA?<NY2"29?AKD
M?@4T7]#5<Y)^SU:,Y>0E"N/L>K#*\_7E<)CY*Q9YV46R9G'QDV621EY>/$T?
MA]DZ9=ZB:A2%0T62QL/("^+!_*IZ[2Z=7R6;/ QB=I>2;!-%7OKCAH7)\_5
M'KR^\#5X7.7E"\/YU=I[9/<L_[:^2XMGPYVR""(69T$2DY0MKP>?Y4M7JQI4
M2_P1L.=L[S$I-^4A2;Z73^CB>B"5:\1"YN<EX17_/+%;%H:E5*S'7S4ZV/59
M-MQ__*J;U<87&_/@9>PV"?\=+/+5]6 Z( NV]#9A_C5YMEF]0:/2\Y,PJ_XF
MS_6RTH#XFRQ/HKIQL091$&__]5[J-V*O@3H[TD"I&RBM!MJQ'M2Z@=IJH,A'
M&FAU ^W<51K5#4;M'I0C#<9U@_&Y#29U@TE[E8XUF-8-IN=NPZQN,#NW!UEZ
M_<U)9S?9_;*W@VX[2JHAIGNY-[]*DV>2ELL77OF@&J=5^V)D!7$9J?L\+7X:
M%.WRN?'7)LA_D ^_>6GJE:/[(_F@L]P+PNPC^>6GJ3I6?B5#DJV\E&4DB,FW
M.,BS3^3GKA=?ER]>^7V5;#(O7E2+[C^_&N;%:I>=#_UZ%?7M*BI'5E$F7Y(X
M7V7$B!=LT='>%+=7!>V'Q=NU>\^4U_?L1A&"G]?I!9'43T21%)5\N]?)AY\_
MDOORW=A[7SI6]%;LFNRA<"<M=^^=/@KK8OB+]X.H,N]V*,89JR>/^F^V*7:=
M37Q!5.GDZEGG,XJ L?NLS4$"CFXD[?$KH/^\)Q]JNB-E1_MPQ'WHS+]X[43I
MP;I]WMBS6"Y6ZNZC2*WZ48^M?I#Y89)MBN&4+(D?>EE6\,7#J@?B>^L@]T+R
M9]F.!#F+LO]T;,S-MA.MNY/R".4R6WL^NQX4AR 92Y_88/[+3_)8^K4KL$A,
M1V(&$C.1F(7$;"1&D9B#Q%P0QN5.V^5.$^GSWS;1 TMW02MVZ%FV80ORW^.?
M&#="L6_(D)B.Q PD9B(Q"XG96VQ<8>4YV--\HHP41=6NAD_[^3E<3E:FHXFL
MJ?R"3A>H29(B\<NYA\MI$U6;3)J.N1$]VHWHD7!$_RM=!'%Q@E@/X$]D[:7D
MR0LWC'Q8%T.]>OEC,<#;.[.NH2[LJN]01V(Z$C.0F(G$+"1F;[')WHB3+B2Y
M-<X[%YI(W)]6&^<<V#VQ$#?8Q[O!/A8.]MLDBHI/[""),U*<8)$D7U6?YDN6
M!O$C82]K%F?=0UL(]QW:2$Q'8@82,[?8:/]7R/^2K<,E9B-^$1NY1A2).4C,
M!6%<+":[6$R$L?B\R5=)&OQ=',CPYP^[3_VN1 C-OHE 8CH2,Y"8B<0L)&8C
M,;K%RBF[)M?5GJ"U(T!VZH(P+D'378*FP@31V$^9ES%"@YAX;XJ3L(.^<4)B
M.A(SD)B)Q"PD9B,Q.CV,DZQUY0G9JPO"N#S-=GF:G9FGN,>9MM#L&R$DIB,Q
M XF92,Q"8C82H[.#LV>E/CEI10C9JPO"N C)4G.Y2CHO1,4^:9T&/B/E";U?
MG ,EAZDZY_1>W%_?@$$U':H94,V$:A94LZ$:K;5^TP'057!1&A^ZO6O$LC!T
MQDM>%U$480N2!5DF*4G6>37GP%Y8Z@=9YY79&S'<.UU(33^QT2/R@WEIUV>&
M 5T/$ZI94,V&:A2J.5#-16E\Q)0F8LJ)B&VGZ4C*_.0Q+D^T.O,D5'KG":GI
MM;8_\25K8_YST8!V:4(U"ZK94(U"-0>JN2B-CTY3-B +KX[.[S8/8> W,]Y_
M?F'E!<W.X@ QU3L_T/( J&9 -1.J65#-AFH4JCE0S45I?-":.@%9>X\"'1E:
M/ #5=*AF0#43JEE0S89J%*HY4,U%:7P&F\H&65S:\)9B'3'9.W"CPRJ0V5A3
MIJU#/1W:K0'53*AF034;JE&HYD U%Z7Q66H*)V1QY<3994+"ZN8;<2^]XW58
M/B!K[61!RR.@F@G5+*AF0S4*U1RHYJ(T/EE-[84L+KZX2Q.?L45&EFD25;LH
M+_99L]?Z1&*6=V8)6H!1:_M94B:C]N41'=JI =5,J&9!-1NJ4:CF0#47I?%Q
M:@HQ9'$EQO]1XB>6>P=J>A@H297;>8(65T U$ZI94,V&:A2J.5#-16E\GII"
M#%E<B6%$ZS#YP5B=IN4R\%F:B2<.H7484$V':@94,Z&:!=5LJ$:AF@/57)3&
M_W?9IFA#D=YCXE"!EFI -1VJ&5#-A&H65+.A&H5J#E1S41J?P::&0Q&7,S03
MAZ^%&X^I%^?5U&'U?[@[$P<MWX!J.E0S:HV;U52E<?M<T83V:D$U&ZI1J.9
M-1>E\5EJBC644\4:VY*GO0K$[9[LU%2AV.V=)VCY!E0S:FW&Y>E"5=IQ@A9P
M0#4;JE&HYD U%Z7Q<6H*.!1Q <<?+,O+>8RZN'!W7%COJ#J#!*WC@&HZ5#-.
MO'?:T2I%$[H>%E2SH1J%:@Y4<U$:GZVF9D,17H^>_YZ49U9EP"*O/-C;7MXJ
M(Y8G_O<Z8IT)@U9I0#4=JAFUQEUQDY59>T\%K;Z :C94HU#-@6HN2N/3U%1?
M*.+JBQ,3A\7QW]<B:L5!81FU^VV!1G5O-.'<HKC3WE&#WF,"JAE0S81J%E2S
MH1J%:@Y4<U$:'\FFB$,9O\O<(K2( ZKI4,V :B94LZ":#=4H5'.@FHO2^ PV
MY1Z*N-RCF5M,F]W?-G^;:N]WSE0CM/(#JNE0S:BU_:G&F7PXT0@M_(!J-E2C
M4,V!:BY*XX/5%'XHXL*/F\1+%R2J#AU[7*P6J[VS!+WQ!E0SH)H)U2RH9D,U
M"M4<J.:B-#YS37&(,GN7 TIHP0A4TZ&: =5,J&9!-1NJ4:CF0#47I?$W@FX*
M1E3Q73[>=+&Z-KE+N&-):Q]9W8K[[ILEJ&9 -1.J65#-AFH4JCE0S45I?)::
MP@]57/CQAJMK)T3Y'\>O.MV*V_9.%[3( ZJ94,V":C94HU#-@6HN2N/3U92"
MJ.)2D#=?7U,/[Y8QG6KM716TP@.J&5#-A&H65+.A&H5J#E1S41H?IKTO !$7
M,YPQW5$< 'X)XB#:1,(9$'%'?<^^H)H.U0RH9D(U"ZK94(U"-0>JN2B-CV%3
M,Z)J[S$#HD(K2*":#M4,J&9"-0NJV5"-0C4'JKDHC<]@4VFBGJ@T>6N)<>UR
MA;?RQ736/K*$5HE -0.JF5#-@FHV5*-0S8%J+DKCX]14B:CB6WV<>63IO9P^
MLH06BD U':H94,V$:A94LZ$:A6H.5'-1&A_#IE!$G;S+D26T5@2JZ5#-@&HF
M5+.@F@W5*%1SH)J+TO@,-C4EJKBFY.U'EM.N(\N9W#ZRA):+0#4#JIE0S8)J
M-E2C4,V!:BY*X^/4E(NHXGN)*)*LD?I;U&GLL[C\$G5R%WJQ^# 26AX"U72H
M9D U$ZI94,V&:A2J.5#-16G\]Q4WY2':N]Q/1(/>3P2JZ5#-@&HF5+.@F@W5
M*%1SH)J+TO@,-F4EVKGW$]F&SGOR@M!["%GUY3"[6SX*OT0<>G<1J*9#-0.J
MF5#-@FHV5*-:QUU9.K_A#-JMB]*VT1IF*\9RW<N]^57$TD=VR\(P(WZRB?-R
M'[?W*DG9LKQ]W>5G93 \>%V7+PVYXW53OK2JUX<-/[]:>X_LBY<^!G%&0K8L
MNI(N)J,!28/'U>Y)GJRO!\76/B1YGD35PQ7S%BPM%RA^ODR2_/5)V<%SDGZO
M-F?^/U!+ P04    " !1@0]7")(%OL "   O!@  &0   'AL+W=O<FMS:&5E
M=',O<VAE970Q-"YX;6R%5=MNVS ,_17"*X866&/':=RB2PPTS2X=UJ%HUNVA
MZ(-BT[$VV7(E.1=@'S]*3MQL2[(7ZT:><TB)]& AU4^=(QI8%J+40R\WIKKT
M?9WD6##=D166=)))53!#2S7S=:60I<ZI$'X8!)%?,%YZ\<#MW:EX(&LC>(EW
M"G1=%$RM1BCD8NAUO<W&/9_EQF[X\:!B,YR@>:CN%*W\%B7E!9::RQ(49D/O
MJGLYBJR],_C&<:&WYF CF4KYTRYNTJ$76$$H,#$6@=$PQVL4P@*1C.<UIM=2
M6L?M^0;]O8N=8IDRC==2?.>IR8?>A0<I9JP6YEXN/N(ZGK[%2Z30[@N+M6W@
M05)K(XNU,RDH>-F,;+G.PY9#&.UQ"-<.H=/=$#F58V98/%!R <I:$YJ=N%"=
M-XGCI;V4B5%TRLG/Q)-ZJO&YQM( SNFKX?@+4XK97)W \1@-XT*?P"F\6&IX
M9TWA\1:+*:HG.AQQ6>6,LK2$#TK6%7PV:>?%X AX"5]S66M6IGK@&U)N^?UD
MK7+4J SWJ/Q4BPYTS]] &(0]>)B,X?CH!#+S^E7W_.+MGW@^9:!-0]BF(70$
MO3T$8ZX3(76M$&0&I2Q/6?J#LL_+V28O+#.HZ!U64KGM"A67*3Q:*. &"_VT
M*["&]VPWKRVY2UVQ!(<>U91&-4<OIJBBX%!4O3:JWB'T^*:<HS:%O2M6R)H&
MNH9*444KL]HEMH'K.SA;SO.X2]4=#/SY#A5GK8JS@RJNJ%G8K JZ>_BUY]8:
M_@8HVN+OA?U]_/V6OW^0_Y[B9P)P28U,XR[:_C]A1V%_-VG4DD;_27U"86NT
M&5?N K1],8G5,G.[]*S4"DRN$&&%3.TLBX:DV]V2%G2"Z"]M_E;]VU9ZR]2,
MEQH$9N06=,XI--6TIV9A9.5:PE0::C!NFE-'1V4-Z#R3TFP6MLNT_XCX-U!+
M P04    " !1@0]7%K9\3$,#  !F$P  #0   'AL+W-T>6QE<RYX;6S=6-%N
MVC 4_94H7:=6F@B0-24K(&U(E29M4Z7RL+?*$ <L.7;FF [ZN,_99^U+YAN'
M$*@O8GW88$$0^Q[?<X^O;["A7^@5I_=S2K6WS+@H!OY<Z_Q=$!33.<U(T9(Y
M%09)I<J(-ETU"XI<49(4X)3QH-MN1T%&F/"'?;'(;C-=>%.Y$'K@1[7)L[>/
MR<#O1&]]S]*-9$('_L/%ZV\+J6]>>?9^]N;LK/UP>;-KORB!2S]PDEZY27_]
M^-FD;;6;S!OP8HUB]-$!FENXZA9*?'T0\3YFE+IW4$KVY ,CCK>)R['GAL=Z
MG9=N054+PWXJQ:8D0M\:#"_)J/=(^, ?$<XFBH%72C+&5];<!<-4<JD\;6K1
M!.J I7BR<,?VH$PKGHP)J<K8-H+]G%3#=X!U#P0RSFN!7=\:AOV<:$V5N#6=
M<G!I? 9Y57N\RHW"F2*K3O?*WSB4-Q-D(E5"51VFXZ]-PSZG*<A1;#:'NY9Y
M *#6,C.-A)&9%*34L/:H&H9V2CF_AV?X:[K%O4P;*]:&]1)UTPBJFI;&=H"_
MR6:YF[3=%_%Z.7N4^L/"3$>4?2@P>J=HRI9E?YG6 C#V#LY.\IROWG,V$QFU
MDS\XX+!/UG[>7"KV9*)!J4R-@2K?>Z1*LVG3\EV1?$R7>EU.RQ37W#U!S7\W
MSS,JJ"*\*=K4_C%G^<6*JTWO7V@NOU9V%3M%AM?'K[':Z(]=9'0*(D]BN7NG
M(#(^2I%!M8$W3@E;9X3:ZL%9;.!_@3,=WP3U)@O&-1-5;\Z2A(IG1P5#K\G$
M_(C8XC?C$YJ2!=?C&ASXF_9GFK!%%M>C[B 1U:A-^Q-,KQ/5!T$3BXF$+FDR
MJKIJ-BF;GFF8J-4%#KO(;7FY$<S'8FX$,"P.I@#SL5Y8G/]I/CUT/A;#M/6<
M2 _UZ:$^ULN%C,H7%L?M$YO+/=,X#L,HPC(Z&CD5C+"\11&\W6R8-O# XD"D
M/\LUOMIXA>RO VQ-]U4(-E.\$K&9XKD&Q)TW\(AC]VIC<< #6P6L=B"^.P[4
ME-LG#&%5,6W8$XPC<8PA4(ON&HTB)#L1O-SK@STE81C';@0PMX(PQ!!X&G$$
M4P :,"0,RWUP9S\*UOM4L/EG;?@;4$L#!!0    ( %&!#U>7BKL<P    !,"
M   +    7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8
M$@6*19V_K]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*N
MU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I
M2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3
MZ:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ 48$/5](F
MN\P: @  8PH   \   !X;"]W;W)K8F]O:RYX;6S%EM]OFS 0Q_\5BZ?V94!^
MM8U*I:GINDA3%RU;7R<'CN14<TYMDVS]ZWO T%Q5\O:"\@+X?#H^_F+NZ^NC
M-D\;K9_$KTJ1S:*=<_MY'-M\!Y6T'_0>B&=*;2KI>&BVL=T;D(7= ;A*Q:,D
MF<651(INKOM:*Q/[ ^T@=ZB)@TW@$>%H_\XW0W% BQM4Z'YG4?NL(!(5$E;X
M D46)9&P.WW\K V^:')2K7.CE<JBM)MX!.,P?Q=>-Y#?Y<:V$2<WWR2#9-$L
MX8(E&NO:C+:^9,8#<'(WJIW^A,J!64@']T;7>Z1M4X97$7O+:'7H[YV(<_,_
M,NJRQ!P6.J\K(-?I:$ U@&1WN+>1(%E!%O4I0E(A[LBQ2&))72G.;5;*KUX6
MW:H=XWH:FCGRA%D6+?APD#](U@4Z*,2MI@+(\M.26#ZLFH@'.0I CDX(^7/D
M08X#D.-30HX]R$D <G)*R(D'.0U 3D\).?4@9P'(V;"0]T!@I/)@+@(P%\/"
MK'%+R+F2N\W'/-<U=QO:BI56F"-8#_(R 'DY+.3=<\TMT&.Y"K!<#2Q8O;'P
M7#?=&0Y\]25*DU [3D[X)=^TNC3H&@/;QI_=+\X>I#&R,>!S<;8 )U'9<Q\R
MY!KIP+;1;;A_,X9,(QW8-=YMQ+>X/F;(-M+6-^+^4%- B03% [_"<IP/6/G*
MB.;6?93)-.6?KZR5NN785_JB9=&?D?KSW<TK4$L#!!0    ( %&!#U<0V3FJ
M_@   &$)   :    >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'/-UDW.@C 0
M@.&KD![ 85!1OX@K-VZ-%VAP^(E FTZ->GL)+G",BV]CRHJTA.FS:-ZP/5*C
M?6TZKFK+T;UM.LY4Y;W] ^"\HE;SS%CJ^C>%<:WV_=*58'5^T25!$L<IN/<9
M:K=]GQF='I;^,]$419W3WN37ECK_93#<C+MP1>15=-*N))\IN#?C-L/PP%D_
M646'<Z;<X8P*0H,2 4K"@^8"- \/6@C0(CQH*4#+\*!4@-+PH)4 K<*#U@*T
M#@_:"- F/ AC6<9X J2/6$^@UBASC1/H-<I@XP2*C3+9^,MFLW\TQ*/GM9;G
M_S+1OO^6QN.'Y6OSX_8.60;Q1[5[ E!+ P04    " !1@0]7]2O5UDT!  "\
M"@  $P   %M#;VYT96YT7U1Y<&5S72YX;6S-EMM.PS ,AE^EZNW49ATP#MIV
M ]S"+GB!T+IKM)P4>V-[>]SN((%&Q30D<M.HL?U_?V+)RN1MZP&3C=$6IVE#
MY!^$P+(!(S%W'BQ':A>,)/X-"^%EN90+$*/A<"Q*9PDL9=1JI+/)$]1RI2EY
MWO V*F>G:0"-:?*X2VQ9TU1ZKU4IB>-B;:MOE&Q/R+FRR\%&>1QP0BI.$MK(
MSX!]W>L:0E 5)',9Z$4:SA(;+9"V&C#OESCAT=6U*J%RY<IP28X^@*RP 2"C
M\YWHH)],?,.P^Q87\SN9/B!GSH/SR!T+<#[NT)*V.O,L!(%4_Q&/1):^^'S0
M=KN"ZI=LOMX/%Y9=/U!TR^5W_+7'1_TS?8PB\7$5B8_K2'S<1.)C'(F/VTA\
MW$7BXSX2'\4P%B.Q3-0BEI%:Q#)3B_\<JN_.+?_Z/=6NN9'*'OBB>[3./@%0
M2P$"% ,4    " !1@0]7!T%-8H$   "Q    $               @ $
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( %&!#U?Y%*$F[P   "L"   1
M              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M %&!#U>97)PC$ 8  )PG   3              "  <T!  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ 48$/5X7&%-A: P  J@L  !@
M     ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M %&!#U=WWZL(QP<  !$D   8              " @9X+  !X;"]W;W)K<VAE
M971S+W-H965T,BYX;6Q02P$"% ,4    " !1@0]7LPW9)=\"  "V"   &
M            @(&;$P  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#
M%     @ 48$/5Q8 SE&N"   ,BP  !@              ("!L!8  'AL+W=O
M<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( %&!#U?*S#;VEP@  ",V
M   8              " @90?  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q0
M2P$"% ,4    " !1@0]7>K"4XMT*   H.P  &               @(%A*
M>&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ 48$/5WJ*./EW
M"0  _10  !@              ("!=#,  'AL+W=O<FMS:&5E=',O<VAE970W
M+GAM;%!+ 0(4 Q0    ( %&!#U=#D>[5Q0,   T*   8              "
M@2$]  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " !1@0]7
M#G>AU\4$  !Y"P  &               @($<00  >&PO=V]R:W-H965T<R]S
M:&5E=#DN>&UL4$L! A0#%     @ 48$/5Q*+:?X*!@  $ T  !D
M     ("!%T8  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( %&!#U<6MGQ,0P,  &83   -              "
M <AB  !X;"]S='EL97,N>&UL4$L! A0#%     @ 48$/5Y>*NQS     $P(
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9>&UL4$L%!@     6 !8 T04  !IL      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>73</ContextCount>
  <ElementCount>140</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>16</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="zk2330152.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="zk2330152.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0002 - Statement - Unaudited Condensed Interim Consolidated Statements of Financial Position</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets</Role>
      <ShortName>Unaudited Condensed Interim Consolidated Statements of Financial Position</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="zk2330152.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0003 - Statement - Unaudited Condensed Interim Consolidated Statements of Financial Position (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Unaudited Condensed Interim Consolidated Statements of Financial Position (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="zk2330152.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0004 - Statement - Unaudited Condensed Interim Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss</Role>
      <ShortName>Unaudited Condensed Interim Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="zk2330152.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0005 - Statement - Unaudited Condensed Interim Consolidated Statements of Changes in Shareholders' Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfChangesInShareholdersEquity</Role>
      <ShortName>Unaudited Condensed Interim Consolidated Statements of Changes in Shareholders' Equity (Deficit)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="zk2330152.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0006 - Statement - Unaudited Condensed Interim Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Unaudited Condensed Interim Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="zk2330152.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0007 - Disclosure - General</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/General</Role>
      <ShortName>General</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="zk2330152.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0008 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="zk2330152.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0009 - Disclosure - Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/Equity</Role>
      <ShortName>Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="zk2330152.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0010 - Disclosure - Subsequent events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="zk2330152.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0011 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://mediwound.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>11</Position>
    </Report>
    <Report instance="zk2330152.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0012 - Disclosure - General (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/GENERALTextual</Role>
      <ShortName>General (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/General</ParentRole>
      <Position>12</Position>
    </Report>
    <Report instance="zk2330152.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0014 - Disclosure - Equity (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/EquityDetails</Role>
      <ShortName>Equity (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/Equity</ParentRole>
      <Position>13</Position>
    </Report>
    <Report instance="zk2330152.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0015 - Disclosure - Subsequent events (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mediwound.com/role/SubsequentEventsNarrativeDetails</Role>
      <ShortName>Subsequent events (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mediwound.com/role/SubsequentEvents</ParentRole>
      <Position>14</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="6-K" isDefinitelyFs="true" isIfrs="true" original="zk2330152.htm">zk2330152.htm</File>
    <File doctype="6-K" isDefinitelyFs="true" isIfrs="true" original="exhibit_99-2.htm">exhibit_99-2.htm</File>
    <File>mdwd-20230630.xsd</File>
    <File>mdwd-20230630_cal.xml</File>
    <File>mdwd-20230630_def.xml</File>
    <File>mdwd-20230630_lab.xml</File>
    <File>mdwd-20230630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="13">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
    <BaseTaxonomy items="575">https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>30
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "zk2330152.htm exhibit_99-2.htm": {
   "nsprefix": "mdwd",
   "nsuri": "http://mediwound.com/20230630",
   "dts": {
    "inline": {
     "local": [
      "exhibit_99-2.htm",
      "zk2330152.htm"
     ]
    },
    "schema": {
     "local": [
      "mdwd-20230630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "mdwd-20230630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "mdwd-20230630_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "mdwd-20230630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mdwd-20230630_pre.xml"
     ]
    }
   },
   "keyStandard": 111,
   "keyCustom": 29,
   "axisStandard": 9,
   "axisCustom": 1,
   "memberStandard": 6,
   "memberCustom": 10,
   "hidden": {
    "total": 18,
    "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full": 12,
    "http://xbrl.sec.gov/dei/2022": 6
   },
   "contextCount": 73,
   "entityCount": 1,
   "segmentCount": 16,
   "elementCount": 228,
   "unitCount": 9,
   "baseTaxonomies": {
    "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full": 575,
    "http://xbrl.sec.gov/dei/2022": 13
   },
   "report": {
    "R1": {
     "role": "http://mediwound.com/role/DocumentAndEntityInformation",
     "longName": "0001 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_20230101to20230630",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2330152.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20230630",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2330152.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets",
     "longName": "0002 - Statement - Unaudited Condensed Interim Consolidated Statements of Financial Position",
     "shortName": "Unaudited Condensed Interim Consolidated Statements of Financial Position",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "C_20230630",
      "name": "ifrs-full:CashAndCashEquivalents",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230630",
      "name": "ifrs-full:RestrictedCashAndCashEquivalents",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheetsParenthetical",
     "longName": "0003 - Statement - Unaudited Condensed Interim Consolidated Statements of Financial Position (Parenthetical)",
     "shortName": "Unaudited Condensed Interim Consolidated Statements of Financial Position (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "C_20230630",
      "name": "ifrs-full:ParValuePerShare",
      "unitRef": "NIS_Per_Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "ifrs-full:ParValuePerShare",
       "ifrs-full:ParValuePerShare",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230630",
      "name": "ifrs-full:NumberOfSharesAuthorised",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss",
     "longName": "0004 - Statement - Unaudited Condensed Interim Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss",
     "shortName": "Unaudited Condensed Interim Consolidated Statements of Profit or Loss and Other Comprehensive Income or Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "C_20230401to20230630",
      "name": "ifrs-full:RevenueFromSaleOfGoods",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230401to20230630",
      "name": "ifrs-full:RevenueFromSaleOfGoods",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfChangesInShareholdersEquity",
     "longName": "0005 - Statement - Unaudited Condensed Interim Consolidated Statements of Changes in Shareholders' Equity (Deficit)",
     "shortName": "Unaudited Condensed Interim Consolidated Statements of Changes in Shareholders' Equity (Deficit)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "C_20211231_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember",
      "name": "ifrs-full:Equity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20220630_ifrsfullComponentsOfEquityAxis_ifrsfullIssuedCapitalMember",
      "name": "ifrs-full:ProfitLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows",
     "longName": "0006 - Statement - Unaudited Condensed Interim Consolidated Statements of Cash Flows",
     "shortName": "Unaudited Condensed Interim Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "C_20230401to20230630",
      "name": "ifrs-full:ProfitLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230401to20230630",
      "name": "ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://mediwound.com/role/General",
     "longName": "0007 - Disclosure - General",
     "shortName": "General",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "C_20230101to20230630",
      "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20230630",
      "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://mediwound.com/role/SignificantAccountingPolicies",
     "longName": "0008 - Disclosure - Significant Accounting Policies",
     "shortName": "Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "C_20230101to20230630",
      "name": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20230630",
      "name": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://mediwound.com/role/Equity",
     "longName": "0009 - Disclosure - Equity",
     "shortName": "Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "C_20230101to20230630",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20230630",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://mediwound.com/role/SubsequentEvents",
     "longName": "0010 - Disclosure - Subsequent events",
     "shortName": "Subsequent events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "C_20230101to20230630",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20230630",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://mediwound.com/role/SignificantAccountingPoliciesPolicies",
     "longName": "0011 - Disclosure - Significant Accounting Policies (Policies)",
     "shortName": "Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "11",
     "firstAnchor": {
      "contextRef": "C_20230101to20230630",
      "name": "ifrs-full:DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20230630",
      "name": "ifrs-full:DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://mediwound.com/role/GENERALTextual",
     "longName": "0012 - Disclosure - General (Narrative) (Details)",
     "shortName": "General (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "12",
     "firstAnchor": {
      "contextRef": "C_20230101to20230630_ifrsfullBorrowingsByNameAxis_mdwdBardaMember",
      "name": "mdwd:ContractAmountForResearchDevelopmentAndManufacturing",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230101to20230630_ifrsfullBorrowingsByNameAxis_mdwdBardaMember",
      "name": "mdwd:ContractAmountForResearchDevelopmentAndManufacturing",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://mediwound.com/role/EquityDetails",
     "longName": "0014 - Disclosure - Equity (Narrative) (Details)",
     "shortName": "Equity (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "13",
     "firstAnchor": {
      "contextRef": "C_20230630",
      "name": "ifrs-full:NumberOfSharesIssued",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "ifrs-full:NumberOfSharesOutstanding",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230531",
      "name": "ifrs-full:NumberOfSharesIssued",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "unique": true
     }
    },
    "R14": {
     "role": "http://mediwound.com/role/SubsequentEventsNarrativeDetails",
     "longName": "0015 - Disclosure - Subsequent events (Narrative) (Details)",
     "shortName": "Subsequent events (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "14",
     "firstAnchor": {
      "contextRef": "C_20230717_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentsEventMember_ifrsfullTypesOfInvestmentPropertyAxis_mdwdBiopharmaxGroupLtdMember",
      "name": "ifrs-full:InvestmentProperty",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20230717_ifrsfullNonadjustingEventsAfterReportingPeriodAxis_mdwdSubsequentsEventMember_ifrsfullTypesOfInvestmentPropertyAxis_mdwdBiopharmaxGroupLtdMember",
      "name": "ifrs-full:InvestmentProperty",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "mdwd_AdditionalProceedsFromFunding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "AdditionalProceedsFromFunding",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/GENERALTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional funding amount.",
        "label": "Additional Proceeds From Funding",
        "verboseLabel": "Additional funding amount"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustedWeightedAverageShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "AdjustedWeightedAverageShares",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average number of ordinary shares used in calculating diluted earnings per share",
        "terseLabel": "Number of shares used in calculating diluted net loss per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Changes in asset and liability items, total.",
        "label": "Adjustments For Changes In Increase Decrease In Asset And Liability Items",
        "terseLabel": "Changes in asset and liability items, total",
        "totalLabel": "Changes in asset and liability items, total"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInInventories",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows": {
       "parentTag": "mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Decrease (increase) in inventories",
        "terseLabel": "(Increase) decrease in inventories",
        "verboseLabel": "Increase in inventories"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows": {
       "parentTag": "mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Decrease (increase) in other receivables",
        "terseLabel": "Decrease in other receivables",
        "verboseLabel": "Decrease (increase) in other receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in other operating receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInTradeAccountReceivable",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows": {
       "parentTag": "mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Decrease (increase) in trade receivables",
        "terseLabel": "Decrease (increase) in trade receivables",
        "verboseLabel": "(Increase) decrease in trade receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in trade accounts receivable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "AdjustmentsForDepreciationAndAmortisationExpense",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation and amortization"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ifrs-full_AdjustmentsForFinanceIncomeCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "AdjustmentsForFinanceIncomeCost",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": -1.0,
       "order": 70.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Net financing income",
        "label": "Adjustments for finance income (cost)"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for net finance income or cost to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Finance income (cost); Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 90.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments for increase (decrease) in employee benefit liabilities",
        "terseLabel": "Increase (decrease) in severance pay liability, net",
        "verboseLabel": "Increase (decrease) in severance pay liability, net"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in employee benefit liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "mdwd_AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "AdjustmentsForIncreaseDecreaseInOtherPayablesAndDeferredRevenue",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows": {
       "parentTag": "mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment for increase in other payables and deferred revenues.",
        "label": "Adjustments For Increase Decrease In Other Payables And Deferred Revenue",
        "terseLabel": "Increase (decrease) in other payables and deferred revenues",
        "verboseLabel": "Decrease in other payables and deferred revenues"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "AdjustmentsForIncreaseDecreaseInTradeAccountPayable",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows": {
       "parentTag": "mdwd_AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) in trade payables and accrued expenses",
        "verboseLabel": "Increase (decrease) in trade payables and accrued expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "mdwd_AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "AdjustmentsForIssuanceExpensesOfWarrantsThroughProfitAndLoss",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment for issuance expenses of warrants through profit and loss.",
        "label": "Adjustments For Issuance Expenses Of Warrants Through Profit And Loss",
        "terseLabel": "Issuance expenses of warrants through profit and loss"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForReconcileProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "AdjustmentsForReconcileProfitLoss",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile profit (loss)",
        "terseLabel": "Adjustments to profit and loss items, total",
        "totalLabel": "Adjustments to profit and loss items, total"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "AdjustmentsForReconcileProfitLossAbstract",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to profit and loss items:"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForSharebasedPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "AdjustmentsForSharebasedPayments",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0,
       "order": 60.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments for share-based payments",
        "verboseLabel": "Share-based compensation"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "mdwd_AdjustmentsToReconcileNetLossToNetCashUsedInContinuingOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "AdjustmentsToReconcileNetLossToNetCashUsedInContinuingOperatingActivitiesAbstract",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments To Reconcile Net Loss To Net Cash Used In Continuing Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in continuing operating activities:",
        "verboseLabel": "Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_AreaOfLand": {
     "xbrltype": "areaItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "AreaOfLand",
     "presentation": [
      "http://mediwound.com/role/SubsequentEventsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The area of land used for business by the entity.",
        "label": "Area Of Land",
        "terseLabel": "Area of land"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r72",
      "r73",
      "r74",
      "r89",
      "r92"
     ]
    },
    "mdwd_AuthorizedShareCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "AuthorizedShareCapital",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Authorized share capital.",
        "label": "Authorized Share Capital",
        "terseLabel": "Authorized: 20,000,000 shares as of June 30, 2023, 12,857,143 as of December 31, 2022; and 7,142,858 as of June 30, 2022; Issued and Outstanding: 7,252,234 as of June 30, 2023; 7,240,020 as of December 31, 2022 and 4,734,774 as of June 30, 2022",
        "totalLabel": "Total issued capital",
        "verboseLabel": "Authorized share capital"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_BardaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "BardaMember",
     "presentation": [
      "http://mediwound.com/role/GENERALTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BARDA [Member]",
        "label": "Barda [Member]",
        "verboseLabel": "BARDA"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BasicEarningsLossPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "BasicEarningsLossPerShare",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic earnings (loss) per share",
        "terseLabel": "Basic net profit (loss) per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r44"
     ]
    },
    "mdwd_BiopharmaxGroupLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "BiopharmaxGroupLtdMember",
     "presentation": [
      "http://mediwound.com/role/SubsequentEventsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Biopharmax Group Ltd [Member]",
        "label": "Biopharmax Group Ltd [Member]",
        "terseLabel": "Biopharmax Group Ltd. [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_BoardMembersAndOfficersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "BoardMembersAndOfficersMember",
     "presentation": [
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for board members and officers.",
        "label": "Board Members And Officers [Member]",
        "verboseLabel": "Board members and officers [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BorrowingsByNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "BorrowingsByNameAxis",
     "presentation": [
      "http://mediwound.com/role/GENERALTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Borrowings by name [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "ifrs-full_BorrowingsByNameMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "BorrowingsByNameMember",
     "presentation": [
      "http://mediwound.com/role/GENERALTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Borrowings by name [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all borrowings when disaggregated by name. It also represents the standard value for the 'Borrowings by name' axis if no other member is used. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "ifrs-full_BottomOfRangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "BottomOfRangeMember",
     "presentation": [
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bottom of range [member]",
        "verboseLabel": "Minimum [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the bottom of a range."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r81",
      "r98",
      "r115",
      "r117",
      "r136"
     ]
    },
    "ifrs-full_CashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "CashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets",
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Balance of cash and cash equivalents at the end of the period",
        "periodStartLabel": "Balance of cash and cash equivalents at the beginning of the period",
        "label": "Cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r11",
      "r56",
      "r69"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) decrease (increase) in short-term deposits and investments",
        "terseLabel": "Investment in short term bank deposits, net",
        "verboseLabel": "(Increase) decrease in short term bank deposits, net"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow (outflow) due to a decrease (increase) in short-term deposits and investments."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "CashFlowsFromUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) financing activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r58"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Financing Activities:"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Investing Activities:"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "CashFlowsFromUsedInInvestingActivitiesContinuingOperations",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Net cash flows from (used in) investing activities, continuing operations",
        "label": "Cash flows from (used in) investing activities, continuing operations",
        "terseLabel": "Net cash provided by (used in) continuing investing activities",
        "totalLabel": "Net cash used in investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) the entity's investing activities, related to continuing operations. [Refer: Continuing operations [member]; Cash flows from (used in) investing activities]"
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "CashFlowsFromUsedInOperatingActivities",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operating activities",
        "terseLabel": "Cash used in operating activities",
        "totalLabel": "Net cash (used in) operating activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]"
       }
      }
     },
     "auth_ref": [
      "r50",
      "r58"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Operating Activities:",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CategoriesOfRelatedPartiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "CategoriesOfRelatedPartiesAxis",
     "presentation": [
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Categories of related parties [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "mdwd_ChangesInAssetAndLiabilityItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "ChangesInAssetAndLiabilityItemsAbstract",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes In Asset And Liability Items [Abstract]",
        "terseLabel": "Changes in asset and liability items:"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ClassesOfShareCapitalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "ClassesOfShareCapitalAxis",
     "presentation": [
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of share capital [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "ifrs-full_ClassesOfShareCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "ClassesOfShareCapitalMember",
     "presentation": [
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share capital [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "ifrs-full_ComponentsOfEquityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "ComponentsOfEquityAxis",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of equity [Axis]",
        "verboseLabel": "Components of equity [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ifrs-full_ComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "ComprehensiveIncome",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfChangesInShareholdersEquity",
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive income",
        "terseLabel": "Total comprehensive loss",
        "totalLabel": "Total comprehensive profit (loss)",
        "verboseLabel": "Total comprehensive income (loss)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r22",
      "r60",
      "r62",
      "r67",
      "r113"
     ]
    },
    "mdwd_ContractAmountForResearchDevelopmentAndManufacturing": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "ContractAmountForResearchDevelopmentAndManufacturing",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/GENERALTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of contract for research, development and manufacturing.",
        "label": "Contract Amount For Research Development And Manufacturing",
        "verboseLabel": "Contract amount for research, development and manufacturing"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_ContractWithCustomers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "ContractWithCustomers",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/GENERALTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of contract with customers.",
        "label": "Contract With Customers",
        "terseLabel": "Contracts with customers"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_CostOfLicenseAgreements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "CostOfLicenseAgreements",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_CostOfSales",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of cost of license agreements.",
        "label": "Cost Of License Agreements",
        "verboseLabel": "Cost of revenues from license agreements"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CostOfMerchandiseSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "CostOfMerchandiseSold",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_CostOfSales",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of merchandise sold",
        "verboseLabel": "Cost of revenues from sale of products"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of merchandise that was sold during the period and recognised as an expense."
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ifrs-full_CostOfSales": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "CostOfSales",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_GrossProfit",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of revenues",
        "totalLabel": "Total cost of revenues"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r27"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "CurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets",
        "totalLabel": "Total current assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]"
       }
      }
     },
     "auth_ref": [
      "r13",
      "r63",
      "r113"
     ]
    },
    "ifrs-full_CurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "CurrentAssetsAbstract",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CURRENT ASSETS:"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "CurrentLeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current maturities of non-current liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "ifrs-full_CurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "CurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities",
        "totalLabel": "Total current liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.\nEffective 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r65",
      "r113"
     ]
    },
    "ifrs-full_CurrentLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "CurrentLiabilitiesAbstract",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CURRENT LIABILITIES:"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentTradeReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "CurrentTradeReceivables",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current trade receivables. [Refer: Trade receivables]"
       }
      }
     },
     "auth_ref": [
      "r104",
      "r106"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForDiscontinuedOperationsExplanatory",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued operation"
       }
      },
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for discontinued operations. [Refer: Discontinued operations [member]]\nEffective 2023-01-01: The description of the entity's material accounting policy information for discontinued operations. [Refer: Discontinued operations [member]]"
       }
      }
     },
     "auth_ref": [
      "r137",
      "r138"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForEarningsPerShareExplanatory",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss per share"
       }
      },
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for earnings per share.\nEffective 2023-01-01: The description of the entity's material accounting policy information for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r138"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-term employee benefits and severance pay liability, net"
       }
      },
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for employee benefits. Employee benefits are all forms of consideration given by an entity in exchange for services rendered by employees or for the termination of employment.\nEffective 2023-01-01: The description of the entity's material accounting policy information for employee benefits. Employee benefits are all forms of consideration given by an entity in exchange for services rendered by employees or for the termination of employment."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r138"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial instruments"
       }
      },
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for financial instruments. [Refer: Financial instruments, class [member]]\nEffective 2023-01-01: The description of the entity's material accounting policy information for financial instruments. [Refer: Financial instruments, class [member]]"
       }
      }
     },
     "auth_ref": [
      "r137",
      "r138"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Functional currency, reporting currency and foreign currency"
       }
      },
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for foreign currency translation.\nEffective 2023-01-01: The description of the entity's material accounting policy information for foreign currency translation."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r138"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForGovernmentGrants",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Participation by governments support"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for government grants, including the methods of presentation adopted in the financial statements. [Refer: Government [member]; Government grants]"
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment of non-financial assets"
       }
      },
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for the impairment of non-financial assets. [Refer: Financial assets]\nEffective 2023-01-01: The description of the entity's material accounting policy information for the impairment of non-financial assets. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r137",
      "r138"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of accounting policy for intangible assets other than goodwill [text block]",
        "verboseLabel": "Intangible assets, net"
       }
      },
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]\nEffective 2023-01-01: The description of the entity's material accounting policy information for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r137",
      "r138"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForLeasesExplanatory",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases"
       }
      },
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time.\nEffective 2023-01-01: The description of the entity's material accounting policy information for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r138"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForMeasuringInventories",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of accounting policy for measuring inventories [text block]",
        "verboseLabel": "Inventories"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for measuring inventories. [Refer: Inventories]"
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of accounting policy for property, plant and equipment [text block]",
        "verboseLabel": "Property, plant and equipment, net"
       }
      },
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for property, plant and equipment. [Refer: Property, plant and equipment]\nEffective 2023-01-01: The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r137",
      "r138"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForProvisionsExplanatory",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provisions"
       }
      },
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for provisions. [Refer: Provisions]\nEffective 2023-01-01: The description of the entity's material accounting policy information for provisions. [Refer: Provisions]"
       }
      }
     },
     "auth_ref": [
      "r137",
      "r138"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForReclassificationOfFinancialInstrumentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForReclassificationOfFinancialInstrumentsExplanatory",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reclassification"
       }
      },
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for the reclassification of financial instruments. [Refer: Financial instruments, class [member]]\nEffective 2023-01-01: The description of the entity's material accounting policy information for the reclassification of financial instruments. [Refer: Financial instruments, class [member]]"
       }
      }
     },
     "auth_ref": [
      "r137",
      "r138"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForRecognitionOfRevenue",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue recognition"
       }
      },
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for recognising revenue. [Refer: Revenue]\nEffective 2023-01-01: The description of the entity's material accounting policy information for recognising revenue. [Refer: Revenue]"
       }
      }
     },
     "auth_ref": [
      "r137",
      "r138"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for research and development expense. [Refer: Research and development expense]\nEffective 2023-01-01: The description of the entity's material accounting policy information for research and development expense. [Refer: Research and development expense]"
       }
      }
     },
     "auth_ref": [
      "r137",
      "r138"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of accounting policy for share-based payment transactions [text block]",
        "verboseLabel": "Share-based compensation"
       }
      },
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The description of the entity's accounting policy for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]\nEffective 2023-01-01: The description of the entity's material accounting policy information for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]"
       }
      }
     },
     "auth_ref": [
      "r137",
      "r138"
     ]
    },
    "mdwd_DescriptionOfAccountingPolicyForShorttermBankDepositsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "DescriptionOfAccountingPolicyForShorttermBankDepositsExplanatory",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of the entity's accounting policy for short-term bank deposits.",
        "label": "Description Of Accounting Policy For Shortterm Bank Deposits Explanatory",
        "verboseLabel": "Short-term bank deposits"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "mdwd_DescriptionOfOtherAccountingPoliciesBasisOfPreparationOfInterimConsolidatedFinancialStatementsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "DescriptionOfOtherAccountingPoliciesBasisOfPreparationOfInterimConsolidatedFinancialStatementsExplanatory",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of accounting policies basis of preparation of the interim consolidated financial statements.",
        "label": "Description Of Other Accounting Policies Basis Of Preparation Of Interim Consolidated Financial Statements Explanatory",
        "terseLabel": "Basis of preparation of the interim consolidated financial statements"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_DescriptionOfOtherAccountingPoliciesChangesInSignificantAccountingPoliciesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "DescriptionOfOtherAccountingPoliciesChangesInSignificantAccountingPoliciesExplanatory",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The description of accounting policies changes in significant accounting policies.",
        "label": "Description Of Other Accounting Policies Changes In Significant Accounting Policies Explanatory"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of presentation of financial statements"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of accounting policies relevant to an understanding of financial statements, which the entity does not separately disclose."
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "DescriptionOfVestingRequirementsForSharebasedPaymentArrangement",
     "presentation": [
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of vesting requirements for share-based payment arrangement",
        "verboseLabel": "Vesting period of share options"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the vesting requirements for a type of share-based payment arrangement that existed at any time during the period. An entity with substantially similar types of share-based payment arrangements may aggregate this information. [Refer: Share-based payment arrangements [member]]"
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "ifrs-full_DilutedEarningsLossPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "DilutedEarningsLossPerShare",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "commentaryGuidance": "The reported value should be tagged twice, with both this element and the element \u2018Basic earnings (loss) per share\u2019 when: (a) basic and diluted earnings per share are equal; and (b) an entity presents one line item to accomplish the dual presentation requirement of paragraph 67 of IAS 33.",
        "label": "Diluted earnings (loss) per share",
        "terseLabel": "Diluted net profit (loss) per share",
        "totalLabel": "Total diluted earnings (loss) per share",
        "verboseLabel": "Basic and diluted net profit (loss) per share - USD"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r43",
      "r44"
     ]
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "DisclosureOfClassesOfShareCapitalLineItems",
     "presentation": [
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of classes of share capital [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "DisclosureOfClassesOfShareCapitalTable",
     "presentation": [
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of classes of share capital [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to classes of share capital."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "ifrs-full_DisclosureOfDepositaryReceiptsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "DisclosureOfDepositaryReceiptsAbstract",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of depositary receipts [abstract]",
        "terseLabel": "Loss per share data:"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory",
     "presentation": [
      "http://mediwound.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of events after reporting period [text block]",
        "terseLabel": "Subsequent events"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for events after the reporting period."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
     "presentation": [
      "http://mediwound.com/role/General"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GENERAL",
        "terseLabel": "General"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for general information about financial statements."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "mdwd_DisclosureOfGeneralInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "DisclosureOfGeneralInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of General Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of non-adjusting events after reporting period [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems",
     "presentation": [
      "http://mediwound.com/role/SubsequentEventsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of non-adjusting events after reporting period [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodTable",
     "presentation": [
      "http://mediwound.com/role/SubsequentEventsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of non-adjusting events after reporting period [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to non-adjusting events after the reporting period."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
     "presentation": [
      "http://mediwound.com/role/Equity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "EQUITY",
        "terseLabel": "Equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for share capital, reserves and other equity interest."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "mdwd_DisclosureOfSignificantAccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "DisclosureOfSignificantAccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of significant accounting policies [Abstract]",
        "verboseLabel": "Significant Accounting Policies"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "DisclosureOfSignificantInvestmentsInAssociatesLineItems",
     "presentation": [
      "http://mediwound.com/role/GENERALTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of associates [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "DisclosureOfSignificantInvestmentsInAssociatesTable",
     "presentation": [
      "http://mediwound.com/role/GENERALTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of associates [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to associates."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r42",
      "r71"
     ]
    },
    "ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
     "presentation": [
      "http://mediwound.com/role/SignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SIGNIFICANT ACCOUNTING POLICIES",
        "terseLabel": "Significant Accounting Policies"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for significant accounting policies applied by the entity."
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentType",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange rate differences on cash and cash equivalent balances"
       }
      },
      "en": {
       "role": {
        "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r53",
      "r54"
     ]
    },
    "mdwd_EmployeesAndOfficersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "EmployeesAndOfficersMember",
     "presentation": [
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employees and Officers [Member]",
        "label": "Employees And Officers [Member]",
        "verboseLabel": "Employees and officers [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityDomain",
     "presentation": [
      "http://mediwound.com/role/GENERALTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://mediwound.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ifrs-full_EntitysTotalForRelatedPartiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "EntitysTotalForRelatedPartiesMember",
     "presentation": [
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity's total for related parties [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "ifrs-full_Equity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "Equity",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets",
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "label": "Equity",
        "totalLabel": "Total equity (deficit)",
        "verboseLabel": "Shareholders' equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r15",
      "r59",
      "r61",
      "r72",
      "r73",
      "r74"
     ]
    },
    "ifrs-full_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "EquityAbstract",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHAREHOLDERS' EQUITY:",
        "verboseLabel": "Shareholders' equity:"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EquityAndLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "EquityAndLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity and liabilities",
        "totalLabel": "Total liabilities and equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]"
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "mdwd_EquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "EquityIncentivePlanMember",
     "presentation": [
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2014 Equity Incentive Plan (the \"2014 Plan\") [Member]",
        "label": "Equity Incentive Plan [Member]",
        "verboseLabel": "2014 Equity Incentive Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EquityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "EquityMember",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense from share-based payment transactions",
        "terseLabel": "Expenses recognized"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense arising from share-based payment transactions in which the goods or services received did not qualify for recognition as assets."
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "mdwd_ExtensionPeriodForOptionsExercised": {
     "xbrltype": "durationItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "ExtensionPeriodForOptionsExercised",
     "presentation": [
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension period for options exercised.",
        "label": "Extension Period For Options Exercised",
        "terseLabel": "Extension period for options exercised"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "FinanceCosts",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "mdwd_FinanceIncomeExpenseNet",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Financial expenses",
        "label": "Finance costs"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of costs associated with financing activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "ifrs-full_FinanceIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "FinanceIncome",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "mdwd_FinanceIncomeExpenseNet",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income associated with interest and other financing activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "mdwd_FinanceIncomeExpenseNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "FinanceIncomeExpenseNet",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of financing income (expenses), net.",
        "label": "Finance Income Expense Net",
        "totalLabel": "Financing income (expenses), net"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": -1.0,
       "order": 80.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Un-realized foreign currency loss",
        "label": "Foreign exchange gain (loss)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Financial instruments, class [member]]"
       }
      }
     },
     "auth_ref": [
      "r5",
      "r37"
     ]
    },
    "ifrs-full_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross profit",
        "totalLabel": "Gross profit"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "ifrs-full_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit or loss [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncomeTaxExpenseContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "IncomeTaxExpenseContinuingOperations",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Taxes on income",
        "label": "Tax expense (income)",
        "terseLabel": "Taxes on income"
       }
      },
      "en": {
       "role": {
        "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]"
       }
      }
     },
     "auth_ref": [
      "r25",
      "r30",
      "r31",
      "r32",
      "r40",
      "r70",
      "r88"
     ]
    },
    "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "IncreaseDecreaseInCashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) in cash and cash equivalents",
        "totalLabel": "Increase (decrease) in cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughExerciseOfOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "IncreaseDecreaseThroughExerciseOfOptions",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) through exercise of options, equity",
        "verboseLabel": "Exercise of options"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from the exercise of options."
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "IncreaseDecreaseThroughExerciseOfWarrantsEquity",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) through exercise of warrants, equity",
        "terseLabel": "Exercise of pre-funded warrants"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from the exercise of warrants."
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based compensation"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]"
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "mdwd_IncreaseInAuthorizedShareCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "IncreaseInAuthorizedShareCapital",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents Increase In authorized share capital.",
        "label": "Increase In Authorized Share Capital",
        "verboseLabel": "Increase Iin authorized share capital"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_IncreaseInPricePerShareOfSharesIssued": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "IncreaseInPricePerShareOfSharesIssued",
     "presentation": [
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the per share or per unit amount of equity securities issued.",
        "label": "Increase In Price Per Share Of Shares Issued",
        "verboseLabel": "Increase in price per common shares issued"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_IncreaseInRentAsPercentageInEveryThreeYear": {
     "xbrltype": "percentItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "IncreaseInRentAsPercentageInEveryThreeYear",
     "presentation": [
      "http://mediwound.com/role/SubsequentEventsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase In Rent As Percentage In Every Three Year.",
        "label": "Increase In Rent As Percentage In Every Three Year",
        "terseLabel": "Increase in rent as percentage in every three years"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_IncreaseInSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "IncreaseInSharesIssued",
     "presentation": [
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase In Shares Issued.",
        "label": "Increase In Shares Issued",
        "terseLabel": "Increase In shares issued"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "IntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets, net"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]"
       }
      }
     },
     "auth_ref": [
      "r9",
      "r46"
     ]
    },
    "ifrs-full_InterestReceivedClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "InterestReceivedClassifiedAsInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest received, classified as investing activities",
        "terseLabel": "Interest received"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from interest received, classified as investing activities."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "ifrs-full_Inventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "Inventories",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventories"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current inventories. [Refer: Inventories]"
       }
      }
     },
     "auth_ref": [
      "r10",
      "r35",
      "r104"
     ]
    },
    "ifrs-full_InvestmentProperty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "InvestmentProperty",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/SubsequentEventsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment property",
        "terseLabel": "Investment amount in property"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of property (land or a building - or part of a building - or both) held (by the owner or by the lessee as a right-of-use asset) to earn rentals or for capital appreciation or both, rather than for: (a) use in the production or supply of goods or services or for administrative purposes; or (b) sale in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r48",
      "r49"
     ]
    },
    "ifrs-full_InvestmentPropertyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "InvestmentPropertyMember",
     "presentation": [
      "http://mediwound.com/role/SubsequentEventsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment property [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for investment property. It also represents the standard value for the 'Types of investment property' axis if no other member is used. [Refer: Investment property]"
       }
      }
     },
     "auth_ref": [
      "r114",
      "r116",
      "r124"
     ]
    },
    "ifrs-full_IssueOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "IssueOfEquity",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issue of equity",
        "terseLabel": "Issuance of ordinary shares, net of issuance expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase in equity through the issue of equity instruments."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ifrs-full_IssuedCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "IssuedCapital",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issued capital",
        "terseLabel": "Ordinary shares of NIS 0.01 par value: Authorized: 20,000,000 shares as of June 30, 2023, 12,857,143 as of December 31, 2022; and 7,142,858 as of June 30, 2022; Issued and Outstanding: 7,252,234 as of June 30, 2023; 7,240,020 as of December 31, 2022 and 4,734,774 as of June 30, 2022",
        "verboseLabel": "Authorized share capital"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal value of capital issued."
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "ifrs-full_IssuedCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "IssuedCapitalMember",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share capital [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing issued capital."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://mediwound.com/role/GENERALTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r72",
      "r73",
      "r74",
      "r89",
      "r93"
     ]
    },
    "ifrs-full_LicenceFeeIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "LicenceFeeIncome",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_Revenue",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues from license agreements"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income arising from licence fees."
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "mdwd_NonCashTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "NonCashTransactionsAbstract",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Cash Transactions [Abstract]",
        "verboseLabel": "Supplement disclosure of Non-cash transactions:"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NonadjustingEventsAfterReportingPeriodAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "NonadjustingEventsAfterReportingPeriodAxis",
     "presentation": [
      "http://mediwound.com/role/SubsequentEventsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-adjusting events after reporting period [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "ifrs-full_NonadjustingEventsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "NonadjustingEventsMember",
     "presentation": [
      "http://mediwound.com/role/SubsequentEventsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-adjusting events after reporting period [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "ifrs-full_NoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "NoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current assets",
        "totalLabel": "Total non-current assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]"
       }
      }
     },
     "auth_ref": [
      "r13",
      "r64",
      "r113"
     ]
    },
    "ifrs-full_NoncurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "NoncurrentAssetsAbstract",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LONG-TERM ASSETS:",
        "verboseLabel": "LONG?TERM ASSETS:"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentGovernmentGrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "NoncurrentGovernmentGrants",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability in respect of IIA grants",
        "verboseLabel": "Liabilities in respect of IIA grants"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current government grants recognised on the statement of financial position as deferred income. [Refer: Government [member]; Government grants]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "mdwd_NoncurrentLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "NoncurrentLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncurrent lease liability.",
        "label": "Noncurrent Lease Liability",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "NoncurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current liabilities",
        "totalLabel": "Total non-current liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]"
       }
      }
     },
     "auth_ref": [
      "r14",
      "r66",
      "r113"
     ]
    },
    "ifrs-full_NoncurrentLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "NoncurrentLiabilitiesAbstract",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LONG-TERM LIABILITIES:"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "NoncurrentRecognisedLiabilitiesDefinedBenefitPlan",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Severance pay liability, net"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current net defined benefit liability. [Refer: Net defined benefit liability]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "ifrs-full_NoncurrentWarrantLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "NoncurrentWarrantLiability",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current warrant liability",
        "terseLabel": "Warrants"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current warrant liabilities. [Refer: Warrant liability]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "NumberOfInstrumentsOtherEquityInstrumentsGranted",
     "presentation": [
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of other equity instruments granted in share-based payment arrangement",
        "verboseLabel": "Number of restricted share units granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r135"
     ]
    },
    "mdwd_NumberOfPatients": {
     "xbrltype": "integerItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "NumberOfPatients",
     "presentation": [
      "http://mediwound.com/role/GENERALTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of patients.",
        "label": "Number Of Patients",
        "terseLabel": "Number of patients"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_NumberOfShareAvailableForIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "NumberOfShareAvailableForIssuance",
     "presentation": [
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share available for issuance.",
        "label": "Number Of Share Available For Issuance",
        "terseLabel": "Number of share available for issuance"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "NumberOfShareOptionsGrantedInSharebasedPaymentArrangement",
     "presentation": [
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of share options granted in share-based payment arrangement",
        "verboseLabel": "Number of options granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options granted in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "ifrs-full_NumberOfSharesAuthorised": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "NumberOfSharesAuthorised",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares authorised",
        "verboseLabel": "Number of shares authorised"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of shares authorised."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "ifrs-full_NumberOfSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "NumberOfSharesIssued",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheetsParenthetical",
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares issued"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of shares issued by the entity."
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ifrs-full_NumberOfSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "NumberOfSharesOutstanding",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary shares, Outstanding"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]"
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "ifrs-full_OperatingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "OperatingExpense",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating expense",
        "totalLabel": "Total operating expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of all operating expenses."
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ifrs-full_OtherComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "OtherComprehensiveIncomeAbstract",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive income (loss):",
        "verboseLabel": "Other comprehensive income:"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherCurrentPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "OtherCurrentPayables",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other payables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current payables that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "ifrs-full_OtherCurrentReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "OtherCurrentReceivables",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current other receivables. [Refer: Other receivables]"
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "ifrs-full_OtherExpenseByFunction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "OtherExpenseByFunction",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expenses that the entity does not separately disclose in the same statement or note when the entity uses the 'function of expense' form for its analysis of expenses."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r39",
      "r102"
     ]
    },
    "ifrs-full_OtherNoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "OtherNoncurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent consideration for purchase of shares",
        "verboseLabel": "Liabilities in respect of TEVA"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Non-current liabilities]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "ifrs-full_OtherNoncurrentReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "OtherNoncurrentReceivables",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other non-current receivables",
        "terseLabel": "Other receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current other receivables. [Refer: Other receivables]"
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "ifrs-full_ParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "ParValuePerShare",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheetsParenthetical",
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Par value per share",
        "terseLabel": "Ordinary shares, par value (per share)"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal value per share."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "mdwd_ParticipationsByBardaAndIia": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "ParticipationsByBardaAndIia",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Participations by BARDA and IIA",
        "label": "Participations by BARDA and IIA"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayment of leases liabilities",
        "label": "Payments of lease liabilities, classified as financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "ifrs-full_ProceedsFromExerciseOfOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "ProceedsFromExerciseOfOptions",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from exercise of options",
        "terseLabel": "Proceeds from exercise of options"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from the exercise of options."
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ifrs-full_ProceedsFromExerciseOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "ProceedsFromExerciseOfWarrants",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from exercise of warrants",
        "terseLabel": "Proceeds from exercise of pre-funded warrants"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from the exercise of share purchase warrants."
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ifrs-full_ProceedsFromIssuingShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "ProceedsFromIssuingShares",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuing shares",
        "terseLabel": "Proceeds from issuance of shares, net",
        "verboseLabel": "Proceeds from (Repayment of) issuance of shares and warrants, net"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from issuing shares."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "ifrs-full_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 0.0
      },
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows",
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfChangesInShareholdersEquity",
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "positiveTerseLabel": "Profit (loss) for the period",
        "label": "Loss for the period",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net profit (loss)",
        "verboseLabel": "Net Profit (loss)"
       }
      },
      "en": {
       "role": {
        "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r2",
      "r21",
      "r51",
      "r60",
      "r62",
      "r89",
      "r91",
      "r113",
      "r120",
      "r121"
     ]
    },
    "ifrs-full_ProfitLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "ProfitLossBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit (loss) before tax",
        "terseLabel": "Loss before taxes on income",
        "totalLabel": "Profit (loss) before taxes on income"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r85",
      "r101",
      "r102",
      "r118",
      "r119"
     ]
    },
    "ifrs-full_ProfitLossFromOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "ProfitLossFromOperatingActivities",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit (loss) from operating activities",
        "totalLabel": "Operating loss"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r109",
      "r128"
     ]
    },
    "ifrs-full_PropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "PropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, plant and equipment, net"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r33"
     ]
    },
    "mdwd_PublicOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "PublicOfferingMember",
     "presentation": [
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "Public Offering [Member]",
        "terseLabel": "Public offering [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of property and equipment",
        "label": "Purchase of property, plant and equipment, classified as investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "ifrs-full_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "RangeAxis",
     "presentation": [
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r81",
      "r98",
      "r115",
      "r117",
      "r136"
     ]
    },
    "ifrs-full_RangesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "RangesMember",
     "presentation": [
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ranges [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r81",
      "r98",
      "r115",
      "r117",
      "r136"
     ]
    },
    "ifrs-full_ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "ReclassificationAdjustmentsOnChangeInValueOfForeignCurrencyBasisSpreadsNetOfTax",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfChangesInShareholdersEquity",
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Foreign currency translation adjustments",
        "negatedNetLabel": "Other comprehensive loss",
        "negatedTerseLabel": "Other comprehensive income (loss)",
        "label": "Reclassification adjustments on change in value of foreign currency basis spreads, net of tax",
        "terseLabel": "Foreign currency translation adjustments",
        "totalLabel": "Total other comprehensive income",
        "verboseLabel": "Other comprehensive income (loss)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of reclassification adjustments related to change in value of foreign currency basis spreads, net of tax. Reclassification adjustments are amounts reclassified to profit (loss) in the current period that were recognised in other comprehensive income in the current or previous periods. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "ifrs-full_RentDeferredIncomeClassifiedAsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "RentDeferredIncomeClassifiedAsNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred revenues"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of rent deferred income classified as non-current. [Refer: Rent deferred income]"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ifrs-full_RentalExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "RentalExpense",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/SubsequentEventsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rental expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense recognised on rental activities."
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "mdwd_RepaymentFromGrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "RepaymentFromGrants",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayment from grants during the period.",
        "negatedLabel": "Repayment of IIA grants, net",
        "label": "Repayment From Grants",
        "terseLabel": "Repayments of IIA grant"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_RepaymentOfLiabilitiesInRespectOfTeva": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "RepaymentOfLiabilitiesInRespectOfTeva",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the amount of Repayment of liabilities in respect of TEVA.",
        "negatedLabel": "Repayment of liabilities in respect of TEVA",
        "label": "Repayment Of Liabilities In Respect Of Teva"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "RepaymentOfProceedsFromIssuanceOfSharesAndWarrantsNet",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from (Repayment of) issuance of shares and warrants.",
        "negatedLabel": "Proceeds from (Repayment of) issuance of shares and warrants, net",
        "label": "Repayment Of Proceeds From Issuance Of Shares And Warrants Net",
        "terseLabel": "Proceeds from issuance of shares, net",
        "verboseLabel": "Proceeds from (Repayment of) issuance of shares and warrants, net"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_ReplenishmentAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "ReplenishmentAmount",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/GENERALTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of replenishment.",
        "label": "Replenishment Amount",
        "terseLabel": "Replenishment amount"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development, net of participations",
        "terseLabel": "Research and development"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expenditure directly attributable to research or development activities, recognised in profit or loss."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "mdwd_ResearchAndDevelopmentExpenseGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "ResearchAndDevelopmentExpenseGross",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and development, gross",
        "label": "Research And Development Expense Gross",
        "terseLabel": "Research and development, gross"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreads": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "ReserveOfChangeInValueOfForeignCurrencyBasisSpreads",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign currency translation adjustments"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity representing the accumulated change in the value of foreign currency basis spreads of financial instruments when excluding them from the designation of these financial instruments as hedging instruments."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r126"
     ]
    },
    "ifrs-full_ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "ReserveOfChangeInValueOfForeignCurrencyBasisSpreadsMember",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign currency translation reserve [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing the accumulated change in the value of foreign currency basis spreads of financial instruments when excluding them from the designation of these financial instruments as hedging instruments."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r103"
     ]
    },
    "ifrs-full_RestrictedCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "RestrictedCashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted deposits"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash and cash equivalents whose use or withdrawal is restricted. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "mdwd_RestrictedSharesUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "RestrictedSharesUnitsMember",
     "presentation": [
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Shares Unit [Member]",
        "label": "Restricted Shares Units [Member]",
        "verboseLabel": "Restricted Shares Units [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RetainedEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "RetainedEarnings",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated deficit",
        "terseLabel": "Accumulated deficit"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r108"
     ]
    },
    "ifrs-full_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated deficit [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r103"
     ]
    },
    "mdwd_RevaluationOfLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "RevaluationOfLeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revaluation of lease liabilities",
        "negatedLabel": "Revaluation of lease liabilities",
        "label": "Revaluation Of Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_RevaluationOfLiabilitiesInRespectOfGrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "RevaluationOfLiabilitiesInRespectOfGrants",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revaluation of liabilities in respect of IIA grants.",
        "negatedLabel": "Revaluation of liabilities in respect of IIA grants",
        "label": "Revaluation Of Liabilities In Respect Of Grants"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_RevaluationOfLiabilitiesInRespectOfTeva": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "RevaluationOfLiabilitiesInRespectOfTeva",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": -1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the amount of Revaluation of liabilities in respect of TEVA.",
        "negatedLabel": "Revaluation of liabilities in respect of TEVA",
        "label": "Revaluation Of Liabilities In Respect Of Teva"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_RevaluationOfWarrantsAccountedAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "RevaluationOfWarrantsAccountedAtFairValue",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": -1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the amount of Revaluation of warrants accounted at fair value.",
        "negatedLabel": "Revaluation of warrants accounted at fair value",
        "label": "Revaluation Of Warrants Accounted At Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Revenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "Revenue",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_GrossProfit",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue",
        "totalLabel": "Total revenues"
       }
      },
      "en": {
       "role": {
        "documentation": "The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r68",
      "r85",
      "r87",
      "r90",
      "r94",
      "r95",
      "r96",
      "r101",
      "r102",
      "r113"
     ]
    },
    "ifrs-full_RevenueFromRenderingOfServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "RevenueFromRenderingOfServices",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_Revenue",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues from development services"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of revenue arising from the rendering of services. [Refer: Revenue]"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "ifrs-full_RevenueFromSaleOfGoods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "RevenueFromSaleOfGoods",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_Revenue",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues from sale of products"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of revenue arising from the sale of goods. [Refer: Revenue]"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "ifrs-full_RightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "RightofuseAssets",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right of-use assets, net"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ifrs-full_RightofuseAssetsIncreaseDecreaseInRevaluationSurplus": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "RightofuseAssetsIncreaseDecreaseInRevaluationSurplus",
     "crdr": "credit",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets, increase (decrease) in revaluation surplus",
        "verboseLabel": "ROU asset, net recognized with corresponding lease liability"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the revaluation surplus that relates to right-of-use assets. [Refer: Revaluation surplus; Right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "mdwd_SaleOfStocksAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "SaleOfStocksAxis",
     "presentation": [
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale Of Stocks [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_SaleOfStocksDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "SaleOfStocksDomain",
     "presentation": [
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale Of Stocks [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SalesAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "SalesAndMarketingExpense",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling and marketing"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense relating to the marketing and selling of goods or services."
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ifrs-full_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_OperatingExpense",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and administrative"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense relating to selling, general and administrative activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ifrs-full_ServicesExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "ServicesExpense",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss": {
       "parentTag": "ifrs-full_CostOfSales",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Services expense",
        "verboseLabel": "Cost of revenues from development services"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense arising from services."
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ifrs-full_ShareIssueRelatedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "ShareIssueRelatedCost",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfChangesInShareholdersEquity",
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Issuance expenses",
        "label": "Share issue related cost",
        "verboseLabel": "Commissions and other offering expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cost related to the issuance of shares."
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "mdwd_ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "ShareOptionsInShareBasedPaymentArrangementExercisePricePerShare",
     "presentation": [
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of exercise price per share.",
        "label": "Share Options In Share Based Payment Arrangement Exercise Price Per Share",
        "verboseLabel": "Exercise price per share"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SharePremium": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "SharePremium",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share premium"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount received or receivable from the issuance of the entity's shares in excess of nominal value."
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "ifrs-full_SharePremiumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "SharePremiumMember",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share premium [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the amount received or receivable from issuance of the entity's shares in excess of nominal value."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ifrs-full_SharebasedPaymentArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "SharebasedPaymentArrangementsMember",
     "presentation": [
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based payment arrangements [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "ShorttermDepositsClassifiedAsCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-term bank deposits",
        "terseLabel": "Short?term bank deposits"
       }
      },
      "en": {
       "role": {
        "documentation": "A classification of cash equivalents representing short-term deposits. [Refer: Cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "ifrs-full_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of cash flows [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "StatementOfChangesInEquityAbstract",
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "StatementOfChangesInEquityLineItems",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "StatementOfChangesInEquityTable",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to changes in equity."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ifrs-full_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of financial position [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_StockOptionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "StockOptionValue",
     "crdr": "debit",
     "presentation": [
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents value of stock option.",
        "label": "Stock Option Value",
        "verboseLabel": "Total estimated value of stock option"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_SubsequentsEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "SubsequentsEventMember",
     "presentation": [
      "http://mediwound.com/role/SubsequentEventsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequents Event [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TopOfRangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "TopOfRangeMember",
     "presentation": [
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Top of range [member]",
        "verboseLabel": "Maximum [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for top of a range."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r81",
      "r98",
      "r115",
      "r117",
      "r136"
     ]
    },
    "ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "TradeAndOtherCurrentPayablesToTradeSuppliers",
     "crdr": "credit",
     "calculation": {
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade payables and accrued expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]"
       }
      }
     },
     "auth_ref": [
      "r105",
      "r127"
     ]
    },
    "ifrs-full_TypesOfInvestmentPropertyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "TypesOfInvestmentPropertyAxis",
     "presentation": [
      "http://mediwound.com/role/SubsequentEventsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of investment property [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "TypesOfSharebasedPaymentArrangementsAxis",
     "presentation": [
      "http://mediwound.com/role/EquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of share-based payment arrangements [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "mdwd_USDepartmentOfDefenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "USDepartmentOfDefenseMember",
     "presentation": [
      "http://mediwound.com/role/GENERALTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U S Department Of Defense [Member]",
        "label": "U S Department Of Defense [Member]",
        "terseLabel": "U.S. Department of Defense (DoD) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "mdwd_USFoodAndDrugAdministrationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://mediwound.com/20230630",
     "localname": "USFoodAndDrugAdministrationMember",
     "presentation": [
      "http://mediwound.com/role/GENERALTextual"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.S. Food and Drug Administration.",
        "label": "U S Food And Drug Administration [Member]",
        "terseLabel": "U.S. Food and Drug Administration (FDA) [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_WeightedAverageShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full",
     "localname": "WeightedAverageShares",
     "presentation": [
      "http://mediwound.com/role/CondensedInterimConsolidatedStatementsOfComprehensiveIncomeLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average number of ordinary shares used in calculating basic earnings per share",
        "terseLabel": "Number of shares used in calculating basic net loss per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "106",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_a&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_d_i&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_d_iii&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "106",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_35&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "51",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_51&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "54",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_a&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "54",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_b&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "54",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_c&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "54",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_g&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "54",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_i&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "69",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_69&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "79",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_a_i&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "79",
   "Subparagraph": "a",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_a_iii&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "79",
   "Subparagraph": "a",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_a_iv&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_a&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "79",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "81A",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81A_a&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "81A",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81A_c&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "82",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_82_a&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "82",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_82_b&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "82",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_82_d&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "92",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_92&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "99",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_99&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "10",
   "IssueDate": "2022-03-24",
   "Paragraph": "21",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2022-en-r&anchor=para_21&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "10",
   "IssueDate": "2022-03-24",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS10_g17-22_IAS10_g17-22_TI",
   "URIDate": "2022-03-24"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2022-03-24",
   "Paragraph": "79",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2022-03-24",
   "Paragraph": "81",
   "Subparagraph": "c",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_c_i&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2022-03-24",
   "Paragraph": "81",
   "Subparagraph": "c",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_c_ii&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2022-03-24",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "2",
   "IssueDate": "2022-03-24",
   "Paragraph": "36",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2022-en-r&anchor=para_36_a&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "2",
   "IssueDate": "2022-03-24",
   "Paragraph": "36",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2022-en-r&anchor=para_36_b&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "20",
   "IssueDate": "2022-03-24",
   "Paragraph": "39",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2022-en-r&anchor=para_39_a&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2022-03-24",
   "Paragraph": "52",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2022-en-r&anchor=para_52_a&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2022-03-24",
   "Paragraph": "19",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_19&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "26",
   "IssueDate": "2022-03-24",
   "Paragraph": "35",
   "Subparagraph": "b",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2022-en-r&anchor=para_35_b_vii&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "26",
   "IssueDate": "2022-03-24",
   "Paragraph": "35",
   "Subparagraph": "b",
   "Clause": "viii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2022-en-r&anchor=para_35_b_viii&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2022-03-24",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_16_b&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2022-03-24",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2022-03-24",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2022-03-24",
   "Paragraph": "67",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&anchor=para_67&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2022-03-24",
   "Paragraph": "70",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&anchor=para_70_b&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2022-03-24",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_118_e&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2022-03-24",
   "Paragraph": "126",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2022-03-24",
   "Paragraph": "76",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2022-en-r&anchor=para_76&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2022-03-24",
   "Paragraph": "79",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2022-en-r&anchor=para_79_d&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2022-03-24",
   "Paragraph": "10",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2022-03-24",
   "Paragraph": "18",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_18_b&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2022-03-24",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2022-03-24",
   "Paragraph": "25",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2022-03-24",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2022-03-24",
   "Paragraph": "31",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2022-03-24",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2022-03-24",
   "Paragraph": "46",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_46&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2022-03-24",
   "Paragraph": "50",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_50_d&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "24",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_24_b&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "32",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_32_a_i&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "32",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_32_a_ii&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2022-03-24",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2022-03-24",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2022-03-24",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2022-03-24",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2022-03-24",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "ix",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2022-03-24",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2022-03-24",
   "Paragraph": "B13",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2022-03-24",
   "Paragraph": "B13",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2022-03-24",
   "Paragraph": "B4",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B4_d&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2022-03-24",
   "Paragraph": "93",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93_a&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2022-03-24",
   "Paragraph": "93",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93_b&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2022-03-24",
   "Paragraph": "93",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93_e&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "14",
   "IssueDate": "2022-03-24",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2022-en-r&anchor=para_33_b&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2022-03-24",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2022-03-24",
   "Paragraph": "53",
   "Subparagraph": "j",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_53_j&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2022-03-24",
   "Paragraph": "57",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_57&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2022-03-24",
   "Paragraph": "45",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_a&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2022-03-24",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_b_ii&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2022-03-24",
   "Paragraph": "45",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_d&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2022-03-24",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2022-03-24",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2022-03-24",
   "Paragraph": "51",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_51_a&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "5",
   "IssueDate": "2022-03-24",
   "Paragraph": "33",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2022-en-r&anchor=para_33_b_i&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "5",
   "IssueDate": "2022-03-24",
   "Paragraph": "33",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2022-en-r&anchor=para_33_c&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2022-03-24",
   "Paragraph": "23",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23_a&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2022-03-24",
   "Paragraph": "23",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23_h&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2022-03-24",
   "Paragraph": "23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2022-03-24",
   "Paragraph": "28",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_a&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2022-03-24",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2022-03-24",
   "Paragraph": "28",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_c&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2022-03-24",
   "Paragraph": "28",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_d&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2022-03-24",
   "Paragraph": "32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2022-03-24",
   "Paragraph": "33",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_33_a&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2022-03-24",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "9",
   "IssueDate": "2022-03-24",
   "Paragraph": "6.5.16",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2022-en-r&anchor=para_6.5.16&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2023-01-01",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2022-03-24",
   "Paragraph": "120",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_120&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2023-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "117",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_117_b&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2023-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "117",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_117&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "102",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_102&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "108",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_108&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "68",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_68&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "70",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_70&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_b&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "IG6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_IG6&doctype=Implementation%20Guidance",
   "URIDate": "2022-03-24"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "32",
   "IssueDate": "2022-03-24",
   "Paragraph": "IE33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2022-en-r&anchor=para_IE33&doctype=Illustrative%20Examples",
   "URIDate": "2022-03-24"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2022-03-24",
   "Paragraph": "16",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_16_a&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2022-03-24",
   "Paragraph": "17",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_17_a&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2022-03-24",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2022-03-24",
   "Paragraph": "B10",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2022-03-24",
   "Paragraph": "94",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_94&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2022-03-24",
   "Paragraph": "B6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_B6&doctype=Appendix&subtype=B",
   "URIDate": "2022-03-24"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2022-03-24",
   "Paragraph": "IE60",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_IE60&doctype=Illustrative%20Examples",
   "URIDate": "2022-03-24"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2022-03-24",
   "Paragraph": "IE63",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_IE63&doctype=Illustrative%20Examples",
   "URIDate": "2022-03-24"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2022-03-24",
   "Paragraph": "23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2022-03-24",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2023-01-01",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2022-03-24",
   "Paragraph": "113",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_113_b&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective on first application of IFRS 9",
   "Name": "IFRS",
   "Number": "4",
   "IssueDate": "2022-03-24",
   "Paragraph": "39L",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2022-en-b&anchor=para_39L_e&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r123": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_d&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r124": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "112",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_112_c&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r125": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r126": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r127": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "78",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r128": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "85",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_85&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r129": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2022-03-24",
   "Paragraph": "16",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_16&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r130": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2022-03-24",
   "Paragraph": "17",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r131": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2022-03-24",
   "Paragraph": "20",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_20_a&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r132": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2022-03-24",
   "Paragraph": "20",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_20_b&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r133": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2022-03-24",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r134": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2022-03-24",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r135": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2022-03-24",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r136": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2022-03-24",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r137": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Effective 2023-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "117",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_117&doctype=Standard",
   "URIDate": "2022-03-24"
  },
  "r138": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2023-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2022-03-24",
   "Paragraph": "117",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-b&anchor=para_117_b&doctype=Standard&forcepdf=true",
   "URIDate": "2022-03-24"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>31
<FILENAME>0001178913-23-002884-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001178913-23-002884-xbrl.zip
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M:FDDK9ND8M4<?@]GKHB3N$79*^@\KY[G>3N&HW7&/3I%3ZC3#W6N8?<U/F]
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M-8&UR#[5MC=1G6[E-*'JR$@J;D0\T:Z@0F,B/IL;R;F5,HM&NZN=?4!U3@F
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M<%5*]3:B )WA1XKI5?B#CR-K-PS)!$'[O _VN2/1@)<$LF*MEQ#:53.\?;
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MS=UNA5Z7*/29]%R$_G+GY2\S6;J+LG=OIY/).&!QM5H^5<TF#\ZA?ZI!K "
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M6KJKD&LP6"]J16F2 ]-;(5:!'2<.(+>OAUK3ZXL[+]) :17F#4O3)94(MK-
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M1"'689 V'5N'841B]^ N>8.IHY%#0K$9'KYD<*BMOJQKP4OTA.IH0MKH*FV
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M,?R+I?RO.@6A%Q&#%IHM.;]Q'C,.<C=F=2 XM_TQEZ5Z/8VZ:M"&:\QBU T
MAL!"1N+".P R57COB.J8#1OS"!D D&G/MB-M5G_(OE/%J0S:=%=L!!$ $,'%
MC*R?YB$;3_E>)I<VG'B,B$'$'.:\.4Y5*Z]_AFKK+<8,YJJ5)N!_8R&+O7'F
MMO'\QR ,DC3VTN '@^;$0V]XM\/;,RJU.6T>Y"?*_8XS.>:4>K$BQ?5ZC3BO
MVEJWW>%M!!>(0?0NWE4$T#(OUK& KJ:XBFUA1AHX+($8!&[911 N];$=OV=7
MX7&SG88C/0AQH(/ /;NH!_#X3;N*DB74Q&98X, $8A"(Z*(>RA+4\-+\E9;J
MZAVWJVNL;MTQ%^9-.F*QPG*!K+>Q+S9 /ZA,4_N-'EUS-(.XQ-1-R]YH;W2$
M^S(3WAF9OO_U:1IF-ZW&73D,GIA_^A\61R?GI^!*-<$HUX;XK0Z_;8.KQ#E9
M&*Y5."-ITXVY$;4]1&WK=UV9!_* ;??%'D?<=A' N.V^S+]XP+Y;07=?W'<1
MM@C;(YR(QZC+Y3D-G89/HY0,VWYF/=:C?MY%J3=6H@D3WNWPH1EO(@9G,*,B
M(UI*-><P+^)<<.M-=R2:2BG6[P&'(Q"#Z&FD=3=V92[%_=BMPIGHJB;M>.6.
M-J(&Q"!P'RZ"9:E?L<A&7'X.HZD2 _=A<#@",0C<AXOZ&(MLQ.5[%PW5=AKN
MPXC8!3H(Q&Y11^-!2G1I+D:=J";!Q,2CW([MK6  J40"I!8RT*81UZD=TXCK
MU(YIQ'5JQS3B.C5^Q )CJB?GSSJY,HZ2IL]E +$EL0UW*]S#K_;8J8YF\NG6
M-,<DDEKN!X=O\T[=GSE*/L71XS-N+OB]?P1IP))ZXKE*DJW+Z<FYHU*[X>!0
MA<V\ 0K<7UHPMTB/\.FQ=6PH"8@?PX851,@7;&BIKMEPA1 H;(CDA^0'EOS:
MKQO*4@J.4PY+SS%8T*&A:EK# 4LH=(C*(?)C>_BQ?70HR=(X3CLL/6UC08=4
MM6QX!TU0.T3V0_9K-_M)\EQ>:!N7E?BRXBDT&NXD@.R'.3O-WZ"E,5%HTXCK
MU(YIQ'5JQS3B.K5C&G&=L.A!Q:KDIR#TPD'@C94@'$2/V. )BGW<D<!(P;,=
MMJL?U @\%UMVE<EL384-;-5P.GZLHXT8 C&(OI[)VHE;21K'/MQ6TH(<*QJ
MPPN(0>#N6P3%LO2#_=MO%>4,'!U;,H$#$8A!X/9;,%"^?_^MH/,2[K_@  -B
M$(C:@@'> [3FTJH8&%;'85OCP;_.^@RQOU+G*T[#R)^>4:>AV9IUA)_P0Y2D
M-9V7.R>JTW1WZ"-K3 .4BZ;S_)!9JF,6N$2RW7&YC4@J*<;:= ?J.F@$60-9
M ^"^4PJ-[/"<;E=(RG><.B[M/H^@.H+$ G G*H='MCMRM^LCY?MQK:8KTJ(^
M@K2!M%&<-K9[D@N8,:4YD@E1+8K,T863/K#S8^M1 6?.[_!AEC"KO)H[P?^B
M*B%+H<5(,(38X10>7;-UD[B:00S#U.9T_^C_]%=CAK,"Z-<LK<D);JH6AOWA
MP07$(#H7]M^MK3UCE!J6=2Q&*RUEYMH=:372O"C4:^DAE>#V+ZC%U$S+UH_>
M_LMW.1NJ2QLN (';/]!!]'3[-XE-*#EZ^Z^P5I5E6]V :O.B@-L_4DD-5$)U
M[0544F'A)T)4@FS23>=O>ZM<8!F-=DPCKE,[IA'7J1W3B.O4CFG$=<(R3W7[
M%?.:L<HKT87M+\H]X_H]4U+OB7]#F!U8"ZI7QBR0I&K=(AJW;2W7,"1UD0^M
M$;4HB_P^$^\[[ZGNEFFZ:EL=*1D%4)[0V]8;@FH='^UL8;:+CRJ-]-O=B<LU
M+SY(/[VA'P"Q_I?1T>X>8KOUH_+3 UPLY 4/7R &@3K&"PM\%54R*LPG,%1J
M]M'H026C_8- _GEAJ;*#C9P*DA!<U=0[<OB@>0'")(26W*"E01YHTXCKU(YI
MQ'5JQS3B.K5C&G&=X"4A=+^4[!WLC(-F:JD4&!?4>BN5#1V@N[Y LK[.+66-
MZ+;V?=/B=HE+R_#XY3G_'$BSM/\/?/Q!..52.^L$'86UE;YMP3EB+$:';(EL
M">$DTW9RY"RH.>51717%>5L0P.Q9T2LD-B2VOJB!DL#+T6I@^>D=1$=R1#40
MV;)=; F/'*EIN)I3HAI8?DUD YD.U4 D-B2V@XC-T%QJ6578MZ55;;;1P(7&
M;)5%HM;FT2@_RJ2MAYBTQ@Z^YJQWS5)ELGP$MLERY-()K[9"/[^EXD?3^S%K
M?),X;EP #;&"J9;4-G6[U..M#9QJ;;IB[":"T'Q'YH''/*TCFIWG5ALXKFK
MZEU6"=$@KR"O@-R;*N29W0=2ZSJ'2AJN57DDNY2-)$0O:@4O.&G:Q '3AAWO
MJ!8@L2"QE$ L.X^0-G%RU'616;K@U.[]4780@RCY/'T3P56L X-R@W+3DD&@
MW+1NR4 , N6F=4L&8A ]EYOZRKRT^I3S33IB,9^#QTG,1BQ,@A]L=N#YK$[;
M$FL'8(T'7*<63".N4SNF$=>I'=.(ZU1S;1M)9C;HGCN5:'V?HIC?(50&TSAF
MX>"7DL9>F(RS-'[%\\68'_E DR;#"T>O3+51._DY$*B67F5#!Y@2M#L82#5'
MLXFF&0:U;$G.\E<V&'M)$@SY_(IO7RQ0<!-^&'GA [L*_^&-I^QF.(//AQEZ
MWGM)D-QR \KSDVN6W@QK:^=S#BLB6!"RF ^-=-AG.FPD(3)/>3")8VYD0NS*
ML*Z>%BM-T]8;KO=0(4%6G&F)?-,9OH&3D6TX5#=EQXOKT+Y>G*0]#)Z8?_H?
M%D<GYZ?(*\@K/>>5^FE$YT:<05QB&Z;A2,JOU*&M5)@]WG214F059)4>LDI!
MZTB6$%ZK>51!5CFLLRIU$$Y]>2%MB1!A"*H=TXCKU(YIQ'5JQS3B.K5C&G&=
MX+7_:2X?HAYGYEV4>N.UM-CFBK+!L&QA&JT=\9X7/,EL$%T_N!FN)-OAP[)D
MY[4]&RC5YC1<XP1S%3K #2 &T=?FW$?QD23-H!@?55W1#5MS(_VT<A#=UX\J
MI"-9O;>B^E$'"[]!C?@AR%''>%E9N*)*1K7UX6@+.I&BD@$+^B &@?SSPNIQ
M!QLYU921<TPDH"[6E6MO  8C/.V81ERG=DPCKE,[IA'7J1W3B.N$&0AU.SQ%
MD6EEPF(E&7DQ4WPO]6JMR(7V;L\+Z+5QR4 , N6F=4L&8A H-ZU;,A"#0+EI
MW9*!&$3/Y:9$XV5EZ/6TK89FKHC3C /%"WW%#\;3E/E*N-['>LF:.56^W5YB
MNZ<.MWN"D#6=EWRS#$VW#-W8C,==YI+ZT8M#+AJ)L+B_L/A62.BAR=#?^1>_
MS[XYB]!IRQ$ZO6B KF!(DO]_&6G@&6I!/;_VFLI*-@$ZI(P-O9%R05)N)2+S
MUQT4F\Q(EA!-,VV3$BJI['08R>[,\*Z'9%<>2)*J?@AGUO,XY+4MJP/:=<Y$
MBD2*!+G-%E)*"=$=4Y)Y?JA2NB,#_84$4Z4N*LNY/TP9K?"YM==$ZP:?5EQU
M"_FJTRJ=0QW+T5^NTNW(IZ]7I=OV0(>I='4\CO;:[:,9C"H=4B0$D2GF5R2F
MK3D2K]K1)N]FOG\;_(JRHPY'&LD53@!][5)DU(Z<>R@0<(.=0UC)LEQ/'^]9
MK$3#/,J6*-.$^4H0*GSB!E/1W2E\4.ZE@;KQ2K9ATRB $7\NLGE!#>!7-_:V
M^EMTT?=)<B@XK]C+_']F@V3^!9]K[X%E6TYR4!AL_I7%YG1U_>DE+A:=;\LF
ML4W"-V J&7HS0W941VO!3@HU[0CIKKMT5XV[IHBWAF@&-2BQ)?&J0PEN>\RJ
M=();&;JDG4,S0S94PVB!_Q<)#@FNQ_H<U30B*_)RN#ZW+9)4F3XG_C4D?J-F
MANRJNM:"] &D.Z2[_NASFF:ZFFY;)1#<]H!5-?K<CJ$W,V1#M:FLSPT2'!(<
M$EQ3ZANQ=%GZTPNLU;7@477JFVZXFB3FU<R0#=5U9!4%>\9NZ\&E/RV]X7%D
M+=[;$]'9A,C\EBM3=O!5JM DOK(D]40()XV4F W';) JY,SFO_,%2CB;B)YT
MBWC03AG831-[YZ"6![X;,<4;B*X<7OA+!+/"*.6?%B?*^-4"CK.'V!LK$R].
MQ5.G_./BQ3AX%"C,NAEFTS4,0B\<!/RCV?QE[?I>[YB=I3^6?]WY^/.O3N8?
MR:."9]GCSZ=S\ORQI6O-PH=I-!$?GD<39U@2KRS)FX@Q\MF4"^. B8=_NW0]
M^P6LOG<YEW_./[C ^O.NEG]7O,U!SHEMO.)4,#3M9/N%_JQE_ZU\8_DBRY<]
M.?^DG"IT?5D+_"-6^%WV8Q3/[W\?,^]?I]Z03^C9A+/[? O/.4_C##<8,R\6
M5#B:$Z&F_=?;F4R(SH:KC[!!B/,WEI9+$.?Z\C^=*&_F8WP>J63Q%Y*Q^"&5
ML,U;I!N:"[_01/)E(I7/ZB1LY<TE+]3;33$[.?_CX^75/V^^75_F8/M\=_E:
MN;B^5*[N;I7;;^]OKRZO+KY>?;S=(@23U4E>_BF;"CE2"S_[&B$\L\SLE\V5
M/CD76]R[%3*2D<E68CIX"ZO']_<M]*9^($CZ0R32*D0&P]6,PS\L<_CM,W,+
MJL];K28BV2%3HD9\?'P+_.\_.SJQWRH?_ST-TE_YB(1.E__]/=LQ@J>+<#"*
MXI/YVBNO+MDP& 3I[C27ET_?DKJRQ#2',\96RL\R4+QI&LU?R,"<OY+SE] 1
MV3+EF!MR;*[R07X'04)+*I9\KRSB2Y[)Q&]K0O';LE34)'FO;U]S,VP\]N),
MCM)1-$V\T-^E-AVL-+W+E%%EP,;CF9*<Y;.)OX7>._];,O;-&5+RX2M+<_0\
M">LZPIHH+3:H)2E<%L?-3"U_M^Z_V<GW -W]$".CM!OI>VZT:J//9F[6$EMZ
MUW73::=2U@R[9MRH#+Q)D'KCO29AZ2OU,@L/I:16*9G$[#&8/J*4H)1(I636
MSEX9S/K9*VGLA8G(,HU")6;\4S_V)Y*B\/13>"X&@^FC2$EF?A'/), G\',;
M 24<)7Q[!^&6RC;+S&/EE5_$#H8FY.N1@ -L&6X 5P.E:G!3$>SKXA><%)P4
MG!2<E,KH_#'P_3&K_I3@QA;^?"!06S\-J&TMT G'$?K>&WOA@"E>YEF_F,3!
M6"%\*C1](YA6MB)06])1:U*.6I=P!#Q]7-<<S2"N86C$-);/M#N:22R=&JY.
MS._K!^-=8ID:V7C9,0Q#M]<.QANFPV]BKQ^C-PR'VD0WO^N2S.\\'B5-]::4
M?!<?%)\3#02C4,2\;H;Y5RZ>@N3Y[:LDF3+_0^[=_8.)P\"EM"0FCNR\'V@F
MJ,](1LI"RNH\94F.%99#65FHX4L>:2B1L80 N%1VB ]9"UD+6:N.*DD :$M6
M9;(<WOJ:Q[=NAGGBT57X#V\\Y7_.@F(?9C$Q408IN9W$S/.3\NAMJ?*O[%Q+
M^RD.G*17[@%'/D8^[@$?2\X$EL7'J<?G_+GF7B5D:Q/5=F5'I4%S S(N,BXR
M;C_M=EEISMV$6XKY3:E*M3Y9WR_+.5A$J"IFE79>OH3FZ VT1@<T@;@^L"<0
MUP?V!.+ZP)Y 7)^J])%JTF/R&\E+:!?*F*E$E_^2]ZKEBFU6.&#"7XWV)Z>7
M9N\!,#DA&I,],A.):SH+PT]4F[$THIG<3I29<;FXBM8*^RL$UIQ ,@R>F'_Z
M'Q9')^>GS5F!, .N"'0$NASHAN:Z-0&]G+0+Q#E(D $8 N)\%\XMUY$4.Z\"
MY[6F*2 =@,0B@"$@'6S2P3P,9.B6X^@;\1Y3,RWBK 5VS"R29+F;82!JVOKZ
MIY_#0(8L[EX-W505A3]WB864 @7/ (: E-(PI;S04D%2J,R#NS)0R;''%U14
M@.:SO4E'+%9$0=B8C5B8!#]$Q5?^=^659[;E&E17^&Q+:A"_X:Q2QG'-?BO)
M^BDZJ);2+N7,2#<,.]<DIBW)./_*!F,O28(AGT]QT;S$>5:Z\B8L;IA=L_1F
M>.<]H;NW*!";/TZ#;-!7-B":IEENF]B@4SYA) ,D P!D,+?(7,VV#4-JD7&
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M4V\&E+RG5</)344'U30NBVT&AJXO$?;"ZK5M2Y(4_Y4-QEZ2!$,^?>*B%[Y
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M"0P>Q(Q)!.)N(+JNJ4, (B8MMP@=",%R3P[89-.98.BN!@*9??=.(H 1P,<
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M>@:)>%N\.!#IN5-1YR0(#\K-K=)PK5Q<ZT=I]0AL@)7;>P-<IW;< ->I'3?
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MWXLH&%@;I*!!J]NV<80'_6HA674?WB,JL6 0--JH4 #;6D9H7%FS#-,Q2R>
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M*EJMBC"KRZ8Y&!L+T C0"- (T-1!_.]6C+WYK*]O.7'F7;96@XX=S,QS['<
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MZ2A.+,%EI\-E.6ZT4O7"TGQFW7I<)E++#-R<U@RGGI3+"1%=NMC5UYLZKD^
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MORHZH,JO2U=;];@A5]2<UX55&RL+CL_Z<.#UJV']*HJYV^W.:;*^X/2:3-!
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MX=SS\7A$EX%# &74]<R)"6 $L,,WEND@Z<'Z4\N'G8]=Q_/(++!\<VZAP\&
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MP(L<^'URX,,?UG723C2;6%_:(45V*1=V8S_6KBJWN[EWN*3[L3X$,]CV*_P
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MW50 (?3H$P_(A'7^]0/7_DE?N7?W,I@3_=&E+ C++Z'Y8#KSJ>[.]!?RJ^O
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M:]*\L25-0^KDP[]'CO$*_TS]F75-_C]02P,$%     @ 48$/5_44Q2Y@#0
M;GD  !$   !M9'=D+3(P,C,P-C,P+GAS9.T=VW;;-O*]7\'UR[8/LGQILHV/
MDQ[9EK,ZQ[%T?&FS3SD0"4K8D  #@+;4K]\9\"+>1<E.3'7]THC$S&!NF!D
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M82SQ).&[Z[EVLFZK.&Y;R0E=VBBU1>C./BG+<6/H62-M2]P."=[P^5Z5K*W
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MKQ&N,Z9K7(59$2JC;44B:HWS-U%!*4&UQ-@Y\9,L$C>546>@+PF3?P $K5-
M,\XNJ."6>)A*M;"_JL&"97V]//2=C\\=?>(P/VH*&;4-6%DN+TSHK!$A&>Q6
MO(UZ"*+&E_A"^@R"J3.):I\!^M>,1KDQ:HO)=1]D97TJI:YU+F1OYPVK^ =0
M(-@0+[^A*>J@%<JS"/NLCI!^PW#%N&$CMQ:K1KMSF[5B[PXA[PIW/-7#WS^:
MS)?8W!!.:?MH@J$B7D2E,JYJL&-WI!D6BXFK/-29_%1?7Z_^7ITR+9YEF]0
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M/S<TT1#D;BS0$66LQ:>),#JBA(VV_:J I"L*6LF[VN1J8I1NZ*L>1L42-PN
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MQ+[OB!*+3S67,F=1)!%,\GU28@YW"6V*$*2$N_ ;S[#XZ!'["4+'J+YSGO:
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M\\$LV;7I$"XV#F(F3'VQL&*P'A-)SORTGE8^@GXS%J4E*$&KLQ/TFK HA/P
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MDCU4G,U3B/I7*6V&;8U4#@.R@-,=SKFE:S=+VGBL(GG ZPYO+--2:?7;3E%
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M@\\7JLMW5T7"SE .P^J) "IW^ 93<?RBEUQL<>90?OA#H'.(?735'-79A&*
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MW]4(GC_X693=;2CQPX'1<GQ]8 ]W6,T.^NL,PKO6"K9QAP4!BIQ&04["'3)
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MKZJT*M-DQ#7U:2>:UZEEIHGG.W.!?1"8R,7:4(YYK5TG8@X"4J;]F4;RQG'
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M\/CM*^^^R+TDS2$&K".>'QS_#",F'G'=VD/^=GHS^XY-KJO-_$WL!\3.(IG
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MKVK^@V5G&)Y&\BU $OY&HM4#9OL  NFOB.)!DJJDY_.BBL?818\Z5D\Y O7
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M=QM5>3ZEZNM\FJF^-]:"%^$%/I@);8K[. H Y))0:U/-;5B@B ).MYTB7OZ
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MXNQ(6C]=!7LW9;:\H63C\R>M\=8KH(G60$4R*!7BT%!GC6PNNW<L)^9AQU/
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M6/CQ;U'^P![TQA'W(=K,4QX7+]*U'R6 I!='=ZFF1/LO;YAJ,$+^_F__!/^
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M\*]T(DF<N)'/S,[3%EU/OI,M?\Q2Z1P=LG@Q3F90073'YW%9+>6GC&\7VR7
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MDQ(C8%E.$ G4^P<OF;;BV(_#&TYH(=S^%&$&VE,+PTDCP)#0( GT"8]\H,)
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M:&EB:71?.3DM,2YH=&U02P$"% ,4    " !1@0]7\.7AS7F?  !)WPX $
M            @ '_2   97AH:6)I=%\Y.2TR+FAT;5!+ 0(4 Q0    ( %&!
M#U?U%,4N8 T  &YY   1              "  :;H  !M9'=D+3(P,C,P-C,P
M+GAS9%!+ 0(4 Q0    ( %&!#U<6 \+&D0L  *BD   5              "
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FEP$ >FLR,S,P,34R+FAT;5!+!08     "  (  ("  !UI $    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
